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ABSTRACT
Most mammalian cells grown in culture undergo only a limited number of rounds of 
replicative activity. This exhaustion of proliferative capacity is termed replicative 
senescence. There is some evidence that replicative senescence may also occur in vivo, 
and it has been postulated that such cellular ageing may contribute to age-related 
pathologies such as atherosclerosis, and to organismic ageing itself. The aim of this 
thesis is to explore the associations between replicative senescence, organismic ageing 
and atherosclerosis.
It was found that a cytochemical assay, senescence-associated P-galactosidase (SA-p- 
gal), could detect in vitro replicative senescence in human endothelial cells (ECs) and 
rabbit vascular smooth muscle cells (VSMCs).
Endothelial denudation was then undertaken in rabbit carotid arteries, and in some 
experiments repeated six weeks later. Morphometric analysis of SA-p-gal activity 
demonstrated that senescent ECs and VSMCs accumulated in the injured vessel wall, a 
second denudation augmenting this accumulation. Further analysis suggested that 
these senescent cells showed no proliferative or apoptotic activity.
An animal model of accelerated organismic ageing, the senescence-accelerated prone 
mouse (SAM-P), and mice from a related strain showing normal ageing (SAM-R), 
were fed a Western-type diet. Morphometric analysis of lipid deposition in their aortic 
roots demonstrated increased lipid deposition in SAM-P compared with SAM-R mice, 
despite lower serum cholesterol levels in SAM-P mice. Study of telomere lengths and 
SA-p-gal activity showed no evidence of accelerated cellular ageing in SAM-P mice.
It is concluded that cellular ageing can occur in the vasculature, and that a murine 
strain which ages at an accelerated rate shows a greater susceptibility to atherogenesis. 
Since no evidence of accelerated cellular ageing was found in this strain, it is 
postulated that the increased susceptibility of SAM-P mice to atherogenesis, and 
perhaps also their ageing phenotype, may be attributable to other abnormalities in 
these mice, such as increased oxidative status.
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CHAPTER ONE
Introduction
Atherosclerosis is a pathological process which has a variety of clinical 
manifestations, including ischaemic heart disease (IHD), cerebrovascular disease and 
peripheral vascular disease. These conditions appear to be markedly age-related in 
terms of their onset and progression. A number of risk factors have been established 
for atherosclerosis in general, and for IHD in particular; these include hypertension 
[Stokes et al. 1987], diabetes mellitus [Kannel and McGee 1979], hyperlipidaemia 
[Zemel and Sowers 1990], smoking [McGill 1988], family history [Friedlander et al.
1985] and increased age of the subject. Of these factors, ageing shows the strongest 
association with lesion extent and severity [McGill 1984, Clarkson et al. 1987]. 
Ironically, when Leonardo da Vinci suggested a causal link between ageing and 
‘thickening’ of blood vessels, his hypothesis was that it was the pathology of the blood 
vessels which led to ageing, rather than the other way round [cited in Belt 1952].
The aim of this thesis is to explore the relationship between ageing and atherosclerosis 
using two animal models. By way of introduction, this chapter will firstly describe 
some of the cellular processes which occur during atherogenesis. Next various theories 
concerning the aetiology of atherogenesis will be reviewed; in particular, the evidence 
that ageing and atherosclerosis may be causally linked will be discussed. Mechanisms 
previously postulated to underlie ageing will then be considered, together with their 
inter-relationships with those processes thought to underlie atherogenesis. Various 
animal models which have previously been used to study ageing and atherosclerosis 
will be described. Finally the more detailed aims of the thesis will be summarized.
1.1 Mechanisms underlying atherosclerosis
Since the experiments described in this thesis concern the effects of ageing at both an 
organismic and a cellular level on the development of atherosclerosis, it is worth 
considering in some detail the cellular interactions which take place during 
atherogenesis.
1.1.1 The development of the atherosclerotic lesion -  histology
The earliest lesion of atherosclerosis is the fatty streak; fatty streak formation has been 
detected as early as foetal development in utero [Napoli et al. 1997]. Fatty streaks 
contain predominantly macrophages, but also some vascular smooth muscle cells 
(VSMCs) (McGill 1968]. Both cell types in the lesion are laden with lipid.
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The fatty streak subsequently progresses to the fibrous plaque [reviewed by Ross 
1986]. This latter lesion consists of increased numbers of intimal smooth muscle cells 
(SMCs), together with some macrophages, and other leukocytes including activated 
lymphocytes. The plaque cells are surrounded by connective tissue matrix, and the 
lesion contains both intracellular and extracellular lipid. The luminal surface of the 
plaque consists of a fibrous cap, containing modified SMCs. Monocytes become 
attached to this luminal surface, usually near the edge of the plaque. Beneath the 
fibrous cap there may be found necrotic debris, cholesterol crystals and calcification. 
The histological sequence of events involved in fatty streak formation, and the 
subsequent conversion of this lesion into a fibrous plaque, have been studied in detail 
in cholesterol-fed primates [Faggiotto and Ross 1984] and in humans [Ross 1986].
In the non-human primate studies, the first histological change noted after initiation of 
an atherogenic diet was the appearance of clusters of leukocytes (mainly monocytes) 
attached to the arterial luminal surface at scattered sites throughout the vascular tree. 
Some of these monocytes were subsequently found interposed between endothelial 
cells (ECs), and later accumulating in clusters in the subendothelial region. Here the 
monocytes developed into macrophages and accumulated lipid, assuming the 
phenotype of foam cells. At about this time, VSMCs migrated from the media into the 
intima and also became laden with lipid. In primates and humans, VSMCs proliferate 
in the intima, and this proliferation, together with the congregation of foam cells, leads 
to enlargement of the fatty streak. As VSMCs proliferate, they become the 
predominant cell type in the intima, and the lesion develops into a fibrous plaque 
[Faggiotto and Ross 1984, Ross 1986].
Atherosclerotic lesions are considered histologically advanced when their 
accumulation of lipid, cells and matrix components is accompanied by structural 
disorganization and derangement of the vessel wall architecture. Extracellular lipid 
pools increase in size and become confluent, leading to the formation of a well- 
delineated lipid core. The intimal tissue lying between the lipid core and the 
endothelial surface becomes progressively more fibrous, eventually forming the 
fibrous cap [Ross 1986].
At a later stage, microscopic discontinuities emerge in the endothelium, to such an 
extent that the underlying fatty lesion is exposed to blood in the vessel lumen 
[Faggiotto and Ross 1984]. This is followed by the adherence and aggregation of
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platelets, with the resultant development of mural thrombus. In humans, the fibrous 
cap is prone to fissure formation, as it contains predominantly proteoglycans and 
macrophages, and relatively few SMCs [Ross 1986]. Thrombotic encrustations are 
thought to occur repeatedly on the luminal surface of the lesions, successively 
overlying newly accumulating lipid; thrombus may thus become incorporated into the 
plaque, contributing to the structural instability of the lesion and to luminal narrowing 
[Stary et al. 1994]. Subsequent development of haemorrhage into the plaque can result 
in plaque rupture and vessel occlusion.
1.1.2 Cells involved in atherogenesis
1.1.2.1 Endothelial cells
ECs have various properties which influence the onset and progression of 
atherogenesis. They bind low density lipoprotein (LDL) via specific receptors 
[Sawamura et al. 1997], and modify it so that it is more readily recognized and 
ingested by macrophages [Steinberg 1983]. Oxidized lipids in turn induce increased 
expression of adhesion molecules on ECs, promoting leukocyte attachment [Dart and 
Chin-Dusting 1999]. ECs also produce vasoactive substances, growth factors and 
growth inhibitors [Moncada et al. 1977, Castellot et al. 1982, DiCorleto and Bowen- 
Pope 1983]; their production and release of nitric oxide (NO) in particular will be 
discussed later. Some mitotic factors, such as platelet-derived growth factor (PDGF), 
are produced by human ECs if they are proliferating, but not if they are quiescent 
[Barrett et al. 1984].
1.1.2.2 Vascular smooth muscle cells
The migration and proliferation of VSMCs are important elements in the evolution and 
enlargement of fatty streaks and fibrous plaques. VSMCs have other properties which 
appear to be involved in atherogenesis. They can secrete large amounts of connective 
tissue matrix [Burke and Ross 1979] and accumulate lipid via specific receptors for 
LDL [Chait et al. 1980, Pitas 1990]. They express receptors for PDGF [Bowen-Pope 
et al. 1985], and can respond to chemotactic factors released by ECs [Cucina et al. 
2003] and activated macrophages [Goetze et al. 1999]. They also proliferate in 
response to stimulation by interleukin-1 (IL-1) [Libby et al. 1988]. Their resultant 
capacity to proliferate and migrate in response to external stimuli is thought to be 
important in atherogenesis. VSMCs can in turn secrete factors chemotactic for
23
monocytes [Jauchem et al. 1982], and can express the pro-inflammatory mediators 
intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 
(VCAM-1) [Shin etal. 1996].
VSMCs exhibit two alternative phenotypes: they can exist either in a ‘synthetic’ or a 
‘contractile’ state [Chamley-Campbell et al. 1981]. The phenotype of the cells affects 
their ability to respond to mitogens and other stimuli.
1.1.2.3 Monocytes and macrophages
As noted above, an early histological finding in atherogenesis is monocyte adhesion to 
the endothelial surface. Peripheral blood monocytes preferentially adhere to 
regenerating rather than quiescent ECs in vitro [DiCorleto and de la Motte 1985], and 
to injured rather than intact endothelium in vivo [Hansson et al. 1981]. The principle 
mediator of monocyte adhesion and recruitment to the injured vascular wall is thought 
to be monocyte chemotactic protein-1 (MCP-1) [Kraemer 2000]. Macrophages 
themselves produce chemotactic agents, including IL-1 and leukotriene B4 [Martin et 
al. 1984], suggesting that as these cells accumulate in the vessel wall, they are able to 
promote further cellular accumulation.
Macrophages take up lipoproteins via a receptor-mediated mechanism; they possess 
receptors for both native and modified LDL [Brown and Goldstein 1983, Mazzone et 
al. 1983]. They themselves can oxidize LDL [Parthasarathy et al. 1986], rendering it 
more susceptible to uptake [Steinberg et al. 1989]. Other monocyte/macrophage 
functions which may contribute to atherogenesis include phagocytosis and the 
synthesis and release of neutral proteases. Macrophages may also be responsible for 
injuring ECs, bringing about their retraction over the foam cells in fatty streaks [Ross
1986].
1.1.2.4 Platelets
In normal circumstances, platelets are unable to adhere to the arterial endothelium, 
partly because ECs produce anti-thrombotic substances such as NO, prostacyclin and 
heparin [Alheid et al. 1987]. If platelets do come into contact with subendothelial 
connective tissue via breaches in the endothelium, they release the contents of their 
granules [Baumgartner 1972]. These include mitogens such as PDGF [Ross et al 
1974], which can induce both migration [Grotendorst et al. 1982] and proliferation 
[Ross et al. 1974] of VSMCs. The platelet granules also contain adenosine
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diphosphate (ADP) [Mustard and Packham 1975] which can enhance platelet 
deposition.
1.1.2.5 T lymphocytes
T cells constitute approximately one fifth of the cell population of the fibrous cap, and 
are also found in the underlying plaque [Jonasson et al. 1986]. The entry of T cells 
into the intima during atherogenesis appears to be mediated by their binding to ICAM- 
1 [Watanabe and Fan 1998]. T cells are attracted by three chemokines, each inducible 
by interferon-gamma (IFN-y): inducible protein-10, monokine induced by IFN-y, and 
IFN-inducible T-cell a-chemoattractant [Mach et al. 1999]. Intimal T cells may then 
be activated by interaction with antigens including oxidized LDL and heat-shock 
proteins [Libby and Aikawa 2002]. Activated T cells can then induce macrophages to 
release tissue factor, matrix metalloproteinases (MMPs) and pro-inflammatory 
cytokines, leading potentially to the amplification of the inflammatory response. The T 
cells themselves appear to polarize into two types: ThI cells produce predominantly 
pro-inflammatory cytokines, while Th2 cells secrete mainly anti-inflammatory 
cytokines [reviewed in Libby and Aikawa 2002]. In human atherosclerotic plaques, 
the T cell response appears to produce predominantly ThI cells [Frostegard et al. 
1999].
1.1.3 Theories of atherogenesis
Over the years, various theories have attempted to explain the initiation and evolution 
of atherosclerotic lesions. Some of these theories are reviewed below. As will be seen, 
they are not mutually exclusive, and there are areas of overlap between the 
mechanisms proposed.
1.1.3.1 The response-to-injury theory
This theory was originally proposed in the nineteenth century, and has more recently 
been further promoted and modified [Ross and Glomset 1976, Ross 1986]. It suggests 
that the atherogenic process is triggered by an initial disruption to endothelial 
integrity. The nature of the agent causing this disruption has been extensively debated, 
with mechanical injury and chemical insults being putatively implicated. The 
disruption is believed to be followed by an accumulation of platelets and monocytes at 
the injury site, and then by the various other cellular interactions detailed above.
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The response-to-injuiy hypothesis, while remaining a widely prevalent view of the 
aetiology of atherosclerosis, has not gone entirely unchallenged. In particular, it is not 
always possible to demonstrate physical disruption of the endothelium during the early 
stages of atherogenesis [Taylor et al. 1989, Busse and Fleming 1996]. Indeed in the 
primate studies detailed above, monocytes appeared to adhere to an intact endothelium 
[Faggiotto and Ross 1984]. Some authors have taken this as evidence that endothelial 
denudation does not play any part in plaque initiation [Davies and Woolf 1993], but 
suggest that it may occur at a later stage, triggering platelet adhesion.
1.1.3.2 The lipid theory
The lipid theory emphasizes the role of circulating lipid in atherogenesis. The potential 
significance of excess dietary fat in atherogenesis has been recognized for nearly a 
century [Anitschkow 1913]. The lipid theory arose from the observations that 
atherosclerotic lesions are lipid-rich, that animals fed a high-cholesterol diet produce 
lesions similar to human atherosclerotic plaques, and that human populations with 
high plasma lipid levels show a high incidence of atherosclerosis [Woolf 1977]. 
Cholesterol and triglycerides are transported in the circulation in the form of 
lipoproteins, which are spherical particles containing cholesteryl ester and triglyceride, 
with an outer surface made up of apo-proteins and phospholipids. Up to seventy 
percent of circulating cholesterol in humans is transported as LDL. This LDL can 
either be taken up by peripheral tissues (when demand is high, via up-regulation of 
peripheral LDL receptors), or be cleared by the liver.
It has been proposed that the earliest event in the development of the fatty streak is the 
transport of LDL into the arterial wall [Navab et al. 1996]. This is a concentration- 
dependent process not requiring receptor-mediated endocytosis [Steinberg et al. 1989].
1.1.3.3 The role of oxidative stress
Atherogenesis is thought to be promoted by peroxidation of lipids by oxidative stress 
[Witztum and Steinberg 1991]. Native LDL is not taken up efficiently by macrophages 
in vitro [Weinstein et al. 1976]; prior to uptake, it must first be modified. One such 
modification involves the progressive oxidation of native LDL to generate a series of 
forms of LDL termed oxidized LDL (OxLDL) [Witztum 1994]. OxLDL is found in 
human atherosclerotic lesions, but not in normal arterial tissue [Palinski et al. 1989, 
Yla-Herttuala et al. 1989].
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OxLDL has a variety of other properties which render it more atherogenic than native 
LDL [Steinberg et al. 1989], and these will be discussed in detail below. Among these, 
its cytotoxic capability may contribute to the EC retraction (mentioned earlier) which 
appears to precede platelet adherence and thrombus formation [Steinberg et al. 1989]. 
There is thus a degree of overlap between the response-to-injury and lipid theories of 
atherosclerosis, and the postulated involvement of oxidative stress.
1.1.3.4 The role of hypoxia
Hypoxia of die arterial wall has also been implicated in atherogenesis by several 
investigators [Hueper 1944, Kjeldsen et al. 1968, Martin et al. 1991]. Inhalation of 
low oxygen concentrations promoted the development of atherosclerotic lesions in 
cholesterol-fed rabbits [Kjeldsen et al. 1968]. Similarly, when LDL-receptor-deficient 
rabbits were exposed to either hyperoxic or hypoxic conditions, hypoxic animals 
developed significantly more severe atheromatous lesions than did those exposed to 
hyperoxia, despite there being no difference in plasma cholesterol levels between the 
two groups [Okamoto et al. 1983]. Hypoxia can lead to increased expression of PDGF 
and acyl CoAxholesterol acyltransferase (ACAT) in the arterial wall, and this has 
been put forward as a potential mechanism by which localized hypoxia might promote 
atherogenesis [Martin et al. 1991].
At first sight the notion that hypoxia is pro-atherogenic appears to gainsay the theory 
that oxidative stress is important in the aetiology of atherosclerosis. It is possible, 
though, that while a generalized increase in oxidative stress in the vessel wall 
promotes atherogenesis (for example via its modification of LDL to OxLDL), more 
focal (perhaps microscopic) regions of the vessel wall may become hypoxic (for 
example through occlusion of the vasa vasorum) leading to a localized release of 
PDGF and ACAT.
1.1.3.5 Foetal and infant nutrition
Barker et al. have proposed that factors in foetal life and infancy determine, to a 
significant extent, an adult’s subsequent risk of developing cardiovascular disease 
[Barker and Osmond 1986, Barker et al. 1989]. They suggested that the foetus’ 
nourishment could ‘programme’ the development of risk factors such as hypertension, 
diabetes mellitus and hypercholesterolaemia. This proposition, though, was based 
entirely on epidemiological data, and no mechanistic explanation was offered. The
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theory has subsequently been widely challenged [Elford et al. 1991, Paneth and Susser
1995].
1.1.3.6 Monoclonal origin of vascular smooth muscle cells
Evidence has been found that the VSMCs contained within the mature atherosclerotic 
plaque are monotypic [Benditt and Benditt 1973]. This has led to the theory that the 
plaque could represent a clonal expansion of the VSMCs in the lesion, and this theory 
has been supported by other research [Pearson et al. 1975]. While clonal expansion of 
VSMCs may indeed occur, the theory offers no explanation for the trigger which 
initiates the atherogenic process; nor does it tie in all the cellular and molecular 
interactions involved in atherogenesis.
1.1.3.7 Atherogenesis as an inflammatory process
As early as the 1950s, it was noted that inflammatory cells were present in 
experimentally induced atheromatous lesions [Poole and Florey 1958]. The 
proposition that atherosclerosis should be regarded as an inflammatory process has 
achieved increasing prominence over the last few years [Libby 2002]. Leukocyte 
recruitment and pro-inflammatory cytokine expression are prominent features of early 
atherogenesis. Pro-inflammatory agents such as tumour necrosis factor (TNF) are also 
atherogenic [Hansson et al. 1989]. Atherosclerotic plaques have been shown to 
contain deposits of immunoglobulins (Igs) [Hollander et al. 1979], and end-products 
of the complement cascade [Vlaicu et al. 1985].
OxLDL is itself pro-inflammatory [Lipton et al. 1995] and its recognition by T cells 
can trigger expression of further inflammatory molecules by these lymphocytes [Libby 
2002]. Statins, which have been used in clinical practice predominantly for their 
cholesterol-lowering effect, are now thought to play a role in improving atheromatous 
plaque stability [Libby and Aikawa 2002], and have been shown to reduce the degree 
of inflammation in atheromatous lesions, independently of their lipid-lowering effect 
[Sukhova et al. 2002].
1.1.3.8 Putative role of viruses
Various viruses have been implicated in atherogenesis. Herpes simplex virus can alter 
the metabolism of cellular cholesterol, activate clotting cascades, and induce the 
infected endothelium to express a receptor for monocytes [Hajjar 1991]. Meanwhile, 
deliberate infection of chickens with Marek’s disease herpes virus induces the
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formation of atheroma-like lesions in the coronary arteries and aorta [Fabricant et al. 
1983]. Furthermore, in heart transplant recipients, there is a strong correlation between 
cytomegalovirus infection and accelerated atherosclerosis [MacDonald et al. 1989]. 
The role of viral infection in atherosclerosis in otherwise healthy human subjects 
remains debatable, though.
1.1.3.9 Homocysteine
Hyperhomocysteinaemia is generally recognized as a risk factor for atherosclerotic 
disease in the coronary, cerebral and peripheral vasculature [Refsum et al. 1998, 
Mangoni et al. 2002]. A causal relationship between hyperhomocysteinaemia and 
atherogenesis remains to be proven, though. Indeed, the most common inherited form 
of hyperhomocysteinaemia is not associated with increased cardiovascular risk 
[Brattstrom et al. 1998]. Exposure of endothelium to homocysteine leads to EC 
dysfunction, and it has been postulated that this effect may trigger and influence the 
progression of atherogenesis [Weiss et al. 2002]. Hyperhomocysteinaemia increases 
expression of tumour necrosis factor-alpha (TNF-a) in coronary arteries, enhancing 
oxidative stress in the vessel wall via up-regulation of inducible NO synthase [Ungvari 
et al. 2003]; this could have pro-inflammatoiy and pro-atherogenic effects.
1.2 Ageing as a risk factor for atherosclerosis
This section explores the inter-relationship between ageing and atherosclerosis. In 
particular it addresses the question of whether atherosclerosis can be regarded as an 
intrinsic part of the ageing process, or whether ageing is simply a risk factor (either 
independent or otherwise) for atheroma formation. It begins, though, with an outline 
of the age-related changes which occur in the arterial wall, even in the absence of 
atherosclerosis.
1.2.1 Physiological changes in the arterial wall with increasing age
Certain changes occur in non-atherosclerotic arteries with increasing age [Bilato and 
Crow 1996]. These changes may be regarded as ‘physiological’; some begin while the 
organism is still comparatively young (for example during the second and third decade 
of life in humans) [McGill et al. 1963].
Some of the age-related changes are histological in nature: the total vessel diameter
increases, and the intima and media become thickened, partly through the
accumulation of extracellular matrix. Elastin tissue content declines (from the age of
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thirty years in human coronary arteries [Ahmed 1970]), while collagen becomes more 
prevalent [Johnson et al. 2001a].
Functional changes in the ageing artery include a deterioration in EC function 
[Celermajer et al. 1994], as demonstrated by a decline in endothelium-dependent 
vasodilation [Gerhard et al. 1996]. A decline in synthesis of endothelial NO by 
systemic arteries with age [Tschudi et al. 1996] may have a significant effect on 
peripheral vascular resistance and therefore on the evolution of hypertension [Luscher 
etal. 1992].
Other age-related changes include increased permeability of the endothelium, and an 
increased ability of SMCs to migrate towards chemoattractants [Bilato and Crow
1996]. The expression of certain vasoactive substances, such as endothelin-1, and of 
the pro-atherogenic inducible nitric oxide synthase isoform II, rises in ageing arteries 
in vivo [Goettsch et al. 2001]. Furthermore, with age, expression of adhesion 
molecules and cytokines is increased in ECs, contributing to vascular inflammation 
[Lusis 2000]. In addition, so-called ‘advanced glycation end-products’ (AGEs) 
progressively accumulate with age [Brownlee 1995] as will be discussed in more 
detail below.
1.2.2 Evidence for ageing as a risk factor for atherosclerosis
As mentioned earlier, ageing appears to be a strong risk factor for atherosclerosis. 
Epidemiological studies show a clear age-dependence of deaths due to atherosclerotic 
disease (including IHD, renovascular and cerebrovascular disease) [Kohn 1977]. The 
risk of death from IHD, for example, rises approximately one hundred-fold between 
the ages of forty and eighty years [Stationary Office 1996]. Study of mortality data for 
various clinical pathologies confirms the age-dependence of deaths attributable to 
atherosclerosis: when all-cause death rates are plotted as a function of age in a semi­
log plot, the resultant curve follows an approximately straight line, reflecting the fact 
that the probability of dying (from any cause) doubles about every eight years after 
maturity; in contrast, the curve for deaths attributable to atherosclerosis (including 
IHD) rises more steeply than the all-cause curve, suggesting that these deaths are age- 
dependent [Kohn 1977].
While mortality data can give a misleading impression of a disease’s age-dependence, 
early clinical and autopsy studies have confirmed an increase in the severity and
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prevalence of atherosclerosis with age [Strong and McGill 1962, Heath et al. 1973, 
Zhdanov et al. 1973, Vikhert and Zhdanov 1975].
Atherosclerosis is not a universal process; most mammalian species and some human 
populations age without developing atheromatous lesions [Bierman 1973]. This lack 
of universality suggests that we should regard atherosclerosis not as an intrinsic part of 
the ageing process (as some have suggested) but as a disease which may be 
exacerbated by basic mechanisms underlying ageing [Kohn 1977].
1.2.3 Ageing as an independent risk factor for atherosclerosis
Atherosclerosis involves a whole panoply of cellular and molecular interactions, and 
these appear to occur on the background of the ‘physiological’ changes in the ageing 
arterial wall described above.
In considering whether ageing is an independent risk factor for atherosclerosis, it is 
necessary to appreciate that simply by ageing, an individual may be exposed to certain 
established risk factors for a longer period of time, perhaps resulting in an 
accumulation of damage caused by those factors. For example, correlations have been 
demonstrated between the severity of atherosclerotic lesion formation and the duration 
of hypercholesterolaemia [Schmidt et al. 1996] and with the number of cigarette pack- 
years [Whisnant et al. 1990].
Furthermore, any disease process which is multifactorial in aetiology will tend to 
become more prevalent and more severe with age, even if there is no direct 
mechanism by which ageing itself contributes to either the disease or the risk factors 
[Bierman 1973]; this is because, with time, the chance of each risk factor emerging 
will increase, and the number of interactions between the various risk factors will 
naturally rise. In the case of atherosclerosis, the situation is further complicated by the 
fact that several of its acknowledged risk factors (in particular hypertension, 
hyperglycaemia and hypercholesterolaemia) are themselves age-related.
While accepting the above considerations, there is also evidence to suggest that ageing 
may exert an independent risk on atherosclerosis. Clinical and pathological studies 
suggest that the commonly accepted risk factors for atherosclerosis (excluding ageing) 
account for only a fraction of the increase in cardiovascular disease with age: they 
account for approximately half of the increase in incidence of clinical events 
[Goldbourt and Neufeld 1986], and about a fifth of the rise in atherosclerotic lesion 
extent and severity as detected at autopsy [Holme et al. 1981]. This would suggest
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either that there remain other risk factors as yet unidentified, or that age itself is 
contributing to the increased risk and severity of disease.
There is further evidence to suggest that ageing may be an independent risk factor for 
atherosclerosis. For example, generalized atherosclerosis is a feature of premature 
ageing syndromes such as progeria (Hutchinson-Gilford syndrome) [Baker et al. 
1981], and Werner’s syndrome [Epstein et al. 1966]. Similarly, patients with diabetes 
mellitus (which has been thought of as a disease of accelerated ageing [Kent 1976]) 
have an earlier onset and more rapid progression of atherosclerosis than non-diabetic 
subjects [Kohn 1978]. In contrast, though, another syndrome which involves at least 
some features of premature ageing, dyskeratosis congenita (DKC), is not associated 
with an increased risk of atherosclerosis [Marciniak et al. 2000].
One method which has been used to investigate the independence of ageing as a risk 
factor for atherosclerosis involves feeding an atherogenic diet, for a specified period of 
time, to young and old individuals, and then comparing the effects of this diet in the 
two groups. For example, Orlandi et al. fed a 0.2% cholesterol diet for two months to 
young (two-month old) and old (five- to six-year old) rabbits, and compared the extent 
of atherogenesis in the aortas of each group. [Orlandi et al. 2000]. Fatty streaks were 
more extensive in the aortas from the older rabbits, even though there was no 
difference in the lipid profiles between the young and old animals.
Likewise, administration of a high-fat diet to young and old Cynomolgus monkeys, 
produced differing degrees of atherogenesis despite similar lipid profiles in the two 
groups [Weingand et al. 1986]. While young animals developed only fatty streaks, the 
older group formed more advanced atherosclerotic plaques. Cynomolgus monkeys are 
considered to be one of the most accurate primate models of human atherosclerosis, 
because of the morphological similarities between their diet-induced lesions and those 
of man, and also because of their relatively high rate of myocardial infarction [Staiy 
and Malinow 1982].
Similar results, showing more severe diet-induced atherosclerosis in older compared 
with younger animals, have been reported in other species, including squirrel monkeys 
[Clarkson et al. 1976] and pigeons [Yost and Herman 1988].
Such evidence suggests that ageing can be regarded as an independent risk factor for 
atherosclerosis, and the question remains as to how this influence may be exerted. In 
order to explore whether mechanisms exist through which ageing can directly
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influence atherosclerosis, it is necessary to consider in some detail the processes 
believed to underlie ageing, and to determine which of these processes are also 
involved in atherogenesis.
It has been proposed that organisms may age owing to a trade-off between the 
evolutionary necessity to produce germ-line cells with extreme accuracy, and the 
possibility of producing somatic cells with less stringency [Toussaint et al. 2000b]; 
since the somatic cells are produced less stringently (thus saving ‘energy’), they are 
more prone than germ-line cells to mutation and to other cumulative molecular 
damage, such as that resulting from oxidative stress.
In a similar and related teleological argument, it has been suggested that as the 
organism is primarily ‘designed* (from a Darwinian point of view) to survive long
enough to reproduce, ageing may simply result from an in-built redundancy in the
design: the organism does not need to survive beyond the reproductive period, and 
evolutionary energy is not expended in the attempt. One could therefore view ageing 
as a passive consequence of this conservation of evolutionary energy [Cristofalo 
2001]. As will be seen in the following paragraphs, though, there are a multitude of 
theories which have instead attempted to explain ageing in terms of an active process 
dependent on various biological mechanisms.
Theories concerning ageing therefore broadly divide into those which concentrate on 
various intrinsic processes believed to take place within the ageing organism 
(‘developmental-genetic’ theories), and those which regard ageing as the result of an 
accumulation of damage from extrinsic insults (‘stochastic’ theories) [Cristofalo et al
1994]. Another possibility is that ageing results from a combination of intrinsic 
processes and extrinsic insults.
1.3 Mechanisms underlying the ageing process
13.1 Developmental-genetic theories
According to these theories, organismic ageing is the consequence of genetically 
programmed and controlled cellular processes which are fundamental to organismic 
development and maturation. A genetic element in the determination of ageing is 
suggested by the fact that an organism’s maximum life-span potential (MLSP) appears 
to be a species characteristic, and that there is a greater than one hundred thousand­
fold variation in MLSPs between species [Brown 1985]. Further evidence for genetic
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control comes from studies involving monozygotic and dizygotic twins, and non-twin 
siblings. Monozygotic twins show a marked similarity in their life-spans, to an extent 
not matched by dizygotic twins or non-twin siblings [Jarvik et al. I960].
One criticism of developmental-genetic theories is the observation that while 
organismic development is a tightly controlled, precise process, the ageing phenotype 
involves a diverse array of deteriorative changes, and it is difficult to reconcile such a 
contrast.
Developmental-genetic theories include the neuroendocrine, immunological and 
replicative senescence theories of ageing.
1.3.1.1 The neuroendocrine theory
This theory attributes ageing to progressive functional decrements in the 
neuroendocrine system, in particular in the hypothalamic-pituitary-adrenal axis [Finch 
and Landfield 1985]. One example is the decline in the female reproductive system 
with age, and its associated systemic pathological effects. Similarly alterations in 
insulin-sensitivity and growth hormone production may be relevant to the ageing 
phenotype. Thus, for example, mutations of genes affecting the production of growth 
hormone and insulin-like growth factor-1 (IGF-1) extend murine life-span [Flurkey et 
al. 2001].
1.3.1.2 The immunological theory
This theory was originally proposed in 1969 [Walford 1969]. It had been observed that 
the functional capacity of the immune system declines with age [Pisciotta et al. 1967], 
and these early observations have been supported by later research showing, for 
example, a decreased response of T cells to mitogens with increasing organismic age 
[Staiano-Coico et al. 1984]. The theory suggested that ageing might, at least in part, 
result from this functional decline (while it was granted that the functional decline 
might also result from the ageing process). Genetic studies have shown that the 
MLSPs of various murine strains are related to the expression of specific alleles in the 
major histocompatibility gene complex [Smith and Walford 1977], suggesting an 
element of immunogenetic programming in the determination of MLSPs.
Both the immunological and the neuroendocrine theories have been criticized on the 
grounds that less sophisticated organisms, which do not possess complex control and
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defence systems, nevertheless do share several aspects of the ageing phenotype with 
more advanced organisms.
1.3.1.3 Replicative senescence
The in vitro phenomenon of cellular replicative senescence, in which cells grown in 
culture lose their replicative potential, will be discussed in detail below. As will be 
seen, replicative senescence may also occur in vivo, and there is some evidence to 
suggest that this cellular process may contribute to ageing of the entire organism.
1.3.2 Stochastic theories
Stochastic theories suggest that organismic ageing results from the progressive 
accumulation of random damage to vital molecules within the cells of an organism. 
Such damage might cause sufficient cellular dysfunction to bring about the 
pathological features associated with ageing. Both actively dividing cells and post­
mitotic tissues, such as muscle, nerve and fat cells, could be affected by stochastic 
damage.
1.3.2.1 The somatic mutation theory
According to this theory, the source of damage to cells is proposed to be background 
radiation. As early as 1959 it was postulated that since high doses of radiation can 
induce mutations and shorten organismic life-spans, mutations caused by background 
levels of radiation may contribute to normal human ageing [Szilard 1959]. Studies of 
survival curves of radiation-treated rodents suggested that at the doses used, ionizing 
radiation caused an initial rise in mortality, but did not affect the subsequent rate of 
ageing [Sacher 1977]. Thus the life-shortening effect of radiation is probably not due 
to accelerated ageing but to radiation-induced disease.
1.3.2.2 The deoxyribonucleic acid repair theory
This theory, which is related to the somatic mutation theory, attributes ageing to a 
failure in the normal function of deoxyribonucleic acid (DNA). There may be a failure 
of DNA repair mechanisms to mend damage caused from a variety of stochastic 
environmental insults. For example, in one study the ability to repair ultraviolet (UV) 
radiation-induced DNA damage in cell cultures derived from various species showed a 
positive correlation with their MLSPs [Hart and Setlow 1974].
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1.3.2.3 The error-catastrophe theory
It has been suggested that random errors in protein synthesis may affect those proteins 
which synthesize DNA and other template molecules; mis-encoded and mis- 
synthesized proteins would then arise, leading to a magnified knock-on effect [Orgel 
1963]. This multiplication of errors could then lead to the development of age- 
associated pathology.
1.3.2.4 Protein cross-linking and advanced glycation end-products
It has been proposed that when certain post-translational proteins undergo cross- 
linking, as occurs progressively with age, the function of these molecules is impaired 
[Kohn 1978]. A particular case of cross-linking involves the process of glycation, the 
non-enzymatic reaction of glucose with amino groups of proteins. Glycation can lead 
to the cross-linking of macromolecules such as collagen and osteocalcin, and so to the 
age-related formation of AGEs (mentioned above in Section 1.2.1) [Brownlee 1995]. 
AGEs may in turn contribute to age-related pathologies including atherosclerosis. 
They are capable of triggering the expression of VCAM-1 by ECs [Schmidt et al.
1995], as well as trans-endothelial migration of monocytes [Schmidt et al. 1993] and 
SMC chemotaxis [Higashi et al. 1997]. When rabbits are injected with AGE-modified 
rabbit serum albumin, their ascending aortas develop atheromatous lesions [Vlassara 
et al. 1995]. In addition, AGEs on the surface of diabetic erythrocytes can bind to the 
endothelium, and lead to an increase in oxidative stress in the vessel wall, and this 
mechanism may underlie some aspects of diabetic vascular complications [Wautier et 
al. 1994]. More recently it has been shown that human ECs grown on glycated 
collagen show several phenotypic features of premature senescence (a phenomenon 
discussed in detail below) [Chen et al. 2002].
As for the cross-linking theory in general, though, the situation is complicated by the 
finding that while increased cross-linking leads to impaired cellular and tissue function 
at some sites, it leads to improved function at others [Hall 1976].
1.3.2.5 The role of mitochondrial dysfunction
Mitochondrial function declines with age [Beckman and Ames 1998a], and 
mitochondrial decay appears to play a significant role in the ageing process [Hagen et 
al. 1997]. It has been postulated that ageing may be due to the reactive oxygen species 
(ROS) produced by mitochondria in the electron transport chain, during normal
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aerobic metabolism [Miquel et al. 1980, Beckman and Ames 1998b]. The term ‘ROS’ 
refers both to non-radical derivatives of oxygen such as hydrogen peroxide, and to 
oxygen-centred radicals such as superoxide ions. ROS not only ‘attack’ cellular 
proteins, but are also harmful to the cells’ DNA (including mitochondrial DNA); they 
are also able to modify lipids, and the significance of this process for atherogenesis 
has been mentioned earlier.
Deletion mutations of the mitochondrial genome accumulate with age, and in animal 
studies the bioenergetic capacity of mitochondria declines [Cortopassi and Wong
1999], alongside an age-related increase in activation of the mitochondrial 
permeability transition pore [Mather et al. 2000]. When mitochondrial function is 
ameliorated by feeding the mitochondrial co-enzyme (R)-a-lipoic acid to aged rats, the 
intracellular build-up of oxidants is reduced, and the age-associated increase in cellular 
susceptibility to oxidative stress is reversed [Hagen et al. 1999, Hagen et al. 2000]. It 
is noteworthy that caloric restriction, a dietary regimen known to prolong life-span in 
animals, maintains mitochondrial function and lowers oxidant production [Merry
2000].
1.3.2.6 The role of free radicals and oxidative stress
Perhaps most prominent among the stochastic theories of ageing is the free radical 
theory, which was brought to prominence by Harman [Harman 1956, Harman 1981]. 
According to this theory, damage is caused to the organism’s macromolecules by free 
radicals -  atoms or molecules containing one or more unpaired electrons -  including 
certain ROS and reactive nitrogen species. This damage was proposed to be the 
principle driving force for ageing. The mechanism of such damage is discussed in 
more detail below.
It is probable that different mechanisms of ageing operate in different tissues in the 
body. The heart, for example, may be particularly prone to damage caused by a 
decline in mitochondrial function: the myocardium is dependent on (3-oxidation of 
fatty acids for energy, and the post-mitotic nature of cardiac myocytes would be 
expected to allow for greater accumulation of mitochondrial mutations and deletions 
[Hagen et al. 2002].
Among the various theories concerning the aetiology of ageing, two processes in 
particular warrant more detailed discussion given their potential relevance to
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atherosclerosis. The mechanisms of replicative senescence and oxidative stress, and 
their relevance to ageing and to vascular pathology, are described in the following 
sections.
1.4 Replicative Senescence
1.4.1 Normal regulation of the mammalian cell cycle
Proliferating cells are usually driven through various check-points in the cell cycle by 
the activity of certain kinases which act by phosphorylating specific protein substrates. 
The activity of these kinases is dependent on their association with specific proteins 
called cyclins, and thus the kinases are referred to as cyclin-dependent kinases (Cdks) 
[Nigg 1995]. Their activity is modulated by the action of certain Cdk inhibitors [Peter
1997].
The Gj check-point seems to be particularly important in controlling progression 
through the cell cycle. Mammalian cells reach a ‘restriction point’ during Gj: prior to 
this point they require the presence of growth factors in order to progress through the 
cell cycle; after it they can continue through the remainder of the cycle without further 
external stimulation.
The retinoblastoma (RB) gene product, pRb, which plays an important role as a 
tumour-suppressor protein, is involved in the control of transition from Gi to S phase 
(Gi/S transition) [Weinberg 1995, Dyson 1998]. During Gi, E2F transcription factors 
are bound to pRb, preventing them from binding to DNA and initiating gene 
transcription. Towards the end of Gi, the pRb subunit of the pRb-E2F complex is 
phosphorylated by cyclin-Cdk complexes [Buchkovich et al. 1989, Sherr 1996, 
Wagner et al. 2001]. The phosphorylated pRb releases its bound E2F, allowing the 
transcription factor to activate gene expression, contributing to the irreversible entry 
into S phase.
The level of another tumour-suppressor protein, p53, is usually very low as cells pass 
through Gi. However, if a cell suffers DNA damage, the level of p53 rises 
dramatically [Vaziri et al. 1997]. p53 then activates the gene which encodes the Cdk 
inhibitor p21. High levels of p21 in turn lead to activation (via hypophosphorylation) 
of pRb, which sequesters E2F transcription factors, and so arrests progression through 
the Gi check-point. In this way the replication of DNA-damaged cells is halted.
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Various mechanisms leading to cell cycle arrest, and the role of other Cdk inhibitors 
including p i6, will be discussed below.
1.4.2 The phenomenon of replicative senescence
The concept of cellular ageing has arisen from studies of cells grown in culture. In the 
early days of in vitro cell culture, it was thought that cells from vertebrate species 
could undergo an indefinite number of replicative cycles. This theory had arisen from 
research which appeared to show indefinite subculture of chick cells [Carrel 1912], but 
this work has subsequently not proved to be reproducible.
Hayflick and Moorhead showed in the early 1960s that when normal human diploid 
fibroblasts (HDFs) were grown in culture, they underwent only a limited degree of 
proliferation [Hayflick and Moorhead 1961]; with continual subculture they gradually 
and inevitably lost their ability to proliferate [Hayflick 1965]. As their replicative 
capacity was exhausted, and the cells entered a terminally non-dividing state, they 
were said to undergo ‘replicative senescence’ [Hayflick and Moorhead 1961, Hayflick 
1965]. This property has subsequently been shown to pertain to a variety of human 
cell types grown in culture [Hayflick and Moorhead 1961, Hayflick 1965, Tassin et al. 
1979, Thornton et al. 1983, Effros and Walford 1984] as well as to cells from other 
species [Rohme 1981, Stanulis-Praeger 1987]. Replicative senescence is therefore a 
widespread phenomenon, which is thought to have been evolutionarily conserved from 
yeast to mammals [Campisi 2001].
Replicative senescence entails an irreversible arrest of cell proliferation and altered 
cell function. Senescent cells are stably arrested in Gi [Stein and Dulic 1995, Effros
1996], and are unable to enter the S phase despite exposure to physiological mitogens 
[Sherwood et al. 1988]. The cells remain metabolically active, maintaining the ability 
to metabolize and synthesize ribonucleic acid (RNA) and protein. Senescent cells 
usually possess intact DNA replicative machinery, and are able to transduce most 
signals during mitogenic stimulation [Rittling et al. 1986, Goldstein 1990], and yet the 
cells themselves are unable to resume mitotic activity.
There appear to be differences between species in the stringency with which cell 
proliferation is limited by replicative senescence. Thus while rodent fibroblasts often 
‘escape’ senescence and spontaneously immortalize, human fibroblasts from normal 
donors have almost never been reported to immortalize spontaneously [McCormick 
and Maher 1988].
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Only a few higher eukaryotic cell types are thought to be entirely unaffected by 
replicative senescence. Cells of the germline are capable of continuous replication, as 
are the immortal cells found within tumours and transformed cell lines; in addition, it 
has been suggested that some stem cells may not senesce [Campisi 1996].
In cells which do senesce, the onset of senescence is thought to be determined by the 
number of rounds of cell division that have occurred, rather than by the chronological 
age of the cultures [Dell’Orco et al. 1973]. As a result senescent cells accumulate 
gradually in culture, the percentage of senescent cells rising as cultures are serially 
passaged, until eventually all the cells become senescent [Smith and Whitney 1980, 
Dimrie/fl/. 1995].
Replicative senescence should be distinguished from other processes by which cells 
can withdraw from the cell cycle. One such process is cellular quiescence. Quiescent 
cells cease to divide under certain culture conditions including nutrient starvation and 
contact inhibition, but, unlike senescent cells, they maintain their capacity to re-enter 
the cell cycle upon mitogenic stimulation [Stein et al. 1985]. Another process 
involving withdrawal from the cell cycle is terminal differentiation. Here the failure to 
proliferate accompanies marked changes in cell phenotype, as part of a programmed 
process resulting from altered transcriptional regulation. Cells which withdraw from 
the cell cycle owing to terminal differentiation show different patterns of gene 
expression and activity from those undergoing replicative senescence [Medrano et al. 
1994], suggesting that the two processes are indeed distinct.
The onset of senescence does not necessarily lead to cell death. Indeed senescent cells 
can remain viable and metabolically active for years if maintained with regular 
changes of culture medium [Matsumura et al. 1979, Wang 1995]. There has been 
some controversy about whether replicative senescence leads to an increased 
propensity to cell death through apoptosis, and this issue will be discussed in detail 
below.
1.4.3 Morphological and molecular features of senescent cells
Senescent cells show characteristic changes in morphology and gene expression, and 
the acquisition of selective changes in differentiated functions [Campisi 1996, Smith 
and Pereira-Smith 1996]. Morphologically, senescent cells in vitro show an increase in 
size and cytoplasmic vacuolation, the development of polymorphic nuclei, an increase 
in their nuclear/cytoplasmic ratio, and the development of large lysosomal bodies
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[Comings and Okada 1970, Lipetz and Cristofalo 1972, Rosen et al. 1981, Repin et al. 
1984, Nichols et al. 1987, Tokunaga et al. 1989, Biirrig 1991].
Senescent cells also show altered activity of certain cell-cycle-related enzymes [Chang 
and Chen 1988, Chen et al. 1989] and decreased efficiency of protein synthesis and 
degradation [Okada and Dice 1984, Dice 1989, Luce and Bunn 1989, Rattan 1991]. 
They display a high frequency of chromosomal aberrations [Thompson and Holliday 
1975].
Several of the differences in gene expression and enzyme activity in senescent cells 
relate directly to their inability to progress from Gi to S phase [Stein et al. 1991, Dimri 
and Campisi 1994a and 1994b]. Examples include reduced expression of c-FOS 
[Seshadri and Campisi 1990], impaired phosphorylation of pRb [Stein et al. 1990], 
and reduced levels of expression of cyclin A [Stein et al. 1991], ribonucleotide 
reductase, histones, proliferating cell nuclear antigen (PCNA) and dihydrofolate 
reductase [Pang and Chen 1994]. As would be expected in cells which have arrested in 
Gi, there is also an accumulation of Gi cyclins [Dulic et al. 1993].
The levels of Cdk inhibitors such as pl4, pl6, p21 and p27 are increased in senescent 
cells, though the pattern of elevation of particular Cdk inhibitors appears to depend on 
the species and cell type studied, and on the nature of the trigger leading to senescence 
[Noda et al. 1994, Stein and Dulic 1995, Hara et al. 1996, Ben-Porath and Weinberg 
2005]. Cdk inhibitors appear to play a causal role in replicative senescence [Xiong et 
al. 1993, el-Deiry etal. 1994].
As well as alterations in cell cycle regulatory genes, differential screening of RNA 
from young and senescent cells, and the use of complementary DNA microarray 
analysis in senescent cells, have identified alterations in the expression of a variety of 
other genes: these include those encoding extracellular matrix components and 
metabolic enzymes [Kumazaki et al. 1991, Thweatt et al. 1992, Park et al. 2001], as 
well as proteins such as cathepsins (discussed in Chapter Five) [Kamino et al. 2003].
1.4.4 Putative mechanisms of replicative senescence
1.4.4.1 Telomere shortening in serially passaged cells
Over thirty years ago it was proposed that the gradual loss of proliferative capacity of 
replicating cell cultures could be explained by incomplete replication of chromosome 
ends [Olovnikov 1973]. Since then it has become widely (if not universally) accepted
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that replicative senescence in normal somatic cells from higher organisms results from 
the shortening of chromosomal telomeres [Allsopp et al. 1992, Harley and 
Villeponteau 1995, Campisi 1996]. This shortening has been attributed to the so-called 
‘end-replication problem’, the incomplete replication of the distal 5’-end of the 
lagging strand during DNA replication [Levy et al. 1992].
Telomeres are specialized structures which cap the ends of the chromosomes, 
protecting the chromosomal ends from degradation and from fusion with other 
chromosomal ends [Greider 1990, Lee et al. 1993]. They comprise multiple repeat 
sequences of base pairs (bp), complexed with telomeric proteins; in humans and many 
other organisms, the DNA component of the telomere consists of tandem 
hexanucleotide repeats of the sequence TTAGGG [Brown 1989]. Their presence 
distinguishes the normal physiological ends of chromosomes from double-strand 
breaks; this is thought to be important in determining whether a cell initiates a DNA 
damage response [Lansdorp et al. 2000].
Harley et al. provided the first formal demonstration that telomeres shorten during 
serial passage of cells in culture [Harley et al. 1990]; this decrease in length occurred 
in a replication-dependent manner, and in normal human fibroblasts grown in vitro 
telomeric DNA shortened by approximately fifty bp per population doubling (PD). 
The rate of telomeric shortening appears to depend on the cell type studied; the rate of 
loss of telomeric DNA in human ECs, for example, has been measured as 
approximately 190 bp per PD [Chang and Harley 1995].
It has been suggested that once a critical degree of telomeric shortening is reached, 
this process is recognized by the cell cycle machinery as DNA damage, leading to a 
signal to block further replication by exiting the cell cycle [Chang and Harley 1995, 
Vaziri and Benchimol 1996, Vaziri et al. 1997]. For example, certain human T cells 
become senescent after approximately twenty-five divisions, at a stage when their 
telomeres have shortened from approximately ten kilo-base pairs (kbp) to 
approximately five kbp [Effros and Walford 1984, Vaziri et al. 1993].
1.4.4.2 The role of telomerase
Telomere attrition is retarded or even prevented in cells immortalized in vitro [Counter 
et al. 1994a], in tumour cells [Counter et al. 1994b], and in germ-line cells [Wright et 
al. 1996], because these cells express relatively high levels of the enzyme telomerase. 
In contrast, telomerase is generally absent, or present only at very low levels, in non-
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transformed, non-malignant somatic cells [Kim et al. 1994]. Non-confluent primary 
cultures of normal human ECs, for example, express only a low level of telomerase 
activity, and this activity disappears altogether in quiescent confluent EC cultures 
[Hsiao et al. 1997, Kurz et al. 2003]. Low levels of telomerase activity have recently 
been demonstrated in normal human fibroblasts, and experimental inhibition of this 
activity led to premature senescence of these cells [Masutomi et al. 2003].
Telomerase is composed of two main subunits. An RNA component (TR) serves as a 
template to synthesize the telomeric DNA sequences; a catalytic component, TERT, 
shows reverse transcriptase activity [Lingner et al. 1997], adding hexameric DNA 
repeats at the linear ends of eukaryotic chromosomes [Kim et al. 1994, Counter et al. 
1994b, Meyerson et al. 1997, Breitschopf et al. 2001].
Various telomere-regulating factors appear to be associated with telomere 
maintenance. These include TTAGGG repeat binding factors 1 and 2 (TRF1 and 
TRF2) [Smogorzewska et al. 2000], tankyrase [Smith et al. 1998] and the telomere- 
associated protein TIN2 [Kim et al. 1999]. Expression of these factors varies between 
species, and to an extent which depends on the replicative age of the cells.
Evidence for a causal role of telomere shortening in replicative senescence has come 
from studies in which cultures of normal human cell-types (such as fibroblasts and 
epithelial cells) were transfected with vectors encoding the human version of TERT 
(hTERT) [Bodnar et al. 1998, Vaziri and Benchimol 1998]. While telomerase- 
negative control cultures showed pronounced senescence, telomerase-expressing 
clones divided vigorously, and exceeded their normal proliferative life-span by at least 
twenty PDs, without causing neoplastic transformation [Bodnar et al. 1998]; the 
transfection led to an elongation of telomere length and reduced staining for 
senescence-associated beta-galactosidase (SA-p-gal) (a marker of replicative 
senescence discussed below).
A similar extension of replicative life-span has been achieved by the forced expression 
of hTERT in human arterial ECs [Yang et al. 1999]. Transfection of ECs with hTERT 
leads to preservation of aspects of the pre-senescent phenotype; thus transfection of 
human aortic endothelial cells (HAECs) with hTERT attenuates the loss of endothelial 
nitric oxide synthase (eNOS) expression and activity usually seen with serial passages 
[Matsushita et al. 2001]. The introduction of hTERT into human VSMCs likewise 
extends their replicative life-span, and leads to the preservation of a younger
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phenotype [Minamino et al. 2001], suggesting that telomere dynamics are relevant to 
the proliferative capacity of more than one vascular cell type.
The role of telomerase in the prevention of senescence requires further clarification, 
however, given that some somatic cells exhibit telomere shortening and undergo 
senescence following rounds of replication, despite expressing telomerase [Broccoli et 
al. 1995, Counter et al. 1995]. Conversely, some cell lines can immortalize in the 
absence of telomerase activity [Mumane et al. 1994, Bryan et al. 1995].
1.4.4.3 Higher order structure of telomeres
Even if the mitotic clock theory of telomere shortening is accepted, it is not clear 
which parameter of cellular telomere length is critical in determining when the cell 
cycle is arrested. It transpires that replicative senescence is induced when telomeres 
have approximately halved in length [Shay et al. 1991a]. Since entry into senescence 
does not require complete telomere attrition, an alternative trigger for cell cycle arrest 
must be sought.
One theory proposes that absolute telomere length is less important than the higher- 
order structure the telomere is able to adopt. In particular, a model has been proposed 
in which telomeres form so-called ‘T-loops’ as telomere-related proteins fold the 3’ 
single strand end of the telomere back into double-stranded DNA repeats [Griffith et 
al. 1999]; this configuration, together with die specific binding of proteins such as 
TRF2 to the T-loop, may protect the G-rich single-strand overhang at the very end of 
the telomere from degradation and from interactions with signalling proteins.
It has been suggested that when cellular telomerase activity is low, progressive 
shortening of the telomere in the T-loop may lead to the T-loop’s becoming 
temporarily uncapped, exposing the G-rich single strand of DNA; this uncapping may 
render the DNA telomerase-accessible, so that if and when telomerase levels 
subsequently rise, the telomere can become lengthened, and form a T-loop once again 
[McEachem and Blackburn 1995].
1.4.4.4 The effect of changes in telomeric structure on the cell cycle
The activation pathways leading to the cell cycle arrest found in senescence have 
proved difficult to elucidate fully; it seems that different pathways are involved, 
depending on the nature of the trigger for senescence, and the species and cell type 
being studied.
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As described above, replicative senescence appears to result from telomere shortening 
following rounds of replicative activity. Other forms of senescence, collectively 
termed stress-induced premature senescence (SIPS), may arise from a variety of other 
insults to the cell; SIPS is discussed in more detail below.
Various theories have sought to link senescence-related changes in telomeres to the 
intracellular signalling pathways which bring about cell cycle arrest. It has been 
proposed that telomere shortening may alter the expression of cell cycle genes located 
in the vicinity of the telomeres; this has been referred to as the ‘telomere position 
effect’. It seems to apply to replication in yeast [Corda et al. 1999], but its role in 
humans is less easy to establish [Ofir et al. 1999].
Telomere loss during replicative senescence may be recognized as a DNA double­
strand break, and induce a corresponding check-point response [Chin et al. 1999]. It 
has been mentioned above that if a cell suffers damage to its DNA, the level of p53 
rises markedly; p53 may then induce Cdk inhibitors such as pl6, p21, and p27, and so 
bring about arrest in Gi [McConnell et al. 1998, Collado et al. 2000, Dai and Enders 
2000, Kim et al. 2002]. Similarly, several studies have suggested that the cell cycle 
arrest found in replicative senescence may also be initiated by activation of p53 [Shay 
et al. 1991a, Atadja et al. 1995, Vaziri et al. 1997]. While activated p53 can induce 
cell cycle arrest at Gi and G2 checkpoints by increasing expression of p21 [el-Deiry et 
al. 1994, Canman et al. 1995, Kulju et al. 1995], inactivation of p53 delays the onset 
of replicative senescence [Hara et al. 1991, Bond et al. 1995]. It has also been 
demonstrated that an abundance of free single-stranded G-rich telomeric DNA, as 
might be found when a T-loop becomes uncapped following telomere attrition, can 
trigger a p53-dependent cell cycle arrest [Saretzki et al. 1999].
The activation of p53 appears to be mediated through clusters of damage-response 
proteins which appear at the telomeres of senescent cells; at the same foci are found 
activated forms of ATM (ataxia telangiectasia mutated DNA damage response kinase), 
and its down-stream targets Chkl and Chk2, which are thought to be the crucial 
activators of p53 in response to DNA damage [d’Adda di Fagagna et al. 2003, Herbig 
etal. 2004].
Inter-species differences in the mechanisms leading to replicative senescence are 
emphasized by studies in which attempts have been made to prevent the onset of 
senescence. In murine cells inactivation of either p53 or pRb is sufficient to inhibit
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senescence [Harvey et al. 1993, Sage et al. 2000], suggesting a murine signalling 
pathway involving sequential activation of p53 and pRb; this pathway is thought to be 
mediated via increased expression of p21; by contrast, in human cells it appears 
necessary to inactivate both p53 and pRb in order halt the replicative cycle [Shay et al. 
1991a, Ben-Porath and Weinberg 2005], implying that p53 may be capable of 
initiating senescence independently of pRb and p21 activity. The situation is not clear- 
cut, though, given that in one study involving human fibroblasts, inactivation of p21 
appeared sufficient to prevent senescence, without the need for the simultaneous 
inactivation of p53 [Brown etal. 1997].
The Cdk inhibitor p i6, which is normally not detectable in adult cells, is over- 
expressed in senescent cells, and is postulated to be a key regulator of replicative 
senescence in human cells [Alcorta et al. 1996], on the basis of studies which have 
shown its expression to be markedly elevated in ageing cultures [Wong and Riabowol 
1996, Kim et al. 2002]. Furthermore, forced over-expression of p i6 can induce pre- 
senescent cells to become senescent [McConnell et al. 1998, Dai and Enders 2000], 
while inactivation of pi 6 in human cells can significantly delay their senescence [Wei 
et al. 2003]. Activation of pi 6 provides a mechanism for the activation of pRb without 
requiring activation of p53. The relevance of this mechanism is emphasized by the 
finding that, in human cells, forced telomere uncapping by inhibition of TRF2 can 
cause an induction of pi 6 and senescence even in the absence of p53 [Smogorzewska 
and de Lange 2002].
There appear to be two main pathways involved in the initiation of senescence in 
human cells: when replicative senescence is triggered by telomere attrition and/or T- 
loop uncapping, a response similar to that involved in a DNA damage response 
(involving sequential p53, p21 and pRb activation) is initiated; if, by contrast, 
senescence is triggered by external stresses (for example SIPS resulting from high 
oxidative stress, as discussed later) it appears to be mediated through activation of pRb 
by p i6, perhaps via the p38-MAPK (mitogen-activated protein kinase) protein 
[Itahana et al. 2003, Iwasa et al. 2003, Ben-Porath and Weinberg 2004 and 2005]. 
This theory is supported by the finding that stress-induced activation of pi 6 appears to 
promote the onset of senescence in human cells via a mechanism independent of 
telomere length [Wei et al. 2003].
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In murine cells, p i6 does not appear to play a significant role in senescence, no matter 
what its trigger; instead murine cell senescence is mediated via p53 and p21, in a 
pathway which also involves up-regulation of pl9ARF (which is encoded by an 
alternative transcript of the INK4a locus also responsible for encoding p i 6) [Itahana et 
al. 2004]. The human equivalent of murine p l9ARF, pl4  is up-regulated in 
senescent human ECs, and is thought to play a role, together with p53, in mediating 
oxidative stress-induced senescence in these cells [Lundberg et al. 2000, Chen et al. 
2002].
1.4.5 Replicative senescence as a tumour-suppressor mechanism
The suggestion that replicative senescence may play a role as a tumour-suppressor 
mechanism has arisen from various strands of evidence. Firstly, since senescence 
prevents multiple rounds of cell replication, it may also reduce the number of 
opportunities at which defects can arise in the cell genome, reducing the chance of 
developing the mutations that are required for malignant transformation [Ponten 1976, 
Sager 1991]. Secondly, oncogenes extend cell replicative life-spans, suggesting that 
oncogenesis and senescence are opposing mechanisms [Dimri et al. 2002]. Thirdly, 
the p53 and RB genes, both of which are known to be potent tumour-suppressor genes, 
are involved in the establishment and maintenance of replicative senescence [Shay et 
al. 1991b]. Indeed, mice containing mutations of activators of senescence (such as p53 
and p i6) are prone to tumourigenesis [Donehower et al. 1992, Krimpenfort et al.
2001].
Some anti-cancer agents appear to induce a senescence-like phenotype. For example, 
when mice with lymphomas were treated with cyclophosphamide, their lymphomatous 
cells underwent replicative senescence in vivo [Schmitt et al. 2002]; this senescence 
acted as a barrier to further replication of the tumour cells. Mice bearing tumours 
whose cells contained an intact machinery for replicative senescence showed a better 
prognosis in response to chemotherapy than did mice whose tumours contained 
senescence defects.
1.4.6 Replicative senescence and organismic ageing
It has been postulated that replicative senescence may occur in vivo, in tissues where 
cellular proliferation continues throughout the entire life-span of the organism 
[Hayflick 1965]. It has further been suggested that in vivo cellular senescence may
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play a role in such diverse conditions as atherosclerosis, Alzheimer’s disease and 
diabetes mellitus [Tesco et al. 1993, Vasile et al. 2001, Chen et al. 2002]. Hayflick 
and Moorhead were among the first to observe that senescent cells in vitro acquired 
characteristics of ageing cells in vivo [Hayflick and Moorhead 1961], and this 
observation led to the suggestion that replicative senescence may have a bearing on (or 
indeed be a cause of) organismic ageing [Hayflick 1965, Finch 1990]. According to 
this theory, cells which have exhausted their replicative capacity accumulate with age 
in certain tissues, and, owing to their altered properties, contribute to the development 
of age-related pathologies [Dimri et al. 1995, Campisi 1996].
A direct relationship has been shown between the longevity of several mammalian 
species and the in vitro replicative life-span of their fibroblasts [Rohme 1981, 
Stanulis-Praeger 1987, Campisi et al. 1996]. For example, while fibroblasts from the 
Galapagos tortoise (which can live for over 100 years) achieve up to 130 PDs in 
culture, those from the mouse (whose MLSP is approximately three years) manage 
only up to ten PDs.
Evidence for the occurrence of a decline in cellular replicative capacity with age is 
found in a variety of studies of human and rodent tissues. Many of these studies have 
shown an inverse relationship between donor age and the in vitro proliferative capacity 
of their cells [Schneider and Mitsui 1976, Buetow 1985, Stanulis-Praeger 1987, 
Cristofalo and Pignolo 1993, Campisi et al. 1996]. This relationship appears to apply 
to several cell types [Martin et al. 1970, Smith et al. 1978, Tassin et al. 1979, Effros 
and Walford 1984, Lipman and Taylor 1987, Blake et al. 1997]. Some studies, though, 
have found either only a weak correlation [Schneider and Mitsui 1976], or no 
correlation at all [Cristofalo et al. 1998]. Nevertheless, the weight of evidence does 
seem to favour the possibility that ageing donors yield cells with reduced replicative 
capacity.
Telomere studies generally support this contention. These investigations often employ 
the measurement of terminal restriction fragments (TRFs); a TRF comprises the 
telomere itself together with a sub-telomeric region of chromosomal DNA; reduction 
in TRF length is therefore indicative of telomere shortening. In various human cell 
types, TRFs in cells from older donors are shorter than those in cells from younger 
donors [Hastie et al. 1990, Allsopp et al. 1992, Harley et al. 1992, Vaziri et al. 1993],
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although no such correlation was found in a more recent study of human fibroblasts 
[Mondello et al. 1999].
The study of telomerase-deficient mice might appear to cast doubt on the relevance of 
telomere shortening to organismic ageing. These mice were genetically engineered by 
disrupting the mouse TR gene (mTR) [Blasco et al. 1997]. Early generations 
developed without any significant phenotypic abnormalities. Defects were only seen in 
later generations, and then only in highly proliferative tissues [Rudolph et al. 1999]. 
As will be discussed in Chapter Four, murine telomeres are generally much longer 
than those found in human cells, and this may explain why early generations of 
telomerase-deficient mice appear to age normally.
Other studies have compared genetic, biochemical and physiological properties of 
early- and late-passage cells with those of cells from young and old donors. Some 
gene expression in senescent cells follows the pattern seen in organismic ageing, with 
proteins such as fibronectin [Kumazaki et al. 1991] and collagenase-1 [West et al. 
1989] being synthesized in increased quantities in senescent HDFs. The exact pattern 
of gene expression in senescent cells, though, appears to vary between cell types 
[Shelton et al. 1999]. Cells derived from subjects with progeria or Werner’s syndrome 
share some biochemical and genetic similarities with late-passage cells from normal 
subjects [Goldstein and Harley 1979, Lecka-Czemik et al. 1996], again suggesting a 
link between cellular and organismic ageing.
Closer study of the genetics of Werner’s syndrome has provided further evidence for 
such a link. Affected individuals have a reduced life-span, and prematurely develop 
several features of the ageing phenotype, including thinning of the hair, 
atherosclerosis, osteoporosis and the emergence of malignancies [Ellison and Pugh 
1955, Epstein et al. 1966]. Their cells senesce significantly earlier than age-matched 
controls [Martin et al. 1970, Stanulis-Praeger 1987]. The responsible gene encodes a 
protein, WRN, which is thought to be involved in telomere maintenance [Li and 
Comai 2000]. Similarly, cells from subjects affected by progeria have decreased 
replicative capacity [Goldstein and Harley 1979], and their telomeres are 
approximately half the length of those in age-matched controls [Allsopp et al. 1992]. 
Study of the clinical syndrome dyskeratosis congenita has also been instructive [Dokal
1999]. Patients have a reduced life-expectancy, and develop premature greying and 
loss of hair, as well as osteoporosis. Their haematopoietic cells and skin fibroblasts
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have a reduced replicative capacity [Dokal et al. 1992]. At least some forms of this 
condition appear to arise from a mutation in a gene which encodes for dyskerin [Heiss 
et al. 1998], a protein which normally stabilizes TR; the resultant disruption in 
telomerase function appears to be associated with abnormally short telomeric lengths 
[Marciniak et al. 2000]. The fact that subjects with DKC exhibit only certain specific 
features of premature ageing may result from differences in telomerase activity 
between their various tissues [Mitchell et al. 1999]. It is interesting to note that several 
of those aspects of the ageing phenotype exhibited by individuals with DKC are 
shared with mTR-knockout mice: these include the emergence of haematological 
abnormalities, greying of the hair and an increased incidence of malignancy [Blasco et 
al. 1997, Marciniak et al. 2000].
Another human genetic condition, ataxia telangiectasia, is believed to involve 
inefficient DNA repair, as a result of an inactivating mutation in the p53 kinase, ATM 
(mentioned earlier in the context of the DNA damage response); fibroblasts from 
affected individuals show an increased DNA-binding capacity of p53, as well as 
accelerated telomere shortening and premature replicative senescence in culture 
[Metcalfe et al. 1996, Vaziri et al. 1997].
More direct evidence for the accumulation of senescent cells in the ageing organism 
has arisen from the study of SA-p-gal, a marker of replicative senescence mentioned 
earlier. Fibroblasts which stain positively for SA-p-gal are found in greater numbers in 
the skin of elderly subjects than in skin from younger donors [Dimri et al. 1995]. The 
use of SA-p-gal in the detection of senescent cells will be discussed in detail below.
In summary, the reduced replicative capacity and shorter telomeres found in cells from 
elderly donors, the study of properties of cells from patients with premature ageing 
syndromes, and the more direct evidence obtained using SA-p-gal, provide a growing 
body of evidence suggesting that cells with reduced replicative capacity accumulate in 
the ageing individual.
It is less clear whether such an accumulation contributes to the ageing process. With 
certain cell types, it is relatively easy to postulate that a reduced proliferative capacity 
could have a direct influence on age-related pathologies: for example, the age-related 
attenuation of the proliferative response of T lymphocytes to antigens mentioned 
earlier [Staiano-Coico et al. 1984] could partly explain the decline in immune 
response observed in the elderly. Similarly, an accumulation of senescent fibroblasts
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could explain some pathophysiological changes found in ageing skin: senescent 
fibroblasts show increased expression of fibronectin and collagenase, and under- 
expression of the collagenase inhibitor, tissue inhibitor of metalloproteinase-1 (TIMP- 
1) [West et al. 1989, Kumazaki et al. 1991, Millis et al. 1992], all of which changes 
could contribute to the thinning and loss of elasticity of ageing skin [Smith and 
Pereira-Smith 1996]. The extent of the contribution of senescent cells to other ageing 
pathologies remains debatable, though.
1.4.7 Replicative senescence and apoptosis
It is possible that the postulated accumulation of senescent cells within ageing tissue 
may in part result from an ability to resist being cleared by the apoptotic process 
which would usually remove defunct cells. Apoptosis was initially described by Kerr 
in 1971, as a process which he referred to as ‘shrinkage necrosis’ [Kerr 1971]. During 
this genetically-encoded programmed cell death [Alison and Sarraf 1992], cells 
undergo cytoplasmic shrinkage, together with DNA fragmentation and condensation, 
leading to the formation of so-called apoptotic bodies [Majno and Joris 1995]. 
Apoptosis appears to be involved in the regulation of cell numbers in normal tissue 
[Wyllie 1992]. Some research has suggested that certain cell types, including human 
fibroblasts, become relatively resistant to apoptosis when they reach replicative 
senescence [Wang 1995]. Subsequent studies, though, have shown that the 
susceptibility of senescent cells to apoptosis depends on the nature of the pro-apoptotic 
signal [Tepper et al. 2000], and on the cell type studied. Thus senescent fibroblasts are 
resistant to apoptosis induced by p53-dependent DNA damage, but are susceptible to 
p53-independent apoptosis induced by various genotoxic stresses [Seluanov et al. 
2001]. Furthermore, while senescent human umbilical vein endothelial cells 
(HUVECs) display a marked increase in spontaneous apoptosis, senescent HDFs do 
not, even though both cell types show similar accumulations of p i6, p21 and p27 
[Wagner et al. 2001].
In the study by Schmitt et al. mentioned earlier [Schmitt et al. 2002], the ability of 
murine lymphomatous cells to enter a senescence programme in response to 
cyclophosphamide depended on inhibition of their apoptotic pathway by over­
expression of the bcl2 gene. Here replicative senescence and apoptosis appeared to be 
mutually exclusive responses to an extrinsic insult. Another study has shown that
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when pRb is inactivated in senescent cells, the cells undergo apoptosis through a 
mechanism dependent on E2F [Alexander et al. 2003].
Regarding organismic ageing, there is growing evidence to suggest that the ageing 
process is associated with dysregulation of apoptosis [Warner et al. 1997]. Apoptosis 
is up-regulated during organismic ageing in certain cell types, including cardiac 
myocytes, hepatocytes, cells of the central nervous system [Higami and Shimokawa
2000], and T lymphocytes [Chrest et al. 1995, Aggarwal and Gupta 1998]. It is notable 
that, with the exception of T cells, these are generally non-dividing cell types; in 
continuously dividing cells, however, the effects of ageing on apoptosis vary between 
cell types [Higami and Shimokawa 2000].
1.4.8 Replicative senescence and atherosclerosis
Endothelial [Rosen et al. 1981, Maciag et al. 1981, Glassberg et al. 1982, Thornton et 
al. 1983, Hoshi and McKeehan 1986] and vascular smooth muscle cells [Bierman 
1978, Cristofalo and Pignolo 1993] taken from normal tissue have a limited replicative 
potential when grown in vitro.
Evidence that replicative senescence of vascular cells can also occur in vivo, and may 
be involved in atherogenesis, has become increasingly direct over recent years. 
Suspicion of a connection between cellular ageing and atherosclerosis is raised by the 
study of premature ageing syndromes, and of other conditions which pre-dispose to 
atherosclerosis. The decreased in vitro replicative capacity of cells derived from 
subjects with progeria and Werner’s syndrome, and the prominence of atherosclerosis 
in these conditions, have already been mentioned. Similarly, fibroblasts derived from 
patients with diabetes mellitus (a disease associated with increased atherosclerotic 
disease) have a lower replicative capacity in vitro than cells from non-diabetic subjects 
[Goldstein et al. 1975].
Some in vitro studies provide indirect evidence that EC and VSMC senescence may be 
relevant to atherosclerosis. The pro-atherogenic molecule homocysteine is capable of 
accelerating EC senescence [Xu et al. 2000]. Similarly, OxLDL significantly inhibits 
telomerase activity in ECs [Breitschopf et al. 2001].
1.4.8.1 Putative role of EC and VSMC senescence in atherosclerosis
Senescent ECs in vitro show a marked increase in the expression of interleukin-1
alpha (IL-la) [Maier et al. 1990], plasminogen activator inhibitor-1 (PAI-1) [Comi et
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al. 1995] and ICAM-1 [Maier et al. 1993]. These proteins are also over-expressed in 
atherosclerotic lesions [Moyer et al. 1991, Schneiderman et al. 1992, van der Wal et 
al. 1992], and have been implicated in the progression of the disease process: IL -la 
secretion promotes the adherence of monocytes to the endothelial surface [Bevilacqua 
et al. 1985]; PAI-1 decreases fibrinolytic activity and is thought to have other pro- 
atherogenic properties [Lupu et al. 1993, Christ et al. 1997]; ICAM-1 facilitates a 
number of intercellular interactions in the atherosclerotic plaque, including the entry of 
T cells into the intima [Watanabe and Fan 1998].
As mentioned earlier, serially passaged ECs show a progressive decline in eNOS 
expression and activity [Matsushita et al. 2001]. Endothelium-derived NO has a 
protective role against atherosclerosis, through its actions as an inhibitor of platelet 
adhesion and reactivity, leukocyte adhesion and SMC proliferation [Radomski et al. 
1987, Mugge et al. 1991]. Furthermore, atherosclerotic coronary arteries have lower 
basal levels of NO secretion than do normal coronary arteries [Chester et al. 1990]. It 
thus seems plausible that EC senescence, if occurring in vivo, could contribute to 
atherogenesis via a decline in endothelial NO production.
Both senescent VSMCs in vitro [Christ et al. 1997] and VSMCs in atherosclerotic 
plaques [Lupu et al. 1993] synthesize increased levels of PAI-1. Senescent VSMCs 
also over-express osteopontin and matrix Gla protein, suggesting that VSMCs which 
have undergone rounds of proliferation in vivo may be involved in regulating 
calcification in vascular lesions [Shanahan et al. 1993].
1.4.8.2 Evidence for EC and VSMC senescence in atherosclerosis 
The study of ex vivo cells and tissue provides rather more direct evidence for a role of 
vascular cell senescence in atherogenesis. ECs with morphological and karyotypic 
characteristics typical of senescent cells in vitro have been found covering the surface 
of arterial intimal lesions [Tokunaga et al. 1989, Btirrig 1991]. For example, ‘giant’ 
ECs have been detected overlying advanced atherosclerotic plaques in human carotid 
arteries [Burrig 1991]. Similarly, VSMCs from arterial fibrous plaques share 
morphological characteristics with senescent cells in vitro [Ross 1986, Newby et al. 
1999]. Furthermore, the conditioned medium of VSMCs derived from atherosclerotic 
plaques can up-regulate EC synthesis of PAI-1, a property shared with late- (but not 
early-) passage cultures of normal VSMCs [Christ et al. 1997].
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1.4.8.3 EC and VSMC proliferation studies
Studies of in vivo cellular proliferative rates and ex vivo replicative capacity also 
suggest that vascular cell senescence can occur in vivo. Cellular turnover in the human 
arterial endothelium in vivo is generally extremely low [Schwartz and Benditt 1973, 
Schwartz and Benditt 1976, Hobson and Denekamp 1984]. In a rat model, aortic ECs 
are essentially quiescent, except at certain ‘hot-spots’ [Schwartz and Benditt 1977]. 
Other animal studies have shown that in the bifurcations and branching points of 
certain arteries, which in humans correspond to atherosclerosis-prone areas, there is an 
increased rate of EC replication [Wright 1968, Caplan and Schwartz 1973, Stary et al. 
1992]. These sites are usually exposed to greater haemodynamic forces of shear and 
stretch [Zarins et al. 1990], and here the endothelium may respond with an increase in 
turnover in an attempt to maintain its integrity [Langille et al. 1986]. The question 
remains as to whether this increased turnover can eventually lead to EC senescence in 
vivo.
Proliferation studies of VSMCs derived from atherosclerotic plaques suggest that they 
experience a reduction in their replicative capacity [Bennett et al. 1995, Lutgens et al. 
1999]. VSMCs isolated from atherosclerotic plaques and grown in culture rapidly 
reach senescence, doing so many times more quickly than medial VSMCs taken from 
non-atherosclerotic arteries [Bennett et al. 1995]; these plaque cells are also more 
prone to apoptosis than normal medial VSMCs. Intimal VSMCs within ruptured 
plaques also show low levels of proliferation [Lutgens et al. 1999], despite their being 
located within a mitogenic environment [Newby et al. 1999], suggesting a loss of 
replicative capacity.
1.4.8.4 Telomere studies
Studies of telomeric length in cells isolated from vascular tissue have also proved 
instructive. The rate of telomere shortening is more rapid in ECs derived from iliac 
arteries than from iliac veins [Chang and Harley 1995]. Similarly, in accordance with 
the higher rates of EC replication at sites of increased haemodynamic stress, telomere 
attrition is faster in the distal than in the proximal segment of the abdominal aorta (the 
distal segment being more prone to atherosclerosis) [Okuda et al. 2000]. In this study, 
the rate of attrition was also higher with increasing donor age. In the following year, 
the same group demonstrated an inverse correlation between telomere length and 
donor age in human abdominal aortic ECs [Aviv et al. 2001].
54
Overall these findings suggest that as age advances, vascular cells which have 
exhausted their replicative capacity may accumulate in clusters in areas prone to 
atherosclerosis.
1.4.8.5 Endothelial denudation studies
Several studies have investigated the kinetics of the vascular cell proliferative 
response which follows a breach of the arterial endothelium, in an attempt to 
understand some of the cellular processes involved in atherosclerosis and the clinical 
phenomenon of post-angioplasty re-stenosis [Ferns et al. 1992]. These studies have 
usually involved denudation of a region of endothelium by passing a balloon or other 
device along the luminal surface of the artery. When only a small area of endothelium 
is injured, the denuded area can be rapidly and totally repaired by replication of the 
remaining ECs [Reidy and Schwartz 1981]. If a larger area is injured, though, EC 
replication may not be sufficient to repair the breach [Reidy et al. 1983], even after a 
long period of time [Clowes et al. 1986]. This suggests that there is a limit to the 
amount of EC replication which can occur. In contrast, other research has shown that 
complete regeneration of large areas of endothelium is possible, provided that the 
denudation injury is performed without trauma to the media [Lindner et al. 1989]. 
VSMC proliferation also occurs during the intimal thickening induced by mechanical 
injury to the luminal surface of the vessel, for example following carotid 
endarterectomy, coronary angioplasty and in endothelial denudation models 
[Stemerman et al. 1982, Davies and Hagen 1994]. It is not known, however, whether 
this proliferation leads to the accumulation of senescent VSMCs.
1.4.9 Detection of senescent cells
As mentioned earlier, senescent cells in culture show characteristic morphological 
features. Demonstration of these features, and of an inability of cells to respond to 
mitogenic stimuli, were once the main methods for identifying senescent cells in vitro. 
Detection of cell senescence in vivo, where the morphology of single cells is less easy 
to assess, and where individual cell growth is difficult to determine, has therefore been 
problematic. While senescent cells in vitro can be identified by their failure to 
synthesize DNA under optimal growth conditions, in vivo DNA synthesis 
measurements cannot distinguish senescent cells from quiescent or terminally 
differentiated cells [Dimri et al. 1995].
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Senescence-associated p-galactosidase, an assay for in vitro replicative senescence 
mentioned earlier, appears to offer the possibility of detecting senescence of individual 
cells in vivo [Dimri etal. 1995].
The term P-galactosidase (p-gal) refers to enzymes capable of cleaving p-D-galactose 
residues in P-D-galactosides. These enzymes are active against a wide range of 
substrates. The lysosomal isoform of P-gal is optimally detected at a pH varying 
between 3.0 and 5.0 depending on the species studied, and at pH 4.0 in humans 
[Morreau et al. 1989]; it has therefore been termed acid P-galactosidase [Koldovsky et 
al. 1969]. This acid P-gal activity is detectable in most mammalian cells, regardless of 
their replicative age [Morreau et al. 1989, Dimri et al. 1995]. A defect in this enzyme 
in humans leads to the accumulation of its usual substrates, as is seen in the inherited 
metabolic disorder G m i gangliosidosis [Mutoh et al. 1988]. A bacterial isoform of P- 
gal has a pH optimum of between 7.4 and 7.5, and is often used as a reporter gene in 
gene transfer studies [Wakita et al. 1991, Cui et al. 1994].
Histochemical detection of p-gal activity (at any pH) is usually carried out by 
incubating cells or tissues with the indigogenic substrate 5-bromo-4-chloro-3-indolyl- 
P-galactopyranoside (known as X-Gal) [Gossrau et al. 1991, Dimri et al. 1995, Xu et 
al. 1997]. This substrate, when cleaved by the enzyme, yields an insoluble end-product 
which appears blue or turquoise under light microscopy.
In 1995, Dimri et al. showed that if cultures of human fibroblasts were assayed for p- 
gal activity at pH 6.0, the enzyme activity appeared to be detected only in senescent 
cells. This endogenous pH 6.0 activity was therefore termed senescence-associated p- 
galactosidase (SA-P-gal) [Dimri et al. 1995]. Dimri et al. demonstrated that this 
activity was not found in quiescent, terminally differentiated or immortal cells [Dimri 
et al. 1995]. Initially, SA-P-gal was found in senescent cultures of human fibroblasts 
and keratinocytes [Dimri et al. 1995], and of epithelial cells [Bodnar et al. 1998], as 
well as in some human skin biopsies [Dimri et al. 1995]. It was not found, though, in 
senescent cultures of murine fibroblasts, despite being detectable in equivalent 
cultures derived from rats [Dimri et al. 1995]; also, in some cell types, for example 
adult melanocytes, and sebaceous and eccrine gland cells, p-gal activity was detectable 
at pH 6.0 whether or not the cells had reached senescence. The ability of the assay to
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identify senescent cells therefore appears to depend on the cell type and the species 
studied.
SA-P-gal has now been widely used to detect cell senescence in vitro [for example in 
studies reported by Serrano et al. 1997, Xu et al. 1997, Tsukamoto et al. 1998, 
Matsunaga et al. 1999]. Its validity as a marker of in vitro (let alone in vivo) 
senescence has not gone unchallenged, though, as will be discussed in Chapter Five.
1.5 Oxidative stress
1.5.1 Definition
As alluded to previously (Section 1.3.2.6), according to the ‘free radical theory of 
ageing’ [Hannan 1956, Harman 1981] organismic ageing is attributable to the 
progressive and irreversible acquisition of molecular oxidative damage ensuing from 
normal metabolic reactions occurring in an aerobic environment [Sohal and Allen 
1990, Sohal and Weindruch 1996]. Such reactions lead to the continuous generation of 
ROS including free radicals, mainly from mitochondria; these ROS are believed to be 
responsible for age-related oxidative damage [Beckman and Ames 1998a]. As well as 
this physiological production of ROS, increased levels of ROS are generated during 
certain pathological processes such as ischaemia-reperfusion injury [Welboum et al.
1991] and inflammation [Bragt etal. 1980].
Oxidative damage accumulates in the DNA, proteins and lipids of the ageing 
organism, and leads to cellular dysfunction, and potentially to necrosis or apoptosis 
[Kurose et al. 1997, Naderi et al. 2003]. To limit these damaging effects aerobic 
organisms possess antioxidant defence systems, including enzymes that repair macro- 
molecular damage [Janssen et al. 1993, Demple and Harrison 1994] and a number of 
mechanisms that ‘mop up’ ROS [Halliwell and Gutteridge 1989, Sies 1991]; the latter 
include intrinsic antioxidant enzymes such as catalase, superoxide dismutase (SOD) 
and glutathione peroxidase, as well as dietary scavengers such as a-tocopherol, 
ascorbic acid and flavanoids.
When the balance between oxidant and antioxidant processes is altered in favour of 
the former, there is said to be an increase in the level of oxidative stress, potentially 
leading to oxidative damage [Sies 1991].
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1.5.2 The generation and effects of oxidative stress
The initial radical generated during normal mitochondrial respiration is the superoxide 
ion. This is metabolized predominantly by mitochondrial SOD [Dionisi et al. 1975] to 
form hydrogen peroxide; some superoxide molecules may also be thrown into the 
intermembrane space of the mitochondria, where they may be metabolized by 
cytosolic SOD. Superoxide molecules generated by pathological processes can 
similarly be metabolized by members of the SOD family, again yielding hydrogen 
peroxide. Hydrogen peroxide molecules are themselves toxic, but can be metabolized 
to non-toxic by-products either by catalase or by various peroxidases (including 
glutathione peroxidase) [Sies 1993]. Hydrogen peroxide may alternatively be 
metabolized, in the presence of Fe , via the Fenton reaction [Imlay et al. 1988], to 
form the hydroxyl radical, which is itself highly toxic.
Superoxide molecules not cleared by the SOD enzyme system are capable of 
generating further damaging molecules by reactions with other free radicals. They 
may, for example, react with NO to form peroxynitrite [Beckman et al. 1990]. 
Peroxynitrite, an example of a reactive nitrogen species, may then either decompose to 
form free radicals including the nitronium ion and hydroxyl ions [Beckman et al. 
1992], or may itself cause damage to various proteins.
Four subcellular sources of pro-oxidants make a prominent contribution to oxidant 
stress during ageing [Roy 1997, Beckman and Ames 1998b]; these are mitochondrial 
and peroxisomal oxidative reactions, microsomal P-450 enzymes, and membrane- 
associated enzymes such as NAD(P)H oxidase and NO synthase.
Because of their high reactivity, ROS are capable of modifying most biological 
macromolecules. This damage can be self-perpetuating, as it can lead to the generation 
of further ROS, themselves capable of inflicting additional damage. The result is an 
amplification of the initial oxidative insult.
Oxidative damage to DNA is thought to have deleterious effects which contribute to 
cellular ageing. For example, as will be discussed in detail below, oxidative stress can 
accelerate the attrition of telomeric DNA which occurs during cell replication; it has 
been proposed that in this way oxidative stress may augment, or indeed drive cellular 
senescence.
Oxidative stress is also believed to be involved in the initiation of cell signalling 
pathways which contribute to various aspects of the ageing phenotype [Lavrovsky et
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al. 2000]. ROS can up-regulate certain genes whose expression is associated with 
ageing. For example, ageing has been shown to be associated with a progressive 
increase in the nuclear level of the activated form of nuclear factor kappa B (NF-kB) 
in various organs [Spencer et al. 1997], and ROS can up-regulate both the expression 
of this transcription factor, and its transportation to the cell nucleus [Verma and 
Stevenson 1997]. Similarly, ROS can induce the expression of another transcription 
factor, activator protein 1 (AP-1), as well as influencing the expression of peroxisome 
proliferator-activated receptors and other members of the nuclear receptor super- 
family [Lavrovsky et al. 2000]; these various molecules are believed to play important 
roles in the initiation and maintenance of chronic inflammatory conditions, including 
the age-related pathologies of rheumatoid arthritis and atherosclerosis.
1.5.3 Oxidative stress and organismic ageing
Most evidence in support of the free radical theory of ageing is correlative and 
circumstantial. The level of production of free radicals in several organs of various 
mammalian species is inversely proportional to the MLSPs of these species [Sohal et 
al. 1989]. Conversely, higher levels of some antioxidants, such as SOD, are found in 
the longer-lived species [Sohal et al. 1990].
When levels of intracellular oxidants are measured in cells derived from animals of 
different ages, higher oxidant levels are found in cells from older animals [Hagen et al. 
1997]. There is also an age-related increase in the products of oxidative stress 
[Schleicher et al. 1997], including an age-dependent accumulation of oxidized proteins 
in various tissues [Stadtman 1992], as well as an age-related decline in antioxidant 
enzymes and molecules [Lykkesfeldt et al. 1998].
Various transgenic animal models have been used to explore the theory further. These 
include fruit-flies over-expressing SOD or catalase [Reveillaud et al. 1991, Sohal and 
Weindruch 1996, Parkes et al. 1998], and mice with increased levels of either SOD 
[Epstein et al. 1987] or glutathione peroxidase [Mirault et al. 1992]. In these models 
some extension of the life-span was found: for example, over-expression of SOD in 
the motomeurones of Drosophila increased the organism’s life-span by some forty 
percent [Parkes et al. 1998].
An association between oxidative stress and ageing is also suggested by the study of
antioxidant mechanisms in subjects with Down’s syndrome (trisomy 21). These
individuals age prematurely, and have a shortened life expectancy [Kedziora and
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Bartosz 1988]. They have an imbalance in their antioxidant enzyme system: they 
possess three copies of the SOD gene, Sod 1, but only two copies of the gene for 
glutathione peroxidase [de Haan et al. 1996], and in various tissues from Down’s 
syndrome patients SOD activity is raised relative to glutathione peroxidase activity, 
leading to an accumulation of hydrogen peroxide molecules [Brooksbank and Balazs 
1984]. This imbalance may play a role in the premature ageing process itself [Groner 
et al. 1990]. Down’s syndrome subjects show an increased susceptibility to lipid 
peroxidation [Brooksbank and Balazs 1984], and this may contribute to their increased 
propensity to develop cardiovascular disease.
1.5.4 Oxidative stress, replicative senescence, and stress-induced premature 
senescence
1.5.4.1 The effects of oxidative status on cellular proliferative activity 
Evidence is accumulating that oxidative stress and replicative senescence are inter­
related phenomena. Such a relationship was suggested by the early findings that cell 
proliferation could be inhibited by hyperoxia [Balin et al. 1977] and that, conversely, 
proliferative activity could be prolonged by hypoxia [Packer and Fuehr 1977].
More recently, other interventions which affect the intracellular redox status of 
dividing cells have been shown to alter their replicative capacity. For example, when 
cell lines are transfected with Sod 1, increasing the ratio of SOD to glutathione 
peroxidase and so producing higher levels of hydrogen peroxide and oxidative stress, 
cellular proliferation is slowed, and there is an alteration in cellular morphology 
consistent with cellular senescence [de Haan et al. 1996].
Markers of oxidative damage to DNA are elevated in senescent HDFs when compared 
with early-passage cells [Chen et al. 1995], suggesting that DNA damage accumulates 
with rounds of replication. In addition, hyperoxia inhibits proliferation of HDFs, and 
this effect is associated with accelerated telomere shortening [von Zglinicki et al. 
1995].
Exposure of HDFs to either hydrogen peroxide or tert-butylhydroperoxide (t-BHP), an 
organic peroxide which generates ROS, also accelerates telomeric attrition [Dumont et 
al. 2001], while rates of telomeric attrition in fibroblasts are halved when cells are 
treated with the spin-trapping agent, a-phenyl-f-butyl nitrone (PBN) [Chen et al. 
1995]. Fibroblasts treated with hydrogen peroxide develop short distal single strand
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DNA breaks at each replication, and undergo telomeric shortening at a rate related to 
the accumulation of these breaks [Petersen et al. 1998, von Zglinicki et al. 2000]. This 
accumulation of single strand breaks implies not only that telomeric shortening may 
trigger replicative senescence, but also that telomeres may act as sensors of cumulative 
oxidative damage [Serra et al. 2000, Toussaint et al. 2000a].
With regard to vascular cells, hypoxia has been shown to extend the replicative life­
span of human VSMCs grown in culture [Minamino et al. 2001]; this hypoxia was 
associated with sustained high levels of hTERT expression. Similarly, exposure of 
HUVECs to a form of ascorbic acid, Asc2P, which acts as a ROS-scavenger precursor, 
resulted in a significant reduction in the rate of age-dependent telomere shortening 
[Furumoto et al. 1998]; the cellular replicative life-span was extended, and the cell 
size enlargement expected in ageing cultures was prevented.
In ECs, the predominant intrinsic defence mechanism against peroxidation appears to 
be provided by the glutathione redox cycle [Suttorp et al. 1986]. It has recently been 
shown that by increasing intracellular oxidative stress in replicating HUVECs (to a 
level which does not induce discernible cytotoxic or cytostatic effects) via 
manipulation of the glutathione redox-cycle, the rate of telomeric attrition is 
accelerated, and the cells enter a senescent state prematurely [Kurz et al. 2004].
1.5.4.2 Stress-induced premature senescence
As well as these effects of oxidative stress on telomere attrition and the emergence of 
replicative senescence in populations of dividing cells, it is also now recognized that 
oxidative stress, as well as certain other sub-lethal stresses, can lead to another form of 
senescence which does not require prior rounds of exhaustive replicative activity. Such 
stresses include DNA-damaging agents, lack of nutrients and growth factors, 
oncogenic over-expression, and other metabolic abnormalities [Fairweather et al. 
1987, Chen and Ames 1994, Serrano et al. 1997, Ben-Porath and Weinberg 2004]. 
These can cause cells to enter the non-dividing state known as stress-induced 
premature senescence (SIPS) mentioned earlier.
1.5.4.3 Relationship between replicative senescence and SIPS
SIPS and replicative senescence appear to be mediated by two distinct, and yet 
overlapping mechanisms. A distinction between the two mechanisms is suggested by 
the responses of cells undergoing either type of senescence to the forced over­
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expression of human telomerase: while, as mentioned above, the onset of replicative 
senescence can be delayed by this intervention [Bodnar et al. 1998, Vaziri and 
Benchimol 1998], the advent of SIPS is not prevented by telomerase over-expression 
[Gorbunova et al. 2002], implying that telomere shortening is not fundamental to the 
emergence of SIPS. In addition, while replicative senescence is generally considered 
to cause cell cycle arrest in Gj, oxidative stress has been shown to cause arrest in G2 in 
some forms of SIPS [Balin et al. 1978, Poot et al. 1988] (although other forms of SIPS 
do appear to lead to arrest in Gi, as will be described below).
Further evidence for the existence of two separate mechanisms leading to two different 
forms of senescence comes from the study of cultures of human epithelial cells: 
replicating keratinocytes can undergo SIPS early in the lifetime of the culture, and this 
arrest is mediated by pl6; if pl6 expression is silenced by deletion of the pl6 locus, 
keratinocytes will bypass this early SIPS, and continue to replicate until they undergo 
a later, p5 3-dependent, replicative senescence [Rheinwald et al. 2002]. The emergence 
of senescence in human cell cultures may thus result from a combination of intrinsic 
senescence (i.e. telomere-based replicative senescence, acting via p53 and p21) and 
extrinsic senescence (i.e. SIPS, effected through p i6 over-expression) [Herbig et al. 
2004, Itahana et al. 2004]. The relative importance of these two forms of senescence 
within an individual culture depends not only on the cell type studied, but even on the 
strain of cells cultured; for example, while WI-38 type human fibroblasts (from the 
lung) can senesce via both intrinsic and extrinsic mechanisms, BJ type human 
fibroblasts (from the skin) produce no senescent cells via the pl6-based (extrinsic) 
mechanism, but senesce purely through the p53/p21 -telomere-based mechanism 
[Itahana et al. 2003].
Other evidence, though, suggests that there may be a considerable overlap between not 
only the triggers but also the mechanisms leading to replicative and stress-induced 
senescence. For example, cells exhibiting either form of senescence share several 
characteristics, including their morphology, SA-p-gal activity and some abnormalities 
in cell cycle regulation [Dumont et al. 2000, Toussaint et al. 2000a]. Thus, when 
human primary fibroblasts are transfected with activated Ras (which rapidly raises 
intracellular levels of ROS), cells enter a permanent G] arrest, accompanied by 
accumulation of p53 and p i6 [Serrano et al. 1997]; this arrest is phenotypically 
indistinguishable from replicative senescence, and is associated with demonstrable
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SA-(3-gal activity. The rise in intracellular ROS appears to be a crucial factor in 
inducing their senescence, in that fibroblasts can be rescued from Ras-induced 
senescence by scavengers of hydrogen peroxide [Lee et al. 1999]. Furthermore, HDFs 
treated with t-BHP show increased levels of messenger RNA (mRNA) corresponding 
to genes encoding fibronectin, osteonectin, al(I)-procollagen, molecules known to be 
over-expressed in replicatively senescent fibroblasts, and indeed in cells derived from 
Werner’s syndrome subjects [Dumont et al. 2000].
It has been proposed that since the intrinsic and extrinsic pathways leading to 
senescence appear to converge on the activation of p53 and pRb, these two proteins 
may act as integrators of stress signals, their combined level of activation determining 
the timing of the onset of senescence [Ben-Porath and Weinberg 2004]. Furthermore, 
given the overlap between conditions which induce replicative senescence and SIPS, 
and given the similarity in the characteristics of cells which have undergone either 
type of senescence, it has been suggested that replicative senescence and SIPS may 
share the same biological function, and should be regarded as two aspects of a cell’s 
response to physiological stress [Ben-Porath and Weinberg 2004].
1.5.5 Oxidative stress and atherosclerosis
1.5.5.1 Epidemiological and dietary studies
As mentioned previously, it has been proposed that oxidative stress may play a role in 
the development and progression of atherosclerotic lesions. This theory has partly 
arisen from epidemiological and nutritional studies. A low prevalence of IHD has been 
reported in geographical areas where dietary antioxidant intake is high [Diaz et al. 
1997], or when various antioxidant vitamin supplementation regimes are implemented 
[Blumberg 1996]. It has also been shown that phenolic substances in red wine are able 
to inhibit the oxidation of LDL [Frankel et al. 1993] and it has been suggested that this 
might help to explain the relatively low prevalence of coronary artery disease among 
the French. The epidemiological data relating to dietary antioxidants and IHD risk are 
not clear-cut, though; in a recent meta-analysis encompassing nine previously studied 
cohorts, only a weak (negative) correlation was found between dietary antioxidant 
levels and IHD risk; while dietary supplementation with high doses of vitamin C was 
associated with a statistically significant reduction in the incidence of major IHD 
events, vitamin E supplementation failed to show such an effect [Knekt et al. 2004].
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A causal role for oxidative stress in the development of atherosclerosis has been 
suggested by studies into the effects of antioxidants in animal models of atherogenesis. 
Antioxidant administration inhibits the development of early atherogenic lesions in 
apoE-deficient mice (described below), without having any significant effect on their 
plasma cholesterol levels [Tangirala et al. 1995a]. The antioxidant used in that study, 
N,N-diphenyl 1,4-phenylenediamine, had a similar effect in cholesterol-fed rabbits, in 
which it was also shown to protect LDL from oxidation [Sparrow et al. 1992]. 
Similarly, administration of the antioxidant probucol to Watanabe heritable 
hyperlipidaemic (WHHL) rabbits (which lack functional LDL receptors) led to a 
dramatic reduction in the rate of atherogenesis [Kita et al. 1987], even when the slight 
hypocholesterolaemic effect of probucol was controlled for by the use of lovastatin in 
the control group [Carew et al. 1987]. A variety of antioxidants have been found to 
share this capacity to retard early atherogenesis, suggesting that this may be a class 
effect.
On the other hand, studies in humans have provided less convincing evidence that high 
antioxidant levels are protective against the progression of atherogenesis. For example, 
when dietary antioxidant intake and carotid artery intima-media thickness were studied 
in subjects aged between 45 and 64 years, only among older subjects (those over 55 
years of age) was an inverse correlation found between vitamin C intake and average 
artery wall thickness; in the case of alpha-tocopherol, the inverse relationship was only 
significant among women, and for carotenoids it was only found among older men, 
and weakened further after adjustment for potential confounders [Kritchevsky et al. 
1995]. It seems likely that the less dramatic effect of antioxidants on disease 
progression seen in humans (compared with their influence in animal models) reflects 
the complex aetiology of human atherosclerosis.
1.5.5.2 Putative mechanism of action of oxidative stress in atherogenesis 
A number of mechanisms have been postulated to act as a potential link between 
oxidative stress and susceptibility to atherosclerosis. Prominent among these is the 
‘oxidative modification hypothesis’ of atherosclerosis [Witztum 1994] mentioned 
earlier. According to this theory, oxidative damage to LDL, converting it to OxLDL, 
renders it more atherogenic than the native lipoprotein [Steinberg 1995].
In atherogenesis, LDL is believed to accumulate in the subendothelial space of 
arteries, where it is exposed to oxidative agents released from ECs, VSMCs, and,
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when present, macrophages and lymphocytes [Morel et al. 1984, Witztum and 
Steinberg 1991]. As a result LDL is mildly oxidized to so-called ‘minimally modified 
LDL’ [Navab et al. 1996]. This form of LDL induces local vascular cells to release 
chemoattractants such as MCP-1, as well as granulocyte and macrophage colony- 
stimulating factors; as a result, monocytes are recruited into the arterial wall, where 
they differentiate into macrophages [Parhami et al. 1993]. Monocytes and 
macrophages are themselves capable of stimulating further peroxidation of LDL, with 
die resultant formation of completely oxidized LDL (OxLDL) [Parthasarathy et al. 
1986]. OxLDL is recognized by scavenger receptors on macrophages, and is 
internalized to form foam cells [Henriksen et al. 1981]. The uptake of OxLDL is not 
subject to negative-feedback regulation, and therefore results in a massive uptake of 
cholesterol into the macrophages.
1.5.5.3 Atherogenic properties of OxLDL
Several other properties of OxLDL appear to make it more atherogenic than the native 
form [Steinberg 1995]. For example OxLDL is chemotactic for circulating monocytes 
[Quinn et al. 1988], and increases monocyte adhesion to the endothelium [Berliner et 
al. 1990] via enhancement of VCAM-1 expression by ECs [Khan et al. 1995]. OxLDL 
also inhibits the egress of monocytes from the arterial wall [Quinn et al. 1987]; as a 
result, once monocytes have crossed die endothelium they become trapped in the 
vessel wall. OxLDL is cytotoxic for vascular cells, including ECs [Steinberg et al. 
1989, Witztum and Steinberg 1991], and as a result promotes the release of lipids and 
lysosomal enzymes into the intimal extracellular space, enhancing the progression of 
lesion formation [Schwartz et al. 1991]. Furthermore, components of OxLDL can 
induce the production of IL-1 by foam cells [Lipton et al. 1995], suggesting a further 
pro-inflammatory role.
In addition to these actions, OxLDL inhibits endothelium-mediated arterial relaxation 
[Kugiyama et al. 1990] and degrades endothelium-derived NO directly [Chin et al.
1992]. Abnormalities in endothelium-derived relaxation have been shown to be 
associated with the occurrence of atherosclerosis [Ludmer et al. 1986], suggesting that 
the OxLDL-mediated impairment of vasodilation may itself be pro-atherogenic. 
Indeed the inactivation of NO by oxidative stress, and in particular by superoxide ions, 
appears to play an important role in vascular pathology generally [Cai and Harrison 
2000, Li and Shah 2004].
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The susceptibility of LDL to oxidation correlates with the severity of coronary 
atherosclerosis [Regnstrom et al. 1992]. Furthermore, LDL isolated from older 
subjects shows enhanced susceptibility to oxidation compared with that taken from 
younger subjects [Walzem et al. 1995], suggesting a link between ageing and altered 
susceptibility to atherosclerosis.
1.5.5.4 Other possible roles for oxidative stress in atherogenesis 
There are other mechanisms by which oxidative stress could promote atherosclerosis. 
These mechanisms may operate in addition to, rather than as alternatives to, the 
oxidation of LDL. The role of ROS in triggering pro-inflammatory intracellular 
pathways has already been mentioned (Section 1.5.2), and the resultant inflammation 
may promote atherogenesis. Oxidative stress can also trigger apoptosis, as mentioned 
earlier, and it has been suggested that apoptosis may contribute to the formation of the 
necrotic core of advanced atherosclerotic lesions [Rosenfeld 1998], and to plaque 
instability [Bennett 1999].
1.6 Experimental models of ageing
A variety of experimental models have been used to study ageing. This variety reflects 
the difficulty in finding a single model capable of reproducing all aspects of the human 
ageing process. This in turn is probably a reflection of the complexity of the 
pathobiological changes involved in human ageing. Experimental models have ranged 
from cell cultures to non-human primates. Pertinent results from cell culture 
experiments have been summarized above, and will not be discussed further here. 
Studies in yeast have provided valuable insights into mechanisms underlying cellular 
senescence, as was mentioned earlier in the context of the telomere position effect. 
Simple organisms such as the fruit-fly Drosophila melanogaster [Nusbaum et al.
1993] and the nematode Caenorhabditis elegans (C. elegans) have also been studied 
in detail. Both are composed, in their adult form, entirely of post-mitotic cells. Genes 
that extend the life-span of C. elegans have been identified [Kenyon 1996], and 
genetic manipulations of both organisms have been used to influence their ageing 
[Antebi et al. 1998, Rauskolb and Irvine 1999].
A multitude of vertebrates have been used in the study of the various aspects of 
ageing. They include mice, rats, rabbits, chickens, pigeons, woodchucks, cats, dogs, 
and non-human primates. Among these, mice have proved a particularly convenient
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model, as their natural life-span is approximately thirty times shorter than that of 
humans [Cristofalo 2001]. Some of these experimental models involve inbred or 
genetically modified strains.
One such strain is the ‘klotho’ mouse [Kuro-o et al 1997]. Mice homozygous for a 
mutation of the so-called ‘klotho gene’ show growth arrest at three to four weeks of 
age, and die prematurely at approximately nine weeks of age [Nagai and Nabeshima 
1997]. They exhibit various age-related pathologies, including skin atrophy, 
osteoporosis, pulmonary emphysema and cerebellar degeneration, and are being used 
extensively in ageing research. Their vasculature shows medial calcification and 
intimal thickening, as well as impairment of endothelium-dependent aortic 
vasodilatation [Saito et al. 1998]. The normal klotho gene encodes a membrane protein 
that shares some sequence homology with the (3-glucosidase enzymes of plants and 
bacteria. An insertional mutation results in severe under-expression of the usual gene 
product. A human homologue of the klotho gene has been isolated, and is situated on 
the q arm of chromosome 13 [Matsumura et al. 1998], a chromosome which contains a 
number of genes involved in cell growth and replication [Zhang et al. 2000].
Another mouse model of ageing is the senescence-accelerated mouse (SAM) [Takeda 
et al. 1981, Takeda et al. 1994b]. This model will be described in some detail, as these 
mice have been used extensively in experiments described in Chapter Four.
1.7 The senescence-accelerated mouse (SAM)
The SAM model has been developed since 1970, and consists of a group of genetically 
related inbred strains originally derived by selective brother-sister inbreeding at Kyoto 
University in Japan, from several pairs of AKR/J mice donated by the Jackson 
Laboratory (Bar Harbor, Maine, USA) in 1968 [Takeda et al. 1981, Takeda et al. 
1991, Hosokawa et al. 1997]. AKR mice have been studied for over forty years 
because of their propensity to develop lymphomas [Siegler and Rich 1963].
It was noticed during the maintenance of the newly-founded Japanese colony of 
AKR/J mice that certain litters appeared to age at an accelerated rate, and to have a 
reduced life-expectancy. This property proved to be inheritable. Five litters with such 
‘severe exhaustion’ were chosen as the progenitors of a series termed senescence- 
accelerated prone mice (SAM-P). Three other litters (also derived from the AKR/J 
mice) which were considered to show a normal ageing process, were selected as the
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progenitors of a series termed senescence-accelerated resistant mice (SAM-R). 
Selective brother-sister mating was performed within each series, using life-span data 
and a grading score of their ageing phenotype [Hosokawa 1994, Hosokawa et al. 
1997]. This grading system assessed the presence and severity of certain criteria 
believed to be associated with ageing: these included passivity of behaviour, hair loss 
and coarseness, skin ulceration, lordokyphosis, and the development of ophthalmic 
lesions (including peri-ophthalmic lesions and cataract formation) [Hosokawa et al. 
1984]. Mice exhibiting these features to the greatest extent were selected for further 
breeding to maintain the senescent phenotype within the SAM-P family, while SAM-R 
mice with the lowest scores were selected for mating.
SAM-P mice have a median life-span of between nine and eleven months, while 
SAM-R mice have a life-span similar to that of AKR/J mice, that is approximately 
nineteen months [Takeda et al. 1981, Takeda et al. 1994b]. These compare with an 
average life-span in wild-type laboratory mice of twenty-four to thirty months. Takeda 
et al. showed that the rate of decline of survival in SAM-P mice was greater with 
advancing age compared with the rate in SAM-R mice [Takeda et al. 1981]; after 
analysing body weights and the grading scores of senescence, they concluded that the 
manifestations of senescence in the SAM-P model did not occur during the animals’ 
developmental stage, but did occur in an accelerated manner following a normal 
development. They inferred that the SAM-P mice exhibited accelerated, rather than 
simply premature, ageing [Takeda et al. 1981]. While the grading score measuring the 
emergence of features of the senescent phenotype rose more steeply in SAM-P than 
SAM-R mice, the scores eventually levelled out: there was no difference between the 
two strains of mouse in the maximum level of total grading score, but SAM-P mice 
reached this maximum earlier than did SAM-R mice [Hosokawa et al. 1984].
The genetic determinants which originally gave rise to the SAM phenotype are not 
known. SAM mice show a low incidence of thymic lymphoma compared with AKR/J 
mice, and so it has been assumed that the genetic background of SAM mice must have 
deviated from that of their progenitors [Takeda et al. 1991]. Indeed analysis of 
biochemical and immunogenetic markers has confirmed genetic differences between 
SAM mice and their AKR/J ancestors. It has been deduced that inadvertent 
outbreeding is likely to have occurred around the time when the progenitors of the 
SAM-P and SAM-R series were selected and inbreeding was initiated [Hosokawa
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1994]. It is still not known which strain may have mated with the original AKR/J 
mice.
By 1994, selective inbreeding from the original SAM-P and SAM-R litters had led to 
the emergence of nine SAM-P sub-strains (SAM-P/1 - SAM-P/3 and SAM-P/6 -SAM­
P/11) and three SAM-R sub-strains (SAM-R/1, SAM-R/4 and SAM-R/5), other strains 
having failed to breed successfully [Takeda et al. 1994a]; these sub-strains were 
delineated by the emergence of certain biological characteristics, as shown in Table
1.1 overleaf.
SAM-P mice have been the subject of intensive research ever since their ageing 
phenotype was recognized. This is mainly because so many of their clinical features 
correspond to processes and pathologies often found in human ageing. Particularly 
noteworthy in this context are the development of osteoporosis, cataracts, senile 
amyloidosis and memory difficulties. Their study has been facilitated by the ready 
availability of a control group of mice, the SAM-R strain.
Interest in these mice has been compounded by the fact that they show abnormalities 
in their cell biology which may have aetiological relevance to their ageing phenotype. 
Thus they show abnormalities in both the replicative capacity of their cells, and in 
their oxidative status; these abnormalities will be discussed in detail in Chapter Four.
1.8 Animal models of atherosclerosis
Atherogenesis, like ageing, has been studied in several species. As might be expected, 
those species most closely related phylogenetically to man generally develop lesions 
most similar to those found in humans. These models include hypercholesterolaemic 
primates and swine [Ross 1986]. Such models, though, are not readily available 
experimental tools, nor the most appropriate for every type of study, for both ethical 
and technical reasons. Other species have also therefore been employed, though these 
do not always provide the most accurate models.
Mice are being used increasingly in the study of atherosclerosis. Their use has both 
advantages and disadvantages. Mice are relatively cheap, and readily obtainable. 
Powerful genetic tools are available in this species which are not applicable in 
otherwise more suitable models. On the other hand, mice are generally highly resistant 
to atherogenesis [Witztum 1993, Breslow 1996], and there are important differences 
between humans and mice in terms of their lipid metabolism: for example, mice lack
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Table 1.1 Pathologies in SAM sub-strains
Strain Pathological phenotype
SAM-P strains
SAM-P/1 Senile amyloidosis, impaired immune response, lung hyperinflation, 
hearing impairment
SAM-P/2 Senile and secondary amyloidosis, impaired immune responsiveness
SAM-P/3 Degenerative joint disease of temperomandibular joint
SAM-P/6 Senile osteoporosis
SAM-P/7 Senile amyloidosis, thymoma
SAM-P/8 Deficits in learning and memory
SAM-P/9 Cataract formation
SAM-P/10 Brain atrophy, deficits in learning and memory
SAM-P/11 Senile amyloidosis, contracted kidney
SAM-R strains
SAM-R/1 Non-thymic lymphoma and histiocytic neoplasm
SAM-R/4 Non-thymic lymphoma and histiocytic neoplasm
SAM-R/5 Nil
Table 1.1 SAM sub-strains were distinguished and defined according to their 
lineage and according to certain specific pathologies. SAM-P/1, SAM-P/2 and SAM­
P/3 sub-strains were developed directly from the original AKR/J mice donated to 
Kyoto University; SAM-P/6 and SAM-P/9 sub-strains were developed from a SAM-R 
sub-strain (SAM-R/3) which subsequently failed to breed successfiilly. SAM-P/7 and 
SAM-P/8 sub-strains were developed from the SAM-P/1 and SAM-P/2 sub-strains 
respectively, while SAM-P/10 and SAM-P/11 sub-strains were developed from SAM­
P/3 mice. SAM-R/1 mice were developed directly from the AKR/J mice, and 
subsequently were progenitors of a genetically distinct sub-strain, SAM-R/4. SAM- 
R/5 mice were developed from a SAM-P sub-strain (SAM-P/4) which subsequently 
failed to breed successfully.
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certain metabolic components, including cholesteryl ester transfer protein and 
apolipoprotein A, which are found in humans.
1.8.1 The C57BL/6 mouse
Of the inbred murine strains, the C57BL/6 mouse is the most prone to an atherogenic 
process [Paigen et al. 1985], and females are more susceptible than males. To provoke 
atherosclerosis, even C57BL/6 mice must be fed a highly unphysiological diet, 
containing not only ten to twenty times the level of cholesterol found in a Western- 
type diet, but also the unphysiological constituent cholic acid [Paigen et al. 1985]. 
Furthermore, the atheromatous lesions found in C57BL/6 mice occur only in the 
portion of the aorta adjacent to the aortic valve leaflets, rather than throughout the 
vascular tree. The lesions resemble the fatty streaks found in early human 
atherogenesis, and do not progress to more advanced stages such as fibrous cap 
formation. No coronary artery lesions have been demonstrated in C57BL/6 mice, nor 
any propensity for lesions to form at bifurcation points [Paigen et al. 1985]. There are 
therefore concerns that the atherogenesis instituted in C57BL/6 mice fed a very high- 
fat diet may not be a valid model of human atherogenesis.
1.8.2 The LDL-receptor deficient mouse
Other strains of mice which show more marked atherogenesis have been developed 
through genetic manipulations resulting in alterations of lipoprotein metabolism. LDL- 
receptor deficient mice develop fatty streaks when fed a Western-type diet [Palinski et 
al. 1995]. These lesions progress to a comparatively advanced stage, including the 
formation of a lipid-filled necrotic core capped with foam cells, when mice are fed a 
high-fat, cholic acid-containing diet [Ishibashi et al. 1994]. These mice do not develop 
lesions when fed a low-cholesterol, low-fat diet.
1.8.3 The apoE-deficient mouse
Mice deficient in apolipoprotein E, so called apoE-deficient mice, are yet more prone 
to atherosclerosis [Plump et al. 1992, Zhang et al. 1992]. Apo-E usually serves as a 
ligand through which lipids are cleared from the plasma via receptor-mediated 
pathways in the liver [Zhang et al. 1994]. Apo-E-deficient mice show spontaneous and 
very marked hypercholesterolaemia even when fed a low-fat diet [Plump et al. 1992, 
Zhang et al. 1992]. Furthermore they develop fatty streak lesions which can progress 
to fibrous plaques, even on a low-fat, low-cholesterol diet free of cholic acid
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[Nakashima et al. 1994, Reddick et al. 1994]. These lesions occur throughout the 
arterial tree, and their progression is faster when the mice are fed a Western-type diet 
[Breslow 1993, Witztum 1993].
1.8.4 Rats
Turning to other animal models, rats do not tend to be used for the study of 
atherosclerosis, as few studies have shown atheromatous plaques in this species. 
However, some research using cholesterol-fed rats has contributed to our 
understanding of the role of macrophages in atherogenesis [Joris et al. 1983].
1.8.5 Rabbits
Rabbits, in contrast, provide a useful model of early atheromatous lesions. Although 
normal rabbits do not develop atherosclerosis on a standard diet, administration of a 
high-fat diet does lead to lesion development in the aorta within a few weeks [Walker 
et al. 1986, Davies and Woolf 1993]; these lesions contain lipid which is almost 
entirely contained by foam cells, and are thus more similar to fatty streaks than to 
advanced plaques; a lipid core is not seen, and there is no evidence of plaque rupture. 
More advanced lesions are seen in rabbits which possess hereditary defects in their 
lipid metabolism. In WHHL rabbits, a defect in the LDL receptor causes an inability to 
bind this lipoprotein, resulting in a marked elevation of serum LDL. This reflects the 
aetiology of the human condition familial hypercholesterolaemia. In these rabbits, a 
less unphysiological diet is required to initiate lipid lesion formation than in wild-type 
rabbits, and the resultant lesions are relatively advanced, containing a lipid core [Buja 
et al. 1990]. WHHL rabbits have also proved useful in highlighting the early role of 
monocytes in fatty streak formation [Rosenfeld et al. 1985].
1.8.6 Pigs
Atherosclerosis in pigs has been studied extensively, partly because porcine coronary 
artery atheromatous lesions are morphologically similar to those found in man [French 
et al. 1965]. Studies in hypercholesterolaemic swine have also been helpful in 
elucidating the role of monocytes in atherogenesis, including their evolution into foam 
cells, and their cellular interactions [Gerrity et al. 1979, Gerrity 1981].
1.8.7 Non-human primates
The use of non-human primates has already been mentioned in relation to studies 
exploring the role of ageing as an independent risk factor for atherosclerosis (Section
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1.2.3). Cholesterol-fed monkeys certainly provide a useful model, developing lesions 
with close similarities to human atherosclerosis [Wissler and Vesselinovitch 1977, 
Faggiotto and Ross 1984].
1.8.8 Denudation models
Many studies, using several species, have involved mechanical injury to the luminal 
surface of the arterial wall. Such research has sought to derive insights into clinical 
phenomena including atherosclerosis and post-angioplasty re-stenosis, and into the 
effect of certain interventions such as the administration of antioxidants. A denudation 
model has been used in work described later in this thesis, and more detail about such 
models is provided in Chapter Three.
1.9 Aims of the studies described
The overall aim of this thesis is to explore the relationship between ageing and 
cardiovascular disease. Two animal models have been used to study ageing at both an 
organismic and a cellular level, in particular with regard to the inter-relationship 
between ageing and atherosclerosis.
In the first model, which involves endothelial denudation of rabbit carotid arteries, the 
aim has been to find direct evidence that replicative senescence can occur in the 
vasculature. As has been described above, such evidence has remained elusive. It is 
known that endothelial denudation injuries are followed by a marked cellular 
proliferative response. It is hypothesized here that such proliferative activity may lead 
to the emergence of senescent cells. If vascular cells can indeed senesce in vivo, this 
could have implications for the pathophysiology of human atherosclerotic lesions.
In the second model, the susceptibility of SAM mice to develop atheromatous lesions 
is studied. If ageing is an independent risk factor for atherogenesis, mice which age in 
an accelerated manner might be expected to show a greater propensity to atheromatous 
lesion formation than mice which age at a normal rate.
By studying these two models, the aim of this thesis is to obtain more insight into the 
relationships between organismic and cellular ageing and atherosclerosis.
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CHAPTER TWO
Materials and Methods
2.1 Materials
2.1.1 Antibodies
Alkaline phosphatase-conjugated goat anti-mouse immunoglobulin (Ig) 
Biotinylated F(Ab’)2 fragment of rabbit anti-mouse Ig 
Biotinylated rabbit anti-rat Ig
Mouse anti-Aspergill us niger (A. niger) glucose oxidase IgGi, clone DAK-GOl
Mouse anti-A niger glucose oxidase IgG2a, clone DAK-G05
Mouse anti-A niger glucose oxidase IgG2t>, clone DAK-G09
Mouse anti-CD31, clone JC/70A
Mouse anti-PCNA, clone PC 10
Mouse anti-rabbit CD45, clone LI2/201
Mouse anti-smooth muscle actin, clone 1A4
Rat anti-mouse macrophages/monocytes, clone MOMA-2
Rat IgG2b negative control, clone LO-DNP-11
Dako Ltd, UK 
Dako Ltd, UK 
Dako Ltd, UK 
Dako Ltd, UK 
Dako Ltd, UK 
Dako Ltd, UK 
Dako Ltd, UK 
Dako Ltd, UK 
Serotec, UK 
Dako Ltd, UK 
Serotec, UK 
Serotec, UK
2.1.2 Kits and reagents used in histology, immunostaining and apoptosis studies
2.1.2.1 Kits
In Situ Cell Death Detection Kit 
Liquid DAB Plus Kit
New Fuchsin Chromogenic Substrate System Kit
2.1.2.2 Reagents
4\6-diamidino-2-phenylindole (DAPI) in Vectashield™ mounting medium for fluorescence
‘Distrene-80’, Plasticizer, and Xylene (DPX) mounting medium
Fast red TR/Napthol AS-MX
Glycergel™ mounting medium
Hexane
Levamisole
OCT™ compound
Oil red O
Serum-free protein-blocking agent 
Streptavidin-conjugated alkaline phosphatase 
Streptavidin-conjugated horseradish peroxidase 
VECTABOND™ reagent
Boehringer Mannheim, Germany 
Dako Ltd, UK 
Dako Ltd, UK
Vector Laboratories Inc, USA
BDH Lab Supplies, England
Sigma Chemical Co., UK
Dako Ltd, UK
BDH Lab Supplies, England
Dako Ltd, UK
RA Lamb Ltd, UK
BDH Lab Supplies, England
Dako Ltd, UK
Dako Ltd, UK
Dako Ltd, UK
Vector Laboratories Inc, USA
X-Gal (5-bromo-4-chloro-3-indolyl P-D-galactopyranoside)
Xylene
2.1.3 Kits and reagents used in cell culture and telomere studies
2.1.3.1 Kits 
184 Elastomer kit
TeloQuant™ Telomere Length Assay Kit
2.1.3.2 Reagents
Hanks balanced salt solution (HBSS)
Lambda ladder pulsed field gel (PFG) marker 
Low melting point (LMP) agarose 
Mbo I restriction endonuclease 
Modified Puck’s saline A 
Phenylmethylsulphonyl fluoride (PMSF)
Trypsin Neutralising Solution
Versene (supplied as a 0.53 M solution in isotonically buffered saline)
Sigma Chemical Co., UK 
BDH Lab Supplies, England
BDH Lab Supplies, England 
Pharmingen, USA
Clonetics Corp., UK
New England Biolabs Inc., USA
Gibco BRL, UK
Gibco BRL, UK
Gibco BRL, UK
Sigma Chemical Co., UK
Clonetics Corp., UK
Gibco BRL, UK
2.1.4 Other kits, reagents and drugs
2.1.4.1 Kits
HDL-Cholesterol Direct cassette 
INFINITY™ Cholesterol Reagent 
INFINITY™ Triglycerides Reagent
2.1.4.2 Reagents
ACCUSET® Liquid Calibrator (A 2539) 
Cardiolipin controls (C4571 and C4696)
2.1.4.3 Drugs 
Buprenorphine 
Ltd, USA
Roche, Switzerland 
Sigma Diagnostics 
Sigma Diagnostics
Sigma Chemical Co., UK 
Sigma Chemical Co., UK
Reckitt and Colman Products
Phoenix Pharmaceuticals Ltd USA 
Bayer AG, Germany 
Janssen Animal Health, Belgium 
Rh6ne M^rieux Ltd, France
Chemical Co., UK, or from BDH Lab
Diazepam 
Enrofloxacin 
Fentanyl/fluanisone 
Sodium pentobarbital
Other chemicals were purchased at least at analytical grade, and were purchased from Sigma 
Supplies, England.
2.1.5 Buffers, solutions and media
2.1.5.1 Buffers
Lvsis buffer for telomere study: 0.5 M EDTA pH 8.0, 2% Sarkosyl, 2 mg/ml 
proteinase K
Phosphate-buffered saline fPBS): Dulbecco’s PBS (IX), without calcium, without 
magnesium (Gibco BRL, UK) containing 0.2 g/L potassium chloride, 0.2 g/L 
monobasic potassium phosphate, 8 g/L sodium chloride, 1.15 g/L dibasic sodium 
phosphate.
10 x PBS: Dulbecco’s PBS (10X), without calcium, without magnesium (Gibco BRL, 
UK) containing 2 g/L potassium chloride, 2 g/L monobasic potassium phosphate, 80 
g/L sodium chloride, 21.60 g/L Na2HPC>4.7H20.
0.2 M phosphate buffer: 0.2 M sodium dihydrogen phosphate, 0.2 M disodium 
hydrogen phosphate, pH 7.4. The buffer was stored in the dark at 4°C for up to 3 
months.
0.5 x TBE (tris base boric acid EDTA buffer): 45 mM Tris base, 45 mM boric acid, 1 
mM EDTA, pH 8.0.
Tris-buffered saline (TBSV 50 mM Tris base, 150 mM sodium chloride, pH 7.6. 
Tris-EDTA (TE1 buffer: 10 mM Tris-HCl, 1 mM ethylenediamine tetra acetic acid 
(EDTA), pH 8.0.
2.1.5.2 Solutions
1% acid alcohol: 1 ml concentrated hydrochloric acid in 99 ml 70% ethanol. 
B-galactosidase staining solution (pH 6.0 or 4.01: 5 mM potassium ferrocyanide, 5 mM 
potassium ferricyanide, 150 mM sodium chloride, 2 mM magnesium chloride, and 40 
mM trisodium citrate, titrated either to pH 6.0 with sodium dihydrogen phosphate, or 
to pH 4.0 with orthophosphoric acid. Solutions titrated to pH 6.0 or pH 4.0 were stored 
at 4°C protected from light, for up to 3 months.
Eosin solution: 1% (w/v) eosin in distilled water.
Harris’ haematoxvlin solution: 0.375% (w/v) haematoxylin monohydrate, 7.5% (w/v) 
ammonium alum, 0.225% (w/v) yellow mercuric acid, 0.4% (v/v) glacial acetic acid, 
the balance made up with distilled water.
1% LMP agarose: 1 g LMP agarose was dissolved in 100 ml PBS, then heated in a 
microwave oven to 50°C. The solution was prepared immediately prior to use.
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Neutral buffered formalin: 4% formaldehyde, 0.1 M sodium dihydrogen phosphate, 
0.1 M disodium hydrogen phosphate, pH 7.4. Stored at RT, and used within 1 month. 
Oil red O stock solution: 1 g Oil red O dissolved in 1 litre of isopropanol in a long­
necked flask over a water-bath at 56°C for 60 min. The solution was cooled to RT, and 
stored for up to 6 months at room temperature (RT) in an air-tight bottle.
Oil red O staining solution: 3 parts Oil red O stock solution were mixed with 2 parts 
distilled water, and left to stand for 5 min at RT. The mixture was filtered, and used 
immediately.
8% paraformaldehyde stock solution: 40 g paraformaldehyde (PFA) dissolved in 400 
ml of distilled water at 80°C, then cooled to room temperature (RT). pH adjusted to 
7.4, and volume made up to 500 ml with distilled water. The stock solution was 
filtered and stored in the dark at 4°C for up to 1 month.
2% or 4% paraformaldehyde / 0.1 M phosphate buffer: These solutions were prepared 
on the day of use, by dilution of the 8% paraformaldehyde stock solution with 
appropriate volumes of 0.2 M phosphate buffer and distilled water. The pH of the final 
solution was re-checked at RT, and if necessary re-adjusted to 7.4.
PMSF working solution: 40 mg PMSF dissolved in 1 ml of isopropanol, then diluted 
1000-fold in TE buffer (pH 8.0), yielding a final concentration of PMSF of 40 pg/ml. 
The solution was prepared immediately prior to use.
Scott’s tap water: 0.35% (w/v) sodium bicarbonate, 2% (w/v) magnesium sulphate.
20 x standard saline citrate (SSCf: 3 M sodium chloride, 0.3 M Na3 citrate.2H20, 
adjusted to pH 7.0 with hydrochloric acid.
1 x SSC / 0.1% sodium dodecvl sulphate (SDSV 50 ml of 20 x SSC, 10 ml of 10% 
SDS, 940 ml distilled water.
30% sucrose / 0.1 M phosphate buffer: 60 g sucrose dissolved at 80°C in 100 ml of 0.2 
M phosphate buffer made up to a final volume of 200 ml with distilled water. The 
solution was cooled to RT, and the pH adjusted to 7.4. It was then stored in the dark at 
4°C for up to 1 month.
Trypsin-EDTA for ECs: 0.025% trypsin / 0.01% EDTA (Clonetics Corp., UK), stored 
at 4 °C.
Trypsin-EDTA for VSMCs: 0.5 g trypsin / 0.2 g EDTA per litre of modified Puck’s 
saline A.
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X-Gal stock solution: 100 mg X-Gal dissolved in 5 ml dimethylformamide (DMF), 
stored in a glass bottle, protected from light, at -20°C for up to 1 month. Since DMF 
can dissolve plastic, DMF and the X-Gal stock solution were pipetted using 
polypropylene tips.
X-Gal working solution (pH 6.0 or 4.01: This solution was prepared immediately prior 
to use. 1 ml of X-Gal stock solution was added to 19 ml of (3-galactosidase staining 
solution (see above) of the required pH (yielding a 1 mg/ml final concentration of X- 
Gal). The mixture was filtered (0.22 pm) prior to use.
2.1.5.3 Media
All cell culture media were stored at 4°C.
Dulbecco’s modified Eagle’s medium (DMEM) with 3.7 g/L sodium bicarbonate 
buffer and 0.11 g/L sodium pyruvate (Gibco BRL. UK)
DMEM buffered with 20 mM Hepes. pH 7.4 (ICN Biomedicals Ltd, UK)
Endothelial cell growth medium (EGM) culture medium: Modified MCDB 131 
medium supplemented with 10 ng/ml human recombinant epidermal growth factor, 1 
pg/ml hydrocortisone, 50 pg/ml gentamicin, 50 ng/ml amphotericin B, 12 pg/ml 
bovine brain extract, and 2% (v/v) foetal bovine serum (EGM, Clonetics Corp., UK). 
Dissecting medium for rabbit aortas: DMEM buffered with 20 mM Hepes, pH 7.4 
(ICN Biomedicals Ltd, UK) supplemented with 10% foetal calf serum (FCS), 0.1 mM 
non-essential amino acids, 1 mM sodium pyruvate, 8 mM L-glutamine, 100 U/ml 
penicillin and 100 pg/ml streptomycin.
VSMC culture medium: DMEM with 3.7 g/L sodium bicarbonate buffer and 0.11 g/L 
sodium pyruvate (Gibco BRL, UK), supplemented with 20% FCS, 0.1 mM non- 
essential amino acids, 1 mM sodium pyruvate, 4 mM L-glutamine, 100 U/ml penicillin 
and 100 mg/ml streptomycin.
2.1.6 Diets
Mouse breeding and maintenance diet (TRM9607): Harlan Teklad, UK 
(composition: wheat, maize, wheatfeed, HiPro soya, barley, white fishmeal, dry whey, 
lucerne, dried brewer’s yeast, limestone, soya oil, iodised salt, magnesium oxide, 
mineral and vitamin supplements, methionine, lysine; yielding in g/kg on proximate 
analysis: crude oil (i.e. fats) 43, crude protein 190, crude fibre 40, cholesterol 0.023. 
Therefore contains 4.3% fat by weight, 0.0023% cholesterol by weight.
Mouse Western Adjusted Calories diet (TD88137): Harlan Teklad, UK 
(composition (g/kg): casein 195, DL-methionine 3.0, sucrose 341.46, com starch 
150.0, anhydrous milkfat 210.0, cholesterol 1.5, cellulose 50.0, mineral mix (AIN-76, 
170915) 35.0, calcium carbonate 4.0, vitamin mix (Teklad 40060) 10.0, ethoxyquin 
0.04. Therefore contains 21% fat by weight, 0.15% cholesterol by weight.
Guinea pig breeder and maintenance diet (RGP1 (used as the standard diet for rabbits 
studied in the experiments describedV. Special Diets Service, UK, supplied by Lillico 
Biotechnology, UK
(contains barley, wheatfeed, oats, linseed cake, fish meal, grass meal, vitamins, major 
minerals, trace minerals, amino acids; yielding, in g/kg on proximate analysis: cmde 
oil 33, cmde protein 187, cmde fibre 83)
2.2 Methods
2.2.1 Home Office Licences for animal research described in this thesis
All animal work described in this project was performed under Home Office Personal 
Licence number 70/14118. The project involving denudation of rabbit carotid arteries 
was performed under Home Office Project Licence number 70/4540. The breeding and 
maintenance of the colony of senescence-accelerated mice was carried out under 
Home Office Project Licence number PPL70/4336, as were the subsequent 
experiments involving this colony and C57BL/6 mice. All experiments involving 
animals were performed in full compliance with the Animals (Scientific Procedures) 
Act 1986, and in accordance with Home Office and University College London (UCL) 
guidelines.
2.2.2 In vitro cell senescence studies
2.2.2.1 Culture of HUYECs
First passage cryopreserved HUVECs were purchased commercially, and cultured in
EGM culture medium at 37°C under 5% C02/95% air in a humidified incubator. Cells
were plated in six-well plates (Falcon, Becton-Dickinson, UK), at a seeding density of 
2 m
2,500 cells/cm , and the medium was replaced the day after seeding, and subsequently 
every 48 h. At each passage, the number of cells in the medium removed the day after 
seeding was counted, and was used to calculate the attachment efficiency, using the
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following formula: attachment efficiency = [number of cells seeded -  number of cells 
in the removed medium] / [number of cells seeded]. In most passages, the attachment 
efficiency was > 0.9.
The cells were grown to confluence (as assessed by light microscopy), and were 
passaged after trypsinization at weekly intervals: the EGM culture medium was 
aspirated, and the cells washed in HBSS at RT; cells were then covered with trypsin- 
EDTA for ECs, and the plates were agitated for 5 min at RT; when cells appeared 
ready to detach, the plates were tapped to release the majority of cells from the culture 
surface; the trypsinization reaction was terminated by the addition to each well of 
Trypsin Neutralising Solution at RT, at a volume equal to that of the trypsin-EDTA in 
the well; the detached cells were transferred to a sterile 25 ml centrifuge tube; the 
plates were rinsed with HBSS to collect residual cells, and this rinse was added to the 
centrifuge tube; the harvested cells were spun at 220 g  for 5 min (using centrifuge 
model CR422, Jouan, France) to form a cell pellet; to this pellet 4 to 5 ml of EGM 
culture medium was added, and the cells were counted using a haemocytometer 
(Neubauer, Germany); volumes of EGM were then adjusted so that cells could be re­
seeded at 2500 cells/cm2. The number of cumulative population doublings (CPDs) 
prior to each passage was calculated from cell counts, employing the formula CPD = 
log2 ([number of cells harvested] / [number of cells seeded x attachment efficiency]).
2.22.2 Establishment of rabbit VSMC cultures
VSMCs were obtained from the thoracic aortas of New Zealand White (NZW) rabbits 
by the explant technique [Stavri et al. 1995, Southgate and Newby 1990, McMurray et 
al. 1991]. An adult male NZW rabbit (Charles River UK Ltd, Kent, UK) was killed by 
an intravenous overdose (280 mg/kg) of sodium pentobarbital, and the aorta (from the 
level of the aortic arch to the origins of the renal arteries) was surgically removed 
using an aseptic and non-traumatic technique. The aorta was placed in the dissecting 
medium for rabbit aortas (detailed above) in a sterile tissue culture plate. The 
procedure was then continued in a tissue culture room under a Class II tissue culture 
hood. Extraneous adventitial tissue was removed using a scalpel, and the vessel was 
pinned, luminal side up, to a layer of set Sylgard™ encapsulating resin (prepared 
using the 184 Elastomer kit, BDH, following the manufacturer’s instructions). The 
aortic endothelium was then removed by gentle abrasion with a cell scraper. Squares 
of media (approximately 1 cm x 1 cm) were cut using a scalpel and forceps. These
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squares were divided into regular 1 mm squares using a Mcllwain tissue chopper 
(Mickle Lab Engineering Co. Ltd, UK).
The resultant explants were washed three times in VSMC culture medium, and plated 
into 100 mm tissue culture plates. Each explant was incubated with 1 ml of VSMC 
culture medium overnight at 37°C under 5% CC>2/95% air. To those wells where the 
medial explants had successfully attached to the underlying plastic of the plate, 10 ml 
of VSMC culture medium were added, and the explants were incubated for a further 
seven to fourteen days in the tissue culture incubator, until the cultures were semi­
confluent. The cell cultures were then trypsinized: the plates were washed three times 
with Versene at 37°C; 2 ml of trypsin-EDTA for VSMCs was added to each plate, and 
the plates were agitated for 5 min at RT; the reaction was terminated by the addition to 
each plate of 10 ml of VSMC culture medium; the cells were then pipetted into a large 
tissue culture flask. The cells were counted with a haemocytometer, and diluted with 
VSMC culture medium to give a final concentration of approximately 50,000 cells per 
ml. The cells were seeded into new 100 mm tissue culture plates at a density of 
approximately 5 x 105 cells / plate. These cells usually re-attached after six to eight 
hours. After two days (by which time the seeded cells had begun to proliferate), the 
culture medium was replaced, in order to remove any residual explants carried over 
with trypsinization, and to remove dead cells. The cultures usually reached confluence 
four to five days after plating. Cultures were then trypsinized again and serially 
passaged.
All staining experiments were carried out on confluent cells.
2.2.2.3 Staining of cell cultures for (3-galactosidase activity
Cultures of either HUVECs or rabbit VSMCs were washed twice in PBS, and fixed for 
3 min at RT with 3% PFA in PBS. After two washes in PBS, cells were incubated for 
24 h in X-Gal working solution at 37°C, titrated to either pH 4.0 (for acid p-gal 
activity) or pH 6.0 (for SA-p-gal) as specified in each experiment described. 
Following the incubation, cells were washed once in double-distilled water (DDW), 
dehydrated by passing through graded ethanol solutions (1 min in each of 75, 95 and 
100% ethanol solutions), and then air-dried. Cells were viewed under phase contrast or 
bright-field illumination, using an Axiovert 25 CFL inverted microscope (Carl Zeiss, 
Germany). SA-P-gal staining was quantified by manual counting: each tissue culture
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dish was divided into quarters, and 125 cells were counted in each quarter using a cell 
counter; the percentage of these 500 cells containing blue precipitate was then 
calculated. Representative fields were photographed under the inverted microscope, 
using Kodak Ektachrome 64T colour positive film. In some cases, cultured cells were 
photographed directly in X-Gal working solution.
2.2.2.4 SA-(3-gal and CD31 double-staining
Ethanol-dehydrated SA-(3-gal-stained HUVECs were incubated in a humidified 
chamber at RT for 30 min in a 1:20 dilution of mouse anti-CD31 monoclonal antibody 
(MoAb) in TBS. Parallel cultures were incubated in an equivalent concentration of 
isotype-matched (IgGi) mouse anti-A. niger glucose oxidase MoAb, clone DAK-GOl. 
Cultures were then washed three times in TBS before a 30 min incubation with a 1:20 
dilution of alkaline phosphatase-conjugated goat anti-mouse immunoglobulin. After 
three further washes in TBS, phosphatase activity was visualized using the Dako New 
Fuchsin Chromogenic Substrate System, according the manufacturer’s instructions: 
equal volumes of the chromogen and an activating solution were mixed together, 
along with buffered substrate, and with levamisole, an inhibitor of endogenous 
alkaline phosphatase activity; the cultures were incubated for 5 min in darkness with 
the resulting substrate solution. This solution was removed, and the cells were washed 
three times in TBS. The cells were mounted under coverslips using the aqueous 
mountant Glycergel™. The cells were viewed under bright-field illumination, and 
photographed as described in the previous paragraph.
2.2.3 Studies of cell senescence in rabbit carotid arteries
2.2.3.1 Acquisition and maintenance of rabbits
Male NZW rabbits weighing between 2.5 and 3.0 kg were obtained from Charles 
River UK Ltd. These rabbits were between sixteen and seventeen weeks old. Rabbits 
were delivered to UCL one week prior to the first planned experimental procedure, to 
allow them time to acclimatize to their new environment. They were housed and 
maintained in standard conditions: rabbits were housed in individual cages, under 
temperature control (16 to 20°C) and under a 12-hour light/dark cycle. A standard diet 
(Special Diet Services guinea pig breeder and maintenance diet, ‘RGP’, detailed 
above), containing 3.3% fat by weight, was provided ad libitum, as was drinking 
water.
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2.2.3.2 Denudation of rabbit carotid arteries
Prior to each denudation procedure, each rabbit was weighed to allow calculation of 
appropriate anaesthetic doses. Fentanyl/fluanisone was given intramuscularly at a dose 
of 0.3 ml/kg. Diazepam (2 mg/kg) was then administered intravenously via the 
marginal ear vein, while the respiratory rate of the rabbit was observed for evidence of 
excessive respiratory depression. Where necessary, anaesthesia was ‘topped up’ by 
giving a further 0.1 ml/kg of fentanyl/fluanisone after 45 min. Enrofloxacin (10 
mg/kg) was administered subcutaneously as prophylaxis against infection.
The depth of anaesthesia was judged by assessing the pupillary light reflex, and the 
withdrawal response to gentle pinching of the rabbit paw. When the rabbit was fully 
anaesthetized, it was placed supine on an operating table, and its neck was shaved to 
reduce the risk of wound contamination. The rabbit was covered with surgical drapes, 
and kept warm by use of a heated pad below the animal. The animal’s arterial oxygen 
saturation and pulse rate were monitored at five-minute intervals using a pulse 
oxymeter (IMS, UK) attached to a hind-paw.
All surgery was performed using aseptic technique. A midline incision (approximately 
3 cm in length) was made in the rabbit’s neck using a scalpel, and the subcutaneous 
tissues were divided by blunt dissection. The longitudinal strap muscles were incised 
in the midline to expose the trachea. The right and left common carotid arteries were 
identified, exposed, and held in silastic slings, taking care to minimize handling of the 
vessels. The right common carotid artery was gently clamped, and an arteriotomy was 
made in the vessel using an ophthalmic ‘beaver blade’, distal to the clamp. A deflated 
embolectomy catheter (size 2F) (Mantis Surgical Ltd, UK) was inserted via the 
arteriotomy, and passed 5 cm distally (i.e. cephalically) along the arterial lumen. The 
balloon of the catheter was then inflated using 0.5 ml of normal saline, and smoothly 
withdrawn towards the arteriotomy site. When the balloon became visible at the 
arteriotomy site, it was deflated, re-advanced 5 cm cephalically, re-inflated, and 
withdrawn again to the arteriotomy site. The deflation, advance, inflation and 
withdrawal sequence was performed for a third time, before the balloon was finally 
withdrawn entirely from the artery. While the artery was held under tension using the 
silastic sling, the arteriotomy incision was closed using a 6/0 proline stitch. The left 
common carotid artery was then raised from the surrounding tissue in its silastic sling, 
and the external surface of the artery was gently manipulated with a pair of surgical
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forceps, to an extent deemed equivalent to the earlier external manipulation of the 
right common carotid artery. The silastic slings around each carotid artery were 
removed, and both common carotid arteries were observed for a few seconds, to check 
for the presence of pulsatile flow. Muscle and fat layers were then surgically closed 
using 3/0 vicryl, and the skin was closed using a subcuticular suture.
The rabbit was given buprenorphine (0.3 mg/kg) subcutaneously for post-operative 
analgesia. The rabbit was then allowed to recover spontaneously from anaesthesia, 
with fresh bedding in its cage. The animal would usually wake within 30 min of the 
procedure, and start eating and drinking within an hour.
As will be described in Chapter Three, the denudation procedure described here was 
performed either once, or on two separate occasions separated by a six-week interval. 
For each animal both carotid arteries were harvested six weeks after the final 
denudation procedure had been performed.
2.2.3.3 Harvesting of rabbit carotid arteries
Each rabbit was prepared for surgery and anaesthetized as described in the above 
section. Once the animal was fully anaesthetized, its neck and thorax were opened 
surgically via a midline incision, in order to expose the carotid arteries, the heart and 
the great vessels. The common carotid arteries were identified, and a silastic sling 
placed around each. Sodium pentobarbital was then given intravenously at a lethal 
dose (280 mg/kg). The descending thoracic aorta was immediately clamped, and 50 ml 
of PBS (pH 7.4) was injected into the left ventricle of the heart, using a syringe and a 
wide-bore needle. This was immediately followed by the injection of 500 ml of 2% 
PFA in PBS at RT, which was injected into the left ventricle over a 20 min period, 
using 50 ml syringes. After the first 50 ml of PFA had been injected, the inferior vena 
cava was divided with a scalpel, to allow excess fluid to be released from the 
vasculature. When the entire 500 ml of fixative had been injected, the arteriotomy site 
in the right common carotid artery was identified (by identifying the 6/0 proline suture 
used for its closure), and the 5 cm portion of artery distal to this site was excised with 
a scalpel. The equivalent portion of the left common carotid artery was also excised.
2.2.3.4 Processing of rabbit carotid arteries, and staining for p-gal activity
The subsequent processing of the harvested carotid arteries is illustrated in Figure 2.1 
overleaf.
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Figure 2.1 Processing of excised rabbit carotid arteries
Portion of carotid artery 
excised, 
rinsed and trimmed. 
Then divided into two 
sections using a scalpel
Snap-frozen in liquid 
nitrogen, and stored at -80°C. 
Cross-sections later stained 
with H&E for morphological 
analysis
P-galactosidase 
staining 
at pH 6.0 (SA-p-gal)
/
p-galactosidase staining 
at pH 4.0 (acid p- 
galactosidase)
i
Eosin-stained cross- 
sections used for 
morphometric studies 
and injury scoring
Cross-sections used for 
immunohistochem istry 
and TUNEL analysis
Frozen sections 
counter-stained with 
eosin
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The excised portion of each artery was trimmed of excess peri-adventitial fat using a 
scalpel and forceps, and rinsed in ice-cold PBS. This tissue was then divided 
transversely into two sections of approximately equal length using a scalpel.
One section was placed in a cryovial, snap-frozen in liquid nitrogen, and stored at -80 
°C; cross-sections from this tissue were subsequently stained with haematoxylin and 
eosin (H&E) in order to study the morphology of the injured arteries (described below 
in Section 2.2.3.6).
The other section was used for detection of P-galactosidase activity. This section was 
immersed in freshly-prepared X-Gal working solution (prepared as described above) 
titrated to pH 6.0, and incubated in this solution for 24 h at 37°C. (In some 
experiments, one end of this section was cut away and placed instead in working 
solution titrated to pH 4.0, in order to detect acid p-gal activity). After the incubation 
in X-Gal working solution, the section of artery was removed, rinsed in ice-cold PBS, 
placed in a cryovial, and snap-frozen in liquid nitrogen. This tissue was then stored at - 
80°C for subsequent morphometric, immunohistochemical and terminal 
deoxynucleotidyl transferase-mediated X-dUTP nick end labelling (TUNEL) analysis.
2.2.3.5 Preparation of arterial cross-sections for further analysis 
Carotid artery tissue which had been incubated in X-Gal working solution titrated to 
pH 6.0, and then stored at -80°C, was brought to -20°C in the cutting chamber of a 
cryostat (5030 Microtome, Bright Instruments Ltd, UK). It was mounted in OCT™ 
compound on the cryostat chuck, so that the long-axis of the vessel was perpendicular 
to the upper surface of the chuck. Serial 10 pm cryostat cross-sections of the OCT™- 
embedded tissue were cut until it was evident that the cryostat blade was cutting 
complete transverse cross-sections of the arterial wall. Because of the possibility that 
the outer ends of the excised arteries might have been subjected to a degree of crush 
injury during cutting with the scalpel, the first 20 complete cryostat cross-sections 
from each artery were discarded and not analysed. The next 100 cross-sections were 
then cut, and placed alternately on two sets of plain histology slides (BDH Lab 
Supplies, England), as described below, and as illustrated in Figure 2.2 overleaf.
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Figure 2.2 Preparation of rabbit carotid artery cross-sections
Carotid artery 100 serial 10 pm 
cross-sections
Microscopy slides
Set A: Morphometry and injury scoring
100
99
98
97
Set B: Immunohistochemistry and 
TUNEL
20
Figure 2.2 One hundred 10 pm cryostat cross-sections were cut from each rabbit 
carotid artery. Serial cross-sections were distributed onto Set A and Set B slides as 
illustrated.
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Prior to use, these slides had been pre-treated with VECTABOND™ reagent to 
improve tissue adhesion: slides were immersed in acetone for 5 min at RT, then in 350 
ml of acetone containing 7 ml of VECTABOND™ for a further 5 min at RT; they 
were then washed in water for 30 seconds and left to air-dry overnight.
Of the 100 cross-sections, the first was placed in the lower left-hand comer of a slide, 
and the second in the corresponding position on another slide. Thenceforward, all odd- 
numbered sections were placed on one set of slides (Set A), and all even-numbered 
sections onto another set of slides (Set B) (Figure 2.2). The Set A slides were allocated 
for morphometric studies and injury scoring, while the Set B slides were reserved for 
immunohistochemical and TUNEL analysis. By mounting the cross-sections on the 
two sets of slides in such a specific arrangement, it was later possible to perform 
immunohistochemical and TUNEL analysis on cross-sections known to have lain 
adjacent to specified sections already studied morphometrically.
After cutting, all Set A and Set B sections were air-dried for 6 h at RT. The Set A 
slides were then counter-stained with eosin as detailed below (Section 2.2.3.7), while 
the Set B slides were stored at -80°C until required for further analysis.
Similarly, in some experiments cryostat cross-sections were prepared from carotid 
artery tissue which had been incubated in X-Gal working solution at pH 4.0, and these 
were subsequently counter-stained with eosin as described below.
In addition, carotid arteries snap-frozen without prior staining for P-gal activity (as 
described in Section 2.2.3.4) were thawed to -20°C and mounted in OCT™; 10 pm 
cryostat cross-sections were then cut and air-dried for 6 h at RT, prior to staining with 
H&E.
2.2.3.6 Morphological studies: haematoxylin and eosin staining 
As just mentioned, H&E analysis was performed in tissue which had not been stained 
for P-gal activity. After the 6-hour drying period, slides were immersed in freshly 
prepared 3% PFA in PBS at RT for 5 min, and then washed in PBS for 1 min. They 
were next immersed in Harris’ haematoxylin for 5 min, washed for 3 min in tap water, 
differentiated for 6 sec in 1% acid alcohol, then immersed in Scott’s tap water for 1 
min. The slides were then immersed in eosin solution for 5 min, washed in tap water 
for 1 min, then passaged through graded ethanol solutions (15 sec in 70%, 30 sec in 
100%, then a further 30 sec in 100% ethanol). They were next immersed for 1 min in
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xylene, and then re-immersed in fresh xylene for a further 1 min. The sections on the 
slides were mounted under coverslips in the synthetic resinous mountant DPX.
Slides were viewed under bright-field illumination using an Axiophot 2 microscope 
(Carl Zeiss, Germany) and were photographed with Kodak Ektachrome 160T colour 
positive film.
2.23.1 Morphometric studies: injury scores, neointima formation and SA-P-gal 
staining
After the 6-hour drying period mentioned above (Section 2.2.3.5), the slides for 
morphometric analysis and injury scoring (Set A) were immersed in freshly prepared 
3% PFA in PBS at RT for 5 min, rinsed in PBS for 1 min, then immersed in eosin 
solution for 5 min. They were next washed in tap water for 1 min, then passaged 
through graded ethanol solutions and xylene as described in the previous paragraph. 
Sections were again mounted using DPX. Representative sections were viewed and 
photographed as described for H&E sections.
For each carotid artery, ten cross-sections which would originally have been spaced at 
100 pm intervals along the intact vessel were analysed morphometrically (i.e. sections 
1, 11, 21, 31 etc.). In cases where a section designated to be analysed was either tom 
or folded, the next intact section was used instead.
These ten cross-sections from each carotid artery were studied using a JVC TK-1281 
colour video camera connected to a Nikon LABOPHOT-2 microscope. Morphometric 
analysis of the cross-sections was performed using a computerized colour image 
analysis software system (LUCIA M, Version 3.52a, Laboratory Imaging Limited, 
Czech Republic). The ten cross-sections were analysed for the extent of neointima 
formation and SA-(3-gal staining, and statistical analysis was used to compare the 
control and treatment groups (as described below).
Injury scores
Cross-sections were scored for the degree of injury using a scoring system devised by 
Schwartz et al. [1992], and adapted by Burchenal et al. [1996] for the study of rabbit 
arteries subjected to balloon angioplasty. According to this system, Grade 0 refers to 
vessels showing an intact internal elastic lamina (IEL), media and external elastic 
lamina (EEL). Grade 1 refers to a vessel in which the IEL is lacerated, but without 
damage to the media or EEL. Grade 2 injury involves disruption of the media, and
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Grade 3 injury involves laceration of the EEL. Of the ten cross-sections from each 
vessel analysed morphometrically, that with the highest neointima/media ratio 
(assessed as described below) was re-examined under the Nikon microscope, and 
scored for the extent of injury exhibited; this score was used as the injury score for that 
vessel.
Neointima formation
Lucia M software (as detailed above) was used to measure the cross-sectional areas 
bounded by the EEL, the IEL, and the luminal surface of the vessel. The medial cross- 
sectional area was derived by subtracting the area bounded by the IEL from that 
bounded by the EEL, while the intimal area was derived by subtracting the luminal 
area from the area bounded by the IEL. These areas were then used to calculate an 
intima/media ratio for each cross-section.
This analysis was performed on each of the ten cross-sections from each vessel, and 
from the ten resultant ratios, a mean intima/media ratio was calculated for that artery. 
These mean intima/media ratios for each artery were then used to derive mean 
intima/media ratios for each treatment group of arteries.
While, strictly speaking, the term ‘intima’ refers to the cell layers within the IEL of 
uninjured arteries, and the ‘neointima’ comprises the new cell layers which appear 
within the IEL following injury to the vessel, in situations where control and denuded 
vessels are being compared in this thesis, the term ‘intima’ has often been used to refer 
to either intimal or neointimal cell layers. Thus, for example, the terms ‘intimal 
thickening’ and ‘neointima formation’ have been used essentially interchangeably.
SA-^-gal staining
The ten Set A cross-sections mentioned above (sections 1, 11, 21, 31 etc.) were re­
analysed, again using the Lucia M system, to determine the cross-sectional area 
covered by cells which had developed a blue stain in the X-Gal working solution. 
Scores of the intimal and medial areas covered by blue cells were made in each cross- 
section, and these were divided by the intimal and medial cross-sectional areas, 
respectively, in that cross-section. The resultant fractions were referred to as 
‘blue/intima’ and ‘blue/media’ respectively. The ten blue/intima and ten blue/media 
scores were each averaged, to give mean blue/intima and blue/media scores for that
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vessel, and were expressed as percentages. These mean percentage areas for each 
vessel were then used to derive mean percentage areas for each treatment group. 
Because blue cells in the adventitia were very sparse, it was possible to perform a 
count of the number of blue cells in each adventitial cross-section. Again, these counts 
were averaged in the ten cross-sections per vessel, to give a mean count for that vessel. 
The counts for each vessel were then used to derive mean counts for each treatment 
group of rabbits.
Representative examples of P-galactosidase staining were photographed under bright- 
field illumination using an Axiophot 2 microscope (Carl Zeiss, Germany) and were 
photographed with Kodak Ektachrome 160T colour positive film.
2.2.3.8 Statistical analysis
(Neo)intima/media ratios were compared statistically using a nested analysis of 
variance (ANOVA) model, following logarithmic transformation of the data. Nested 
analysis was required since each animal contributed arteries to more than one group 
(i.e. to ‘control’ and ‘single’, or to ‘control’ and ‘double’ groups). Given the low n 
numbers in each group, normal distributions of data cannot be guaranteed, even after 
log transformation, so P values were re-calculated using the non-parametric Wilcoxon 
rank sum test. The blue/neointima and blue/media percentage areas were compared 
between the control and single-denudation groups using the Wilcoxon rank sum test, 
while comparison of these percentage areas between the single- and double­
denudation groups was initially performed using ANOVA following log 
transformation of the data, then re-calculated using the Wilcoxon rank sum test. 
Statistical analysis was performed using the Intercooled Stata software package 
(release 6.0), and a value of P < 0.05 was considered statistically significant.
2.2.3.9 Immunohistochemistry
Common features o f the immunohistochemical protocols used 
Immunohistochemical analysis was performed on cross-sections selected from Set B 
slides from each artery. As mentioned above, these sections had been cut on a cryostat, 
air-dried for 6 h, then stored at -80°C.
When required, frozen sections were thawed to RT, and circumscribed using a Dako 
‘Pen for Immunohistochemistry’, which contains a material which is water-repellent, 
and acetone- and alcohol-insoluble. The use of this pen minimizes the volume of
94
antibody solutions required, as it prevents solution from dispersing away from the 
tissue section.
All immunohistochemistry involving rabbit arterial cross-sections was performed 
using mouse monoclonal primary antibodies, following a 30-minute incubation with 
Dako serum-free protein-blocking agent at RT. In all these studies, a biotinylated 
F(Ab’)2 fragment of rabbit anti-mouse antibody diluted in TBS was used as the 
secondary agent, and this was in turn detected using streptavidin conjugated with 
either horseradish peroxidase (HRP) or alkaline phosphatase (ALP), diluted in TBS. 
Chromogenic substrates were used as tertiary agents to visualize the relevant enzyme 
activity (see below).
All primary and secondary antibodies were spun at 4000 g  for 15 min at 4°C (using 
centrifuge model Mikro 22R, Hettich Zentrifugen, Germany) prior to use, and were 
diluted as specified in the following paragraphs using TBS. After incubation with each 
primary, secondary and tertiary agent, slides were washed three times in TBS at 4°C (5 
min per wash).
All incubations with primary, secondary and tertiary agents, and with the protein- 
blocking agent, were performed in a humidified chamber at RT. Incubations with the 
chromogenic substrates were performed in darkness. After mounting with coverslips, 
slides were viewed and photographed as described for H&E sections.
The detailed protocols for detection of the various cell types are described below, and 
are summarized in Table 2.1 overleaf.
Identification o f endothelial cells
After thawing of stored tissue cross-sections to RT, slides were immersed in acetone at 
4°C for 20 min, then washed three times in TBS. The slides were then treated with 
0.6% hydrogen peroxide in TBS at 4°C for 10 min, and subsequently washed three 
times in TBS at 4°C (5 min per wash). Slides were placed in a humidified chamber, 
and each cross-section was covered with serum-free protein-blocking agent. After a 
30-minute incubation at RT, the protein-blocking solution was removed, and replaced 
with a 1:20 dilution of mouse anti-CD31 (clone JC/70A), using approximately 250 pi 
of diluted antibody per section. Parallel sections were covered with a solution of 
mouse anti-A niger glucose oxidase IgGi at an equivalent antibody concentration to 
the primary antibody, to act as a negative control.
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Table 2.1 Summary of immunohistochemistry protocols used in rabbit carotid artery model
Cell type Fixation Pre­
treatment
Primary Ab, 
dilution, 
incubation time
control
isotype
Secondary 
agent dilution, 
incubation 
time
Tertiary
agent,
dilution,
incubation
time
Chromogen,
incubation
time
ECs Acetone, 
20 min, 
4°C
0.6% HP in 
TBS,
10 min, 4°C
Anti-CD31,
1:20,
30 min
IgGi 1:600, 
30 min
Str- HRP, 
1:500,
30 min
DAB, 
10 min
VSMCs Acetone 
20 min, 
4°C
N/A Anti-SM a-actin, 
1:100,
30 min
IgG2a 1:300, 
30 min
Str-ALP,
1:100,
30 min
Fuchsin, 
20 min
Leukocytes, 
including T cells 
and monocytes / 
macrophages
Acetone, 
20 min, 
4°C
N/A Anti-CD45,
1:50,
30 min
IgGi 1:300, 
30 min
Str-ALP,
1:100,
30 min
Fuchsin, 
20 min
Proliferating cells 4% PFA in TBS 
for 2 min, then 
100% ethanol for 
10 min, all at RT
0.6% HP in 
TBS,
10 min, 4°C
Anti-PCNA,
1:50,
30 min
IgG2a 1:300, 
30 min
Str- HRP, 
1:500,
30 min
DAB, 
10 min
Table 2.1 The table shows the main differences between the immunohistochemical staining protocols used in the rabbit carotid 
artery denudation model. Abbreviations used: Ab = antibody, DAB = diaminobenzidine, ECs = endothelial cells, HP = hydrogen 
peroxide, N/A = not applicable, PCNA = proliferating cell nuclear antigen, PFA = paraformaldehyde, SM = smooth muscle, Str-ALP = 
streptavidin-conjugated alkaline phosphatase, Str-HRP = streptavidin-conjugated horseradish peroxidase, TBS = Tris-buffered saline, 
VSMCs = vascular smooth muscle cells.
The sections were incubated with the respective antibody for 30 min at RT. The 
primary antibody (or negative control) was removed, and the slides were washed three 
times in TBS. Each section was then covered with approximately 250 pi of a 1:600 
dilution of biotinylated F(Ab’)2 fragment of rabbit anti-mouse antibody. Sections were 
again incubated in the humidified chamber for 30 min at RT. The secondary agent was 
removed, and the slides were washed three times in TBS. Sections were then covered 
with approximately 250 pi of streptavidin-conjugated HRP (Str-HRP), diluted 1:500 in 
TBS. Slides were incubated for 30 min at RT in the humidified chamber. The tertiary 
agent was removed, and the slides were washed three times in TBS. Peroxidase 
activity was visualized using the Liquid DAB Plus kit (Dako Ltd) according to the 
manufacturer’s instructions: one drop of diaminobenzidine (DAB) chromogen was 
added to 1 ml of buffered substrate, and mixed; the mixture was then used to cover 
each of the sections to be studied. Slides were incubated in this solution in the 
humidified chamber for 10 min at RT, in darkness. They were then washed three times 
in TBS at 4°C (5 min per wash), and sections were mounted under coverslips using 
Glycergel™.
Identification o f vascular smooth muscle cells
VSMCs were detected using a protocol similar to that employed for ECs (Table 2.1).
Thawed sections were fixed in acetone and washed three times in TBS as just
described, but without the need for subsequent treatment with hydrogen peroxide.
Instead, after the TBS washes, the sections were blocked for 30 min with serum-free
protein-blocking agent. A 1:100 dilution of mouse anti-smooth muscle a-actin (clone
1A4) was used as the primary antibody, parallel sections being covered with an
equivalent antibody concentration of mouse anti-A niger glucose oxidase IgG2a as a
negative control. Following incubation in the primary antibody for 30 min at RT, and
after three washes in TBS, the sections were covered with a 1:300 dilution of
biotinylated F(Ab’)2  fragment of rabbit anti-mouse antibody, and incubated with this
for 30 min. The secondary agent was removed, and the slides were washed in TBS.
Sections were then covered with streptavidin-conjugated alkaline phosphatase (Str-
ALP) diluted 1:100 in TBS, and incubated for 30 min at RT. The tertiary agent was
removed, and the slides were again washed in TBS. Sections were then covered with
Dako New Fuchsin Chromogenic Substrate System solution and levamisole (prepared
as described previously (Section 2.2.2.4)). Slides were incubated for 20 min at RT in
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darkness. They were then washed three times in TBS at 4°C, and mounted with
Timcoverslips, using Glycergel
Identification o f leukocytes (including monocyte/macrophages and T cells)
The protocol for detection of leukocytes was the same as for the detection of VSMCs, 
except for the following variations: the primary antibody used was mouse anti-CD45 
(clone LI2/201), used at a dilution of 1:50, and mouse anti-,4. niger glucose oxidase 
IgGi was used as the negative control. The secondary agent and the Str-ALP dilutions 
were as described for smooth muscle a-actin detection, as were the methods of 
enzyme visualization and mounting of the slides.
Detection o f proliferating cells
Proliferating cells were identified using a murine antibody to PCNA (clone PC 10). 
The protocol was similar to that used for the detection of ECs, with the following 
specific differences. Thawed slides were initially immersed in 4% PFA in TBS at RT 
for 2 min, then in 100% ethanol at RT for 10 min. Slides were next washed three times 
in TBS at 4°C, before proceeding through the hydrogen peroxide and protein blocking 
stages as described for ECs. The anti-PCNA antibody was used at a dilution of 1:50 in 
TBS. The secondary agent was used at a dilution of 1:300, and the Str-HRP at a 
dilution of 1:500. Mouse anti-,4, niger glucose oxidase IgG2a was used as the negative 
control. As with the ECs, the Liquid DAB Plus kit was used for enzyme visualization.
2.2.3.10 Detection of apoptotic cells
Studies to detect apoptosis were performed on cross-sections selected from the 
remaining slides of Set B from each artery. Apoptotic cells were detected using 
TUNEL analysis, employing an ‘//i Situ Cell Death Detection Kit’ (Boehringer 
Mannheim) according to the manufacturer’s instructions.
Frozen sections were thawed to RT, and then immersed in 4% PFA in PBS at RT for 1 
h. After three ten-minute washes in PBS at RT, slides were immersed in 0.1% Triton 
X-100/0.1% sodium citrate for 2 min at 4°C. After a further three 10-minute washes in 
PBS at RT, cross-sections were covered with 50 pi of TUNEL staining solution, 
containing terminal deoxynucleotidyl transferase (TdT) and fluorescein-conjugated 
deoxyuracil triphosphate (dUTP), and were incubated with this solution in a 
humidified chamber for one hour at 37°C. After three further 10-minute washes in 
PBS at RT, the sections were covered with a solution of 4’,6-diamidino-2-
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phenylindole (DAPI) in Vectashield™ mounting medium for fluorescence detection 
(Vector Laboratories). The sections were then examined by fluorescence microscopy 
using an Axiophot 2 microscope fitted with a X63/1.4 numerical aperture Plan 
Apochromat objective, and fluorescence filter sets appropriate for fluorescein and 
DAPI (Carl Zeiss, Germany). The sections were also observed under bright-field 
illumination. Bright field and epifluorescence images were photographed with Kodak 
Ektachrome 400X colour reversible film. Sections processed with labelling solution 
without TdT were used as negative controls. Rabbit aortic VSMCs treated with 2 pM 
staurosporine overnight were used as positive controls.
2.2.3.11 Protocols tested during development of ex vivo SA-(3-gaI assay 
In the development of the protocol described above for the detection of endogenous 0- 
gal activity in ex vivo rabbit carotid arteries, various preliminary protocols were tested. 
For these experiments, all (3-gal staining was performed at pH 4.0, since this would be 
expected to detect lysosomal acid (3-galactosidase activity in all layers of the vessel 
wall, regardless of the replicative age of the cells.
Two protocols used in pilot studies are illustrated in Figure 2.3 overleaf, together with 
the final protocol adopted for the actual SA-p-gal experiments (as described in detail 
above, in Sections 2.2.3.4, 2.2.3.5 and 2.2.3.6).
Protocol 1
This protocol was similar to that described by Dimri et al. for use with human skin 
samples [Dimri et al. 1995]. A rabbit which had had no previous surgery was culled 
by administration of a lethal dose of sodium pentobarbital, as described above. Its 
carotid arteries were excised without prior perfusion fixation. After trimming of excess 
peri-adventitial tissue with a scalpel, the arteries were briefly rinsed in PBS, then snap- 
frozen in cryovials in liquid nitrogen. The frozen arteries were mounted in OCT™, 
and transverse 7 pm cross-sections were cut on a cryostat and placed on histology 
slides. After air-drying for 2 h, these sections were fixed with 1% PFA in PBS at RT 
for 1 min, and then washed twice (30 sec per wash) in PBS at RT. The slides were 
then immersed in X-Gal working solution at pH 4.0 for 36 h at 37°C.
99
Figure 2.3 Protocols used for detection of p-galactosidase activity in excised rabbit carotid arteries
Protocol 1 Protocol 2 Final Protocol
Culling Culling Culling
Vessels excised, trimmed, rinsed
Vessels snap-frozen, mounted in OCT, 
7 pm sections cut and air-dried
oo
Fixation of sections 
(1% PFA in PBS, 1 min, RT)
PBS washes
Immersion of sections in X-Gal 
working solution 
(pH 4.0, 36 h, 37°C)
PBS washes
Vessels excised, trimmed, rinsed
Immersion of vessels in X-Gal 
working solution 
(pH 4.0,24 h, 37°C)
Fixation of vessels 
(4% PFA/0.1 M P04, 6h, 4°C)
30% sucrose/0.1 M P04 (24 h, 4°C)
PBS wash
Vessels snap-frozen, mounted in OCT, 
7 pm sections cut and air-dried
Perfusion-fixation 
(2% PFA in PBS, 20 min, RT)
Vessels excised, trimmed, rinsed
Vessels immersed in X-Gal working 
solution (pH 4.0 or 6.0,24 h, 37°C)
PBS wash
Vessels snap-frozen, mounted in OCT, 
10 pm sections cut and air-dried
Fixation of sections 
(3% PFA in PBS, 5 min, RT)
PBS wash
Graded ethanol, Graded ethanol, Eosin (5 min)
Glycergel Xylene, DPX Tap water wash
Figure 2.3 Protocol 1 involved immersion of cryostat cross-sections in X-Gal 
working solution, while in Protocol 2 and the Final Protocol lengths of carotid artery 
were immersed in toto in this solution. The most significant change between Protocol 
2 and the Final Protocol was the introduction of perfusion fixation.
Graded ethanol, 
Xylene, DPX
After three 5-minute washes in PBS at RT, the slides were passaged through graded 
ethanol solutions (1 min each in 50%, 70% and 100% ethanol) and then mounted in 
Glycergel™.
Protocol 2
This protocol was also tested using carotid arteries from animals which had not been 
perfusion-fixed. Carotid arteries were excised from a freshly culled rabbit, trimmed of 
excess peri-adventitial tissue, rinsed briefly in PBS, and then placed directly into X- 
Gal working solution at pH 4.0. The vessels were incubated in this solution for 24 h at 
37°C. The arteries were then fixed with 4% PFA/0.1 M phosphate buffer (pH 7.4) for 
6 h at 4°C, and next immersed in 30% sucrose/0.1 M phosphate buffer (pH 7.4) for 24 
h at 4°C. After a brief rinse in PBS, they were snap-frozen in liquid nitrogen, then
• TWmounted m OCT . 7 pm ciyostat-cut transverse cross-sections were air-dried for 2 h, 
then processed through graded ethanol solutions (as for Protocol 1). After two 1- 
minute immersions in xylene, they were mounted in DPX.
Tissues stained according to Protocols 1 and 2 were viewed under bright-field 
illumination using an Axiophot 2 microscope (Carl Zeiss, Germany) and were 
photographed with Kodak Ektachrome 160T colour positive film. An example of an 
artery stained at pH 4 using the Final Protocol detailed earlier (Sections 2.2.3.4,
2.2.3.5 and 2.2.3.6, and Figure 2.3) was photographed under an Olympus-BX 
microscope using a charge-coupled device camera, both as detailed below (Section 
2.2.4.12).
2.2.4 Studies in senescence-accelerated mice
2.2.4.1 Establishment and maintenance of a colony of senescence-accelerated mice 
Acquisition o f breeding pairs
Breeding pairs of SAM-P/8Ta and SAM-Rl/Ta mice were kindly provided by Dr M 
Hosokawa (Experimental Animal Unit, Pharmaceutical Research Division, Takeda 
Chemical Industries Ltd, Japan) in January 1999. SAM-P/8Ta and SAM-Rl/Ta mice 
are members of a colony of SAM mice maintained at Takeda Chemical Industries, 
Osaka, Japan. Colonies of these strains had been established using breeding pairs of 
SAM-P/8 and SAM-R/1 mice delivered from Kyoto University.
Nine mice of each strain (SAM-P/8Ta and SAM-Rl/Ta) were delivered to UCL (five 
male and four female in each strain). The nine mice from each strain were litter-mates.
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The SAM-P/8Ta mice were 14 weeks old, and the SAM-R/lTa mice 16 weeks old, at 
the time of shipment. All mice were certified free from the following pathogens or 
diseases: salmonella species, corynebacterium kutscheri, pasteurella pneumotropica, 
mycoplasma pulmonis, sendai virus, mouse hepatitis virus, minute virus of mice, 
pneumonia virus of mice, reovirus III and tyzzer.
Housing conditions at UCL
The SAM colony was housed and maintained under standard conditions. After an 
initial isolation period following transportation from Japan, the breeding pairs were 
housed in filter racks, under temperature control (20 to 24°C) and under a 12-hour 
light/dark cycle. Drinking water was provided ad libitum. Unless otherwise stated, 
after weaning mice were fed ad libitum with a standard laboratory chow (Harlan 
Teklad mouse breeding and maintenance diet, TRM9607), which contained 4.3% fat 
by weight and 0.0023% cholesterol by weight.
The welfare of the mice was checked daily by a designated technician, and 24-hour 
veterinary cover was available. Since SAM mice are known to develop clinically 
significant pathologies, a table of clinical end-points was used to provide guidance for 
the day-to-day care of the colony (Table 2.2, overleaf). Mice were examined daily for 
any obvious signs of pain or distress, or for the emergence of any of the clinical end­
points listed. If these were detected, a decision was made between the veterinary staff 
and the project licence holders concerning management of the problem, sometimes 
resorting to culling of affected animals to relieve suffering. In such cases, a Schedule 1 
method of killing, as designated by the Animal (Scientific Procedures) Act 1986, was 
used.
Breeding programme
Six weeks after arrival at UCL, one male mouse from each strain was sacrificed and 
post-mortems were performed at the Royal Veterinary College, London, to confirm 
the disease-free status of the colony. The other eight mice in each strain were housed 
in separate brother-sister pairs, in four boxes. The colony was then allowed to breed, 
using exclusively brother-sister mating.
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Table 2.2 Notice used by designated technicians in the management of the 
UCL colony of SAM mice
Clinical Sign Appropriate Action
1. Persistent failure to feed ^
2. Persistently unresponsive
3. Suspected bone fiacture
4. Comeal ulceration
5. Significant skin ulceration
6. Evidence of arthritis of a large joint
> Schedule 1 culling
7 .15% decrease in body weight ^
8. Minor skin ulceration
9. Cataract formation
10. Significant decrease in stride length j
> Consult veterinary surgeon
Table 2.2 Mice were examined daily for signs of pain or distress, and for the 
emergence of any of the clinical end-points detailed. If these were found, the above 
table was used to guide further management. In the case of significant pain or 
distress, or if severe pathology was discovered, mice were culled without further 
consultation, using a Schedule 1 method (as designated by the Animal (Scientific 
Procedures) Act 1986. When less clinically significant pathology was detected, a 
decision was made between the veterinary staff and the project licence holders as to 
whether the pathology was likely to improve spontaneously or might improve with 
appropriate treatment. In cases where it was felt that deterioration was inevitable, 
mice were culled (using a Schedule 1 method) to avoid further suffering.
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In order to preserve the senescent phenotype, new breeding pairs among the SAM-P 
mice were chosen from those mice that appeared to show most evidence of the ageing 
phenotype, using a previously described protocol [Hosokawa et al. 1997]; the main 
criteria used were small animal size, loss of fur glossiness, and lack of activity. 
Inevitably this meant that several of the SAM-P breeding pairs failed to produce 
litters. In contrast, breeding pairs of SAM-R mice were chosen from those mice that 
appeared the most healthy. In cases where a breeding pair failed to produce litters, 
mice were generally re-allocated to other brother-sister pairs in order to maintain the 
colony.
Litters were weaned at four weeks of age, the male and female offspring being housed 
in separate cages. In the case of larger litters, mice were further subdivided so that 
mice were usually housed with three to five animals per cage. Labels on each cage 
were used to record the date of birth, date of weaning, and dates of death and culling 
of the mice, together with a record of the emergence of any adverse clinical signs. The 
size of litters bom to breeding pairs was also recorded.
Selected age-matched SAM-P and SAM-R mice were photographed in their cages in 
order to illustrate differences in size and phenotype between the two strains.
2.2.4.2 Acquisition and maintenance of C57BL/6 mice
A number of male and female C57BL/6 mice were purchased from Harlan UK Ltd, 
and were housed under identical conditions to those in which SAM mice were 
maintained. Unless otherwise stated, they were fed ad libitum with the same standard 
laboratory chow (TRM9607) used for SAM mice. Drinking water was again provided 
ad libitum. The C57BL/6 mice were twenty-three weeks old when delivered to UCL.
2.2.4.3 Administration of a Western-type diet
As will be described in Chapter Four, the effect of a relatively high cholesterol diet 
was assessed in SAM-P, SAM-R and C57BL/6 mice. For these studies a Western-type 
diet (Harlan Teklad Western Adjusted Calories Diet, TD88137) was employed. This 
diet is designed to contain the cholesterol and fat content equivalent to a human 
Western diet, and has been used in several previous studies [Nakashima et al. 1994, 
Palinski et al. 1995, Tangirala et al. 1995a and b]. It contains 21% fat by weight and 
0.15% cholesterol by weight. It does not contain cholic acid. The diet is supplied by 
the manufacturer as a powder, because of its high fat content. In order to make it more
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palatable to the mice, the powder was manually clumped together prior to 
administration. The diet was administered ad libitum, by daily re-stocking of a tray in 
each cage with excess quantities of the diet. The diet was stored at 4°C prior to 
stocking of the cages. Mice were weighed at regular intervals during the 
administration of the diet.
2.2.4.4 Preparation of serum from SAM mice
Prior to bleeding, mice were deprived of food for a 16-hour period. During this time, 
they had free access to drinking water. On the day of bleeding, mice were warmed to 
35°C (for a maximum of 15 min) in a thermostatically heated warm-air chamber (IMS, 
UK). Venous blood was obtained by making a nick in the superficial tail vein using a 
scalpel. Approximately 200 pi of venous blood was collected in a V-shaped collecting 
tube (Microvette CB300, Sarstedt, UK) and immediately stored over ice, in order to 
inhibit lipoprotein lipase activity. The blood was allowed to clot over 3 h, and was 
then spun twice, each time at 1000 g  for 15 min at 4°C (using centrifuge model Mikro 
22R). Between the two spins, the blood clot was dispersed using a pipette tip, in order 
to maximize the yield of serum.
2.2.4.5 Measurement of total serum cholesterol and triglyceride levels in individual 
SAM mice
Total serum cholesterol
Total cholesterol levels in serum samples from individual mice were assayed using the 
INFINITY™ Cholesterol Reagent (Sigma Diagnostics, #401-25P). This reagent 
contains cholesterol oxidase (CO), cholesterol esterase (CE), HRP, 4-aminoantipyrine 
(4AAP) and hydroxybenzoic acid (HBA). In the presence of this reagent, cholesterol 
esters are hydrolysed by CE to cholesterol and free fatty acids. The free cholesterol, 
including that originally present, is oxidized by CO to cholest-4-en-3-one and 
hydrogen peroxide. The hydrogen peroxide then reacts with HBA and 4AAP, in the 
presence of HRP, to form a chromophore, quinoneimine dye. The formation of this 
chromophore can then be detected by its absorbance at 500 nm, and is proportional to 
the original concentration of cholesterol in the sample.
Serum samples were collected and prepared as described above, stored at -20°C, and 
individual samples were then analysed in batches. On the day of analysis, the frozen 
samples were thawed on ice to 4°C. For each sample, 3 pi of serum was added to 300
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pi of INFINITY™ Cholesterol Reagent in a 96-well plate, at RT. The plate was 
incubated at 25°C for 15 min, and then read on a plate-reader (primary wavelength 500 
nm, secondary wavelength 660 nm) (Spectra Max 250 plate reader, Molecular Devices 
Ltd, UK). Experiments were performed in triplicate, and mean concentrations 
calculated. The plate-reader was calibrated using the ACCUSET® Liquid Calibrator 
(Sigma Diagnostics) which has a general assigned value of total cholesterol, as 
measured enzymatically, of 173 mg/dl (4.48 mM). Cardiolipin controls (#C4571 and 
#C4696, Sigma Diagnostics) of known cholesterol concentrations (175 mg/dl and 283 
mg/dl respectively) were analysed with each batch to control for inter-assay 
variability, and a well containing INFINITY™ Cholesterol Reagent with no added 
serum was used as a blank.
Serum triglycerides
Serum triglyceride levels in individual SAM serum samples were assayed using the 
INFINITY™ Triglycerides Reagent (Sigma Diagnostics). This reagent contains 
lipoprotein lipase, adenosine triphosphate (ATP), glycerol kinase (GK), glycerol 
phosphate oxidase (GPO), 3,5 dichloro-2-hydroxybenzene (3,5 DHBS), 4-AAP, and 
HRP. In the presence of this reagent, triglycerides are hydrolysed by lipoprotein lipase 
to free fatty acids and glycerol. The glycerol is in turn phosphorylated by GK with 
ATP to glycerol-3-phosphate and ADP. Glycerol-3-phosphate is then oxidized to 
dihydroxyacetone phosphate by GPO, yielding hydrogen peroxide. The hydrogen 
peroxide then reacts with 3,5 DHBS and 4AAP, in the presence of HRP, to produce 
quinoneimine dye, whose absorbance is proportional to the original concentration of 
triglycerides in the sample. For this assay, the formation of the chromophore is 
detected by its absorbance at 520 nm.
Because of the potentially deleterious effects of serum lipoprotein lipase activity on 
triglyceride levels prior to analysis, the assays of triglyceride levels in individual 
serum samples were performed on freshly obtained serum, within 3 h of venesection. 
On the day of bleeding and analysis, 3 pi of freshly obtained serum was added to 300 
pi of INFINITY™ Triglycerides Reagent in a 96-well plate, at RT. The plate was 
incubated at 25°C for 15 min, and then read on a Spectra Max 250 plate-reader 
(primary wavelength 520 nm, secondary wavelength 660 nm). Experiments were 
performed in triplicate, and mean concentrations calculated. The plate-reader was
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again calibrated using the ACCUSET® Liquid Calibrator (see above) which has a 
general assigned value of total triglycerides, as measured enzymatically, of 105 mg/dl 
(1.19 mM). Cardiolipin controls (Sigma, #C4571 and #C4696) of known total 
triglyceride concentrations (119 mg/dl and 297 mg/dl respectively) were again 
analysed, and a well containing INFINITY™ Triglycerides Reagent with no added 
serum was used as a blank.
2.2.4.6 Determination of lipid profiles in pooled sera of SAM mice 
More detailed lipid profiles were determined in mice fed either a standard laboratory 
chow or the Western-type diet. Because such studies required at least 100 pi of serum, 
it was necessary to pool sera from age- and sex- matched mice fed on one or other diet 
for this analysis.
The pooled samples were subjected to a fully automated cauldron chemistry technique, 
HDL-Cholesterol Direct, manufactured for use with the COBAS® INTEGRA analyser 
(both by Roche Diagnostics, Switzerland). The underlying principle was first 
described by Hino et al. [Hino et al. 1996]. It relies on coating the surface of 
lipoproteins with synthetic polyanions. This coating transforms LDL, very low density 
lipoprotein (VLDL), and chylomicrons into detergent-resistant lipoprotein-polyanion 
complexes. In contrast, HDL does not form these complexes. Instead, the cholesterol 
content of the HDL is solubilized by the combined action of the polyanions and a 
detergent to form micelle complexes. This solubilized cholesterol is oxidized by the 
sequential action of cholesterol esterase and cholesterol oxidase, to form oxidized 
cholesterol and hydrogen peroxide. The hydrogen peroxide reacts with N,N-bis(4- 
sulphobutyl)-m-toluidine and 4-AAP in the presence of HRP, to form quinoneimine 
dye. The colour intensity of the quinoneimine dye is directly proportional to the HDL- 
cholesterol concentration in the sample analysed, and is determined by measuring the 
increase in absorbance at 552 nm. The mechanized analysis thus gives a direct 
measurement of HDL cholesterol content; it also calculates an estimation of the LDL 
content, as well as directly measuring total cholesterol and triglyceride levels.
In all cases, this method was used with freshly obtained pooled sera. Individual serum 
samples were obtained as described above. For same-gender litter mates, equal 
volumes of sera were pooled together to give a total volume of 100 pi. This 100 pi 
sample was then analysed by the HDL-Cholesterol Direct cassette in the COBAS
107
INTEGRA ANALYSER, within 30 min of pooling; the pooled sera were stored at 4°C 
prior to analysis. HDL/total cholesterol ratios were calculated from the automated 
measurements of HDL and total cholesterol in each pooled sample.
2.2.4.7 Harvesting, fixation and storage of tissue for analysis of atherogenesis 
Some of the studies to be described in Chapter Four involved analysis of lipid 
deposition in SAM and C57BL/6 aortic roots. At specified time-points, mice were 
culled by cervical dislocation, and their thoracic and abdominal cavities immediately 
opened surgically. The heart and aorta were identified, excised as a single piece of 
tissue, and placed in PBS at RT for one hour; this allows the tissue to relax, facilitating 
subsequent preparation of cryostat cross-sections [Paigen et al. 1987b].
The tissue was then fixed in 4% PFA/0.1 M phosphate (pH 7.4) for 6 h at 4°C. It was 
next removed, rinsed in PBS, and placed in 30% sucrose/0.1M phosphate (pH 7.4), 
rendering the tissue more amenable to subsequent cryostat sectioning. The tissue 
remained in this solution for 20 h at 4°C.
The heart and aorta were then placed on a square of aluminium foil, and the apex of 
the heart was removed under a dissecting microscope using a scalpel to cut 
transversely across the ventricles in a plane parallel with the lower tip of each atrial 
appendage, as described by Paigen et al. [Paigen et al. 1987b]; subsequent ciyostat 
sectioning parallel with this plane produces true cross-sections of the aortic root.
The apex of each heart was discarded, together with the distal aorta, while the 
remaining tissue (comprising the base of the heart, the aortic root and the proximal
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aorta) was covered with OCT compound. The tissue, foil and OCT were together 
placed in a beaker of hexane which had been pre-cooled by placing it within another 
beaker containing liquid nitrogen. This technique minimizes tissue distortion during 
freezing. Once frozen, the tissue, still attached to the aluminium foil by the frozen 
OCT™, was placed in a 50 ml Falcon tube, and stored at -80°C.
2.2.4.8 Preparation of cryostat cross-sections
The frozen tissue, coated in OCT™, was brought to -20°C in the cutting chamber of a 
ciyostat. The tissue was then mounted in further OCT™ on a ciyostat chuck, with the 
cut surface of the ventricles uppermost.
Cryostat sections were cut as described by Emeson and Shen [1993]. Serial 10 pm 
sections were cut through the ventricles, until the left ventricular cavity size was seen
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to reduce in size. From this point onwards, individual unstained sections were 
observed under a light microscope until the valve cusps of the aortic valve first 
became visible (corresponding to line I in Figure 2.4, overleaf). At this stage, all 
cryostat cross-sections were mounted onto slides previously treated (as described 
previously) with VECTABOND™ reagent. Alternate sections were mounted onto 
separate slides, so that one set of slides (Set A) could be stained for lipid deposits, and 
the second set (Set B) bearing the adjacent cross-sections, could be used for 
immunohistochemistry. This distribution of sections was similar to that used in the 
rabbit carotid study described above, and is illustrated in Figure 2.4.
Sectioning was continued until the valve cusps were no longer visible in the lumen of 
the aorta, and until the aortic wall had acquired a circular shape. At least 80 serial 
cross-sections were cut and mounted from each mouse, covering the 800 pm of aortic 
root distal to line I. The distance along the aorta from the initial appearance of the 
caudal portion of the valve cusps to their eventual disappearance beyond the tips of the 
cusps has been reported to be 450-500 pm in C57BL/6 mice [Emeson and Shen 1993], 
but has not been documented for SAM mice. By checking visually that the valve cusps 
had disappeared, and by cutting at least 80 cross-sections after line I, it was possible to 
ensure that the entire aortic root had been cross-sectioned.
2.2.4.9 Staining of aortic cross-sections for lipid
Set A slides were air-dried for 6 h at RT, before being immersed in freshly prepared 
Oil red O staining solution (see above) for 10 min. They were washed in tap water for 
4 min, then counter-stained in Harris’ haematoxylin for 1 min. The slides were washed 
in tap water for a further 10 min, then mounted with coverslips using Glycergel™.
2.2.4.10 Morphometric analysis of lipid deposition in aortic cross-sections
For each aorta, eight cross-sections which would originally have been spaced at 100 
pm intervals along the intact aortic root were analysed morphometrically. These 
sections (i.e. sections 1, 11, 21, 31 etc., all located on the Set A slides) had been 
stained with Oil red O as described above. As in the rabbit carotid study, if the 
relevant cross-section was found to be damaged or folded, the next available intact 
cross-section was used.
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Figure 2.4 Preparation of SAM aortic root cross-sections
SAM aortic root 80 serial Microscopy slides
10 pm cross-sections
Distal
Set A: Oil red O analysis
00
Line I
1Proximal
13 15 17 19
Set B: Immunohistochemistry
0@@@0
Figure 2.4 80 cryostat sections were cut from each aortic root, starting at line I
and continuing distally. Cross-sections were distributed onto Set A and Set B slides 
as shown. The photomicrograph shows a representative cross-section from a SAM 
aortic root, stained with Oil red O and haematoxylin, at the level of the valve cusp 
attachments (arrowheads). Bar = 250 pm.
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The eight cross-sections from each aorta were studied using a Nikon LABOPHOT-2 
microscope, to which was attached a JVC TK-1281 colour video camera (both as 
mentioned for the rabbit carotid artery studies). Morphometric analysis of the cross- 
sections was performed, again using the LUCIA M computerized image analysis 
software system detailed above.
In each section, the cross-sectional area stained with Oil red O was measured, 
discounting areas of perivascular fat. Cross-sectional areas were recorded for those 
lesions related to aortic valve cusps and their attachments (type I lesions) and for those 
lesions present within the free aortic wall (type II lesions), following the classification 
introduced by Qiao et al. [1994]. For each section, a total lesion area (type I area plus 
type II area, referred to below as ‘any lesion’) was also recorded. Mean values for 
each of the three scores (type I area, type II area, and area of ‘any lesion’) in the eight 
cross-sections from each vessel were calculated, and these mean scores for each 
mouse were used to derive median scores for each treatment group. In addition, the 
number of type I and type II lesions per aortic root cross-section was recorded and the 
resultant scores for each lesion type in the eight cross-sections were summated. These 
three total scores (sums for type I, type II, and ‘any lesion’) for each mouse were used 
to derive median scores for each treatment group. A record was also kept of the 
number of mice in each treatment group that developed type I and/or type II lesions, to 
give an indication of the prevalence of each lesion type.
2.2.4.11 Photography of lipid lesions
Representative cross-sections displaying type I and/or type II lipid lesions were 
viewed under bright-field illumination using an Axiophot 2 microscope (Carl Zeiss), 
and were photographed with Kodak Ektachrome 160T colour positive film.
2.2.4.12 Immunohistochemical detection of murine macrophages 
Macrophages were detected using a protocol adapted from that described by Fazio et 
al. [1997], and using the antibody MOMA-2 which has previously been employed to 
detect murine macrophages [Fazio et al. 1997, Hasty et al. 1999]. 
Immunohistochemistry was performed using slides from Set B. These slides had been 
stored at -80°C. After sections had been thawed to RT, they were further air-dried for 
10 min, then immersed in acetone at 4°C for 20 min. After three 30-second washes in
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TBS at 4°C, the sections were incubated with Dako serum-free protein-blocking agent 
in a humidified chamber for 25 min at RT.
The protein-blocking agent was then replaced with the primary antibody, rat anti­
mouse macrophages/monocytes, clone MOMA-2 (Serotec, UK) diluted 1:500 in TBS. 
Rat IgG2b, clone LO-DNP-11 (Serotec, UK), diluted to an equivalent immunoglobulin 
concentration, was used as a negative control in parallel sections. Sections were 
incubated with the primary antibody for 30 min, before three further 30-second washes 
in TBS at 4°C. Sections were next incubated for 30 min at RT with the secondary 
antibody, biotinylated rabbit anti-rat immunoglobulin (Dako Ltd, UK) diluted 1:300 in 
TBS. After three further 30-second washes in TBS at 4°C, the sections were incubated 
for 30 min at RT with Str-ALP, diluted 1:200 in PBS. Following three further 30- 
second washes in TBS at 4°C, the sections were incubated with 0.01 M Tris buffer, pH 
8.0 for 25 min at RT. The buffer was removed and replaced with Fast Red TR/Napthol 
AS-MX solution (Sigma Chemical Co., UK). The sections were incubated with this 
solution for 6 min at RT in darkness, then washed three times (30 sec each) in TBS at 
4°C. They were then immersed in haematoxylin solution for 50 sec, and then in tap 
water for 20 min. They were next mounted in Glycergel™, and the slides were sealed 
with nail varnish. Sections were examined under an Olympus-BX microscope 
(Olympus Optical Company Ltd, UK), and representative sections were photographed 
using a charge-coupled device (CCD) camera (Victor Company, Japan).
As with the immunohistochemical experiments described earlier in the chapter, all 
incubations were performed in a humidified chamber, and all primary and secondary 
antibodies were spun at 4000 g  for 15 min at 4°C prior to use.
A score was kept of the percentage of lesions (of any type) which, on adjacent 
sections, showed immunohistochemical evidence of macrophage invasion.
2.2.4.13 Statistical analysis
SAM weights and litter sizes were compared using a two-tailed impaired Student’s t- 
test. Total serum cholesterol levels and total triglyceride levels were compared 
statistically using ANOVA, using the Intercooled Stata software package employed 
for the rabbit study. Serum triglyceride levels were log-transformed prior to ANOVA, 
to ensure a normal distribution. HDL/total cholesterol ratios and morphometric data 
were analysed using the Mann Whitney sign rank test. Lesion counts, and data 
concerning the prevalence of macrophages in lipid lesions, were analysed using a
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Poisson regression model since these data were non-continuous. Lesion prevalence 
data (again non-continuous) were compared using a Chi-squared test. In all of these 
analyses, a value of P  < 0.05 was considered statistically significant.
2.2.4.14 Terminal restriction fragment length analysis
Terminal restriction fragment lengths in splenic cells from SAM-P and SAM-R mice 
were assayed using pulsed field gel (PFG) electrophoresis, in an adaptation of the 
protocol described by Kipling and Cooke [1990]. The use of PFG electrophoresis to 
separate out the TRFs was necessitated by the length of murine telomeres (as 
discussed in Chapter Four).
Experiments were performed using a TeloQuant Telomere Length Assay Kit 
(Pharmingen, USA), which included a hybridisation buffer, a biotinylated 
(TTAGGG)4 telomere probe, and a membrane blocking buffer, together with 
components of a chemiluminescent ‘Detection Substrate Working’ solution.
In outline, cells were obtained from fresh SAM-P and SAM-R spleens, formed into 
agarose blocks, and then subjected to digestion of their DNA by the restriction enzyme 
Mbo I. This enzyme acts as a frequent cutter, and its recognition sequence is not found 
within the repeated hexamer sequence of the telomere. It therefore cuts the DNA into 
small fragments, except for the telomeres and subtelomeric regions, which together 
constitute the terminal restriction fragment. The digested DNA was then separated by 
PFG electrophoresis and blotted onto a Hybond N+ membrane. As described below, 
this membrane was then probed for TTAGGG repeat sequences which were 
subsequently detected through a chemiluminescence system involving the use of Str- 
HRP. The average TRF length was then calculated from the position of the detected 
signal relative to the position of known size standards. The details of the protocol were 
as follows.
Sample preparation
SAM-P and SAM-R mice of various ages were culled by cervical dislocation, and 
their spleens removed and placed in ice-cold PBS in individual Petri dishes. Cells were 
liberated by gently macerating each spleen between two scalpel blades. Tissue debris 
was removed, and the cells from each spleen were suspended in 10 ml of ice-cold 
PBS. These samples were then spun at 200 g  (using centrifuge model CR422) for 10 
min at 4°C. The resultant pellets were re-suspended in 3 ml of ice-cold PBS and
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counted using a haemocytometer. PBS was added to each sample to adjust the cell 
concentration of each sample to 25 x 106 cells/ml. The diluted cell suspensions were 
warmed to 50°C, and to each sample an equal volume of molten (50°C) 1% low 
melting point (LMP) agarose (in PBS) was added. 100 pi aliquots were pipetted into 
pre-cooled block formers, and left to cool and harden on ice for 20 min. The blocks 
were then dispensed from the block-formers into lysis buffer (detailed in Section 
2.1.5.1). 0.5 ml of lysis buffer was used per block, and the blocks were incubated in 
this buffer for 48 h at 50°C in a water bath, with gentle agitation every few hours. 
They were then washed three times (30 min per wash) in Tris-EDTA (TE) (pH 7.5) at 
4°C, and then incubated in 50 ml of PMSF working solution (detailed above) for 2 x 
30 min at 50°C. After two very brief rinses in ice-cold TE, the blocks were washed for 
3x15 min in TE at 4°C. The blocks were then stored in 0.5 M EDTA at 4°C.
Restriction enzyme digestion
Blocks from each mouse spleen were washed for 3 x 10 min in TE at 4°C, and then 
equilibrated in 600 pi of reaction buffer for 90 min. This reaction buffer (supplied 
together with the restriction endonuclease Mbo I by the manufacturer) contained 50 
mM Tris-HCl (pH 8), 10 mM magnesium chloride and 50 mM sodium chloride. The 
samples were then incubated in 500 pi of reaction buffer containing 10 to 20 units of 
Mbo I per 100 pi plug, at 37°C overnight.
Pulsed field gel electrophoresis
A gel was prepared (using approximately 150 ml of 1% LMP agarose in 0.5 x TBE) 
on a PFG electrophoresis apparatus (CHEF-DRII pulsed field electrophoresis system, 
Bio-Rad, USA). Blocks from each mouse spleen were loaded, together with a high 
molecular weight ladder (Lambda ladder PFG marker), a control sample containing 
long telomeres (TeloHI DNA), and a sample of biotinylated lambda DNA digested 
with the restriction enzyme Hindlll (biotinylated X DNA/Hindlll Marker), the latter 
two agents having been supplied in the Telomere Length Assay Kit mentioned above. 
The blocks were sealed above with molten 1% LMP agarose. The gel was run for 15 h 
at 14°C, at 200 V, with pulse parameters of 0.1 to 10 sec, and a start ratio of 1.0.
The gel was then removed and stained in 0.25 pg/ml ethidium bromide (5 pi of 10 
mg/ml ethidium bromide diluted in 200 ml of 0.5 x TBE) for 1 h and photographed 
using a UVP gel documentation system (Ultra-violet Products Ltd, UK).
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Transfer to Hybond N* membrane
The nucleic acids in the gel were de-purinated in 0.25 M hydrochloric acid for 40 min 
at RT, and then de-natured in 1.5 M sodium chloride / 0.5 M sodium hydroxide for 2 x 
15 min at RT. The gel was then transferred to an MSC charged Hybond-N+ membrane 
which had been pre-wetted with DDW and then soaked in the de-naturing solution for 
5 min. The transfer was performed overnight. After the well positions had been 
marked, the membrane was removed, and neutralised by rinsing in 2 x SSC (prepared 
from 20 x SSC) for 2 x 5 min. It was then cross-linked for 12 sec in a UV crosslinker 
(Stratalinker, Stratagene Ltd, UK) and allowed to air-dry.
Hybridisation and immunoblotting
The membrane was pre-wetted with 2 x SSC for 5 min, and pre-hybridised at 65°C for 
4 h in 14 ml of hybridisation buffer in a hybridisation oven (Techne, UK). 4 pi of 20 
ng/ml biotinylated telomere probe was added, and the membrane was hybridised at 
65°C overnight. Following two brief rinses in 1 x SSC/0.1% SDS at RT, the 
membrane was incubated in pre-warmed 1 x SSC/0.1% SDS at 42°C for 2 x 15 min. 
The membrane was rinsed twice in PBS, then incubated with 30 ml of membrane 
blocking buffer at RT for 1 h. The blocking buffer was removed, and replaced with 1.5 
pi of Str-HRP in 30 ml of fresh blocking buffer. The membrane was incubated in this 
solution for 1 h at RT, and shaken continuously. After two brief rinses and 3 x 1 5  min 
washes in 0.1% Tween-20 in PBS, the membrane was shaken for 5 min in 14 ml of 
freshly prepared Detection Substrate Working solution. The membrane was then 
placed between two sheets of plastic wrap, placed in an X-ray film cassette, and 
exposed to light-sensitive film, which was developed in an automatic developing 
machine (X-OGRAPHY Compact x2, Medivance Ltd, UK).
Calculation ofTRF length
Three gels were run using DNA from mice of various ages. A representative 
autoradiogram was scanned (using a Hewlett Packard ScanJet 5300C scanner), and a 
TIFF image obtained. This image was analysed using public domain NIH Image 
software (version 1.62). This software calculates mean TRF lengths by integrating the 
signal intensity over the entire TRF distribution as a function ofTRF length, using the 
formula TRF length = S(ODj) / £(ODi/Lj), where ODj and Li are the signal intensity
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and TRF length respectively at any position, i, on the autoradiogram. Mean TRF 
lengths were compared using a Mann Whitney sign rank test.
2.2.4.15 SA-p-gal staining in tissue from SAM mice
Murine tissue was stained for SA-p-gal activity using a protocol which evolved from 
that used in rabbit carotid arteries. Three- and twelve-month-old SAM-P and SAM-R 
mice were culled by cervical dislocation. The aorta of each mouse, extending from the 
arch to the iliac bifurcation, was dissected out using aseptic technique, and extraneous 
fat removed using a scalpel. The dorsum of each mouse was shaved with a razor blade, 
and full-thickness squares of dorsal skin (measuring approximately 3 mm x 3 mm) 
were excised. The aortas and skin squares were rinsed in ice-cold PBS, then immersed 
in X-Gal working solution titrated to pH 6.0 (or on some occasions at pH 4.0). The 
tissue was incubated in this solution at 37°C for 24 h, and then rinsed briefly in ice- 
cold PBS. The samples were then fixed in 4% PFA/0.1 M phosphate buffer (pH 7.5) at 
4°C for 6 h, before being immersed in 30% sucrose/0.1 M phosphate buffer (pH 7.4) at 
4°C for 36 h. They were next removed from the sucrose solution, coated with liquid
T * k /fOCT , and rapidly frozen by immersion in hexane which had been pre-cooled in 
liquid nitrogen. The OCT™-embedded tissue was then stored at -80°C.
10 pm cryostat sections were subsequently cut from the OCT™-embedded tissue, and 
placed on microscope slides. Tissue was orientated on the cryostat chuck so as to 
obtain full-thickness cross-sections of the skin, and transverse cross-sections of the 
aorta. After air-drying for 2 h, the slides were fixed in neutral buffered formalin for 10 
min, washed in water for 3 min, and then immersed in eosin solution for 5 min. After 
washing in tap water for 5 min, sections were air-dried for 2 min, and then mounted 
under coverslips using Glycergel™. Coverslips were sealed with commercially 
available nail varnish so as to prevent dehydration of the tissue sections.
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CHAPTER THREE
Cell senescence in denuded rabbit carotid arteries
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The central aim of the experiments described in this chapter was to determine whether 
cellular replicative senescence can occur in vascular tissue in vivo. The experiments 
described involved the use of a cytochemical assay, SA-p-gal, which appears to be 
capable of detecting senescent cells both in culture and in certain ex vivo tissue 
samples [Dimri etal. 1995].
The chapter is divided into two sections. Section One begins with a description of 
preliminary in vitro studies carried out to establish whether SA-P-gal is capable of 
identifying replicative senescence in vascular cells (ECs and VSMCs). It concludes 
with an account of the adaptation of this assay for the study of ex vivo rabbit vascular 
tissue samples.
Section Two describes the use of the adapted assay in a rabbit carotid artery 
denudation model. The assay was used to detect senescent cells in carotid arteries 
which had been subjected to either a single endothelial denudation, or to two serial 
denudations. Morphological and morphometric studies were used to establish the 
extent of endothelial regeneration and neointimal formation following the denudation 
procedures. Immunohistochemistry was used to determine which cell types exhibited 
SA-P-gal activity. The results of experiments designed to discriminate between 
senescent, apoptotic and proliferating cells in the vessel wall are also described.
3.1 Section One: Preliminary experiments
3.1.1 Introduction
The use of SA-P-gal to detect senescent cells in culture has been described in Chapter 
One. This assay involves the detection, at pH 6.0, of the activity of the enzyme p- 
galactosidase. The use of this assay to identify senescent cells appears to be applicable 
only to certain cell types, and only in certain species.
Dimri et al. have commented that later passages of HUVECs show greater numbers of 
SA-P-gal-positive cells than do early passages, though no data were provided to 
support the contention that the assay was identifying senescent cells in these cultures 
[Dunn et al. 1995]: they did not describe the relationship between passage number and 
SA-P-gal-positivity in detail, nor did they give evidence that SA-p-gal-positivity 
correlated with a senescent phenotype.
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In addition, prior to the current study, the use of SA-p-gal to detect senescence in 
VSMCs of any species, or in rabbit cells of any type, had not been described.
The aims of the cell culture studies described in this section were to confirm that the 
SA-P-gal assay does indeed specifically identify senescence in endothelial and 
vascular smooth muscle cells, and also to establish whether the assay is an effective 
marker of senescence in cells derived from rabbits. A further goal was to establish 
whether SA-p-gal staining was compatible with subsequent immunocytochemical 
identification of cell types. The aim of the remaining experiments in this section was 
to adapt the cellular P-gal staining protocol for use in excised rabbit arterial tissue.
3.1.2 Experimental design
As described in Chapter Two (Sections 2.2.2.1 and 2.2.2.2), first passage 
ciyopreserved HUVECs, and rabbit VSMCs obtained by the explant technique, were 
grown in culture and serially passaged.
In initial experiments, early passage cultures of HUVECs were stained for P-gal 
activity at pH 4.0, to assess whether, as with other mammalian cells [Morreau et al. 
1989, Dimri et al. 1995], acid P-gal activity is detectable in ‘young’ cultures. The 
assay was then performed in other similarly ‘young’ HUVECs at pH 6.0, in order to 
establish whether this led to more selective staining.
Other HUVECs were serially passaged, and the prevalence of cells staining positively 
for P-gal activity at pH 6.0 (i.e. for SA-p-gal) was determined. The relationship 
between the accumulation of SA-p-gal-positive cells and the decline in cell density at 
confluence was studied, and the morphology of cells showing SA-P-gal activity was 
noted. Similarly, SA-p-gal activity was assayed in serially passaged rabbit VSMCs. 
Immunocytochemistry was next used to detect the EC surface antigen CD31 in early- 
and late-passage HUVEC cultures which had already been stained for SA-p-gal.
The experiments designed to adapt the cellular SA-p-gal assay for use in rabbit 
vascular tissue involved staining non-injured rabbit carotid arteries for P-gal activity. 
The aim was to develop a protocol which could detect p-gal activity (if present) in all 
layers of the vessel wall, while providing optimal preservation of the vessel wall 
architecture. Various modifications were made to the original protocol described by
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Dimri et al. for use with skin biopsies [Dimri et al. 1995], including the introduction 
of perfusion fixation.
3.1.3 Results
3.1.3.1 P-galactosidase staining in early passage HUVEC cultures
As described in Chapter One (Section 1.4.9) p-gal activity can be detected by the 
enzyme’s ability to cleave the indigogenic substrate 5-bromo-4-chloro-3-indolyl-P- 
galactopyranoside (X-gal) to leave a blue end-product [Gossrau et al. 1991, Dimri et 
al. 1995]. An endogenous lysosomal enzyme activity is detected at pH 4.0, and this 
activity is found in most mammalian cell types, regardless of the replicative age of the 
cells [Morreau et al. 1989, Dimri et al. 1995].
Figure 3.1 Panel A (overleaf) shows the result of incubating confluent early-passage 
HUVECs with X-gal working solution at pH 4.0. As indicated in this 
photomicrograph, all the cells in the culture exhibited dark blue staining. In contrast, 
Figure 3.1 Panel B shows the result of staining early-passage HUVECs at pH 6.0. 
Under these conditions, only occasional cells displayed an accumulation of blue 
precipitate. A frequent finding in these experiments was that those cells staining 
positively for p-gal activity at pH 6.0 (SA-P-gal activity) were larger than the non­
staining cells in the same dish, as is illustrated in this panel.
3.1.3.2 SA-P-gal staining in serially passaged HUVEC cultures
The prevalence of SA-p-gal staining in serially passaged HUVECs was then 
investigated.
Figure 3.2 (overleaf) shows SA-p-gal staining in early-passage (Panel A) and late- 
passage (Panel B) HUVECs. While very few early passage cells stained for SA-p-gal, 
it was evident that by late passages the majority of cells showed positive staining. 
Comparison of the two panels, which show cells at the same magnification, reveals an 
increase in size of the HUVECs in later cultures.
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Figure 3.1 P-galactosidase staining in confluent early passage HUVECs
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Figure 3.1 Representative photomicrographs showing early passage ECs stained 
for P-gal activity. Panel A shows staining at pH 4.0, detecting acid p-gal activity; all 
cells show positive (blue) staining. In contrast, the ECs shown in Panel B were stained 
at pH 6.0, to detect SA- P-gal activity; only one EC in this culture (marked with an 
arrow) shows strong blue staining, and this cell appears larger than the surrounding 
ECs. Both photomicrographs were taken under bright field illumination using an 
Axiovert 25 CFL inverted microscope with a 10X objective.
Figure 3.2 SA-P-gal staining in early- and late-passage HUVECs
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Figure 3.2 Photomicrographs showing early- (Panel A) and late- (Panel B) passage 
ECs stained for SA-p-gal activity. In Panel A, very few early-passage ECs show 
positive (blue) staining. In contrast, the majority of late-passage ECs in Panel B stain 
positively for SA-p-gal. Both photomicrographs were taken in staining solution under 
bright field illumination using an Axiovert 25 CFL inverted microscope with a 20X 
objective. Comparison of the two photomicrographs shows the increase in cell size in 
later passages. 121
Figure 3.3 shows the percentage of SA-p-gal-positive cells in each culture dish plotted 
against cumulative population doublings (CPDs). As shown, until approximately 32 
CPDs, the percentage of cells staining for SA-P-gal activity remained low, at less than 
20%, though even in these early passages there appeared to be a trend for the 
percentage to rise with increasing CPDs. Beyond 32 CPDs, however, there was a 
dramatic rise in the percentage of cells staining for SA-f3-gal, reaching approximately 
62% at about 38 CPDs. Also shown on this graph is the decline in cell density at 
confluence with serial passages. This decline suggests a pronounced increase in mean 
cell size in later passages, and suggests that the cultures were approaching senescence. 
It is notable that the dramatic rise in SA-P-gal staining appears to coincide with a 
sudden acceleration in the decline of cell density at confluence.
Figure 33  Semi-quantitative analysis of SA-P-gal staining in serially 
passaged HUVECs
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Figure 3.3 HUVECs were grown to confluence, and serially passaged 
at weekly intervals. Harvested cells were counted at each passage, as 
described in Chapter Two. Parallel cultures were stained for SA-P-gal 
activity. In this graph the cell density at confluence (white circles) and the 
percentage of HUVECs staining positively for SA-p-gal (black circles) are 
shown as a function of the cumulative population doublings (CPDs) at each 
passage. Values for cell density are the mean of replicate dishes ± s.d..
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3.1.3.3 SA-p-gal staining in serially passaged rabbit VSMC cultures
Rabbit VSMCs were obtained by the explant technique and serially passaged. In 
contrast to HUVECs, rabbit VSMCs lost their proliferative capacity after only three to 
four passages. When primary cultures of rabbit VSMCs were stained for SA-p-gal, no 
positive staining was observed, either in the central area of confluent cells surrounding 
the explant, or at the leading edge of growth (Figure 3.4, Panel A, overleaf). In 
contrast, the majority of third-passage VSMCs showed positive SA-p-gal staining 
(Figure 3.4, Panel B). Again, comparison of the two panels demonstrates the increase 
in size of the later passage cells. In the later cultures, those cells which stained blue 
also showed a veil-like appearance and irregularities of cellular shape.
3.1.3.4 SA-P-gal and CD31 double-staining in HUVECs
Immunocytochemistry was used to detect the EC surface antigen CD31 in early- and 
late-passage HUVEC cultures which had been stained for SA-P-gal activity. The 
antigen-antibody complexes were visualized using an ALP-conjugated secondary 
antibody in combination with the chromogenic substrate fuchsin. Figure 3.5 (overleaf) 
shows representative results of these experiments. Both early- (Panel A) and late- 
(Panel B) passage HUVEC cultures showed a similar intensity of CD31 labelling (the 
pink/red colour of fuchsin). The increase in cell size in late-passage HUVECs is again 
evident in the figure. From Panel B it is clear that SA-p-gal staining was still easily 
detectable despite the CD31 counter-stain, and that, conversely, detection of CD31 
was not significantly impaired by prior staining for P-gal activity. Parallel cultures 
stained with a negative-control primary antibody at an equivalent immunoglobulin 
dilution did not show positive counter-staining (data not shown).
3.1.3.5 Development of a protocol for staining rabbit carotid arteries for p- 
galactosidase activity
Dimri et al. have described a protocol for detecting SA-P-gal activity in excised 
samples of human skin [Dimri et al. 1995]. In Chapter Two details are given of two 
preliminary protocols used in the adaptation of Dimri’s method for use in excised 
rabbit vascular tissue (Section 2.2.3.11). In these preliminary protocols, incubation 
with X-gal working solution was performed at pH 4.0, in order to detect the ubiquitous
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Figure 3.4 SA-0-gal staining in early- and late-passage rabbit vascular smooth 
muscle cells
A B
Figure 3.4 Representative photomicrographs showing early- (Panel A) and late- 
(Panel B) passage rabbit VSMCs stained for SA-^-gal activity. Panel A shows rabbit 
VSMCs outgrowing from an aortic media explant, which is adjacent to the area of 
confluent growth but outside the photographic field. These primary culture cells show 
no blue staining, either in the area of tightly packed cells or at the leading edge of 
growth. In contrast, the majority of third-passage VSMCs shown in Panel B stain 
positively for SA-P-gal; these cells show the giant size and veil-like appearance of 
senescent VSMCs. Phase-contrast photomicrographs were taken using an Axiovert 25 
CFL inverted microscope with a 10X objective.
Figure 3.5 SA-P-gal staining and CD31 labelling in early- and late-passage 
HUVECs
A B
Figure 3.5 Representative photomicrographs showing early- (Panel A) and late- 
(Panel B) passage HUVECs stained for SA-p-gal activity (blue stain), and labelled for 
CD31 by immunocytochemistry (pink stain). In Panel A no passage 3 cells show blue 
staining. In contrast, the majority of passage 11 HUVECs in Panel B stain positively for 
SA-p-gal. The SA-p-gal staining appears to be localized predominantly in or around the 
nuclei. Both photomicrographs were taken under bright field illumination using an 
Axiovert 25 CFL inverted microscope with a 20X objective. 124
acid P-gal activity which was expected to be present in cells throughout the vessel 
wall; testing of the various protocols at this pH would therefore indicate the extent of 
tissue penetration by the working solution, and allow an assessment of the 
compatibility of tissue fixation with p-gal detection.
Protocol 1
The first protocol used (Protocol 1, Figure 2.3) was almost identical to that described 
by Dimri et al. for use with skin samples [Dimri et al. 1995]. It involved snap-freezing 
excised rabbit carotid arteries and preparing cryostat-cut cross-sections. These sections 
were fixed in PFA, incubated in X-Gal working solution at pH 4.0, passaged through 
graded ethanol solutions, and mounted on histology slides. The only difference from 
Dimri’s protocol was that a longer immersion in X-Gal working solution was used (24 
h, rather than an overnight immersion) in order to allow time for permeation of the 
working solution through the thicker cross-sections used in the rabbit study (7 pm, 
rather than 4 pm in the Dimri study). Figure 3.6 Panel A (overleaf) shows a 
representative cross-section processed according to this protocol. As shown, no blue 
staining was detected in any layer of the vessel wall.
Protocol 2
Since various minor adaptations to Protocol 1 failed to yield any improvement in P-gal 
staining, a fundamental change was instituted in the staining protocol. In Protocol 2 
(Figure 2.3), freshly excised carotid arteries were immersed in toto in X-gal working 
solution (again at pH 4.0) for 24 h at 37°C. They were subsequently fixed in PFA and 
snap-frozen. Cryostat sections were cut, air-dried, and mounted in DPX. Figure 3.6 
Panel B shows a representative section of carotid artery stained using this protocol. 
Blue staining is observed in all layers of the vessel wall, and the intensity of staining 
appears homogeneous throughout the artery.
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Figure 3.6 Preliminary protocols for staining for ^-galactosidase activity
in ex vivo tissue
A B
Figure 3.6 Panel A shows a representative carotid artery cross-section stained 
for p-gal activity using Protocol 1, as detailed in Figure 2.3; in this protocol, 
ciyostat cross-sections were immersed in X-Gal working solution at pH 4.0. As 
shown, no positive (blue) staining was detected in any layer of the arterial wall. 
The area of positive staining marked with an arrow was believed from its size and 
position to be the vagus nerve. Panel B shows a carotid artery cross-section 
prepared using Protocol 2, as detailed in Figure 2.3; in this protocol carotid arteries 
were immersed in toto in X-Gal working solution at pH 4.0. While positive 
staining was demonstrated throughout the vessel wall, preservation of tissue 
structure was poor. Bar =125 pm.
Figure 3.7 Acid p-galactosidase activity in non-denuded rabbit carotid artery
Figure 3.7 The photomicrograph shows a representative rabbit carotid artery 
cross-section stained following the Final Protocol detailed in Figure 2.3 and 
summarized overleaf. According to this protocol rabbits were perfusion-fixed, and 
their carotid arteries were immersed in toto in X-Gal working solution (in this case 
at pH 4.0); cryostat cross-sections were prepared, and counter-stained with eosin. 
As shown, at pH 4.0, blue staining was demonstrable throughout the vessel wall. 
The introduction of perfusion fixation significantly improved the preservation of 
vessel wall integrity. Bar =125 pm. .
Thus, in toto immersion of fresh tissue in X-Gal working solution appeared to yield 
strong p-gal staining. This protocol, though, was not adopted as it stood, because light 
microscopy of H&E-stained cross-sections revealed very poor preservation of the EC 
layer (data not shown). This finding suggested that fixation of tissue prior to excision 
would be required in order to preserve the integrity of the endothelial monolayer.
Final Protocol
In the protocol eventually adopted for the subsequent balloon denudation studies 
(‘Final Protocol’ in Figure 2.3), therefore, rabbits were perfusion-fixed prior to 
excision of the carotid arteries (as described in Section 2.2.3.3). 2% PFA was used as 
the perfusate because preliminary experiments suggested that use of a higher 
concentration of the fixative rendered subsequent frozen sections brittle and non­
adherent to histology slides. After perfusion fixation, the carotid arteries were excised, 
immersed in toto in X-Gal working solution for 24 h, and then snap-frozen. 10 pm 
cryostat sections were further fixed in PFA, counter-stained with eosin, and mounted 
in DPX; these thicker sections provided better preservation of vessel structure than the 
7 pm sections used earlier. Figure 3.7 (previous page) shows a representative section 
from an artery stained in this way. The section again shows blue staining of cells 
throughout the entire vessel wall. This finding is in agreement with the contention that 
lysosomal P-gal activity is relatively ubiquitous, and that the tissue was adequately 
permeated by X-gal working solution. As will be shown below, this protocol preserved 
endothelial integrity, as demonstrated by immunohistochemical detection of CD31.
3.1.4 Discussion of preliminary studies
The cell culture studies described above demonstrate that p-gal activity can be
detected at pH 6.0 in vascular cells. As well as confirming the increase in this SA-p-
gal staining in late-passage HUVECs as previously reported by Dimri et al., the results
strongly suggest that this enzyme marker specifically identifies cellular senescence in
endothelial and vascular smooth muscle cells. This conclusion is suggested by the
following findings: firstly, in serially passaged HUVECs, an abrupt rise in the
percentage of cells staining positively for SA-p-gal coincided with a sharp decline in
the cell density at confluence, indicating that the emergence of positive staining
corresponded with an increase in mean cell size, a feature of senescent ECs in culture
[Johnson and Longenecker 1982]; similarly, the finding that individual SA-p-gal-
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positive HUVECs and rabbit VSMCs appear larger than their non-staining neighbours, 
and in the case of VSMCs show the veil-like appearance and irregular shape 
previously described in senescent VSMCs [Dartsch et al. 1990], further supports the 
contention that this enzyme activity specifically detects senescence in vascular cells. 
The widespread p-gal staining at pH 4.0 in young HUVECs, and the almost complete 
absence of staining at pH 6.0 in these cells, are in accordance with the proposition that 
while all early passage HUVECs contain lysosomal p-gal activity, only selected cells 
harbour SA-p-gal activity. Dimri et al. have similarly reported the presence of 
occasional SA-p-gal-positive cells in early passages of human fibroblasts [Dimri et al. 
1995]. The explanation for the occurrence of SA-P-gal-positive cells in early passages 
remains unclear, but it is possible that they are either cell contaminants (i.e. senescent 
cells from other cultures), or cells which have senesced via a mechanism other than 
replicative senescence; one such mechanism might be SIPS, a process discussed in 
Chapter One.
Conversely, it is notable that even in cultures containing large numbers of senescent 
cells, a substantial proportion of cells appeared still to be pre-senescent, in that they 
did not stain positively for SA-p-gal. This finding may reflect inter-cell variability in 
proliferative rates. Alternatively the SA-p-gal-negative cells may be cells which have 
been rendered quiescent (by either intrinsic or extrinsic signals), and which have 
therefore failed to reach senescence.
It was striking that rabbit VSMCs reached senescence after fewer passages than did
human ECs. This finding could have a number of explanations. If the telomere theory
of replicative senescence is valid, one might attribute the observed difference in
proliferative activity between the two cell types to a difference in their mean telomere
length. There is no published data concerning the telomere length of rabbit VSMCs,
and so a direct comparison of TRF length between rabbit VSMCs and HUVECs is not
possible. HUVECs are thought to have a mean TRF length of 14 kbp in neonates, and
have been found to senesce when their TRF lengths reach approximately 6 kbp [Chang
and Harley 1995]. TRF length has been measured in preparations of cells from human
aortic intima and media (presumed, but not proven, to be predominantly VSMCs); in
preparations from one-month-old subjects, mean TRF lengths were approximately 7
kbp, this parameter falling to approximately 5 kbp in eighty-year-old subjects [Okuda
et al. 2000]. In humans then, neonatal HUVECs appear to have longer TRFs than do
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one-month-old VSMCs. It would be unwise, though, to extend this comparison to 
rabbit VSMCs without further investigation; given that mice have substantially longer 
telomeres than do humans (as detailed in Chapter Four), it is evident that there can be 
significant inter-species differences in telomere length even in equivalent cell types. 
The speed with which rabbit VSMCs reach senescence, compared with HUVECs, may 
relate either to a shorter TRF length prior to the onset of proliferative activity, or may 
reflect a greater degree of telomere attrition with each round of replication. 
Alternatively, there may be other factors, not related to telomere dynamics, which halt 
rabbit VSMC after only a few passages. These factors may be either intrinsic 
biological signalling mechanisms, such as over-expression of Cdk inhibitors, or may 
be artefactual constraints related to the culture conditions in which the cells were 
grown.
Establishment of the compatibility of CD31 staining with SA-p-gal detection was 
important for the planned study of excised rabbit carotid artery specimens. As 
mentioned in Chapter One (Section 1.4.3) senescent cells show alterations in gene 
expression and protein synthesis. It was therefore necessary to confirm that senescent 
ECs continue to express CD31. Furthermore, the results show that fuchsin does not 
mask SA-p-gal staining, and that this might therefore be a suitable chromogen for use 
in the rabbit carotid artery model. This experiment therefore suggested that the 
combination of CD31 labelling and SA-P-gal staining might be used to detect 
senescent ECs.
The adaptations in the staining procedure described above for use in excised rabbit 
arterial tissue yielded a protocol capable of detecting endogenous p-gal activity 
throughout the vessel wall while maintaining arterial architecture.
3.2 Section Two: The detection of in vivo senescence in the rabbit 
carotid artery denudation model
3.2.1 Introduction
As has been discussed in Chapter One (Section 1.4.6), it has been suggested that the in 
vitro phenomenon of replicative senescence may also occur in vivo. Recently the use 
of SA-P-gal has confirmed the emergence of senescent cells in tissues where rates of 
cell turnover are relatively high, such as normal skin, healing venous ulcers, and
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hyperplastic prostate glands [Dimri et al. 1995, Mendez et al. 1998, Choi et al. 2000]. 
In contrast, in tissues where rates of cell turnover are low, such as in the blood vessel 
wall [Schwartz et al. 1980, Hobson and Denekamp 1984], the suggestion that 
senescent cells may accumulate in vivo has remained controversial [Reidy et al. 1983, 
Clowes et al. 1986, Lindner et al. 1989].
As also mentioned in Chapter One, one tool for studying the replicative capacity of 
vascular cells has been the use of endothelial denudation models. Following 
mechanical injury to the luminal surface of the arterial wall, a proliferative response 
occurs, involving both endothelial and vascular smooth muscle cells [Reidy and 
Schwartz 1981, Stemerman et al. 1982]. More recent research has shown that 
repetition of the denudation injury leads to a further wave of endothelial and VSMC 
proliferation [Azuma et al. 1995]. If senescence of cells in the vasculature can occur at 
all in vivo, one might therefore expect it to emerge following repetitive injury of the 
luminal surface of the arterial wall, where vascular cells will have undergone an 
unusually high number of rounds of replication.
The main aim of the experiments described in this section was to use the SA-(3-gal 
assay to establish whether the proliferative response provoked by an endothelial 
denudation injury could indeed lead to the accumulation of senescent cells in vivo. If 
this proved to be the case, a further goal would be to discover whether a second 
denudation injury would result in a more marked accumulation of senescent cells than 
a single injury. The next aim was to identify which, if any, cell types expressed SA-J3- 
gal activity in vivo. The final aim was to study the relationship between these 
putatively senescent cells and the occurrence of proliferative and apoptotic activity in 
the vessel wall.
3.2.2 Experimental design
The final protocol for tissue harvesting and (3-gal staining described above (Final 
Protocol in Figure 2.3) was used to look for cellular senescence in two groups of adult 
male NZW rabbits (as illustrated in Figure 3.8 overleaf). The first group, referred to as 
the ‘single-denudation’ group, consisted of six adult rabbits which were subjected to a 
single trans-luminal injury of the right common carotid artery, and culled six weeks 
later.
130
Figure 3.8 Experimental design for rabbit carotid artery denudation studies
Time-point (weeks) 
0 6 12
Single-denudation (n = 6) Key:
^  Denudation 
Culling
Double-denudation (n = 6)
Figure 3.8 Twelve Male New Zealand White animals were divided into two groups: the single-denudation group 
underwent denudation of the right carotid artery, and were culled six weeks later; the double-denudation rabbits 
underwent two denudations to the right carotid artery, six weeks apart, and were culled six weeks after the second 
denudation. The left carotid arteries from both groups of mice were sham-operated, and acted as the control group.
The second group, referred to as the ‘double-denudation’ group, consisted of six age- 
matched rabbits which were subjected to two trans-luminal injuries of the right 
common carotid artery, with a six-week interval between the two procedures; these 
anim als were culled six weeks after the second denudation. In both groups, at the time 
of each denudation to the right common carotid artery, the left common carotid artery 
was sham-operated (as detailed in Section 2.2.3.2) to act as a control; the resultant 
sham-operated arteries are henceforward referred to as the ‘control’ group.
After culling, each rabbit was perfusion-fixed, and the common carotid arteries were 
excised. The tissue was processed as detailed earlier (Section 2.2.3.4 and Figure 2.1). 
Ciyostat-cut sections were prepared, and used for morphological and morphometric 
analysis. The degree of injury caused to each vessel was assessed according to a 
grading score, and the extent of intimal hyperplasia was measured morphometrically. 
Morphometric analysis was also used to determine the extent of staining for SA-(3-gal 
activity in the various layers of the arterial wall. Other sections were used for 
immunohistochemical analysis, in order to identify the cell types showing SA-p-gal 
activity, and to determine whether these cells also showed evidence of proliferative 
activity. Further sections were subjected to TUNEL analysis, to establish whether the 
cells showing SA-P-gal activity also showed evidence of apoptotic activity.
Data concerning the extent of intimal hyperplasia and the prevalence of SA-p-gal 
staining were compared between groups using statistical analysis, as described in 
Chapter Two (Section 2.2.3.8).
3.23 Results
3.2.3.1 Morphology and morphometry of neointimal lesions in the single- and 
double-denudation groups
Morphology
H&E staining was used to study the morphology of cross-sections from control and 
denuded arteries. Neointimal formation occurred in all twelve denuded arteries. In two 
single-denudation arteries, and two double-denudation arteries, the injured vessel had 
become completely occluded by the time of culling. This occlusion appeared to consist 
of a combination of neointimal cells and acellular material, possibly including 
thrombus. This finding was in keeping with the results of Bosnians et al., who found 
occlusive thrombus in approximately 30% of their rabbit carotid arteries following
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balloon angioplasty [Bosnians et al. 1997]. Since in the four occluded vessels in the 
current study there was severe disruption of the architecture of the vessel, with loss of 
the integrity of the IEL, re-modelling of the vessel wall, and neovascularization of the 
occluding material, as shown in Figure 3.9, these arteries and their sham-operated 
controls were omitted from further study.
Figure 3.9 Morphology of occluded rabbit carotid artery
Figure 3.9 shows a representative cross-section of a rabbit carotid arteiy 
found to be occluded six weeks after a denudation injury. The tissue has 
been stained with haematoxylin and eosin. The vessel wall architecture is 
markedly disrupted, and the lumen is almost entirely filled with cellular and 
acellular material. Arrows show examples of re-canalization by new vessels.
Bar = 125 pm.
The remaining eight denuded vessels (four single-denudation and four double­
denudation) were patent at the time of culling. These eight vessels, together with their 
corresponding control arteries, were used for all further analysis described below.
Injury Scores
Injury scores were determined in the eight denuded arteries which remained patent at 
the time of culling. As described in Chapter Two (Section 2.2.3.9) the injury score for 
each vessel was determined by analysis of the cross-section for that vessel which 
showed the greatest degree of neointima formation. Using this method, among the 
single-denudation vessels, three had an injury score of grade 0, possessing an intact
133
IEL; the fourth vessel had a score of grade 1, with laceration of the IEL, but with 
intact deeper structures. Similarly, among the double-denudation group, three vessels 
showed grade 0 injury, while one showed grade 1 injury. Thus the single- and double­
denudation groups appeared to have sustained equivalent degrees of injury.
Neointimal appearance in single- and double-denudation vessels 
Figure 3.10 (overleaf) shows representative cryostat cross-sections, stained with H&E, 
from control, single- and double-denudation vessels. Panel A shows a typical sham- 
operated control vessel. Although not clearly seen with H&E staining, the lumen of 
the vessel is bordered by a single layer of ECs, which lie adjacent to the IEL. It is 
known from previous work that a small number of VSMCs lie within the rabbit intima, 
sometimes lying between duplicate layers of the IEL [Kockx et al. 1992], though 
again this is not obvious in Figure 3.10. Outside the IEL, the concentric VSMC layers 
of the media are clearly seen, and these are separated from the surrounding adventitia 
by the EEL.
Panel B shows a cross-section of carotid artery six weeks after a single denudation 
injury. A concentric neointima is seen, and appears somewhat less cellular than the 
underlying media. In Panel C, the neointima of a double-denudation vessel is shown. 
Again a neointima has formed, and this appears thicker than the single-denudation 
neointima shown in Panel B.
In single denudation vessels, the majority of neointimal VSMCs appeared to be 
aligned axially in the vessel wall. By contrast, after a second denudation, the 
neointima appeared stratified, containing two layers of cells (see, for example, Panel 
C): the deeper layer consisted of cells aligned axially, while the more superficial layer 
contained cells oriented circumferentially, and so perpendicular to the cells in the 
deeper intimal layer. The possible significance of this finding will be discussed below.
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Figure 3.10 Morphology of control, single- and double-denudation rabbit
carotid arteries
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Figure 3.10 Photomicrographs of representative cross-sections from control 
(Panel A), single- (Panel B), and double-denudation (Panel C) rabbit carotid 
arteries. Sections were stained with haematoxylin and eosin. Arrows in Panels B 
and C indicate the internal elastic lamina of each injured vessel. The neointima 
in Panel C appears stratified: the more superficial cells appear to be aligned 
parallel with medial cells; the deeper neointimal cells appear more disorganized. 
Bar = 80 pm.
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Morphometric analysis o f neointimal and medial size
As mentioned in Chapter Two, (neo)intima/medial ratios were used as a surrogate 
marker of the VSMC proliferative response to the mechanical insult. Table 3.1 and 
Figure 3.11 (both overleaf) show the results of this analysis in the eight injured and 
eight control vessels.
As shown, neointimal formation was significantly greater in the double-denudation 
than in the single-denudation vessels, whether measured as neointimal cross-sectional 
area (P = 0.003), or as a fraction of the corresponding medial area (P = 0.008 by 
nested ANOVA, P = 0.02 by Wilcoxon rank sum test). In contrast, no statistically 
significant difference was found when comparing the medial cross-sectional areas of 
the vessels in the single- and double-denudation groups.
Extent o f re-endothelialization in single- and double-denudation arteries 
CD31, which is used as a marker of ECs [Albelda et al. 1990], was detected in ex vivo 
arteries as described in Chapter Two (Section 2.2.3.9). Figure 3.12 Panel A (page 138) 
shows a representative cross-section from a sham-operated arteiy, immunostained for 
CD31. The continuous brown stain circumscribing the lumen of the vessel 
demonstrates the presence of an intact EC layer. Similar results were obtained with 
randomly selected sections from the other control arteries.
Previous research has shown that the balloon catheter denudation procedure used in 
the current study leads to complete removal of the EC layer [Reidy et al. 1983]; this 
finding was confirmed in preliminary studies for this project using CD31 
immunostaining (data not shown).
When single-denudation vessels were studied six weeks after a denudation injury 
(Figure 3.12 Panel B), an intact (or very nearly intact) layer of CD31 staining was 
demonstrated, suggesting that in the time between the denudation procedure and 
culling, complete re-endothelialization of the denuded surface had been achieved. The 
section shown is representative of the findings in the other single-denudation vessels.
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Table 3.1 Luminal, (neo)intimal and medial cross-sectional areas 
of rabbit carotid arteries
Cross-sectional areas Lumen (Neo) intima Media (Neo)intima/ 
media ratio
Control
(n=8)
9.76 ± 2.29 0.09 ± 0.02 4.21 ± 0.62 0.02 ±0.01
Single
(n=4)
7.35 ±4.22 1.22 ±0.38 4.21 ± 0.73 0.29 ±0.10
Double
(n=4)
9.61 ±2.71 6.54 ± 3.02 4.16 ±1.34 1.79 ±0.91
P value 
(Control v. Single)
0.91 0.07 0.22 0.00005
P value 
(Single v. Double)
0.40 0.003 0.95 0.008
Table 3.1 The table shows the luminal, (neo)intimal and medial cross-sectional 
areas of control, single-denudation and double-denudation rabbit carotid arteries, 
together with the (neo)intima/media ratios for these vessels. Areas are expressed as 
mean ± s.d. (x 105 pm2). (Neo)intima/media ratios are expressed as mean fractional 
values. Areas and ratios are rounded to two decimal places. P values were calculated 
using a nested ANOVA following log transformation of the data.
Figure 3.11 (Neo)intima / media ratios in rabbit carotid arteries
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Figure 3.11 The graph illustrates the (neo)intima/media ratios of control, 
single- and double-denudation rabbit carotid arteries, using data from Table 3.1. 
Ratios are expressed as mean fractional values ± s.d.. P values were calculated 
using a nested ANOVA following log transformation of the raw data.
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Figure 3.12 Endothelial regeneration following denudation injuries in rabbit
carotid arteries
C DoubleA Control
Figure 3.12 Photomicrographs of representative cross-sections from control 
(Panel A), single- (Panel B), and double-denudation (Panel C) rabbit carotid arteries 
immunostained for the EC surface antigen CD31 (brown stain). In single­
denudation vessels the EC layer was consistently intact (or near-intact) six weeks 
after injury, while large areas devoid of endothelium were found in double­
denudation vessels. Arrows in Panels B and C indicate the IELs of the injured 
vessels. Bar = 125 pm.
Figure 3.13 pH dependence of p-galactosidase staining in control rabbit 
carotid arteries
A B
*
Figure 3.13 Representative photomicrographs showing control rabbit carotid 
arteries stained for p-galactosidase activity at pH 4.0 (Panel A) and pH 6.0 (Panel 
B). In Panel A positive staining is present throughout the vessel wall, reflecting the 
ubiquitous presence of acid p-gal activity. In contrast only occasional cells showed 
positive staining (see arrow in Panel B) when control vessels were stained for SA- 
P-gal activity; in control arteries these rare cells were found either in the adventitia 
or the media, but never bordering the vessel lumen. Bar = 80 pm.
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Figure 3.12 Panel C shows a representative cross-section from a double-denudation 
vessel, stained for CD31 six weeks after the second injury. In contrast to the findings 
in single-denudation vessels, there are marked discontinuities in the EC layer, 
suggesting a failure of complete re-endothelialization. Indeed complete re- 
endothelialization was not observed in any of the double-denudation vessels in this 
study.
3.2.3.2 Detection of SA-p-gal activity in control, single- and double-denudation 
vessels: qualitative assessment
SA-p-gal activity in control arteries
As described previously, when sham-operated carotid arteries were stained for p-gal 
activity at pH 4.0, positive staining was detected in all layers of the vessel wall 
(Section 3.1.3.5 and Figure 3.7). A similar result, this time without an eosin counter­
stain, is illustrated in Figure 3.13 Panel A (page 138). By contrast, Figure 3.13 Panel B 
shows a representative section from a control vessel stained for P-gal activity at pH 
6.0 (SA-p-gal). Here no positive staining is seen in the intima or media, and only a 
single blue cell is seen in the adventitia. Indeed, in all the control vessels stained for 
SA-P-gal, only occasional blue cells were found in the adventitia, and the finding of 
blue cells in the media was even rarer. In no control vessels were blue cells found in 
the intima.
Panels A and D of Figure 3.14 (overleaf) show a ftuther example of the rarity (or, as in 
this case, absence) of SA-P-gal staining in control arteries, here with an eosin counter­
stain.
SA-p-gal activity in single- and double-denudation vessels
When single-denudation vessels were stained at pH 6.0, an accumulation of blue cells 
was consistently demonstrable in the neointima and media (Figure 3.14, Panels B and 
E). These SA-p-gal-positive cells, while present in increased numbers compared with 
control arteries, were still relatively rare, and tended to be found as isolated cells, 
scattered apparently randomly in the layers of the neointima and media, with no 
evident tendency to form clusters.
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Figure 3.14 SA-(3-gal staining in control, single- and double-denudation vessels 
control single double
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Figure 3.14 Photomicrographs showing SA-|3-gal staining in representative carotid artery cross-sections from control (Panels A and D), single- 
(Panels B and E) and double-denudation (Panels C and F) vessels, counter-stained with eosin. Panels D, E and F show at high-power areas close 
to the vessel lumen within Panels A, B and C respectively. The black arrows in Panels B and E indicate a single positively-stained cell in the 
neointima of a single-denudation artery. In Panel C two layers of blue cells (white arrows) are seen in a double-denudation vessel: one near the 
luminal border of the neointima and one in the region of the IEL. Bar = 160 pm in Panels A, B and C, and 20 pm in Panels D, E and F.
In double-denudation vessels, however, the accumulation of SA-p-gal-positive cells 
was markedly increased, and these cells appeared either as a discontinuous layer near 
the luminal border of the neointima, or in clusters distributed at various depths in the 
neointima and media (Panels C and F of Figure 3.14).
In both single- and double-denudation vessels, a few scattered SA-(3-gal-positive cells 
were found in the adventitia, but these occurred as rare isolated cells.
3.2.3.3 Assessment of the accumulation of SA-J3-gal-positive cells in denuded vessels 
The extent of SA-(3-gal activity in the carotid arteries was assessed morphometrically, 
as described in Chapter Two (Section 2.2.3.7), and was expressed as the percentages 
of neointimal and medial cross-sectional areas occupied by blue cells.
Figure 3.15 (overleaf) shows the results of this analysis. As mentioned above, no blue 
cells were detected in die intima of any of the control arteries, and in these vessels 
only a negligible percentage of the medial cross-sectional area was occupied by blue 
cells. After a single denudation, sufficient SA-j3-gal-positive cells emerged to occupy 
a measurable percentage of the neointimal cross-sectional area (Figure 3.15, Panel A). 
A second denudation led to a further accumulation of SA-(3-gal-positive cells in the 
neointima, the percentage of neointimal cross-sectional area covered by blue cells 
rising from 0.06% to 0.99% (P < 0.001 by nested ANOVA, P = 0.02 by Wilcoxon 
rank sum test). Similarly, the percentage of medial area covered by blue cells rose 
from 0.00068% to 0.01% after a single denudation, and to 0.11% after a second injury 
(P < 0.02 by nested ANOVA, P = 0.02 by Wilcoxon rank sum test) (Figure 3.15, 
Panel B).
The progressive increase in medial occupation by blue cells appeared to parallel the 
accompanying rise in neointimal occupation (as shown in Figure 3.15), although the 
percentage of media occupied by blue cells was always markedly lower than the 
corresponding percentage of neointimal area.
As mentioned in Chapter Two, the occurrence of SA-p-gal-positive cells in the 
adventitia of vessels in all three groups was assessed by counting individual cells. The 
mean numbers of SA-(3-gal-positive cells per cross-section in the control, single- and 
double-denudation groups were 2.4,1.7 and 2.2 respectively.
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Figure 3.15 Percentage areas of SA-P-gal staining in the (neo)intima and media of rabbit carotid arteries
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Figure 3.15 illustrates the percentages of (neo)intimal (Graph A) and medial (Graph B) areas covered by SA-P-gal-positive 
cells in control, single- and double-denudation rabbit carotid arteries. Percentages are shown as mean values +/- s.d.. P 
values for comparisons between control- and single-denudation percentages were calculated using the Wilcoxon rank sum 
test, since data were non-parametrie and zero values in the control group precluded log transformation. P values for 
comparisons between single- and double-denudation vessels were calculated using a nested ANOVA following log 
transformation of the data; when P values were re-calculated using non-parametric tests, differences between single- and 
double-denudation groups remained statistically significant for both neointimas and medias.
3.2.3.4 Identification of SA-P-gal-positive cell types
Immunohistochemistry was used to determine which cell types expressed SA-p-gal 
activity in the carotid artery cross-sections. Antibodies were used to detect the 
presence of CD31 (for ECs), smooth muscle a-actin (for VSMCs), and CD45 (a 
leukocyte marker found on all white cells, including T lymphocytes [Lefrancois et al. 
1986] and cells of the monocyte/macrophage lineage [Kurtin et al. 1985]).
CD31 labelling
When single- and double-denudation vessels which had been stained for SA-p-gal 
activity were immunostained for CD31, cells were detectable which co-stained for SA- 
P-gal activity and the presence of CD31 (as shown in Figure 3.16, Panels A and B, 
overleaf). These co-staining cells were more numerous in double-denudation than in 
single-denudation vessels, assessed qualitatively. These cells bordered the vessel 
lumen, and in the double-denudation vessels tended to be found in regions 
neighbouring discontinuities in the endothelium, as is illustrated in the figure.
Smooth muscle a-actin labelling
Panels C and D of Figure 3.16 show a representative example of smooth muscle a- 
actin labelling in a double-denudation vessel. As shown, numerous cells were detected 
which co-stained for SA-p-gal activity and for smooth muscle a-actin. Such cells were 
detected in both the neointima and the media, and the clusters of blue cells in the 
neointima of double-denudation vessels (mentioned above) were found to co-stain for 
smooth muscle a-actin. Similar co-staining was found in the neointima and media of 
single-denudation vessels, though as mentioned above, blue cells were rarer in these 
arteries than in double-denudation vessels.
CD45 labelling
Study of near-adjacent sections stained for either CD31 or smooth muscle a-actin 
suggested that all the blue cells in these sections stained positively for one or other of 
these antigens. Nevertheless, immunohistochemical detection of CD45 was undertaken 
in order to establish whether leukocytes might also express SA-p-gal activity.
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Figure 3.16 Identification of SA-0-gal-positive cell types
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Figure 3.16 Photomicrographs showing immunostaining for CD31 (Panels A and 
B, brown), smooth muscle a-actin (Panels C and D, red) and CD45 (Panels E and F, 
red) in representative double-denudation rabbit carotid artery cross-sections. Panels 
B, D and F show at high-power the boxed areas in Panels A, C and E respectively. 
The SA-P-gal (blue) staining co-localizes with the immunostaining in Panels B and 
D, but not in Panel F. The arrow in Panel F indicates a CD45-positive cell apparently 
adhering to SA-p-gal-positive cells in the neointima; these blue cells were found, in 
adjacent cross-sections, to be VSMCs. Bar = 160 pm in Panels A, C and E, and 20 
pm in Panels B, D and F. i a a
Panels E and F of Figure 3.16 show a representative result from these experiments. No 
SA-P-gal-positive cells in any sections studied (from either single- or double­
denudation vessels) showed CD45 labelling. Instead, as illustrated in the figure, some 
CD45-positive cells were detected in the lumen, adjacent to the vessel wall, apparently 
adhering to SA-p-gal-positive cells.
3.2.3.5 Detection of proliferating cells in carotid artery cross-sections 
Immunohistochemistry was also used to detect proliferating cells in double-denudation 
carotid arteries; several cross-sections from each of the four double-denudation vessels 
were stained for PCNA. These sections contained a low but measurable number of 
PCNA-positive cells, suggesting residual cellular proliferative activity six weeks after 
the second injury. Figures 3.17 (overleaf) shows that PCNA-positive cells could be 
detected in both the neointima (Panels A, B and C) and the media (Panel D) of injured 
arteries. Although these vessels also contained a considerable number of SA-P-gal- 
positive cells, none of these blue cells was found to stain positively for PCNA. There 
was no apparent relationship between the location of proliferating cells and SA-p-gal- 
positive cells.
3.2.3.6 Detection of apoptotic cells in carotid artery cross-sections 
Cross-sections from double-denudation arteries were labelled using the TUNEL 
technique in order to detect apoptotic cells. Figures 3.18 and 3.19 (both on page 147) 
show representative results of this analysis. TUNEL-positive cells were found in all 
arterial cross-sections studied. They were few in number (ranging from one to four 
cells per cross-section), and were found in both the neointima (Figure 3.18) and the 
media (Figure 3.19). The TUNEL-positive nuclei tended to show a marked degree of 
fragmentation, as confirmed on DAPI fluorescent staining (Figure 3.18 Panel B, and 
Figure 3.19 Panel B), suggesting that they were late apoptotic cells.
As mentioned above, a large number of SA-p-gal-positive cells were found near the 
luminal border of the neointima of double-denudation vessels. In none of the sections 
studied with TUNEL analysis was any TUNEL-positivity found in this region of the 
vessel wall. Indeed, it was notable that despite an extensive survey of die sections 
analysed, including sections containing large numbers of SA-P-gal-positive cells, no 
cells were detected which displayed both TUNEL- and SA-P-gal-positivity.
145
Figure 3.17 Detection of cellular proliferation and senescence in injured arteries
Figure 3.17 Photomicrographs showing immunostaining for PCNA (brown) in 
representative double-denudation rabbit carotid artery cross-sections. The upper 
panels show an isolated PCNA-positive cell (Panel A) and an isolated SA-p-gal- 
positive cell (blue, Panel B), both in the neointima. The lower panels show areas of 
neointima (Panel C) and media (Panel D) where proliferating cells (arrows) and 
senescent cells are found in close proximity. The SA-p-gal staining does not co- 
localize with the PCNA immunostaining. Bar = 1 0  pm in Panels A, B and C, and
12.5 pm in Panel D.
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Figure 3.18 TUNEL analysis and SA-P-gal staining in rabbit neointima
A
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Figure 3.18 shows representative bright-field images of two areas of neointima 
(Panels A and D) from two double-denudation vessels, together with their 
corresponding fluorescent images of DAPI (Panels B and E) and TUNEL (Panels C 
and F) staining. The arrows in Panels B and C indicate an apoptotic cell which does 
not show SA-p-gal staining in Panel A. The SA-P-gal-positive cells in Panel D do not 
show TUNEL fluorescence (Panel F). The background autofluorescence in Panels C 
and F is similar to that seen in negative controls. Bar = 10 pm.
Figure 3.19 TUNEL analysis and SA-p-gal staining in rabbit media 
A
Figure 3.19 shows bright field images of two areas of media (Panels A and D) from 
two double-denudation vessels, together with their corresponding fluorescent images 
of DAPI (Panels B and E) and TUNEL (Panels C and F) staining. The arrows in 
Panels B and C indicate an apoptotic cell which does not show SA-p-gal staining in 
Panel A. The SA-p-gal-positive cell in Panel D does not show TUNEL fluorescence 
(Panel F). The background autofluorescence in Panels C and F is similar to that seen 
in negative controls. Bar =10 pm.
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3.2.4 Discussion
3.2.4.1 Key findings
The results of the in vivo experiments described in this chapter can be summarized as 
follows. In those vessels which did not become totally occluded, the denudation injury 
used in this study led to a consistent degree of injury, with no (or minimal) disruption 
of the IEL. Morphometric studies showed that a second denudation injury led to a 
greater degree of neointima formation than a single injury, while the medial cross- 
sectional area was not significantly affected by denudation injuries. Furthermore, the 
neointima of vessels denuded twice had a stratified appearance, with an apparent 
difference in the alignment of the neointimal cells in the superficial and deep layers. 
The endothelial layer completely regenerated after a single denudation, but failed to do 
so after a second injury. Staining of control vessels at pH 6.0 showed only very 
occasional cells expressing SA-|3-gal activity, and these cells were confined to the 
media and adventitia; after a single denudation small numbers of SA-P-gal-positive 
cells were also found in the neointima; their numbers in the neointima and media 
increased following a second denudation. Immunohistochemistry confirmed that these 
SA-P-gal-positive cells were endothelial and vascular smooth muscle cells, and that 
they did not express PCNA. TUNEL analysis showed that while apoptosis was present 
in the arterial wall, it occurred in cells distinct from those showing SA-p-gal activity.
3.2.4.2 Comments on the experimental design
In order to discuss the implications of the above findings, it is worth firstly reviewing 
the changes which are known to occur in the arterial wall following denudation 
injuries, since these data informed the design of the experiments described in this 
chapter, and are useful in the interpretation of the results given above.
The use o f endothelial denudation models
Endothelial denudation models have been used extensively over the last twenty-five
years; they have employed a variety of different arteries (including the iliac, femoral,
carotid, and coronary arteries, as well as the aorta) in a number of species (including
mouse, rat, rabbit and pig) [for example: Reidy et al. 1982, Clowes et al. 1986,
Weidinger et al. 1990, Schneider et al. 1993, Burchenal et al. 1996, Bosnians et al.
1997, Perlman et al. 1997, Hutter et al. 2003]. Such research has often been
undertaken in order to study the clinical scenario of post-angioplasty re-stenosis.
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Because the injury leads to intimal hyperplasia, a process which also occurs in 
atherosclerosis, denudation studies have also been used to investigate certain aspects 
of atherogenesis [for example: Moore et al. 1982, Lindner and Reidy 1991, Niimi et 
al. 1994, Efendy et al. 1997, Dzau et al. 2002].
Histological changes following denudation injuries
The changes in the arterial wall which follow endothelial denudation can be 
summarized as follows. Almost immediately after removal of the endothelium, 
platelets [Groves et al. 1979] and leukocytes [Reidy and Silver 1985] adhere to the 
luminal surface of the vessel wall. As noted previously, platelets contain mitogens and 
chemoattractants for VSMCs (such as PDGF), as well as pro-thrombotic agents. 
Leukocytes enter the vessel wall, and are subsequently found in the gradually 
developing neointima [Ferns et al. 1991]. A few of these are neutrophils [Jonasson et 
al. 1988, Verheyen et al. 1988], while others are T cells [Jonasson et al. 1988], 
suggesting an inflammatory element to the vessel wall response. Macrophages have 
also been detected in the neointima formed following denudation injury in some 
normocholesterolaemic animals, and these cells can become foam cells if the animals 
have been fed a high-cholesterol diet [Verheyen et al. 1988]. Macrophage invasion is 
in fact not found in the neointimas of normocholesterolaemic rabbits [Azuma et al. 
1995].
Another major component of the vessel’s response to injury comprises proliferation of 
VSMCs within the media, migration of VSMCs from the media to the neointima, and 
their further proliferation within this newly-forming layer [Clowes et al. 1983, Clowes 
and Schwartz 1985]. These changes have been attributed to the release of 
chemoattractants and growth factors released by activated platelets adhering to the 
denuded vessel wall [Fingerle et al. 1989] and to the release of cytokines by other cells 
[Liu et al. 1989]. Basic fibroblast growth factor, released from dead vascular cells, has 
been postulated to be the major mitogen controlling the proliferation of VSMCs 
following trans-luminal injury [Lindner and Reidy 1991]. Other mediators involved in 
the promotion of intimal proliferation and matrix accumulation include transforming 
growth factor-(3, angiotensin II, epidermal growth factor, and IGF-factor 1 [reviewed 
in Dzau et al. 2002].
Bone marrow-derived cells may contribute to neointimal SMC content. Female
C57BL/6 have been subjected to total body irradiation, and then transfused with
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marrow cells from congenic male donors; after endothelial denudation of their iliac 
arteries, approximately half of the neointimal a-smooth muscle actin-containing cells 
are of male donor origin, suggesting that they originate in the bone marrow [Campbell 
et al. 2001]. Stromal cell-derived factor-la, which is involved in the mobilization and 
homing of stem cells, has been demonstrated in the neointima of apoE-deficient mice, 
while systemically-injected peripheral blood progenitor cells are recruited to 
neointimal lesions after vascular injury [Schober et al. 2003].
There is a heterogeneity in the proliferative capacity of medial VSMCs [Haudenschild 
and Grunwald 1985]; of those VSMCs which migrate to the neointima, only fifty 
percent subsequently proliferate [Clowes and Schwartz 1985]. There is also a well- 
documented alteration in the VSMC phenotype following denudation injury: this 
apparently reversible change involves a move from a contractile towards a synthetic 
phenotype, with a loss of myofilament density, and the development of large quantities 
of endoplasmic reticulum and free ribosomes [Manderson et al. 1989], decreased 
desmin and increased vimentin expression [Kocher et al. 1984], and a change from a- 
actin to P-actin expression [Baija et al. 1986].
In areas of incomplete re-endothelialization, the luminal border of the vessel wall 
becomes lined with phenotypically altered VSMCs, which form a layer which has 
been termed a ‘pseudoendothelium’ [Reidy 1985]. These cells again show a decline in 
myofilament density. The pseudoendothelium is non-thrombotic, but lacks the 
permeability barrier properties of the normal endothelium. The presence of such a 
pseudoendothelium does not retard the rate of re-endothelialization of an area denuded 
by balloon injury [Reidy 1988].
Denudation injuries lead to a wave of apoptotic activity [Han et al. 1995, Bochaton- 
Piallat et al. 1995, Perlman et al. 1997]. In the media, this wave starts very soon after 
the mechanical insult: in one study, involving balloon denudation of rat carotid arteries 
and rabbit external iliac arteries, up to 70% of medial VSMCs were apoptotic within 
thirty minutes of the injury [Perlman et al. 1997]; the extent of apoptosis in the media 
then declined sharply over the following few hours. A wave of apoptosis is also 
observed in the developing neointima; this wave reaches its peak between one and 
three weeks after the denudation, depending on the model studied [Han et al. 1995, 
Bochaton-Piallat et al. 1995]. In the rat model, the wave of neointimal apoptotic 
activity has disappeared by six weeks after the denudation injury [Bochaton-Piallat et
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al. 1995]. The time-course of the apoptotic wave in the rabbit carotid model has not 
been fully characterized.
ROS may play a role in the promotion of apoptosis in denuded vessels. An 
intracellular rise in ROS levels can mediate p53-dependent apoptosis in vitro [Johnson 
et al. 1996]. More recently, increased oxidative stress has been detected in the injured 
vessel wall using an assay of glutathione levels in denuded rabbit carotid arteries 
[Pollman et al. 1999], and this alteration of the redox status was associated with 
induction of pro-apoptotic stress-activated protein kinases (SAPK). Medial VSMCs 
were more susceptible to apoptosis than their neointimal counterparts [Pollman et al. 
1999].
Following denudation injuries ECs proliferate and migrate into the denuded area from 
neighbouring regions of the vessel; in a rat denudation model a combination of EC 
migration and proliferation caused a sheet of regenerating endothelium to advance at 
approximately 70 pm per day in the circumferential direction, and about six times 
faster axially [Haudenschild and Schwartz 1979].
Nearly thirty years ago it was observed that areas which re-endothelialized earliest 
developed least intimal thickening [Stemerman et al. 1977]. Re-endothelialization 
appears to inhibit both migration and proliferation of VSMCs. Thus in a rat denudation 
model, VSMCs migrated into the intima only in those areas not re-covered by 
regenerating endothelium seven days after injury [Haudenschild and Schwartz 1979]; 
in another denudation model, rates of VSMC proliferation in the intima were lower in 
re-endothelialized than in persistently denuded areas [Clowes et al. 1983]. Conversely, 
repeated endothelial removal promotes subsequent intimal thickening [Niimi et al.
1994]. Recently over-expression of a specific inhibitor of EC growth, endostatin, in a 
mouse arterial denudation model, has been shown to retard re-endothelialization, and 
this retardation was associated with increased neointima formation [Hutter et al. 
2003].
A potential mechanism for the interaction between endothelial denudation and intimal 
hyperplasia is suggested by in vitro evidence that ECs can inhibit VSMC proliferation 
via NO signalling [Scott-Burden et al. 1993], and that serial passage of ECs leads to a 
progressive decline in eNOS activity [Matsushita et al. 2001]. It has been suggested 
that the decline in NO secretion by ECs which follows denudation injuries [Niimi et 
al. 1994], or the suppression of their NO production by ROS [Jaimes et al. 2001], may
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remove one inhibitory control on VSMC proliferation and migration [Dzau et al. 
2002].
Previous studies involving balloon injury to the rabbit carotid artery 
The histological changes described so far are thought to occur in most endothelial 
denudation models. The rabbit carotid artery model employed in the current study has 
been used extensively in previous investigations [for example: Reidy et al. 1983, 
Reidy 1988, Manderson et al. 1989, Azuma et al. 1990, Niimi et al. 1994, Azuma et 
al. 1995, Bosnians et al. 1997, Efendy et al. 1997, Pollman et al. 1999, Rosenthal et 
al. 2002, Herdeg et al. 2003, Francis et al. 2003].
The model was first used by Reidy et al. specifically to explore the question of 
whether rabbit ECs have a limited replicative life-span in vivo [Reidy et al. 1983]. It 
had previously been noted that after denudation of rabbit aortas, EC replication halted 
after fourteen days of vigorous proliferative activity [Reidy et al. 1982]. Attention then 
turned to the carotid artery, since the more straightforward anatomy at this latter site 
(not complicated by multiple branch-points) simplified the study of endothelial re- 
growth. Following balloon denudation of the carotid artery (using a 2F saline-filled 
embolectomy catheter, as employed in the current study), endothelial re-growth 
progressed from either end of the vessel, but, as in the aorta, stopped after fourteen 
days, leaving an area still devoid of endothelium [Reidy et al. 1983]. A second 
catheter injury (this time effected by passing a nylon catheter along the artery, 
removing a zone of endothelium approximately ten cells wide) led to further EC 
replication, but ECs did not spread or migrate to cover the previously denuded area. 
This second proliferative response was cited as evidence that the initial cessation of 
replicative activity had not been caused by replicative senescence [Reidy et al. 1983]. 
It did not exclude the possibility, though, that the original halt in endothelial re- 
coverage was caused by a combination of contact inhibition occurring in central areas 
of the partially regenerated endothelium, and replicative senescence occurring at the 
leading edge of endothelial regrowth. If this were the case, the re-activation of 
replication by a second injury could be explained by the release from contact 
inhibition of non-senescent cells in the re-denuded area.
Azuma et al. have studied the kinetics of re-endothelialization in this model in more 
detail [Azuma et al. 1990]. They found that one week after injury, approximately 30% 
of the arterial luminal surface was covered with regenerating ECs, this percentage
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rising to 95% by four weeks; by six weeks after the injury full endothelial coverage 
had been achieved. In this study it was found that regenerated ECs differed from 
‘native’ cells in that they were elongated in shape and irregularly orientated. There 
was also evidence of EC dysfunction, as manifested by impaired endothelium- 
dependent relaxation in response to acetylcholine. Intimal thickening and VSMC 
proliferation were also noted, and no evidence was found of lipid accumulation in the 
arterial wall.
In a later study using the rabbit model, the same group performed two balloon 
denudations of the right carotid artery six weeks apart, then culled the animals two 
weeks after the second injury [Niimi et al. 1994]. Following this protocol, they found 
that full endothelial coverage had been achieved within two weeks of the second 
injury, suggesting that re-endothelialization proceeded more rapidly following a 
double- than a single-denudation. They also noted that intimal thickening became 
more pronounced after the second denudation injury, and speculated that this might 
result from reduced production of NO by the endothelium.
In a further study, the same group performed balloon denudation of the right carotid 
arteries of a group of ten-week-old Japanese White rabbits; six weeks later they 
injured both the right and left carotid arteries [Azuma et al. 1995]. They then used 
scanning electron microscopy and immunohistochemistry to investigate the resultant 
EC and VSMC proliferative responses. Cells expressing PCNA were detected in both 
the neointima and the media within twenty-four hours of a single denudation; their 
number rose dramatically over the next forty-eight hours, then gradually declined 
almost to basal levels over the following four to six weeks. In contrast, after a second 
denudation injury, there was a more pronounced and more prolonged proliferative 
response in both the neointima and the media, such that a substantial number of cells 
still showed evidence of proliferative activity in both layers six weeks after the second 
injury, although the wave did appear to have peaked two weeks earlier. After a double 
injury, the proliferative response in the neointima was more pronounced, and occurred 
earlier, than that in the media.
When rabbits whose carotid arteries have undergone endothelial denudation are 
subsequently fed a high cholesterol diet, lipid is deposited in the neointima [Efendy et 
al. 1997]; the neointima contains a peri-luminal layer of densely populated cells, a 
central lipid-rich layer, and a deeper VSMC-rich region. The rabbit carotid balloon
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denudation model has therefore sometimes been used in the study of atherogenesis. It 
has subsequently also been employed to evaluate the potential benefits of agents as 
diverse as brachytherapy, sulphated oligosaccharides, retinoids and garlic extract 
[Efendy et al. 1997, Rosenthal et al. 2002, Herdeg et al. 2003, Francis et al. 2003] in 
the context of either atherosclerosis or post-angioplasty re-stenosis.
Benefits o f using the rabbit carotid denudation model in the current study 
There were several reasons for choosing the rabbit carotid artery denudation model in 
particular in the current study. Firstly, as just detailed, the kinetics of the proliferative 
response to balloon injury in this model have previously been documented in detail. 
This was important in a study primarily designed to investigate an attenuation of 
proliferative capacity. Secondly, the capacity for rabbits to undergo repeated arterial 
denudation meant that the proliferative response could be re-triggered, and therefore 
prolonged, by a second injury. The size of rabbit carotid arteries, and the virtually 
complete de-endothelialization known to occur following the standard balloon 
denudation [Reidy et al. 1983], meant that the second injury could safely be regarded 
as affecting the site already injured. Another benefit of the model is that it affords a 
readily-available control, using sham operations of the contralateral carotid artery.
Further comments concerning the experimental design and methods used 
The use of a six-week interval between denudation injuries, and between the final 
injury and culling, was based on the studies detailed above, showing that such an 
interval allows time for a full-blown proliferative response to occur (and indeed to 
begin to decline) [Azuma et al. 1990, Niimi et al. 1994, Azuma et al. 1995].
The prevalence of SA-P-gal-positive cells in the neointima and media was expressed 
in terms of the percentage areas of neointima and media covered by blue cells. 
Percentage areas were used in preference to absolute areas in order to control for 
variations in arterial size between animals. The use of individual cell counts was 
considered, but it was found in preliminary experiments that the use of a counter-stain 
to detect cell nuclei made the SA-P-gal staining difficult to visualize.
In the immunohistochemical studies, the two staining kits (the New Fuchsin 
Chromogenic Substrate System and the Liquid DAB Plus kits) were each tested on 
carotid artery cross-sections to determine which method gave the most effective 
staining for each cell type investigated. For example, while the fuchsin system was
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able to detect rabbit ECs (in the same way as it had labelled HUVECs in the in vitro 
studies), it in fact proved less effective than the DAB system in demonstrating the 
presence (or absence) of a continuous endothelium in excised arteries.
TUNEL has been employed since 1992 for the detection of programmed cell death, 
and relies on the incorporation of dUTP (conjugated with agents such as fluorescein or 
biotin) at sites of DNA breaks, as are found in the fragmented DNA of apoptotic cells 
[Gavrieli et al. 1992]. The role of TUNEL in detecting apoptosis in vascular tissue has 
been established since it was used to detect apoptotic VSMCs in human atherosclerotic 
plaques [Geng and Libby 1995], and its use in balloon-injured rabbit carotid artery has 
been described more recently [Kamenz et al. 2000].
3.2.4.3 Discussion of the results
The aim of the ex vivo experiments described in this chapter was to assess whether a 
cellular proliferative response to a denudation injury could lead to the emergence of 
senescent cells. It was important to characterize the nature of the proliferative 
responses to single- and double-denudation injuries in order to correlate these with the 
development of senescence. The EC proliferative response was assessed by 
immunohistochemical detection of CD31; (neo)intima/media ratios were used as an 
indication (though not a direct measurement) of the degree of VSMC proliferation. In 
addition, die presence of proliferating cells six weeks after a double-denudation was 
detected by staining for PCNA, and the results of this analysis will be discussed later 
in this Section.
If the proliferative response and the occurrence of senescence were to be compared 
between the single- and double-denudation groups, it was desirable that the severity of 
the initial trauma to the vessel wall should be similar in each group. The similarity of 
the injury scores in the eight denuded arteries which did not occlude suggests that the 
balloon catheter technique employed in the current study delivered a comparatively 
consistent mechanical insult.
EC proliferative response to denudation injury
There were clear-cut differences in the vascular cell proliferative response to injury 
following single- and double-denudations. Complete re-endothelialization occurred 
after a single denudation, but not after a second injury. The complete re- 
endothelialization six weeks after a single injury in this model is consistent with the
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findings of Azuma et al. mentioned earlier [Azuma et al. 1990]. It also corresponds 
with research mentioned in Chapter One, showing that complete regeneration of large 
areas of endothelium can be achieved in rat carotid arteries, provided that the 
denudation injury is performed without trauma to the media [Lindner et al. 1989]. As 
mentioned above, most of the arteries in the current study showed an intact IEL after 
injury, and so complete repair of the endothelium might be expected. As mentioned 
earlier, Reidy et al. have described incomplete re-endothelialization of the rabbit 
carotid artery up to twelve weeks after endothelial denudation with a 2F saline-filled 
embolectomy catheter [Reidy et al. 1983]; in that study, though, the entire length of 
the common carotid artery, from the aorta to the bifurcation of the internal and 
external carotid arteries was denuded, while a much shorter section was injured in the 
current experiments.
The failure of the endothelium to regenerate completely after a second injury in this 
study could be interpreted as a failure of the ECs to continue to proliferate as a result 
of replicative senescence. On the other hand, as mentioned earlier (Section 3.2.4.2), 
Reidy et al. argued that their ability to re-stimulate EC replication through a second 
denudation injury [Reidy et al. 1983] disproved the theory that the initial cessation in 
EC replication was caused by replicative senescence. Thus, for direct evidence of in 
vivo EC senescence, one must turn to the SA-p-gal experiments discussed below.
The failure of complete re-endothelialization in double-denudation vessels in the 
current study might appear to be inconsistent with previous research using this model, 
showing total re-endothelialization two weeks after a second denudation [Niimi et al. 
1994, Azuma et al. 1995]. These two cited studies, though, employed a balloon 
catheter inflated with air, while the balloon used in the current study was filled with 
saline. It is possible that the use of saline in the balloon leads to a more stringent 
removal of ECs, resulting in a more extensive area of denudation. As a result a larger 
number of EC doublings would be required to re-cover the exposed area. If the onset 
of senescence prevents these extra replications from occurring (particularly after a 
second denudation, when some proliferative capacity may have been expended 
repairing the initial injury), the luminal surface could remain denuded.
VSMC proliferative response to denudation injury
Turning to the VSMC proliferative response, neointimal sizes attained in the current
study were similar to those reported in previous cell proliferation research using the
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same animal model [Azuma et al. 1995]. Neointimal size can be used only as an 
indicator (and not a direct measure) of the VSMC proliferative response, since the 
neointimal bulk compromises not only VSMCs, but also other cell types (such as 
neutrophils, T cells and macrophages) and extracellular matrix.
Even given this qualification, the consistent finding that neointima/media ratios 
following double-denudation injuries were greater than those following single 
denudation injuries, at very least suggests an increased VSMC proliferative response 
following the second denudation. This concurs with the finding of Azuma et al. 
mentioned earlier, that a second denudation injury led to a more persistent and 
extensive wave of cell proliferation within the neointima and media than did a single 
denudation [Azuma et al. 1995]. The apparent stratification of the double-denudation 
neointima raises another possibility, though: the second denudation injury may have 
left some of the original neointima intact, so that the observed rise in neointima/media 
ratio after a second injury may simply have resulted from the superimposition of a 
second neointima on the remains of the first.
The stratification within the double-denudation neointima has not been described 
previously. Regenerating ECs in injured rabbit arteries fail to align themselves axially, 
parallel with blood flow; they have variable sizes and irregular shapes, raising the 
possibility that their misalignment reflects senescence-related changes in cell-to-cell 
interactions [Reidy et al. 1983, Weidinger et al. 1990]. The stratification of the 
double-denudation neointimas in rabbit carotid arteries may reflect an equivalent 
alteration in the properties of VSMCs which are the product of a double proliferative 
response: some of these neointimal cells, having reached senescence, may have lost 
their ability to form normal intercellular interactions, and may also influence the 
behaviour of neighbouring cells, disrupting the homogeneity of the surrounding 
neointima.
The emergence o f senescent cells in denuded arteries
Turning to the experiments involving staining for SA-p-gal activity, the almost 
complete absence of positive staining in control arteries stained at pH 6.0 (compared 
with the widespread staining at pH 4.0) demonstrates, at the very least, that (3-gal 
activity in intact rabbit arteries shows a pH-specificity similar to that displayed by 
non-senescent human skin fibroblasts, HUVECs and rabbit VSMCs in culture. It is
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tempting to deduce that it also demonstrates that intact rabbit carotid arteries contain 
very few, if any, senescent cells.
As will be discussed in Chapter Five, SA-P-gal has not been universally accepted as a 
marker of replicative senescence. For the purposes of the following discussion, the 
assumption will be made (as it was by Dimri et al.) that the selective ability of SA-p- 
gal to detect senescent cells in vitro is mirrored in ex vivo tissue [Dimri et al. 1995]. 
Given the low rates of cell turnover in the normal arterial wall, it is not surprising that 
only very scarce SA-P-gal-positive (senescent) cells were detected in control arteries. 
The emergence of SA-P-gal-positive cells in the neointima and media of denuded 
arteries appears to mirror the gradual appearance of such cells in serially-passaged in 
vitro cultures, strengthening the inference that the blue-stained cells in the vessel wall 
are indeed senescent.
The emergence of senescent cells in a vessel recovering from a mechanical injury 
would make mechanistic sense. The telomeric theory of replicative senescence 
suggests that for cells to become senescent, they must have undergone a certain 
number of cell divisions. The wave of proliferative activity which occurs after a 
denudation injury may lead to sufficient rounds of replicative activity to allow 
senescence to emerge. In the case of the endothelium, ECs bordering the area recently 
denuded by the second of two sequential injuries might themselves be the product of 
rounds of EC replication ensuing from the first injury; if so these ECs would be 
expected to have partially exhausted their replicative capacity, and so might reach the 
limit of their replicative potential before achieving complete repair of the breach in the 
endothelium. Similarly, the fact that a second denudation led to a dramatic increase in 
the percentage area of neointima and media covered by SA-p-gal-positive cells could 
be explained if the second wave of proliferative activity in the vessel wall involved 
cells whose replicative capacity had already been partially depleted following the 
initial denudation.
The finding that SA-P-gal-positive cells were observed in the adventitia reflects the
increasingly appreciated fact that the adventitia is not an inert outer envelope of the
artery, but is actively involved in processes such as vessel re-modelling [Stenmark et
al. 2002]. Following endothelial denudation injuries, the adventitia contains a
significant population of proliferating cells, some of which migrate to the neointima
and acquire characteristics of myofibroblasts [Shi et al. 1996]. It seems plausible that
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the occasional S A-[3-gal-positive cells found in the adventitia of injured arteries in the 
current study might result from such proliferative activity.
Most of the blue cells found in single- and double-denudation vessels were located in 
the neointima. If positive staining is indeed a manifestation of senescence, this finding 
could have various explanations. Firstly, the majority of proliferative activity in the 
injured arterial wall may occur in the neointima, as is suggested by quantitative 
analysis of PCNA detection [Azuma et al. 1995]. Alternatively, or in addition, those 
cells which proliferate in the neointima may do so at a greater rate than cells in the 
media, or may intrinsically have reduced replicative capacity compared with their 
medial equivalents; this could be explained by the notion that VSMCs undergo some 
rounds of proliferation in the media, migrate to the neointima, and then undergo 
further cell divisions [as suggested in Clowes et al. 1983, Clowes and Schwartz 1985]. 
The demonstration of more senescence in the neointima than in the media of the 
injured artery has parallels in atherosclerotic lesions. As mentioned in Chapter One, 
VSMCs derived from fibrous plaques show reduced proliferative capacity compared 
with cells from the underlying media [Ross 1986, Bennett et al. 1995]. Similarly, 
intimal cells from arteries known to be susceptible to atherosclerosis show more 
marked age-related telomere attrition than do intimal cells from arteries which are 
usually free of disease; in contrast, no difference is found in the age-related rate of 
telomere loss between medial cells from the two types of artery [Chang and Harley 
1995].
Immunohistochemistry showed that in the current study most of the SA-|3-gal-positive 
cells in the injured vessels were VSMCs, and that a minority were ECs. The 
demonstration that the SA-(3-gal-positive cells were not leukocytes or macrophages 
was in itself important, since these cell types contain a significant number of 
lysosomes, and it might be expected that their lysosomal content could be detectable 
by staining for [3-gal activity even at the sub-optimal pH of 6.0.
Replicative senescence or SIPS?
While it is tempting to attribute the presence of senescent vascular cells to telomeric 
attrition resulting from rounds of proliferative activity, another explanation for the 
emergence of SA-[3-gal-positive cells must be considered. In Chapter One (Section 
1.5.4.2) it was mentioned that manipulation of a cell’s redox status could result in
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SIPS, a process which does not involve prior rounds of replicative activity and 
telomeric attrition, but which may result from other forms of DNA damage. Ex vivo 
mechanical injury to dissected rings of rabbit iliofemoral artery leads to increased 
oxidative stress in the tissue [Souza et al. 2000]. Furthermore, balloon-induced injury 
to porcine coronary arteries in vivo leads to an early increase in superoxide production 
via a mechanism dependent on the activity of NAD(P)H oxidase [Shi et al. 2001], the 
major enzymatic source of intracellular ROS in vascular cells [Pagano et al. 1995]. 
This raises the possibility that mechanical injury to the arterial wall may, via a 
localized increase in oxidative stress, lead to stress-induced premature senescence of 
vascular cells, which, given the in vitro experiments of Dumont et al. mentioned in 
Chapter One, may explain the emergence of SA-0-gal activity in the current study 
[Dumont et al. 2000].
Previous experimental data suggest that other agents are also capable of inducing SIPS 
in vascular cells: for example, when early passage HUVECs are grown in culture on 
glycated extracellular matrix proteins, they show some features of premature 
senescence, including SA-p-gal expression, without having undergone telomeric 
attrition [Chen et al. 2002]. While such proteins were not used in the rabbit carotid 
artery experiments, the results of Chen et al. do emphasize that SA-(3-gal expression 
by ECs can occur via mechanisms other than replicative senescence.
Proliferative and apoptotic activity in the injured vessel wall
Arterial cross-sections were immunostained for PCNA, a 36 kD nuclear protein
associated with the cell cycle. Nuclear PCNA immunoreactivity is found in the
proliferative component of normal tissues [Hall et al. 1990], and has, as mentioned
above, been used previously as a marker of proliferative activity in the rabbit carotid
model [Azuma et al. 1995]. The immunohistochemical demonstration of cells still
proliferating in the vessel wall six weeks after a double-denudation injury in the
current study was consistent with findings from that earlier research [Azuma et al.
1995]; any discrepancy in the relative abundance of proliferating cells in the two
studies may reflect the fact that Azuma et al. used a larger balloon (3F, rather than 2F
in the current study), and may thus have caused a more traumatic injury.
Several sections from each of the four double-denudation arteries were examined, so
that, although there were relatively few PCNA-positive cells in each section, in all a
considerable number of PCNA-positive cells were observed, together with a large
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number of SA-P-gal-positive cells. Despite this, no examples were found of cells 
staining positively for PCNA while also exhibiting SA-0-gal activity. Instead PCNA- 
positive and SA-p-gal-positive cells co-existed in the same vessel, but formed two 
distinct populations. This suggests that cell proliferation and senescence can coincide 
temporally in the same tissue, and that SA-p-gal identifies cells which are not 
dividing. Any dual-staining within a single cell for both PCNA and SA-P-gal would 
strongly have argued against the validity of SA-p-gal as a marker of senescent cells.
As mentioned in Chapter One (Section 1.4.7), the relationship between replicative 
senescence and apoptosis has been the subject of some debate. Several studies have 
reported the occurrence of apoptosis during neointima formation [Han et al. 1995, 
Bochaton-Piallat et al. 1995, Perlman et al. 1997, Malik et al. 1998].
The TUNEL results described in this chapter suggest that the apoptotic cells are 
distinct from those undergoing senescence: no evidence for co-staining with SA-P-gal 
and TUNEL was found, despite an extensive study of the double-denudation vessels. 
This would support (though admittedly not prove) the contention that senescent rabbit 
vascular cells are resistant to apoptosis. It would also suggest that, in these cell types 
at least, apoptosis is not an inevitable consequence of senescence.
The sparsity of apoptotic cells in the vessel walls in this study is consistent with 
previous research which has shown that the wave of apoptosis which follows a 
denudation injury has subsided considerably only four weeks after the mechanical 
insult [Bochaton-Piallat et al. 1995, Kollum et al. 1997]. It also concurs with the 
suggestion that following a second denudation injury, neointimal cells are relatively 
resistant to death by apoptosis [Pollman et al. 1999].
3.2.5 Conclusion
The results described in this section strongly suggest that endothelial and vascular 
smooth muscle cells are able to undergo senescence in vivo following an endothelial 
denudation injury, and that the prevalence of senescent cells can be increased by 
repeated injury to the arterial wall. The senescent cells do not appear to be prone to 
apoptosis.
The pathological and clinical implications of the emergence of senescent cells in the 
vessel wall will be discussed in Chapter Five.
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CHAPTER FOUR
Atherogenesis in senescence-accelerated mice
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The experiments described in Chapter Three were designed to explore whether cellular 
ageing can occur in the vasculature. In contrast, the studies detailed in this chapter 
used an animal model of accelerated organismic ageing to investigate whether an 
ageing phenotype, per se, is associated with increased susceptibility to atherogenesis. 
Additional experiments were performed to look for evidence of accelerated cellular 
ageing in this model.
To these ends, two related strains of mice, senescence-accelerated prone (SAM-P) and 
senescence-accelerated resistant (SAM-R), were studied; the origin of these strains has 
been described in Chapter One (Section 1.7).
In the only previously published study looking for evidence of susceptibility to 
atherosclerosis in this model [Yagi et al. 1995], microscopy of the thoracic aortas of 
SAM mice fed a physiological murine diet revealed subendothelial invasion by 
macrophages in SAM-P but not SAM-R vessels; furthermore, when the aortic walls 
were analysed for their content of lipid peroxides, triglycerides and cholesterol, all 
three parameters were found to be higher in SAM-P than in SAM-R aortas. These 
findings were taken as an indication that SAM-P mice might be more prone to 
atherogenesis than SAM-R mice, although no atheromatous lesions were demonstrated 
in either strain.
In the current study, SAM-P and SAM-R mice were fed a diet with a higher fat and 
cholesterol content than that used by Yagi et al., in an attempt to provoke a more 
marked atherogenic response. The susceptibility of each murine strain to 
atherosclerosis was assessed by measuring the extent of lipid deposition in their aortic 
roots. Immunohistochemical studies were carried out to look for evidence of 
macrophage infiltration in the arterial wall. Serum cholesterol and triglyceride levels 
were measured in each strain, in order to establish whether any observed difference in 
lipid lesion formation could be attributed to inter-strain differences in serum lipid 
levels. In a pilot study, lipid deposition was compared in SAM-P mice and C57BL/6 
mice, an inbred strain known to be relatively susceptible to atherogenesis [Paigen et 
al. 1985]. In further studies, two markers of cellular replicative senescence, telomere 
shortening and SA-p-gal activity, were used to investigate SAM cells and tissue 
samples for evidence of accelerated cellular ageing.
This chapter begins with a brief description of the SAM colony maintained at UCL. 
The protocols for the studies of atheroma formation in SAM-P, SAM-R and C57BL/6
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mice are given, and the results of these studies are then reported in detail. The results 
of the telomere and SA-p-gal studies are then described, and the chapter ends with a 
discussion of all the results obtained from studies of the murine model.
4.1 Description of the SAM colony established at UCL
All four of the original SAM-P breeding pairs produced litters, while one of the four 
SAM-R breeding pairs failed to breed. Another SAM-R breeding pair produced 
several litters, but all these offspring were eaten by their parents while still pups. The 
remaining two SAM-R breeding pairs bred successfully. In subsequent generations, 
most newly-formed SAM-P and SAM-R breeding pairs successfully produced litters. 
The mean litter size was slightly larger for SAM-R mice (7.9 pups per litter) than for 
SAM-P mice (7.0 pups per litter), though this difference did not reach statistical 
significance (P = 0.26).
Maintenance of the senescent phenotype in SAM-P mice was judged qualitatively by 
assessing fur glossiness and the incidence of senescence-associated pathologies. A 
quantitative assessment was made on the basis of the weight of the SAM-P and SAM- 
R strains. Unfortunately, meaningful data concerning the life-spans of the generations 
of SAM mice used in this project could not be produced; insufficient numbers of mice 
from the generations studied reached the end of their natural life-spans. Mice died 
‘early’ for a variety of reasons: several were culled for this study and for related work; 
others were culled to relieve suffering from senescence-related pathologies or other 
illnesses; other mice were injured by fighting with litter mates, and were either found 
dead or were culled to relieve suffering.
Figure 4.1 (overleaf) shows the phenotypes of age-matched female SAM-P and SAM- 
R mice, fed a standard laboratory chow (the ‘mouse breeding and maintenance diet’ 
described in Chapter Two) since weaning. As shown, female SAM-P mice were 
smaller than their SAM-R counterparts, and showed loss of fur glossiness. Similar 
differences in phenotype were found between male SAM-P and SAM-R mice.
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Figure 4.1 Phenotypes of SAM-P and SAM-R mice
Figure 4.1 The figure shows female SAM-P (left box) and SAM-R mice 
(right box), photographed at forty-five weeks of age. They had been fed a 
standard laboratory chow since weaning. The SAM-P mice are smaller than their 
SAM-R counterparts, and show loss of fur glossiness.
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The smaller size of SAM-P mice is also illustrated by the weights at twenty-eight 
weeks of age of fourteen SAM-P and fourteen SAM-R mice fed the standard 
laboratory chow since weaning (Table 4.1); these mice would subsequently be fed the 
Western-type diet. Female mice tended to be smaller than their male counterparts in 
both strains (a feature common to many other murine strains). Male and female SAM- 
P mice were smaller than age- and sex-matched SAM-R mice, the differences in each 
case reaching statistical significance.
Table 4.1 Weights of SAM mice fed a standard laboratory chow
Male Female
SAM-R 36.2 ± 1.7 g 
(n=8)
29.8 ± 5.8 g
(n=6)
SAM-P 27.0 ± 2.6 g 
(n=7)
23.1 ± 2.8 g
(n=7)
P  value <0.00001 0.02
Table 4.1 The table shows the mean weights (± s.d.) of 28-week-old SAM mice 
fed a standard laboratory chow since weaning at four weeks of age. P values were 
calculated using a two-tailed unpaired t-test, assuming equal variance (as had been 
demonstrated using Bartlet’s test).
Age-related pathologies were more common in SAM-P than in SAM-R mice. 12 
SAM-P mice (from a total of 178 SAM-P mice in the colony) developed peri- 
ophthalmic lesions (erythema and swelling), and this sign was not found in any of the 
187 SAM-R mice in the colony. Four SAM-P were culled at less than one year of age 
because of skin ulceration and exhaustion; only one SAM-R mouse was culled to 
relieve suffering. This mouse, one of the original breeders transported from Japan, was 
culled at eighty weeks of age, and this was because it showed signs of exhaustion. 
SAM-P mice in general showed reduced levels of activity compared with the SAM-R 
mice, but this was not formally assessed at UCL. Similarly, facilities for testing 
learning and memory in the SAM mice were not available, and so this element of their 
ageing phenotype was not assessed as part of this project.
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4.2 Experimental designs for the study of atherogenesis in SAM
and C57BL/6 mice
Two studies of atherogenesis were undertaken: a pilot study comparing atherogenesis 
in C57BL/6 and SAM-P mice, and a more detailed study comparing atherogenesis in 
SAM-P and SAM-R mice.
The pilot study was designed to establish whether SAM mice could tolerate a 
Western-type diet, and to give an indication of the relative susceptibility of SAM-P 
and C57BL/6 mice to atherogenesis. The ‘Mouse Western Adjusted Calories Diet’ 
(detailed in Chapter Two) was fed ad libitum to seven male SAM-P mice, and to seven 
C57BL/6 mice (two male, five female), from twenty-four weeks of age, for twelve 
weeks. Until the initiation of this Westem-type diet, SAM-P and C57BL/6 mice had 
been fed the standard laboratory chow from weaning onwards. The mice were culled 
at the end of the administration of the Westem-type diet, and their hearts and aortas 
were harvested, processed and analysed for the extent of lipid deposition in their aortic 
roots (as described in Chapter Two, Section 2.2.4.10). Parameters measured included 
the number of lesions detected in each aortic root, and the area of Oil red O staining in 
each aortic root cross-section.
The experimental design for the study comparing atherogenesis in SAM-P and SAM- 
R mice, is illustrated in Figure 4.2 overleaf. Fourteen SAM-P (seven male, seven 
female) and fourteen SAM-R (eight male, six female) age-matched mice were weaned 
at four weeks of age, then fed the standard laboratory chow until reaching twenty-eight 
weeks of age. For the following seventeen weeks these mice were fed the Westem- 
type diet ad libitum.
As illustrated in Figure 4.2, venous blood samples were obtained from these mice one 
week before, and sixteen weeks after starting the Westem-type diet. These samples 
were analysed for the semm cholesterol and triglyceride levels of individual mice. In 
addition, pooled serum samples prepared from the blood taken sixteen weeks after 
starting the Westem-type diet were used to determine HDL/total cholesterol ratios on 
this diet. (This analysis was not possible one week before starting the diet, as the 
automated analyser was not available at that time-point).
167
Figure 4.2 Experimental design for SAM atherogenesis study
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Figure 4.2 14 SAM-P and 14 SAM-R mice were weaned at 4 weeks of age, fed a standard laboratory chow for the next
24 weeks, and then fed a Westem-type diet until culling at 45 weeks of age. Venous blood samples were taken at 27 and 44 
weeks of age to allow the measurement of serum lipid levels in individual mice. Some of the blood taken at 44 weeks of 
age was used to prepare pooled serum samples for the assessment of HDL/total cholesterol levels in each group. After 
culling, SAM aortic roots were analysed for lipid deposition and macrophage invasion.
The mice were weighed at intervals during the administration of the high-cholesterol 
diet (at 0, 5, 10 and 15 weeks on the diet) in order to assess the relative ability of the 
SAM-P and SAM-R mice to thrive on this diet.
All mice were culled at forty-five weeks of age, and their hearts and aortas were 
harvested for further analysis, including morphometric studies and 
immunohistochemistry.
In order to determine the HDL/total cholesterol ratios of SAM mice fed a 
physiological diet, venous blood samples were also taken from two other groups of 
SAM mice which were fed the standard laboratory chow throughout their lives (from 
weaning onwards). These groups comprised twenty-seven 27-week-old SAM mice (9 
male and 2 female SAM-P, 9 male and 7 female SAM-R), and thirty-one 44-week-old 
SAM mice (3 male and 9 female SAM-P, 13 male and 6 female SAM-R).
4.3 Results of pilot study comparing lipid deposition in SAM-P 
and C57BL/6 mice
As mentioned above, in the pilot study SAM-P and C57BL/6 mice were fed the 
Westem-type diet for twelve weeks. All the mice in the pilot study gained weight 
during the administration of this diet (data not shown); none died, and none developed 
any of the significant adverse clinical end-points detailed in Table 2.2. Thus the 
Westem-type diet appeared to be well-tolerated by both strains of mouse.
Figure 4.3 (overleaf) shows lipid lesions typical of those found in C57BL/6 and SAM- 
P aortic roots. The figure shows Oil red O staining in the attachments of the valve 
cusps to the aortic wall, categorized as type I lesions according to the classification of 
Qiao et al. [Qiao et al. 1994] described in Chapter Two. Oil red O was typically found 
at the luminal border of the valve attachments, as illustrated here. Lesions were ‘flat’ 
rather than ‘raised’, in that they did not impinge on the vessel lumen.
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Figure 4.3 Morphology of lipid deposits in C57BL/6 and SAM-P mouse 
aortic roots (pilot study)
A C57BL/6 (low magnification)
B C57BL/6 (high magnification)
C SAM-P (high magnification)
Figure 4.3 Photomicrographs of representative cross-sections from C57BL/6 
(Panels A and B) and SAM-P (Panel C) aortic roots, stained with Oil red O (red) and 
counter-stained with haematoxylin (blue). These mice had been fed the Westem-type 
diet for 12 weeks. Panel A shows the structure of a typical murine aortic root at the 
level of the aortic valve cusps. The arrow in Panel A indicates Oil red O staining in one 
of the valve cusp attachments; this type I lesion is shown at higher power in Panel B. 
The arrow in Panel C indicates a similar type I lesion in a SAM-P cusp attachment. Bar 
= 125 pm in Panel A, and 30 pm in Panels B and C.
Table 4.2 shows the total number of lipid lesions found in the aortic roots of these 
mice, calculated as described in Chapter Two (Section 2.2.4.10). While all C57BL/6 
and SAM-P mice developed type I lipid lesions, no type II lesions (lesions in the free 
aortic wall) were detected in either mouse strain in this pilot study. There was no 
statistically significant difference between the number of type I lesions found in 
C57BL/6 and SAM-P mice (with median values of 3 lesions (inter-quartile range 
(IQR): 1-6) in C57BL/6 mice, and 6 lesions (IQR: 4-6) in SAM-P mice, P = 0.07).
Table 4.2 Number of lesions in C57BL/6 and SAM-P mice in pilot study
Mouse strain, designation and gender Type I lesions Type II lesions
C57BL/6
#1 (M) 6 0
#2 (M) 3 0
#3 (F) 1 0
#4 (F) 7 0
#5 (F) 1 0
#6 (F) 2 0
#7 (F) 4 0
SAM-P/8
#1 (M) 1 0
#2 (M) 4 0
#3 (M) 6 0
#4 (M) 5 0
#5 (M) 6 0
#6 (M) 6 0
#7 (M) 10 0
Table 4.2 shows the total number of fatty lesions in the aortic roots of the 
C57BL/6 and SAM-P mice investigated in the pilot study, calculated as described 
in Chapter Two. These mice were fed the Westem-type diet for twelve weeks, 
starting at twenty-four weeks of age.
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The mean areas stained with Oil red O in the eight cross-sections from each aortic root 
are given in Table 4.3. There was no statistically significant difference between 
C57BL/6 and SAM-P mice in terms of the cross-sectional areas of type I lipid 
deposition (median values of 329.7 pm2 (IQR: 111.1-406.7) in C57BL/6 mice, and 
87.9 pm2 (IQR: 79.5-227.5) in SAM-P mice, P = 0.28). In summary, lipid deposition 
on a Westem-type diet therefore appeared similar in C57BL/6 and SAM-P mice in this 
small study, whether assessed by lesion type, lesion number, or lesion area.
Table 4.3 Extent of Oil red O staining in C57BL/6 and SAM-P mice in 
the pilot study
Mouse strain, designation and gender Type I lesions Type II lesions
C57BL/6
#1 (M) 1010.3 0
#2 (M) 406.7 0
#3 (F) 9.7 0
#4 (F) 396.1 0
#5 (F) 185.3 0
#6 (F) 111.1 0
#7 (F) 329.7 0
SAM-P/8
#1 (M) 82.9 0
#2 (M) 61.1 0
#3 (M) 227.5 0
#4 (M) 79.5 0
#5 (M) 87.9 0
#6 (M) 115.7 0
#7 (M) 1435.7 0
Table 4.3 shows the mean area stained with Oil red O (in pm2, accurate to one 
decimal place) in the eight cross-sections from each C57BL/6 and SAM-P aortic 
root investigated in the pilot study. Within each group of mice, the mean areas of 
type I lipid deposition were distributed non-parametrically.
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4.4 Results of SAM atherogenesis studies
4.4.1 Weight gain of SAM mice on a Western-type diet
Figure 4.4 shows the weight gain of the fourteen SAM-P and fourteen SAM-R mice 
fed the Western-type diet for seventeen weeks. Each subgroup (male and female, 
SAM-P and SAM-R) gained weight on this diet.
Figure 4.4 Weights of SAM mice fed the Western-type diet
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Figure 4.4 SAM mice were fed the Western-type diet for 17 weeks, 
beginning at 28 weeks of age. The graph shows the weights of these mice 
(expressed as mean values ± s.d. for each strain- and gender-matched group) 
at the initiation of the diet (0 weeks) and at 5-weekly intervals thereafter. As 
shown, mice of both strains, and of either gender, gained weight on the 
experimental diet.
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4.4.2 Serum cholesterol and triglyceride levels in SAM mice
Tables 4.4 shows the total serum cholesterol and triglyceride levels in these fourteen 
SAM-P and fourteen SAM-R mice at 27 weeks of age. At this stage they had been fed 
the standard laboratory chow since weaning at four weeks of age, and would 
subsequently be fed this chow for another week, followed by the Westem-type diet for 
seventeen weeks (as illustrated in Figure 4.2).
Table 4.4 Serum lipid levels in SAM mice prior to Western-type diet
Table 4.4a Serum cholesterol
Male Female
SAM-R 166.3 ± 16.4 146.6 ± 39.6
(n=8) (n=6)
SAM-P 91.7 ±14.7 84.3 ± 13.6
(n=7) (n=7)
P  value < 0.00001 0.002
Table 4.4b Serum triglycerides
Male
SAM-R 
SAM-P 
P  value
Tables 4.4a and 4.4b show, respectively, the serum cholesterol and triglyceride 
levels in the four groups of mice (male and female, SAM-P and SAM-R) at 
twenty-seven weeks of age. Lipid levels are expressed as mean values ± s.d., and 
are given in mg/dl. P values were calculated using ANOVA, with a log 
transformation of triglyceride values to ensure a normal distribution.
50.7 ±14.0 
(n=8)
70.5 ± 32.0 
(n=7)
0.25
42.4 ±10.0
(n=6)
96.1 ±23.2 
(n=7)
0.0001
Female
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Serum cholesterol levels were lower in SAM-P than in SAM-R mice, whether male or 
female mice were studied. Within each strain, there was a tendency for male mice to 
have a higher serum cholesterol level than their female counterparts, though no 
statistically significant inter-gender differences were detected. Serum triglyceride 
levels, in contrast, tended to be higher among SAM-P than SAM-R mice, whether 
male or female mice were studied (Table 4.4b). No statistically significant inter- 
gender differences in serum triglyceride levels were detected in either strain.
Table 4.5 shows the lipid levels in the same group of SAM mice, now measured at 
forty-four weeks of age, by which time they had received the Western-type diet for 
sixteen weeks.
Table 4.S Serum lipid levels in SAM mice fed a Western-type diet
Table 4.5a Serum cholesterol
Male Female
SAM-R 286.8 ± 45.7 259.2 ± 23.8
(n=8) (n=6)
SAM-P 150.8 ±15.6 175.8 ±26.9
(n=7) (n=7)
P  value <0.0005 < 0.0001
Table 4.5b Serum triglycerides
Male Female
SAM-R 173.3 ± 106.3 89.2 ± 42.6
(n=8) (n=6)
SAM-P 156.1 ± 32.3 169.9 ± 92.7
(n=7) (n=7)
P  value 0.92 0.09
Tables 4.5a and 4.5b show the serum lipid levels in the SAM mice at forty-four 
weeks of age. These mice had been fed the standard laboratory chow for twenty- 
four weeks, and then the Western-type diet for the next sixteen weeks. Lipid 
levels (in mg/dl) are expressed as mean values ± s.d.. P values were calculated by 
ANOVA, with log transformation of triglyceride values.
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Figure 4.5 Serum cholesterol and triglyceride levels in SAM mice before and after administration
of a Western-type diet
A. Serum cholesterol (mg/dl) B. Serum triglycerides (mg/dl)
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F i g u r e  4.5 Graph A shows the serum cholesterol, and Graph B the serum triglyceride levels, o f  14 SAM-P and 14 SAM-R mice before 
and after administration o f  a W estern-type diet. Pre-diet samples were taken from 27-week-old mice which had been fed a standard 
laboratory chow since weaning. Post-diet samples were taken when the same mice had reached 44 weeks o f age; they had been fed the 
standard laboratory chow from weaning until 28 weeks o f age, and thenceforward the W estern-type diet. Serum cholesterol and triglyceride 
levels (in mg/dl) are expressed as mean values +/- s.d.. ** = P<0.01, *** = P<0.001 by ANOVA.
As shown, administration of the Western-type diet led to parallel, statistically 
significant increases in the serum cholesterol levels of SAM-P and SAM-R mice. 
SAM-P mice showed lower total cholesterol levels than SAM-R mice, both on the 
standard laboratory chow (P < 0.001) and after administration of the Westem-type diet 
(P< 0.001).
Similarly, statistically significant rises in serum triglycerides were observed in both 
SAM-P and SAM-R mice following administration of the Westem-type diet. While 
serum triglyceride levels were higher in SAM-P than SAM-R mice on the standard 
chow (P = 0.001), there was no statistically significant difference in serum triglyceride 
levels between SAM-P and SAM-R mice after they had received the Westem-type diet 
(P = 0.2).
4.43 HDL/total cholesterol ratios in SAM mice
More detailed serum lipid analysis was performed using an automated analyser, as 
described in Chapter Two. Pooling of samples from same-strain, same-gender mice 
was required in order to provide a sufficient volume of serum for the analyser.
Table 4.7 (overleaf) shows HDL/total cholesterol levels in young mice fed a standard 
laboratory chow, and in old mice fed the Westem-type diet for sixteen weeks. These 
results are illustrated in Figure 4.6 (also overleaf).
As shown, no statistically significant differences in the HDL/total cholesterol ratios 
were found between groups. In particular, SAM-R and SAM-P mice fed the Westem- 
type diet developed very similar HDL/total cholesterol ratios (with median values of 
0.72 for SAM-R, 0.75 for SAM-P, P = 0.38). There did appear to be a trend for the 
HDL/total cholesterol ratio to be lower in older mice (whether SAM-P or SAM-R) on 
a Westem-type diet than in younger mice on a standard chow, though this difference 
did not reach statistical significance (P = 0.11 for each strain).
A similar trend was observed when comparing 44-week-old SAM mice either fed the 
standard chow from weaning onwards, or fed the Westem-type diet for the last sixteen 
weeks before blood sampling (Table 4.8, page 180). Mice fed the Westem-type diet 
showed lower HDL/total cholesterol ratios than age-matched mice fed the standard 
chow, though this difference only reached statistical significance among the SAM-R 
mice (P = 0.01). Whether fed the standard chow or the Westem-type diet, there were 
no statistically significant differences in the HDL/total cholesterol between age- 
matched SAM-P and SAM-R mice.
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Table 4.7 HDL/total cholesterol ratios in young SAM fed a standard 
chow and in old SAM fed a Western-type diet
27-week-old mice 
Standard chow
44-week-old mice 
Western-type diet
P  value
SAM-R 0.92
(IQR: 0.90-0.92, n=3)
0.72
(IQR: 0.67-0.77, n=4)
0.11
SAM-P 0.86
(IQR: 0.76-0.88, n=3)
0.75
(IQR: 0.72-0.80, n=4)
0.11
P  value 0.05 0.38
Table 4.7 shows the HDL/total cholesterol ratios in pooled sera from four 
groups of mice: 11 young SAM-P and 16 young SAM-R mice had been fed 
the standard laboratory chow from weaning onwards; 14 old SAM-P and 14 
old SAM-R mice had been fed the standard chow for 24 weeks from weaning, 
and then the Westem-type diet for the next 16 weeks. For each group, 
HDL/total cholesterol ratios were measured in 3 or 4 pooled samples (see n 
values provided). Median ratios and IQRs were calculated for each group of 
mice. P  values were calculated using the Mann-Whitney sign rank test.
Figure 4.6 HDL/Total cholesterol ratios in SAM mice
R R P P
Figure 4.6 illustrates the median HDL/total cholesterol ratios (± IQR) in 
pooled sera from the four groups of mice detailed in the legend to Table 4.7. 
No statistically significant differences were found between strain- or diet- 
matched groups.
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Table 4.8 HDL/total cholesterol ratios in old SAM mice fed a standard
chow or a Western-type diet
44-week-old mice 
Standard chow
44-week-old mice 
Western-type diet
P value
SAM-R 0.89
(IQR: 0.84-0.94, n=6)
0.72
(IQR: 0.67-0.77, n=4)
0.01
SAM-P 0.86
(IQR: 0.81-0.86, n=3)
0.75
(IQR: 0.72-0.80, n=4)
0.07
P value 0.52 0.38
Table 4.8 Sera were pooled from four groups of old mice: 12 SAM-P 
and 19 SAM-R mice had been fed the standard laboratory chow from weaning 
onwards; 14 SAM-P and 14 SAM-R mice had been fed the standard chow for 
24 weeks from weaning, and then the Westem-type diet for 16 weeks. For each 
group, HDL/total cholesterol ratios were measured in between 3 and 6 pooled 
samples. Median ratios, inter-quartile ranges and P values were calculated as 
described for Table 4.7.
4.4.4 Lipid deposition in the aortic roots of SAM mice fed a Western-type diet
In order to compare the susceptibility to atherogenesis of the two SAM strains, lipid 
deposition was analysed in the aortic roots of the fourteen SAM-P and fourteen SAM- 
R mice fed the Westem-type diet, using methods described in the pilot study above.
4.4.4.1 Morphology of lipid lesions
Oil red O staining was detected in aortic root cross-sections from both SAM-P and 
SAM-R mice. Oil red O was found in regions underlying the endothelium, at the 
luminal border of the intima, but not impinging on the lumen.
Both type I and type II lesions were found in SAM-P and SAM-R mice, and typical 
lesions are shown in Figure 4.7 (overleaf). Panels A, C, E and G show typical type I 
lesions; the Oil red O staining is found in the attachment of the aortic valve cusps to 
the aortic wall. Panels B, D, F and H show typical type II lesions; the Oil red O is 
found at the luminal border of the free aortic wall, bearing no relation to any of the 
valve cusp attachments. As shown, SAM-R Oil red O deposits tended to be smaller 
and fainter than deposits in SAM-P mice.
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Figure 4.7 Morphology of fatty lesions in SAM-P and SAM-R mice
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Figure 4.7 Photomicrographs of representative fatty lesions in SAM aortic roots. Panel A shows a SAM-P type I lesion situated on the 
attachment of an aortic valve leaflet. Panel B shows a SAM-P type II lesion in the aortic free wall. Panels C and D show magnified views of 
the areas indicated by black arrows in Panels A and B respectively. Panels E and F show other examples of SAM-P type I and type II lesions 
respectively. Panels G and H show SAM-R type I and type II lesions respectively, indicated by white arrows. Panels A-D were photographed 
oo under an Axiophot 2 microscope. Panels E-H were photographed using a CCD camera attached to an Olympus-BX microscope. Bar = 100 pm
in Panels A and B, 25 pm in Panels C, D, E and G, and 50pm in Panels F and H.
The lipid lesions appeared to have reduced cellularity (as judged by the paucity of 
haematoxylin-stained nuclei in these regions) compared with the surrounding tissue. 
No evidence was found of more complex lesions.
4.4.4.2 Number of lesions per aortic root
As in the pilot study, the number of distinct lesions in each of eight aortic root cross- 
sections was recorded, categorized as either type I or type II lesions; a score was also 
kept of the number of lesions of any type. These three scores from the eight cross- 
sections were then summated, to give three total scores for each mouse. Table 4.9 
(overleaf) shows the results of this analysis.
Using this method, a lesion extending along the length of the aortic root, and therefore 
appearing in more than one analysed cross-section, was scored for each time it 
appeared in an aortic root cross-section, so that, strictly speaking, the table does not 
record die actual number of lesions in the aortic root, but merely gives an indication of 
the true figure. For convenience though, and with this qualification in mind, the scores 
for each aortic root are referred to henceforward as the ‘number of lesions’ per aortic 
root.
It is evident from Table 4.9 that type II lesions were less common than type I lesions, 
in both SAM-P and SAM-R mice. The data for each SAM-R group (male and female) 
are heavily skewed, each group containing a single mouse (a male mouse designated 
#1, and a female mouse designated #4) with a high number of lesions compared with 
the remainder of their respective groups. When these cross-sections were re-examined, 
it was noted that the lesions in these two mice were small compared with the less 
numerous lesions found in other SAM-R mice, so that the cross-sectional area of Oil 
red O staining per aortic root was in fact typical of that found among the other SAM-R 
mice (see below). Furthermore, the lipid profiles of these two mice were unremarkable 
when compared with those of the other SAM-R mice.
Since there were no statistically significant inter-gender differences in lesion counts in 
each strain of mouse, SAM-P were compared with SAM-R mice irrespective of 
gender. The data in Table 4.9 were used to calculate the median number of lesions per 
aortic root in each group.
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Table 4.9 Number of lesions in SAM mice fed a Western-type diet
SAM gender, strain, and designation Any lesion Type I lesions Type II lesions
Male SAM-R
#1 5 5 0
#2 1 0 1
#3 0 0 0
#4 0 0 0
#5 1 1 0
#6 0 0 0
#7 0 0 0
#8 1 1 0
Female SAM-R
#1 1 1 0
#2 1 1 0
#3 0 0 0
#4 7 7 0
#5 0 0 0
#6 2 2 0
Male SAM-P
#1 6 4 2
#2 6 5 1
#3 2 1 1
#4 2 0 2
#5 1 1 0
#6 2 2 0
#7 0 0 0
Female SAM-P
#1 0 0 0
#2 3 1 2
#3 5 5 0
#4 4 4 0
#5 2 2 0
#6 1 1 0
#7 1 0 1
Table 4.9 shows the total number of fatty lesions in the aortic roots of the 14 SAM- 
P and 14 SAM-R mice fed the Westem-type diet for 17 weeks, calculated as 
described in Chapter Two.
Table 4.10 shows the results of this analysis. SAM-P mice developed a greater number 
of lesions of any type than did SAM-R mice (P = 0.03). Similarly, SAM-P mice 
developed more type II lesions than did SAM-R mice (P = 0.04). There was, however, 
no statistically significant difference in the number of type I lesions found in the two 
strains of mouse (P = 0.23).
Table 4.10 Median number of lesions in the aortic roots of SAM mice 
fed a Western-type diet
Any lesion Type I Type II
SAM-R 1
(IQR: 0-1) 
(mean 1.36)
0.5 
(IQR: 0-1) 
(mean 1.29)
0
(IQR: 0-0) 
(mean 0.07)
SAM-P 2
(IQR: 1-4) 
(mean 2.50)
1
(IQR: 0-4) 
(mean 1.86)
0
(IQR: 0-1) 
(mean 0.64)
P value 0.03 0.23 0.04
Table 4.10 shows the median number of lesions (classified as type I and type 
II lesions, and lesions of any type) in the 28 SAM mice fed the Westem-type 
diet for 17 weeks. Inter-quartile ranges are given in brackets. These values 
were calculated using the non-parametric data in Table 4.9. Mean values for 
each group are also provided, to emphasize the fact that type II lipid 
deposition was found in both SAM-P and SAM-R aortic roots in this 
experiment. P values were calculated using Poisson regression analysis.
4.4.4.3 Prevalence of lesions in aortic roots
An alternative approach to assessing the extent of atherogenesis in SAM mice 
involved determining how many mice in each group developed each type of lesion. 
The results of this analysis are given in Table 4.11 (overleaf), each field in the table 
showing the number of mice developing each lesion type, as a fraction of the 
number of mice within the specified group.
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Table 4.11 Prevalence of lesion types in SAM mice fed a Western-type diet
Any lesion Type I lesions Type II lesions
Gender M F M and F M F M andF M F M andF
SAM-R 4/8 4/6 8/14 3/8 4/6 7/14 1/8 0/6 1/14
SAM-P 6/7 6/7 12/14 5/7 5/7 10/14 4/7 2/7 6/14
P  value N/S N/S 0.1 N/S N/S 0.25 N/S N/S 0.03
Table 4.11 shows the number of mice displaying lesions of each specified type, as a fraction of the number 
of mice in each group. For example, 3 of the 8 male SAM-R mice developed type I lesions, while 6 of the 
14 SAM-P mice of either gender developed type II lesions. P values were calculated using a Chi-squared 
test. Abbreviation: N/S = statistically non-significant.
12 of the 14 SAM-P mice developed fatty lesions of any type, compared with 8 of the 
14 SAM-R mice, this difference not reaching statistical significance (P = 0.1). 10 of 
the SAM-P mice developed type I lesions, compared with 7 of the SAM-R mice, again 
without reaching statistical significance (P = 0.25). More strikingly, there was a 
statistically significant difference in the proportions of mice developing type II lesions, 
(6 of the SAM-P mice, compared with a single SAM-R mouse, P = 0.03).
4.4.4.4 Results of morphometric analysis
The mean areas stained with Oil red O in the eight cross-sections from each SAM-P 
and SAM-R aortic root are given in Table 4.12 (overleaf). Using the data in Table 
4.12, Table 4.13 (page 188) shows the median area per cross-section covered by Oil 
red O for each treatment group, categorized according to lesion type. Data from male 
and female mice have been combined within each group. Since the data in Table 4.12 
are non-parametric, groups were compared statistically using median values and non- 
parametric tests, yielding the P values given in Table 4.13.
SAM-P mice showed a greater extent of fatty lesions development than SAM-R mice, 
as assessed by the cross-sectional area of Oil red O staining in lesions of any type (P = 
0.003). This difference appeared to be partly accounted for by a statistically significant 
difference in type II lesion formation (P = 0.03); SAM-P mice also appeared to show 
more extensive type I lipid lesion formation than SAM-R mice, but this difference did 
not reach statistical significance (P = 0.17).
It will be noted that although type II lipid deposition occurred in both SAM-P and 
SAM-R mice, and was more extensive in SAM-P than SAM-R mice (as noted above), 
median lesion areas in each group were identical (0.0 in each case, because of the 
number of mice in each group where no type II lipid deposition was found). Graphic 
depiction of median areas of type II lesion areas in the two groups might thus be 
misleading, failing to demonstrate the calculated difference between the two groups. 
For the sake of illustration, therefore, the graph in Figure 4.8 (page 189) uses the mean 
lesion areas (± s.d.) also provided in Table 4.13; the P values quoted in the graph 
remain those given in Table 4.13, having been calculated from the (appropriate) non- 
parametric test, the Mann-Whitney sign rank test.
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Table 4.12 Extent of Oil red O staining in SAM mice fed a Western-type diet
SAM gender, strain, and designation Any lesion Type I lesions Type II lesions
Male SAM-R
#1 37.8 37.8 0
#2 20.2 0 20.2
#3 0 0 0
#4 0 0 0
#5 13.6 13.6 0
#6 0 0 0
#7 0 0 0
#8 33.3 33.3 0
Female SAM-R
#1 76.8 76.8 0
#2 115.2 115.2 0
#3 0 0 0
#4 111.3 111.3 0
#5 0 0 0
#6 48.9 48.9 0
Male SAM-P
#1 38.6 37.8 0.7
#2 290.6 92.9 197.7
#3 311.2 20.7 290.5
#4 288.6 0 288.6
#5 66.8 66.8 0
#6 118.3 118.3 0
#7 0 0 0
Female SAM-P
#1 0 0 0
#2 260.6 9.2 251.4
#3 180.5 180.5 0
#4 423.9 423.9 0
#5 36.8 36.8 0
#6 134.6 134.6 0
#7 144.4 0 144.4
Table 4.12 shows the mean areas stained with Oil red O (in pm2, accurate to one 
decimal place) in the eight cross-sections from each of the aortic roots of the 14 
SAM-P and 14 SAM-R mice fed the Westem-type diet for 17 weeks.
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Table 4.13 Median areas of Oil red O staining in SAM mice fed a 
Western-type diet
Any lesion Type I Type II
SAM-R 16.9 
(IQR: 0.0-48.9) 
(mean 32.6±41.3)
6.8
(IQR: 0.0-48.9) 
(mean31.2±42.1)
0.0
(IQR: 0.0-0.0) 
(mean 1.4±5.4)
SAM-P 139.5 
(IQR: 38.6-288.6) 
(mean 163.9±132.7)
37.3 
(IQR: 0.0-118.3) 
(mean 80.1±114.7)
0.0
(IQR: 0.0-197.7) 
(mean 83.8±121.7)
P  value 0.003 0.17 0.03
Table 4.13 shows the extent of Oil red O staining (in pm2) in the aortic 
roots of the 28 SAM mice fed the Westem-type diet for 17 weeks. Areas 
were calculated using the non-parametric data in Table 4.12, and are 
expressed as median values together with their inter-quartile ranges. 
Mean values (± s.d.) for each group are also provided, to illustrate that 
type II lipid deposition was detected in both murine strains. P values 
were calculated using the Mann-Whitney sign rank test.
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Figure 4.8 Morphometric analysis of lesion size in SAM mice
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Figure 4.8 shows the mean areas (in pm2, ± s.d.) of Oil red O staining in aortic root 
cross-sections from SAM-P and SAM-R mice fed the Westem-type diet, categorized 
according to lesion type. As described in the text, P values were calculated using the 
Mann Whitney sign rank test.
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4.4.5 Detection of macrophages in SAM-P and SAM-R aortic roots
Aortic root cross-sections adjacent to those showing lipid deposition were analysed for 
the presence of macrophages using immunohistochemistry, in an attempt to establish 
whether the lipid lesions were indeed a manifestation of early atherogenesis.
Figure 4.9 (overleaf) shows representative type I (Panel A) and type II (Panel C) 
lesions in SAM-P mice, containing macrophages (Panels B and D, respectively). The 
figure also shows a lipid deposit in the aortic root of a SAM-R mouse (Panel E) where 
no macrophage infiltration could be detected (Panel F).
In fact the presence of macrophages was demonstrated in only a minority of lesions 
studied, in both SAM-P and SAM-R mice, regardless of the type of lesion analysed. 
Nevertheless, analysis of the prevalence of macrophage infiltration showed that a 
higher proportion of lesions from SAM-P mice contained macrophages, compared 
with those from SAM-R mice (24.4% of lesions in SAM-P mice, compared with 9.7% 
of lesions in SAM-R mice, P < 0.001).
4.5 Results of telomere length analysis in SAM mice
In order to look for evidence of accelerated cellular ageing in SAM-P mice, telomere 
lengths were measured in splenic cells from male SAM-P and SAM-R mice, using 
pulsed field gel electrophoresis, as described in Chapter Two.
Figure 4.10 (page 192) shows a representative autoradiograph from these studies. This 
autoradiograph was analysed using NIH Image software, and Table 4.14 (also page 
192) shows the mean terminal restriction fragment length in each of the SAM-P and 
SAM-R mice; from these values, a mean TRF length was calculated for each strain of 
mouse. As shown, the two groups of mice were approximately age-matched. SAM-P 
mice had shorter mean TRF lengths than SAM-R mice (53.4 kbp in SAM-P mice 
versus 64.4 kbp in SAM-R mice, P = 0.02, Mann-Whitney sign rank test). There was 
no evidence of a correlation between mean TRF length and age, in either SAM-P or 
SAM-R mice (Spearman rank correlation coefficient 0.19, P = 0.65).
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Figure 4.9 Macrophages in SAM lipid lesions
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Figure 4.9 Photomicrographs show representative aortic root cross-sections 
stained with Oil red O (left-hand column) and MOMA-2 (right-hand column), all 
counter-stained with haematoxylin. Panels B, D and F show sections adjacent to those 
in Panels A, C and E respectively. The illustrated SAM-P type I lesion (Panel A, 
arrow) and SAM-P type II lesion (Panel C, arrow) contain macrophages (red stain 
indicated by arrows in Panels B and D respectively), while the SAM-R type I lesion 
shown in Panel E (arrow) does not (Panel F, arrow). Bar = 60 pm. As detailed in the 
text, only a minority of SAM-P and SAM-R lesions exhibited macrophage infiltration.
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Figure 4.10 TRF lengths in SAM-P and SAM-R mice
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Figure 4.10 shows a representative autoradiograph from the gels run to measure 
SAM TRF lengths. Lanes 1-4 contain DNA from SAM-P mice of the following 
ages respectively: 21 days, 21 days, 294 days and 120 days. Lanes 5-8 contain 
DNA from SAM-R mice of the following ages respectively: 21 days, 21 days, 269 
days and 127 days. The mice studied in lanes 1-4 were therefore approximately 
age-matched with those studied in lanes 5-7.
Table 4.14 TRF lengths in SAM splenic cells
Mouse strain Age (days) Mean TRF length (kbp)
SAM-R 21 62.9
SAM-R 21 64.3
SAM-R 127 67.2
SAM-R 269 63.1
Mean 64.4
SAM-P 21 53.3
SAM-P 21 52.5
SAM-P 120 52.4
SAM-P 294 55.2
Mean 53.4
Table 4.14 shows the mean TRF lengths in SAM mice of various ages, 
calculated using NIH Image software to analyse the gel shown in Figure 4.10.
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4.6 Results of SA-|3-gal studies in SAM mice
SA-p-gal was used to study tissue obtained from SAM mice. This enzyme activity was 
assayed in murine tissue using a protocol similar to that used for rabbit carotid arteries. 
SA-p-gal was assayed in vascular tissue and skin, examples of tissues which usually 
have low and high rates of cellular turnover respectively.
Figure 4.11 Panels A-D show sections of SAM-R (Panels A and B) and SAM-P 
(Panels C and D) skin, stained for SA-P-gal and counter-stained with eosin (see 
overleaf); these samples were taken from twelve-month-old mice. In SAM-R skin, 
SA-p-gal staining was usually undetectable; in a few cases, as illustrated in Panel B, 
faint blue staining could be seen; such staining, when found, appeared to be localized 
exclusively in the eccrine and sebaceous glands. In SAM-P skin, from both young and 
old animals, strong blue staining indicative of SA-P-gal activity was seen in the dermis 
of all samples analysed; again staining in all cases was detected only in the eccrine and 
sebaceous glands (Panel D). There was no discernible age-related increase in the 
intensity of staining among either SAM-P or SAM-R mice.
A representative SAM-P aortic cross-section stained for SA-P-gal is shown in Figure 
4.11 Panels E and F; as shown, no blue staining was detected in this aorta from a 
twelve-month old mouse. Indeed, no positive SA-p-gal staining was found in any 
aortic sections from SAM-P or SAM-R mice irrespective of their age, despite 
employing several variations to the staining protocol, and despite the fact that p-gal 
activity was detectable at pH 4.0.
4.7 Discussion
4.7.1 Key findings
The results described in this chapter can be summarized as follows. SAM-P mice were 
more susceptible than SAM-R mice to fatty lesion development, as assessed by 
analysis of the cross-sectional area of Oil red O staining in the aortic roots of each 
strain. SAM-P mice showed a greater extent of Oil red O staining in lesions of any 
type (i.e. type I and type II combined), and the greater extent of type II lesion 
development in SAM-P mice (compared with SAM-R mice) also reached statistical 
significance.
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Figure 4.11 SA-p-gal staining in SAM skin and aorta
SAM-R skin
SAM-P skin
SAM-P aorta
Figure 4.11 Panels A-F show SA-P-gal staining in SAM tissue at low- 
(Panels A, C and E) and high- (Panels B, D and F) magnification. In SAM-R 
skin only very faint blue staining is found in the sebaceous glands (arrow in 
Panel B). In SAM-P skin stronger blue staining is seen in the sebaceous and 
eccrine glands (black and white arrows, respectively, in Panel D). No SA-p- 
gal staining was detectable in SAM-P aortas (Panels E and F); nor was it 
found in SAM-R aortas (data not shown). Bar =160 pm in Panels A and C, 
40 pm in Panels B and D, 100 pm in Panel E, and 25 pm in Panel F.
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Furthermore, a greater proportion of SAM-P mice than of SAM-R mice developed 
type II lesions. SAM-P mice also developed a greater number of lesions per aortic root 
(as defined above), and in particular a greater number of type II lesions, than SAM-R 
mice.
On a standard chow, SAM-P mice had lower serum cholesterol levels but higher 
serum triglyceride levels than SAM-R mice. After administration of the Westem-type 
diet, SAM-P and SAM-R mice showed parallel increases in their serum cholesterol 
levels, and serum triglyceride levels in the two strains rose to similar levels in each 
strain. In SAM-P and SAM-R mice, the HDL/total cholesterol ratio was similar, 
whether mice were fed the standard chow or the Westem-type diet. 
Immunohistochemistry confirmed the presence of macrophages in the lipid deposits, 
and macrophage invasion occurred more frequently in SAM-P than in SAM-R lesions. 
TRF analysis in splenic cells showed that SAM-P telomeres were shorter than those of 
SAM-R mice. There was no discernible shortening of SAM telomere length with 
increasing age. SA-p-gal activity was detected strongly in SAM-P, but only very 
faintly (if at all) in SAM-R skin; the staining in SAM skin was, though, confined to the 
sebaceous and eccrine glands. SA-P-gal activity was not detected in vascular tissue 
from either SAM strain.
4.7.2 Comments on the experimental design
4.7.2.1 The use of SAM mice in the study of ageing and atherogenesis 
The main aim of this study was to establish whether a phenotype of accelerated ageing 
is associated with an increased susceptibility to atherosclerosis. The SAM model was 
chosen for use in this study for several reasons. Most importantly, it provides not only 
a strain exhibiting accelerated ageing (SAM-P), but also an appropriate control strain 
(SAM-R) sharing a similar genetic background. Furthermore, the ageing phenotype of 
SAM-P mice includes several characteristics found in human ageing. Indeed the 
research group which established the original SAM colony have pointed out that 
certain clinical and pathological features (namely osteoporosis, degenerative joint 
disease, cataract formation, and hearing impairment) which have elsewhere been 
described as “inevitable disorders as a direct consequence of physiologic senescence” 
[Cotran et al. 1989] are all found in the SAM model [Takeda et al. 1994a].
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The genetic background of SAM mice may provide a further advantage for their use in 
the study of atherogenesis. SAM mice are derived, as mentioned in Chapter One, from 
AKR/J mice. In a previous study of the relative susceptibility of ten inbred murine 
strains to atheroma formation on a high-fat diet, the AKR/J strain was the fourth most 
susceptible, behind C57BL/6J, C57L/J and DBA/2J, as assessed by lesion size and 
number in the aortic root [Paigen et al. 1985]. It is a matter for speculation whether 
this susceptibility may have been handed down to their descendants, the SAM mice. 
The use of murine models in general to study either ageing or atherosclerosis is open 
to criticism. Murine cells contain much longer telomeres than do human cells, with 
TRFs of up to 150 kilo-bases in mice, compared with TRF lengths of five to ten kilo- 
bases in humans [Kipling and Cooke 1990]. This difference alone may suggest that 
different mechanisms underlie the ageing processes in the two species. Similarly, 
differences in lipid metabolism between mice and humans (discussed below), together 
with the relative athero-resistance of most murine strains, suggest that murine 
atherogenesis does not exactly replicate human disease. Nevertheless, as discussed in 
detail in Chapter One (Sections 1.8.1, 1.8.2 and 1.8.3) mice have been extensively 
used in the study of atherosclerosis, partly because of their ready availability, and 
partly because of the well-established techniques developed to measure the extent of 
lesion formation.
4.7.2.2 The choice of SAM-P/8 and SAM-R/1 strains
SAM-P/8 mice show many of the typical features of the SAM-P ageing phenotype, 
including the development of hair loss, lack of fur glossiness, periophthalmic lesions, 
and spinal lordokyphosis [Hosokawa 1994]. Their median survival time mice has been 
quoted as between 10.0 [Takeda et al. 1994a] and 12.1 [Takeda et al. 1991] months. 
SAM-P/8 mice have been the subject of several studies investigating derangement of 
oxidative stress as part of the ageing phenotype [Zhao et al. 1990, Edamatsu et al.
1995, Butterfield et al. 1997]; it has been shown that manipulation of the oxidative 
status of these mice can affect their life-span [Edamatsu et al. 1995].
SAM-R/1 mice have been used as a control strain in several studies, whether in 
comparison with SAM-P/8 mice [Zhao et al. 1990, Yoshino et al. 1994a, Butterfield et 
al. 1997, Han et al. 1998, Kurokawa et al. 1998, Ye et al. 2002], SAM-P/1 mice 
[Kohno et al. 1985, Yagi et al. 1988, Nisitani et al. 1990, Yagi et al. 1995, Park et al.
1996, Odagiri et al. 1998], SAM-P/6 mice [Jilka et al. 1996] or SAM-P/11 mice
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[Hosokawa et al. 1994, Nakamoto et al. 1994, Zhu et al. 2001]. Their median survival 
time has been quoted as between 18.9 [Takeda et al. 1994a] and 19.0 [Takeda et al. 
1991] months. They may develop non-thymic lymphoma or histiocytic neoplasms, but 
do not exhibit features of the accelerated ageing phenotype [Takeda et al. 1991].
The groups of SAM-P and SAM-R mice fed the Westem-type diet had slightly 
different compositions in terms of their male-female mix. This was necessitated by the 
limited number of age-matched SAM-P and SAM-R mice available in the new colony 
at UCL. In fact the lack of statistically significant inter-gender differences in serum 
lipid levels, or in aortic root lipid deposition in SAM mice, meant that the discrepancy 
in group composition did not influence the overall finding of increased lipid deposition 
in SAM-P compared with SAM-R mice.
4.7.2.3 Choice of the pro-atherogenic diet
For the reasons given in the introduction to this chapter, the diet chosen for the current 
study had a higher fat and cholesterol diet than that employed by Yagi et al. [Yagi et 
al. 1995]. The Westem-type diet used here has previously been employed in several 
studies of atherogenesis in mice [Nakashima et al. 1994, Palinski et al. 1995, 
Tangirala et al. 1995a and b]. Administration of this diet results in the development of 
fatty streaks in LDL-receptor-deficient mice [Palinski et al. 1995]; in ApoE-deficient 
mice more advanced lesions develop, to the extent of fibrous plaque formation 
[Nakashima et al. 1994, Tangirala et al. 1995b].
This diet was used in preference to those with a higher fat content for a variety of 
reasons. Firstly, it was considered desirable that the experimental diet should be as 
close as possible to a physiological murine diet in terms of its fat content, while still 
provoking atherogenesis. Secondly, many of the higher-cholesterol diets contain 
cholic acid, which promotes atherogenesis by inhibiting cholesterol 7a-hydroxylase, 
an enzyme which in mice is involved in the clearance of cholesterol from the body 
[Dueland et al. 1993]; the Westem-type diet did not contain this unphysiological 
constituent. Furthermore, many of the very high cholesterol diets are unpalatable to 
mice despite various modifications in their formulation to increase their appeal. Since 
SAM-P mice generally thrive less well than SAM-R mice, it was important that their 
diet should be as palatable as possible, so that both strains would feed freely, and so 
that there should be no in-built bias, with one strain eating more food than the other.
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4.7.2.4 Timing of the initiation of the Westem-type diet
When the severity of organismic ageing is scored serially in SAM-P and SAM-R mice, 
a divergence in the ageing phenotype between the two families of mice becomes 
evident at six months of age [Hosokawa et al. 1994], and this divergence becomes 
more marked over the following weeks. By administering the experimental diet when 
the mice reached twenty-eight weeks of age, it was intended that the pro-atherogenic 
stimulus should coincide with the period of accelerated organismic ageing, thus 
allowing the two processes to interact.
4.7.2.5 Duration of administration of the Westem-type diet
Given the absence of overt atherogenesis in SAM mice fed a standard chow for five 
months [Yagi et al. 1995], SAM mice were exposed to the pro-atherogenic stimulus 
for as long as possible after the chosen initiation date. The seventeen-week 
administration time was a compromise between this goal and the need for mice to 
survive until the end of the treatment period. One concern was that administration of a 
high-fat diet might reduce the SAM life-span, particularly as a previous study has 
shown, conversely, that chronic caloric restriction can prolong the life-span of SAM 
mice [Kohno etal. 1985].
4.7.2.6 Measurement of serum lipid profiles
Measurement of lipid profiles should if possible be performed using fresh samples, 
since lipoprotein lipase activity within stored serum can affect triglyceride levels in 
particular. On the other hand, it was also desirable that sera from all mice from a 
particular time-point should be assayed simultaneously so as to eliminate the 
possibility of inter-assay variability. Serum triglyceride levels were therefore analysed 
in freshly obtained samples, using cardiolipin controls to check for inter-assay 
variability, while serum cholesterol levels were measured in batches of frozen sera 
from age-matched mice.
The use of an automated cauldron chemistry technique for the analysis of HDL/total 
cholesterol ratios has the advantage that it can be used with veiy small volumes 
(100pi) of serum. The method is accurate, according to the manufacturer, for serum 
samples with a total lipid content of up to 1000 mg/dl.
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4.7.2.7 Tissue harvesting and fixation
In several studies of murine atherogenesis, perfusion fixation has been employed to 
preserve vessel and lesion architecture [Zhang et al. 1994, Tangirala et al. 1995b, 
Groot et al. 1996]. In other similar studies, though, perfusion fixation has not been 
used [Stewart-Phillips and Lough 1991, Lin et al. 1995, Fyfe et al. 1994], even when 
such studies were designed specifically to compare susceptibility to atherosclerosis 
between various murine strains [Paigen et al. 1985, Qiao et al. 1994]. Perfusion 
fixation was not undertaken in the current study of SAM mice because it was felt that 
the physical manipulation of the murine heart involved in positioning the perfusion 
catheter might in fact disrupt the integrity of the aortic root.
While it is possible that the absence of perfusion fixation might itself lead to a 
distortion of the aortic tissue at the moment of culling, and might therefore affect the 
results of morphometric analysis, it was felt that by treating all the tissues from SAM- 
P and SAM-R mice identically, valid comparisons could still be drawn between the 
two strains. Emeson and Shen have used equivalent reasoning to justify omission of 
perfusion fixation in a study of atheroma formation in C57BL/6 aortic roots [Emeson 
and Shen 1993].
4.7.2.8 Morphometric analysis of murine aortic roots
The degree of atherogenesis in each mouse was assessed by studying the cross- 
sectional area of lipid lesions in the aortic root. This approach was developed in 1985 
[Paigen et al. 1985], and subsequently further refined [Paigen et al. 1987b], as a means 
of determining the susceptibility of various murine strains to atherosclerosis. Initially 
the appropriateness of this method for the study of human atherosclerosis was 
questioned, because the location and appearance of murine lesions appeared to differ 
from those in humans. Nevertheless the approach proved useful in studies 
investigating genetic loci that distinguished atherosclerosis-prone from 
atherosclerosis-resistant mice [Paigen et al. 1987a], and the model began to gain 
acceptance. It has become a standard tool for comparing susceptibility to 
atherosclerosis in different murine strains [Paigen et al. 1985, Qiao et al. 1994], and 
for investigating the effects of various interventions (such as dietary, pharmacological 
and genetic modifications) on the atherogenic process [Zhang et al. 1992 and 1994, 
Emeson and Shen 1993, Emeson et al. 1995, Marotti et al. 1993, Reddick et al. 1994, 
Lin et al. 1995, Tangirala et al. 1995a and 1995b, Groot et al. 1996].
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Furthermore, the degree of lipid lesion development in the aortic root has been shown, 
in certain mouse strains, to correlate well with the overall extent of atherosclerosis in 
the remainder of the vascular tree [Tangirala et al. 1995b], suggesting that under pro- 
atherogenic conditions, lesion formation in the aortic root and throughout the 
vasculature as a whole are determined by common pathological factors. This finding 
has been used to justify employing aortic root analysis as an indicator of an animal's 
overall susceptibility to atherogenesis [Tangirala et al. 1995b].
The use of Oil red O to detect lipid deposition in murine aortic roots is also well- 
established [Paigen et al. 1985, Emeson and Shen 1993, Emeson et al. 1995, Fyfe et 
al. 1994, Qiao et al. 1994, Reddick et al. 1994, Zhang et al. 1994, Lin et al. 1995, 
Groot et al. 1996]. Oil red O is a non-ionic, hydrophobic azo dye. The rationale for its 
use for detecting lipid is that the dye is more soluble in lipid than it is in the solvent 
(isopropanol).
The classification of lesions as type I or type II deposits, introduced by Qiao et al. 
[Qiao et al. 1994], was described in Chapter Two; Paigen et al. had previously drawn 
a distinction between these two lesion types [Paigen et al. 1987b], but had not applied 
the ‘type I’ and ‘type II’ designations introduced later by Qiao et al.. The significance 
of the distinction between the two lesion types is discussed below.
4.7.3 Discussion of the results
4.7.3.1 Preservation of the senescent phenotype
The appearance of the mice, and the incidence of senescence-related pathologies, 
suggest that the senescent phenotype was maintained in the colony of SAM-P mice. 
The lower weight of SAM-P mice compared with age- and sex-matched SAM-R mice 
was a consistent finding, and was preserved whether mice were fed a standard chow or 
the atherogenic Western-type diet. It is well-recognized that without scrupulous 
selectivity of brother-sister mating (ensuring that the most exhausted-looking SAM-P 
sibling pairs are bred together, and conversely that the healthiest SAM-R pairs are 
matched) the senescent phenotype can easily be lost [Hosokawa et al. 1997].
4.7.3.2 Susceptibility of SAM-P and SAM-R mice to atherogenesis
The amount of lipid deposition in the SAM aorta roots was analysed using a variety of 
approaches. Lesion counts and morphometric analysis of lesion size suggested a 
greater susceptibility to atherogenesis in SAM-P than in SAM-R mice, while no
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statistically significant difference was found in prevalence of lesion formation between 
the two strains.
It has previously been suggested that type I lesions (related to the valve cusps and their 
attachments) are not an accurate reflection of the atherogenic process in mouse 
models, while type II lesions (on the aortic free wall) are more discriminating, giving a 
more accurate and more reproducible indication of the degree of atherogenesis in the 
remainder of the vascular tree [Paigen et al. 1987b]. Furthermore, type II lesions are 
considered more relevant to the pathology of human disease, which involves lesions in 
free arterial walls [Paigen et al. 1987b]. In C57BL/6 mice fed a high-cholesterol diet, 
lesions in the aortic free wall (later designated type II lesions by Qiao et al. [Qiao et 
al. 1994]) were typically filled with foam cells, invaded the underlying media, had a 
raised endothelium, and bulged into the aortic lumen [Paigen et al. 1987b]; in the same 
model, lesions confined to the valve cusp (later termed type I lesions) remained small 
and did not invade the underlying media.
It is therefore interesting to note that for each of the three parameters measured in the 
current study (number of lesions per aortic root, prevalence of lesion formation, and 
cross-sectional lesion area) statistically significant differences between SAM-P and 
SAM-R mice were found only in the lesion type considered to be a better indicator of 
an animal’s susceptibility to atherosclerosis, and to be more representative of human 
disease.
Macrophages are not normally present in the murine arterial wall [Qiao et al. 1994], so 
the demonstration of macrophages coincident with Oil red O staining (albeit on 
adjacent cross-sections) suggests that the fatty lesions were the product of a 
pathological process involving cellular infiltration of the vessel wall, and it seems 
reasonable to infer that this process was atherogenesis. The presence of macrophages 
militates against the possibility that the Oil red O staining was merely artefactual.
The absence of macrophages in other Oil red O-staining lesions does not exclude the 
possibility that these too were atheromatous lesions; the detected lipid may either 
represent extracellular lipid pools which might, at a later stage, be invaded by 
macrophages, or alternatively this lipid may have been taken up already by VSMCs. 
Further experiments are required to investigate whether lipid deposition in the SAM 
aortic root correlates with the degree of atheroma formation elsewhere in the 
vasculature of this strain. Some preliminary experiments were performed for this
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thesis, in which whole aortas (from the aortic root to the iliac bifurcation) were 
excised from other SAM mice fed the Western-type diet, opened length-wise, and 
immersed in Oil red O staining solution. Employing this method, no clearly defined 
lipid lesions were seen in either SAM-P or SAM-R aortas (data not shown). This is not 
surprising, as even lesions in the SAM aortic root (the site most prone to atherogenesis 
in many murine strains) were microscopic.
The fatty lesions demonstrated in both SAM strains were small, particularly in 
comparison with the lesions which develop in atherosclerosis-prone strains fed a very 
high-fat diet. The fact that neither SAM strain developed large lesions does not, 
though, invalidate the finding of statistically significant differences in lesion formation 
between the two SAM strains. It is interesting to note that on the Western-type diet 
lesion size was comparable between SAM-P and C57BL/6 aortic roots. It would be 
interesting to determine how large lesions would grow if SAM-P mice were fed a diet 
with the higher cholesterol and fat levels usually employed in studies of atherogenesis 
in the C57BL/6 model.
The current study investigated susceptibility to atherogenesis in only two SAM strains 
(P/8 and R/l). Before any firm inferences can be drawn from this study concerning the 
relationship between accelerated ageing and atherosclerosis, further studies need to be 
undertaken to confirm that the observed differences apply to other SAM-P and SAM- 
R strains.
4.7.3.3 Possible explanations for the greater lesion formation in SAM-P/8 mice 
The apparently greater susceptibility of SAM-P/8 mice to atherogenesis compared 
with SAM-R/1 mice could be attributed to a variety of causes. Since the SAM-P/8 and 
SAM-R/1 mice were housed and maintained in identical conditions, and were fed an 
identical diet, it seems reasonable to infer that the greater susceptibility of SAM-P/8 
mice to atherosclerosis is an intrinsic biological property which has probably arisen as 
one aspect of their senescent phenotype.
Ultimately, atherosclerosis results from an interaction of blood constituents with 
components of the arterial wall. The difference in susceptibility to atherogenesis 
between the two murine strains is therefore likely to arise from differences either in 
their blood constituents or in the properties of their vessel walls. Alternatively, there 
may be a difference in the microenvironment in which the blood constituents interact 
with the arterial wall; one influence on this microenvironment could be the oxidative
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status of the vessel wall. It is also possible that other acknowledged risk factors for 
atherosclerosis are more prominent in one SAM strain than the other, and of the 
various explanations for the greater susceptibility to atherogenesis of SAM-P mice, 
this possibility is addressed first below.
Blood pressure and diabetes in SAM mice
Since in humans hypertension and diabetes mellitus are two of the main established 
risk factors for atherosclerosis [Kannel and McGee 1979, Stokes et al. 1987], it is 
important to consider the possibility that the apparent difference in susceptibility to 
atherogenesis between SAM-P and SAM-R strains may result from differences in their 
blood pressure and/or serum glucose levels.
In fact evidence from a study comparing blood pressures in SAM-P/8 and SAM-R/1 
mice argues against a prominent role for hypertension as a pro-atherogenic factor in 
SAM-P mice [Han et al. 1998]. Young SAM-P/8 and SAM-R/1 mice have similar 
blood pressures, and while the blood pressure of SAM-R/1 mice remains 
approximately constant throughout their life, the blood pressure of SAM-P/8 mice 
actually falls after approximately six months of age.
Furthermore, in a study looking at age-related changes in the thoracic aortas of SAM­
P/11 and SAM-R/1 mice, the more marked histological changes found in the 
vasculature of SAM-P 11 mice (detailed below) developed over the first nine months 
of their lives, during which time the blood pressures of the SAM-P/11 and SAM-R/1 
mice were indistinguishable [Zhu et al. 2001].
The prevalence of diabetes mellitus in SAM-P and SAM-R mice has not been 
documented in the literature to date, and serum glucose levels in these mice have not 
been systematically compared. In fact the only relevant published study suggests that 
SAM-P/8 hearts are more sensitive than SAM-R/1 hearts to insulin [Kurokawa et al. 
1998], suggesting, if anything, that SAM-R/1 mice are likely to be the more insulin- 
resistant (and therefore more glucose-intolerant) strain. Determination of the relative 
prevalence of diabetes mellitus in the two SAM strains is clearly necessary in order to 
clarify whether this disease may be involved in the pathology of SAM mice.
Serum lipid profiles in SAM mice
A third major risk factor for human atherosclerosis is hypercholesterolaemia [Zemel 
and Sowers 1990]. It was therefore necessary to establish whether the relative
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susceptibility to atherogenesis of SAM-P mice could be attributed to an abnormality in 
their serum lipid profile. A comparison of the serum lipid profiles of SAM-P/8 and 
SAM-R/1 mice fed a standard laboratory chow or a high-fat diet had not previously 
been published.
In the current study, on a standard laboratory chow SAM-P/8 mice had lower serum 
total cholesterol levels but higher serum triglyceride levels than SAM-R/1 mice at 
twenty-seven weeks of age. Similarly, when SAM-P/1 and SAM-R/1 mice were fed a 
standard chow [Yoshino et al. 1994a], SAM-P/1 mice tended to show lower total 
cholesterol and higher serum triglycerides levels than SAM-R/1 mice, though these 
differences reached statistical significance only at a few time-points in the course of 
their lives.
Administration of a high-fat diet has been shown to raise the serum lipid levels in 
several strains of mouse [Nakashima et al. 1994, Qiao et al. 1994]. Similarly in the 
present study, administration of the Western-type diet led to statistically significant 
increases in the serum cholesterol and triglyceride levels in both SAM-P/8 and SAM- 
R/1 mice. After sixteen weeks on this diet, SAM-P/8 mice still had lower serum 
cholesterol levels than SAM-R/1 mice, but the two strains now had similar triglyceride 
levels.
Since SAM-P/8 mice showed lower serum cholesterol levels than SAM-R/1 mice both 
before and after administration of the Western-type diet, the greater accumulation of 
lipid in SAM-P/8 aortic roots cannot be explained by the total serum cholesterol level 
of these mice. The greater susceptibility of SAM-P mice also occurred despite a 
convergence of serum triglyceride levels between the two murine strains.
HDL/total cholesterol ratios were similar in SAM-P/8 and SAM-R/1 mice fed either 
the standard chow or the Western-type diet. In humans, HDL removes cholesterol 
from the peripheral tissues and from lipid deposits in the arterial wall, transporting it 
back to the liver for further degradation and subsequent excretion in bile; this process 
is known as ‘reverse cholesterol transport’. As a result, subjects with high HDL 
cholesterol levels (especially those in whom the total/HDL cholesterol ratio is less 
than 4.5) achieve a protective effect against atherosclerosis [Miller 1987, Assmann 
and Gotto 2004]. The ratio of total/HDL cholesterol is therefore used in clinical 
practice as part of the assessment of a subject’s cardiovascular risk.
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Similarly, in several inbred strains of mouse fed a high-cholesterol diet, HDL levels 
are inversely proportional to the degree of atherosclerotic lesion formation in then- 
aortic roots [Nishina et al. 1993]. There are, though, reasons to question whether the 
role of murine HDL is analogous to that of human HDL.
In humans, HDL cholesterol constitutes only a minority of total cholesterol levels, the 
majority being made up of LDL. By contrast, in mice HDL is the most abundant 
cholesterol-carrying particle [Rubin and Smith 1994], and this applies to SAM-P/1 and 
SAM-R/1 mice [Komura et al. 1994]. In the present study, HDL also constituted the 
majority of total cholesterol in SAM-P/8 and SAM-R/1 mice whether fed a standard 
chow or a Western-type diet.
The major protein associated with HDL (in both humans and mice) is apolipoprotein 
Al (apoAI), and the concentration of this apolipoprotein is the major determinant of 
HDL concentration. If the human apoAI gene is over-expressed in transgenic mice of 
strains usually susceptible to atherosclerosis, this manipulation leads to an elevation in 
their HDL levels, and renders the mice resistant to atherogenesis [Rubin et al. 1991]. 
On the other hand, although mice created with an inactive apoAI gene have a 
significantly lower HDL concentration than wild-type mice, they do not display 
increased susceptibility to atherosclerosis [Li et al. 1993]. It is generally felt, though, 
that HDL particles do perform an anti-atherosclerotic protective role in mice at least 
approximately analogous to that in humans [Rubin and Smith 1994, Rigotti et al. 
1997].
When C57BL/6 mice are fed a high cholesterol diet their total plasma cholesterol rises 
and their HDL cholesterol falls; their HDL/total cholesterol ratio consequently falls 
dramatically [Emeson et al. 1995] and mice develop atheromatous lesions in the aortic 
root. This atherogenesis is thought to be largely attributable to the reduction in HDL 
levels [Paigen et al. 1987a, LeBoeuf et al. 1990]. After various interventions, though, 
such as the addition of alcohol to the high-fat diet, the extent of atherosclerosis does 
not appear to correlate with the HDL/total cholesterol ratio [Emeson et al. 1995]. 
Clearly this casts some doubt on the ability of this ratio to predict susceptibility to 
atherosclerosis in certain situations.
In the present study, the similarity between SAM-P and SAM-R mice in terms of their 
HDL/total cholesterol ratios when fed either diet, combined with their parallel 
increases in serum cholesterol and triglycerides and the lower cholesterol levels in
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SAM-P mice, suggest that any observed difference in fatty lesion formation cannot 
easily be attributed to differences in lipid profile between the two strains.
Histological changes in the SAM arterial wall
As mentioned above, one possible explanation for the apparent increased susceptibility 
of SAM-P mice to atherogenesis may relate to intrinsic changes in the arterial wall. 
Histological differences have been described between the arteries of SAM-P and 
SAM-R mice.
With age, there is an increase in aortic wall thickness in SAM mice (as indeed there is 
in humans [Virmani et al. 1991]), and this thickening is more pronounced in SAM-P 
than SAM-R mice [Zhu et al. 2001]. Age-related aortic wall thickening in humans has 
been attributed to the accumulation of extracellular matrix within the subintima and 
media of the vessel [Cooper et al. 1994]. Similarly, in SAM mice there is an increase 
in the abundance of collagen fibres between the VSMCs, together with breakage and 
disorganization of the elastic laminae; the VSMCs undergo hypertrophy, but their 
number in the media falls significantly [Zhu et al. 2001]. These changes are observed 
earlier and are more exaggerated in SAM-P than SAM-R mice, and, as mentioned 
earlier, cannot be attributed to differences in blood pressure between the two strains. 
Zhu et al. found no evidence of amyloid or lipid deposition in either SAM-P or SAM- 
R aortas [Zhu et al. 2001].
Such differences in vessel wall architecture between SAM-P and SAM-R mice may 
well contribute to, or indeed be a manifestation of, a difference in susceptibility to 
atherosclerosis. They may arise from factors ‘extrinsic’ to the vessel wall, such as high 
serum glucose levels in the lumen; alternatively, they may arise from ‘intrinsic’ 
differences in vascular cell biology between the two strains.
The previous chapter dealt with the question of whether cellular replicative senescence 
occurs in the vasculature in a pathological situation. It is now worth considering 
whether the accelerated ageing of SAM-P mice might be accompanied by accelerated 
ageing at a cellular level, and whether any such loss of cellular replicative capacity 
might contribute to an increased susceptibility to atherosclerosis.
Evidence for reduced cellular replicative capacity in SAM-P mice
The relationship between vascular cell replicative senescence and the development of
atherosclerosis in humans and animal models has been discussed in detail in Chapters
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One and Three. Not only is there evidence to suggest that senescent vascular cells are 
present in atherosclerotic lesions, but it is also thought that these cells may play an 
aetiological role in the development and progression of the disease (discussed further 
in Chapter Five).
No studies to date have looked specifically for evidence of replicative senescence in 
SAM vascular cells. Some research, though, has suggested that other cell types 
derived from SAM-P mice are more prone to replicative senescence than their 
counterparts from SAM-R mice. For example, a higher rate of chromosomal 
aberrations has been found in bone marrow cells from SAM-P/1 compared with SAM- 
R/1 mice [Nisitani et al. 1990], and the rate of increase in chromosomal aberration 
frequency paralleled the emergence of the ageing phenotype in each strain. 
Furthermore, when dermal fibroblasts isolated from SAM-P/11 neonates were grown 
in culture, they were able to perform fewer rounds of cell replication before reaching 
crisis than equivalent cells derived from SAM-R/1 neonates [Hosokawa et al. 1994]; 
as cells lost their replicative capacity they assumed the morphological features 
characteristic of senescent cells.
If evidence were to be found for an increased propensity of SAM-P vascular cells to 
cellular senescence, it would be possible to postulate a mechanism whereby this 
propensity could lead to the susceptibility of SAM-P mice to atherogenesis; one might 
for example speculate that if SAM-P arteries are lined by ECs with reduced replicative 
potential, the SAM-P endothelium might be less resistant to vascular atherogenic 
insults, if only because of an impairment of the endothelium’s ability to repair any 
breach in its integrity.
In order to investigate cellular senescence in more detail in SAM mice in the current 
study, splenic cells were subjected to TRF length analysis, and aortas and skin were 
stained for SA-p-gal activity. The analysis of TRF length provides a useful guide to 
the length of the telomere itself when, as in mice, telomeres are very long. While 
splenic cells from SAM-P/8 mice had shorter TRFs than cells from SAM-R/1 mice, no 
obvious shortening of TRF length with increasing murine age was detected. These 
results are interesting because they do suggest a fundamental difference between the 
chromosomes of SAM-P and SAM-R mice generally, and the shorter TRF length 
observed in the mouse strain which ages more quickly certainly fits with the theory 
that telomere shortening may be related to replicative, and possibly organismic ageing.
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On the other hand, the lack of progressive telomeric shortening with increasing age in 
either SAM-P or SAM-R mice would argue against a central role for telomere 
shortening in the ageing process of SAM mice. Indeed Kipling and Cooke detected no 
age-related decrease in telomere length in their study of TRF lengths in hepatocytes 
from various murine species [Kipling and Cooke 1990]. This finding, together with the 
great length of murine telomeres, and the presence of telomerase activity in some 
murine cells, have been cited as evidence that replicative senescence of murine cells is 
likely to occur via mechanisms independent of telomere shortening [Sherr and 
DePinho 2000, Wright and Shay 2000]. The study of telomerase-deficient mice 
mentioned in Chapter One also casts doubt on the relevance of telomere shortening to 
murine cellular senescence [Blasco et al. 1997].
The telomere study in this chapter and the work of Kipling and Cooke have looked 
only at splenic and hepatic cells; the findings in these cells may or may not be 
mirrored in other cell types, particularly as research in other mouse strains has 
suggested that there are marked differences in telomerase activity and telomere length 
between various tissues within individual mice [Coviello-McLaughlin and Prowse 
1997]. It is therefore possible that in SAM mice there are other cell types in which 
telomeres do shorten with age, and the question of whether age-related telomere 
attrition occurs in SAM vascular cells remains open.
Another explanation for the telomere data in this chapter is that other fundamental 
differences between SAM-P and SAM-R mice, such as differences in oxidative status 
(discussed below), may affect telomerase function and/or telomere length in SAM 
mice, without necessarily playing a causal role in the accelerated ageing of SAM-P 
mice. In this respect it is of note that the emergence of replicative senescence in 
murine cell cultures has recently been attributed to the high sensitivity of murine cells 
(compared, for example, with human cells) to oxidative stress [Parrinello et al. 2003]. 
Telomere analysis in SAM splenic cells thus did not show clear-cut evidence of 
accelerated cellular ageing in SAM-P mice. Attention therefore turned to the detection 
of SA-P-gal activity in SAM tissues. The results reported by Dimri et al., showing an 
absence of SA-p-gal staining in senescent fibroblasts from two murine strains had 
implied that this marker of senescence was unlikely to be helpful in the study of SAM 
mice [Dimri et al. 1995]. In fact more recent studies have shown that SA-p-gal
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staining can be detected in certain murine tissue, in particular in lymphomatous cells 
[Schmitt et al. 2002] and in regenerating liver tissue [Satyanarayana et al. 2003].
The subsequent failure in the current study to detect SA-p-gal staining in either SAM- 
P of SAM-R aortas could be attributable either to a genuine absence of cellular 
senescence in these vessels, or to the use of an assay which was inappropriate for the 
study of murine vascular cells. Given the apparent ability of SA-P-gal to detect 
senescence in human and rabbit vascular cells (as described in Chapter Three), and in 
other murine tissues, it seems likely (though by no means definite) that SA-p-gal 
would be able to detect murine vascular cell senescence if it were present; the results 
in this chapter therefore imply that SAM-P aortas do not contain senescent cells. This 
might be predicted from the known low rate of cellular turnover in normal vascular 
tissue [Schwartz and Benditt 1973 and 1976, Hobson and Denekamp 1984], and it was 
for this reason that the SA-P-gal staining was also applied to a tissue likely to show a 
higher degree of proliferative activity.
Staining of SAM-P and SAM-R skin for SA-P-gal activity did show a difference 
between the two substrains, with markedly stronger SA-P-gal staining in SAM-P than 
SAM-R skin, though this staining was limited to the sebaceous and eccrine glands. 
Eccrine glands decrease in number and become disorganized in ageing human skin 
[Montagna 1965], while sebaceous glands maintain their numbers but undergo 
hyperplasia [Plewig and Kligman 1978]. Any inferences from the detection of SA-P- 
gal staining in SAM-P skin must be guarded, given the findings of Dimri et al. that 
human adult melanocytes express SA-p-gal activity independent of replicative age, 
and that sebaceous and eccrine gland cells express SA-P-gal activity independent of 
donor age [Dimri et al. 1995]. SA-P-gal staining was undertaken in SAM skin in the 
expectation that this enzyme activity might be found in the keratinocyte population, 
given the proliferative nature of this tissue; this turned out not to be the case. Thus in 
murine skin, SA-p-gal positivity does not appear to detect cellular ageing, and there is 
thus no clear evidence of replicative senescence in SAM skin. Nevertheless it is 
interesting that a difference between SAM-P and SAM-R skin is demonstrable, despite 
these considerations.
The results of the TRF analysis do lend support to the contention that SAM-P/8 cells 
have different replicative machinery from SAM-R/1 cells, but neither these results nor
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those from the SA-p-gal staining of SAM skin provide evidence of an age-related 
accumulation of senescent cells in either strain. Given the putative role of replicative 
senescence both in organismic ageing and in atherosclerosis, a difference in propensity 
to replicative senescence between SAM strains would be an attractive explanation (at 
least in part) for both the ageing phenotype and the increased susceptibility to 
atherogenesis of SAM-P mice. In the absence of conclusive evidence of excessive 
replicative senescence in SAM-P mice, other strain-specific differences must be 
considered as aetiological factors in the increased susceptibility of SAM-P mice to 
atherogenesis. One such candidate may be the level of oxidative stress in SAM-P and 
SAM-R mice.
Differences in oxidative status between SAM-P and SAM-R mice 
Several studies have pointed to differences in the levels of oxidative stress in the 
tissues of SAM-P and SAM-R mice. For example, SAM-P mice show higher levels of 
oxidatively-modified proteins in tissues such as the brain and liver, than do SAM-R 
mice [Butterfield et al. 1997, Nakamoto et al. 1994]; similarly, higher levels of lipid 
peroxidation products have been found in the brain [Choi et al. 1994], liver [Park et al. 
1996] and skin [Yoshino et al. 1994b] of SAM-P mice. Malonyldialdehyde levels (a 
marker of oxidative damage) are elevated in SAM-P compared with SAM-R brain 
tissue [Nomura et al. 1989].
In accordance with this evidence of increased oxidative damage in SAM-P mice, these 
mice have relatively impaired antioxidant defence mechanisms; for example, in SAM- 
P liver and kidney tissue, mitochondrial SOD activity is lower than in SAM-R mice 
[Zhao et al. 1990, Park et al. 1996]. SAM-P mice also show age-dependent decreases 
in glutathione levels in the brain and liver [Liu and Mori 1993].
Differences in oxidative status between SAM-P and SAM-R mice may play a 
causative role in the accelerated ageing phenotype. The life-span of SAM-P/8 mice 
can be dramatically increased (from forty-two to fifty-six weeks, approximately) by 
intra-peritoneal administration of the free radical scavenger PBN [Edamatsu et al. 
1995]. This prolongation of life-span is associated with an amelioration of their 
oxidative status [Butterfield et al. 1997].
There is therefore good evidence for differences in oxidative status between SAM-P
and SAM-R mice. The shorter telomere length found in SAM-P mice may reflect a
higher degree of oxidative stress in these mice, given the causal relationship between
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increased oxidative stress and accelerated telomere attrition described in Chapter One 
(Section 1.5.4.1). It was suggested there that telomeres may act as sensors of 
cumulative oxidative damage [Serra et al. 2000, Toussaint et al. 2000a]. The shorter 
TRF lengths in SAM-P mice may be evidence of this phenomenon, though if that were 
the case, TRF length might be expected to decrease progressively with increasing 
organismic age.
The relevance of oxidative stress to both cellular and organismic ageing, as well as to 
atherosclerosis, has been discussed in detail in Chapter One. In the absence of clear 
evidence of accelerated cellular senescence in SAM-P mice, an abnormality in their 
oxidative status provides an alternative potential explanation for the observed 
difference in susceptibility to atherogenesis between SAM-P and SAM-R strains.
4.8 Conclusion
To summarize, the findings in this chapter suggest that SAM-P mice are more prone to 
atherogenesis than are SAM-R mice, implying an intrinsic link between organismic 
ageing and susceptibility to atherosclerosis. The difference in susceptibility to 
atherogenesis could not easily be explained by any observed differences in lipid 
profile between the two strains. Telomere and SA-p-gal studies showed differences 
between the two mouse strains, but did not provide conclusive evidence for the in vivo 
occurrence of replicative senescence in these mice. Nevertheless it is noteworthy that a 
strain of mouse with reduced cellular replicative capacity and increased oxidative 
stress shows both accelerated ageing and increased atherogenesis.
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CHAPTER FIVE
Discussion
The overall aim of this thesis has been to explore the relationship between ageing and 
vascular pathophysiology. It was hoped in particular, to shed light on the mechanisms 
through which ageing may predispose to atherogenesis. Since associations have 
previously been postulated between organismic ageing and cellular senescence (as 
discussed in Chapter One, Section 1.4.6) and between cellular senescence and 
atherosclerosis (as detailed in Chapter One, section 1.4.8) it was proposed that cellular 
senescence might provide a mechanistic link between organismic ageing and 
atherosclerosis.
In order to investigate this possibility, it was first necessary to look for firm evidence 
that cellular senescence can occur in the vasculature. To this end, a marker of cellular 
senescence, SA-(3-gal, was employed in a pathological situation -  an artery’s response 
to endothelial denudation -  in which a cellular proliferative response is known to 
occur. Pilot in vitro studies established that this marker could detect senescence 
emerging among cultured vascular cells. Subsequently, use of this assay in the rabbit 
carotid model yielded evidence that endothelial and vascular smooth muscle cell 
senescence can indeed occur in vivo following balloon denudation. The emergence of 
senescent cells was augmented by repetition of the injury.
Since interpretation of these results, and of some of the data from the SAM mouse 
studies, depends heavily on the validity (or otherwise) of SA-p-gal as a marker of 
cellular senescence, it is worth considering at this stage the strengths and weaknesses 
of this assay in some detail, before going on to consider the implications of the results 
described in Chapters Three and Four.
5.1 SA-P-gal as a marker of cellular senescence
5.1.1 Possible weaknesses and limitations
Some of the limitations of SA-p-gal in the identification of senescent cells have 
already been mentioned in Chapter One: certain cell types in certain species do not 
express SA-p-gal when they senesce; conversely other cell types, including adult 
melanocytes, express SA-P-gal irrespective of their replicative status [Dimri et al.
1995].
It has been argued that in some cell types SA-p-gal expression may not necessarily 
indicate the irreversible cell cycle arrest which is the hallmark of cellular senescence.
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Macieira-Coelho has suggested that the expression of this enzyme activity may merely 
reflect a prolonged resting phase in the cell cycle, no matter whether it is reversible or 
irreversible [Macieira-Coelho 1998]. Macieira-Coelho cited his earlier data showing 
that levels of lysosomal enzymes increased during prolonged resting phases of 
fibroblasts in vitro, but decreased soon after stimulation of these quiescent cultures 
[Macieira-Coelho et al. 1971]. He argued that as a result the detection of lysosomal 
enzymes such as (3-gal would be expected to rise during any prolonged non-mitotic 
state, whether reversible or not, and that therefore SA-p-gal activity would be unable 
to distinguish between a reversible and a terminal resting phase.
While this argument seems reasonable in theory (and Macieira-Coelho presented no 
experimental data to prove his contention) other research suggests that at a practical 
level SA-P-gal is in fact able to distinguish between quiescence and senescence. Dimri 
et al. had already shown that SA-p-gal was not detected in cultures which had been 
made quiescent by serum deprivation, even after seven days [Dimri et al. 1995]. 
Furthermore, while low levels of P-gal staining were detectable at pH 6.0 when cells 
were made quiescent by confluence, this staining was less intense than that found in 
senescent cells, and was lost within two days of re-plating; in contrast SA-P-gal 
staining in senescent cells was stronger than in quiescent cells, and was not lost after 
re-plating [Dimri et al. 1995].
Another study has suggested that the expression of SA-p-gal may not be specific to 
replicative senescence, but may be dependent on cell density in culture, or on other 
causes of growth arrest [Severino et al. 2000]. This study confirmed that SA-p-gal 
activity increased in low-density cultures of proliferatively senescent cells; on the 
other hand p-gal activity at pH 6.0 could also be detected in supposedly immortal 
fibroblast cultures which had reached a high cell density, and in low-density, young, 
normal cultures treated with hydrogen peroxide. In the latter two situations, though, 
the presence of SA-p-gal staining may be a manifestation of stress-induced premature 
senescence: cultures with high cell densities may experience culture stress resulting 
from nutrient depletion, while increased oxidative stress in fibroblasts, as well as 
accelerating telomere shortening [von Zglinicki et al. 1995], is also known to 
precipitate SIPS and detectable SA-P-gal activity in these cells [Serrano et al. 1997].
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In the rabbit carotid artery model, it seems unlikely that SA-p-gal activity, in 
endothelial cells at least, might have arisen from contact inhibition, given that these 
cells often neighboured discontinuities in the endothelium. Nevertheless, in this 
model, as with the cell culture experiments described above, the demonstration of SA- 
p-gal staining cannot be taken as unequivocal evidence that cells have reached 
replicative senescence. Instead, as mentioned in Chapter Three (Section 3.2.4.3), cells 
staining for SA-p-gal in the injured artery may have undergone SIPS, as a result of 
alterations in redox status previously shown to occur in balloon-injured arteries [Shi et 
al. 2001]. As discussed in Chapter One, the distinction between replicative and stress- 
induced senescence is becoming increasingly blurred, as it is becoming appreciated 
that these two forms of senescence share several common features and mechanisms, 
and may be regarded as related aspects of a cell’s response to stress [Ben-Porath and 
Weinberg 2004].
5.1.2 Biological rationale for the ability of SA-p-gal to detect senescence
Another potential weakness of SA-P-gal as a marker of replicative senescence has 
been that, until recently, a mechanistic explanation for the effectiveness of the assay 
had not been elucidated. In particular, it was not clear whether SA- P-gal becomes 
detectable at pH 6.0 due to an increased expression of lysosomal p-gal, allowing 
detection of enzyme activity despite measurement at a suboptimal pH, or whether a 
particular senescent isoform of the enzyme, detectable optimally at pH 6.0, is 
expressed in senescent cells. With respect to the latter possibility, it is known that 
alternate splicing of the P-galactosidase molecule can lead to the generation of both 
the classic lysosomal enzyme and a protein similar (but not identical) to this enzyme 
[Morreau et al. 1989].
It has more recently been shown that the increase in SA-P-gal expression in senescent 
cells can in fact be attributed solely to the increase in lysosomal mass within these 
cells [Kurz et al. 2000]. In this study, the intracellular and lysosomal pH levels of 
young and senescent HUVECs were manipulated, and the resultant alterations in p-gal 
activity were studied using flow cytometry. It was found that lysosomal alkalinization, 
together with equilibration of the intracellular milieu to pH 6, caused a profound 
inhibition of the total intracellular p-gal activity. However, no matter what the 
intracellular and lysosomal pH, senescent cells showed levels of p-gal activity
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significantly higher than in young cells. This higher level of activity correlated with 
higher P-gal protein levels. Acridine Orange staining showed an increase in lysosomal 
content with replicative age, which correlated with the rise in P-gal levels. It was 
concluded that SA-p-gal is a manifestation of residual lysosomal activity present at a 
suboptimal pH, which becomes detectable due to the increased lysosomal content of 
senescent cells. The same group have subsequently suggested that the increased 
lysosomal mass in senescent cells may result from an accumulation of autophagic 
vacuoles, in response to an intracellular accretion of non-degradable macromolecules 
and organelles [Erusalimsky and Kurz 2005].
These recent findings may help to explain why SA-p-gal does not appear to be a 
universal marker of cellular senescence, and why, conversely, a few non-senescent 
cells appear to be SA-p-gal-positive. It seems likely that this assay would be of use 
only in those cell types which exhibit increased lysosomal mass when (and only when) 
they undergo senescence. Cells with a constitutively high lysosomal content, such as 
phagocytes, might be expected to show SA-p-gal positivity even in the absence of 
senescence.
The increase in lysosomal content in senescent cells, as manifested by increased SA-p- 
gal staining, is relevant to considerations about the inter-relationship between 
apoptosis and replicative senescence. Lysosomal activation plays a significant role in 
cell death by apoptosis [Lockshin and Zakeri 1996], so a similar accumulation of 
lysosomes in senescent cells suggests a possible overlap between apoptosis and 
senescence. In this context it was notable that in the rabbit studies apoptotic cells did 
not express sufficient lysosomal activity to become SA-P-gal-positive.
DeJesus et al. have measured four different lysosomal enzymes (p-galactosidase, a- 
galactosidase A, p-glucuronidase and acid phosphatase) in young and senescent 
human foetal fibroblasts [DeJesus et al. 2002], and found that while levels of each 
enzyme rose with repeated passages, p-galactosidase showed the least dramatic 
increase of the four enzymes. Thus while a chance of cytochemistry makes it easy to 
assay P-galactosidase activity in vitro and in vivo, detection of other lysosomal 
enzymes may in the future provide more sensitive assays for cell senescence. This in 
itself does not invalidate SA-p-gal as a marker of senescence
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5.1.3 Subsequent use of SA-p-gal to detect ex vivo senescence
At the time the rabbit carotid artery experiments were designed, SA-p-gal had become 
widely adopted as a tool to detect senescent cells in vitro, and was only starting to be 
used in the study of ex vivo tissue. Subsequently its value in the detection of in vivo 
senescence has if anything become increasingly accepted: tissues and organs studied 
include the cornea [Mishima et al. 1999], the prostate [Choi et al. 2000], the breast [te 
Poele et al. 2002], and lymphomatous masses [Schmitt et al. 2002], as well as liver 
and vascular tissue (discussed below); species investigated include mice, rats, rabbits, 
monkeys and humans.
SA-p-gal has been used in a study involving partial hepatectomies in telomerase- 
deficient mice [Satyanarayana et al. 2003]. The ability of the remaining hepatic cells 
to regenerate in vivo was monitored, and it was found that those cells showing SA-P- 
gal activity contained critically shortened telomeres and were unable to proliferate. 
Since its use in the rabbit carotid model, SA-P-gal has gone on to be used in the 
identification of senescent vascular cells in other species. It was employed in the 
detection of senescent ECs in diabetic rats [Chen et al. 2002], and has been used as a 
marker of both in vitro and in vivo human VSMC senescence by Minamino et al. 
[Minamino et al. 2003]; in this study they showed that introduction of a ras allele into 
human VSMCs in culture led to the emergence of a senescent phenotype, including 
large cell size, expression of Cdk inhibitors, and also SA-p-gal-positivity; this effect 
appeared to be mediated via the extracellular signal-regulated kinase (ERK) signalling 
pathway. As will be discussed below, in the same study, the detection of co-staining 
for SA-p-gal and a-smooth muscle actin was taken as evidence of VSMC senescence 
in diseased human arteries.
In conclusion, then, SA-p-gal has become a widely accepted marker of cell 
senescence, whether replicative in origin or stress-induced.
5.2 Implications of vascular cell senescence for human vascular 
pathology
The results described in Chapter Three strongly suggest that endothelial denudation of
rabbit carotid arteries leads not only to a proliferative response, but also to the
emergence of senescent ECs and VSMCs in the vessel wall. It has subsequently
transpired that this finding is not species-specific; SA-p-gal-positive VSMCs also
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emerge in balloon-injured rat carotid arteries [Minamino et al. 2003]; this emergence 
can be enhanced by the introduction into these arteries of activated Ras protein, 
mirroring the promotion of a senescent phenotype in cultured VSMCs by the 
introduction of a ras allele, as mentioned above.
While senescent cells have thus been found in rabbit and rat neointimas, no such cells 
have to date been demonstrated in human arteries following angioplasty, so the 
question of whether human ECs and VSMCs senesce in this situation remains open.
5.2.1 Evidence for EC senescence in human atheroma
As mentioned earlier, however, there is now evidence that cellular senescence occurs 
within human atheromatous lesions. SA-|3-gal-positive ECs have been demonstrated at 
sites overlying atherosclerotic plaques in human aorta [Vasile et al. 2001] and in 
human coronary arteries [Minamino et al. 2002]. In coronary arteries these cells 
appeared flattened and enlarged compared with ECs in non-atheromatous areas, 
further suggesting a senescent phenotype; it has been proposed that the specific 
localization of SA-P-gal-positive ECs to areas of plaque in the human coronary 
arteries may be evidence for a causative role of EC senescence in atherogenesis 
(Minamino et al. 2002].
5.2.2 Evidence for VSMC senescence in human atheroma
Recently the same group has detected SA-p-gal-positive VSMCs in the intima of 
advanced human atherosclerotic lesions [Minamino et al. 2003]; a few SA-P-gal- 
positive VSMCs were also found in the media of these vessels. The senescent intimal 
VSMCs showed p53 immunoreactivity in their nuclei, as well as 
immunohistochemical evidence of ERK activation, and expression of the pro- 
inflammatory cytokine interleukin-ip (IL-lp); in contrast, non-senescent VSMCs in 
the media did not show p53 immunoreactivity or IL-lp expression, and showed only 
occasional evidence of ERK activation [Minamino et al. 2003].
It is worth considering the various pathological implications of the emergence of 
cellular senescence in the arterial wall, in the context of both atherosclerosis and post­
angioplasty re-stenosis.
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5.2.3 Atherosclerosis as an Inflammatory phenomenon
As mentioned in Chapter One, according to the response-to-injury hypothesis, the 
trigger for atherogenesis is a breach in the endothelium; a perpetuation of the insult 
may contribute to the chronicity of the atheromatous lesions. In such a situation, the 
endothelium’s capacity to repair itself is likely to be important, and while several 
extrinsic factors may influence this capacity, an intrinsic limitation of EC proliferative 
activity would be expected to be detrimental. Conversely, replicative senescence in 
VSMCs might be expected to limit the extent of intimal hyperplasia seen in 
atherosclerotic lesions, while also retarding formation of the fibrous cap.
In addition, though, the pathological consequences of vascular cell senescence in 
atherogenesis may extend beyond die limitation senescence imposes on cellular 
proliferation; the altered functional capacity of senescent cells may also have 
important deleterious consequences. In order to assess these effects, it is necessary to 
consider in more detail the contribution of inflammation to atherogenesis.
Various lines of evidence strongly suggest a significant role for an inflammatory 
process in the development of atherosclerotic lesions [Libby 2002]. As has been 
mentioned, blood leukocytes adhere to the endothelium early in atherogenesis. This 
process is mediated by VCAM-1 [Cybulsky and Gimbrone 1991], and the expression 
of VCAM-1 by ECs appears to result from an inflammatory process in the arterial 
intima instigated by inflammatory cytokines including IL-lp and TNF-a, as well as by 
oxidized lipoproteins [Khan et al. 1995, Collins and Cybulsky 2001]. The recruitment 
of monocytes across the endothelium is then promoted by MCP-1 [Boring et al. 1998], 
and interleukin-8 [Boisvert et al. 1998], while lymphocytes are attracted by 
chemokines induced by IFN-y [Mach et al. 1999]. Macrophages promote 
inflammation in the atheromatous plaque via the production of the pro-oxidant agent 
hypochlorous acid [Sugiyama et al. 2001], and can produce MMPs [Saren et al. 1996] 
which may contribute to plaque instability. MMPs are also produced by ECs and 
VSMCs, and this production is augmented by inflammatory mediators such as IL-lp, 
TNF-a and CD 154; plaque instability may also be promoted by pro-inflammatory 
cytokines such as IFN-y, which can inhibit collagen production by VSMCs [Libby and 
Aikawa 2002]. Thus, in the inflammatory environment, not only does destruction of 
the collagenous matrix increase, but the laying down of new collagen is also impaired.
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There is now ample evidence to suggest that the development of cellular senescence in 
ECs and VSMCs renders them pro-inflammatory, and this alteration in their phenotype 
may therefore confer on them a pro-atherogenic role.
5.2.4 Pro-inflammatory properties of senescent ECs
It has been mentioned earlier that senescent ECs in vitro show increased expression of 
IL -la [Maier et al. 1990] and ICAM-1 [Maier et al. 1993], both of which are over­
expressed in atherosclerotic lesions [Moyer et al. 1991, van der Wal et al. 1992], and 
both of which promote the adherence of inflammatory cells to the endothelial surface 
[Bevilacqua et al. 1985, van der Wal et al. 1992].
In addition, senescent human ECs demonstrate reduced eNOS activity [Minamino et 
al. 2002]. NO produced by the normal endothelium is believed to have a variety of 
anti-inflammatory and anti-atherogenic properties (including the inhibition of 
monocyte adhesion, P-selectin expression, and MCP-1 expression [Busse and Fleming
1996]) so the appearance of senescent ECs in an atheromatous lesion might lead to the 
loss of this protective effect.
5.2.5 Pro-inflammatory properties of senescent VSMCs
Turning to VSMCs, there is evidence that in atheromatous lesions these cells develop 
an inflammatory phenotype associated with the emergence of replicative senescence. 
During atherogenesis, VSMCs are involved in fibrous cap formation, and the presence 
of this cap is thought to contribute to plaque stability. It is possible that a loss of 
normal VSMC function accompanying the onset of senescence may affect their ability 
to maintain the stability of the fibrous cap. This loss of normal function may simply 
lead to an inability of VSMCs to align themselves normally within the vessel wall, as 
discussed in Chapter Three (Section 3.2.4.3). In addition, though, other changes in 
VSMC function may be relevant. It is thought that the fibrous cap becomes more 
susceptible to rupture as a result of the depletion of matrix components by various 
matrix-degrading enzymes, such as proteinases and cystine and aspartate proteases 
[Shah 2003]. VSMCs are normally capable of synthesising extracellular matrix, and a 
decline in this function with senescence may contribute to plaque instability.
The Ras-induced senescence of cultured VSMCs, mentioned earlier, is associated with 
increased expression of pro-inflammatory cytokines and chemokines including IL-la, 
IL-lp, interleukin-6 (IL-6) and MCP-1 [Minamino et al. 2003]. The expression of IL-
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IP by intimal VSMCs in human atheromatous lesions (mentioned earlier) may have 
important consequences for both lesion formation and the development of plaque 
instability. Both these processes involve remodelling of the extracellular matrix and 
the degradation of elastin. Various enzymes have been implicated in this context, and 
these include MMPs, serine proteinases and, more recently, cysteine proteinases 
including cathepsins K and S. Cathepsins are lysosomal enzymes which can also 
function extracellularly, and which, at least in culture, are employed by macrophages 
to degrade extracellular elastin [Reddy et al. 1995]. Since macrophages and VSMCs 
with greatly expanded lysosomal compartments are found in atherosclerotic plaques 
[Sukhova et al. 1998], it seems reasonable to postulate that these cells may secrete 
increased levels of cathepsins, and that these may be involved in extracellular matrix 
degradation. Indeed, immunohistochemical studies of human atheromatous lesions 
have demonstrated that intimal VSMCs, especially those appearing to traverse the 
IEL, contain cathepsins K and S, while VSMCs in normal arteries contain little or no 
cathepsin K or S [Sukhova et al. 1998]. The same group has also found evidence of 
co-localization of cathepsin S with ECs in human atheroma [unpublished data, referred 
to in Sukhova et al. 2003]. In this context it is noteworthy that Western blotting 
studies have shown a dramatic up-regulation of another cathepsin, cathepsin B, in 
senescent (compared with pre-senescent) HUVECs [Kamino et al. 2003].
More recently, it has been found that when LDL receptor-deficient mice were cross­
matched with cathepsin S-deficient mice, the progeny showed reduced susceptibility 
to atherogenesis compared with LDL receptor-deficient mice possessing normal 
cathepsin S activity [Sukhova et al. 2003]. This reduced susceptibility in cathepsin S- 
deficient mice was associated with dramatic reductions in the numbers of 
macrophages, VSMCs, and lymphocytes in the intima, as well as in the intimal content 
of lipid, collagen and IFN-y.
Furthermore, when VSMCs in culture were stimulated with either IL-1 p or IFN-y, they
secreted activated cathepsin S, and degraded substantial quantities of insoluble elastin
[Sukhova et al. 1998]. Thus there is evidence not only that VSMCs in atheromatous
lesions contain cathepsins K and S, but that these enzymes can be used by VSMCs to
degrade elastin. It has been mentioned above that senescent VSMCs both in culture
and in atheromatous lesions show increased expression of IL-lp [M inamino et al.
2003]. One might conclude that senescent VSMCs in atheromatous lesions, through
221
increased expression of IL-lp, may stimulate the secretion of cathepsins from 
neighbouring VSMCs, and that this may lead to degradation of the surrounding 
extracellular matrix, resulting in remodelling of the vessel wall and/or plaque 
instability.
The co-localization of IL-lp with SA-P-gal activity in intimal VSMCs [Minamino et 
al. 2003], and the fact that both p-galactosidase and cathepsins are lysosomal 
enzymes, together suggest close links between IL-lp expression, senescence (with its 
concomitant increase in lysosomal mass and therefore expression of SA-P-gal activity) 
and the production of cathepsins; the mechanisms underlying this association remain 
uncertain though. The work of Minamino et al. [Minamino et al. 2003] suggests that 
pro-inflammatory signals can trigger both VSMC senescence and IL-lp expression, 
but it remains unclear whether the expression of IL-lp leads to the development of 
senescence and an expansion of the lysosomal mass (and therefore increased cathepsin 
production), or whether increased IL-ip expression itself results from the senescence 
of these cells.
The pro-inflammatory properties of senescent ECs and VSMCs may provide one link 
in a possible vicious circle of processes involved in the initiation and propagation of 
atherogenesis. It has been mentioned in Chapter Three (Section 3.2.4.3) that NAD(P)H 
oxidase is a major enzymatic source of intracellular ROS in vascular cells [Pagano et 
al. 1995]. It transpires that hypercholesterolaemia in general [Stokes et al. 2001] and 
OxLDL in particular [Rueckschloss et al. 2001] are able to stimulate the generation of 
ROS via induction of endothelial cell NAD(P)H activity; superoxide generated in this 
way can then promote the adhesion of leukocytes to endothelial cells [Stokes et al. 
2001]. Similarly, NAD(P)H activity can mediate TNF-a-induced endothelial cell 
production of superoxide [Li et al. 2002]. If the production of ROS by the 
endothelium, in response to either OxLDL or pro-inflammatory cytokines, then leads 
to the emergence of SIPS in the vessel wall, and if the emerging senescent cells 
themselves have pro-inflammatory properties, the resultant inflammatory response 
may further increase ROS generation, perpetuating the cycle.
5.2.6 Putative role of EC senescence in an artery’s response to injury
Turning to post-angioplasty re-stenosis, the pathology of this phenomenon has often
been studied using endothelial denudation models. These models are not ideal, though:
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while angioplasty in clinical practice involves the inflation of a balloon in a localized 
segment of diseased artery, denudation models usually involve repeatedly drawing an 
inflated balloon along a segment of previously healthy artery. Despite this 
discrepancy, these models have suggested mechanisms through which cellular 
senescence could play a role in this clinically important pathological entity.
It has been postulated that a failure of re-endothelialization following luminal injury in 
rabbit arteries may be attributable directly to the emergence of EC senescence [Reidy 
et al. 1983]. Furthermore, as discussed in Chapter Three (Section 3.2.4.2) there is also 
evidence that a failure of re-endothelialization promotes neointima formation [Hutter 
et al. 2003], and that this effect may be mediated via a decline in NO synthesis by ECs 
[Dzau et al. 2002]. The demonstration in Chapter Three of rabbit EC senescence 
following balloon injury, combined with the known decline in eNOS activity in 
senescent human ECs [Minamino et al. 2002], suggests that human ECs may also 
senesce after denudation injuries (such as angioplasty), and that if they do, their 
senescence may promote neointimal formation via decreased eNOS expression.
5.2.7 Putative role of VSMC senescence in an artery’s response to injury
The demonstration of VSMC senescence may similarly have consequences in the 
context of post-angioplasty re-stenosis. Here, however, the onset of VSMC senescence 
might be expected to be beneficial, limiting the degree of intimal hyperplasia by acting 
as a brake on VSMC proliferation. The situation may not be so straightforward, 
though. Matrix-degrading enzymes, in addition to their supposed role in atherogenesis 
discussed above, are thought to play an essential role in neointima formation following 
luminal injuries, by remodelling the extracellular matrix and permitting VSMC 
migration into the developing neointima [Zempo et al. 1996, Dollery et al. 1999, 
Johnson et al. 2001b]. As was argued above, in the context of atherogenesis, it seems 
reasonable to suspect that the expression of IL-1(3 by senescent VSMCs in the 
neointima of injured vessels may stimulate neighbouring cells to secrete matrix- 
degrading enzymes; the resultant breakdown of extracellular matrix may allow 
enhanced migration of other, non-senescent, VSMCs into this layer, accelerating 
neointima formation.
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5.2.8 Potential widespread effect of a small number of senescent cells
It was notable in the current study that even in double-denudation vessels only a small 
proportion of the cross-sectional area of the vessel wall was occupied by SA-p-gal- 
positive cells. This finding might appear to cast doubt on the pathological significance 
of in vivo senescence in this situation. On the other hand, a few points are worth 
considering in this respect.
Firstly, the number of senescent cells in the vessel wall may be greater than suggested 
by the percentage areas provided; it is possible that more senescent cells had emerged 
in the six weeks following the injury, but that a proportion had been ‘lost’, either 
through shedding into the vessel lumen (while the animal was still alive, or during the 
harvesting process) or through a physiological process such as apoptosis (though no 
evidence was found of senescent cells undergoing apoptosis in this study); also, the 
neointima is known to contain acellular areas filled with extracellular matrix, and the 
existence of such areas would mean that the reported percentage areas were 
underestimates of the proportion of neointimal cells staining for SA-p-gal.
Secondly, because of the alteration in function known to occur in senescent cells, the 
significance of the presence of such cells may be out of proportion to the number of 
cells present. Thus if senescent cells do synthesize and release inflammatory 
mediators, adhesion molecules and matrix-degrading enzymes, a small number of 
these cells could have important influences on a much larger number of pre-senescent 
cells in their vicinity.
In summary, there is ample evidence to suggest that the emergence of senescent 
vascular cells could have pathophysiological consequences, either during the evolution 
of atheromatous lesions or during neointima formation following denudation injuries 
and angioplasty.
5.3 Organismic and cellular ageing, and atherogenesis
5.3.1 Accelerated ageing and atherogenesis
Having established that vascular cells can senesce in vivo, and having considered the 
various pathological implications of this finding, attention turned to the question of 
whether the emergence of vascular cell senescence could explain the association 
between organismic ageing and an increased susceptibility to atherosclerosis.
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Clinical, pathological and experimental evidence suggests that ageing is an 
independent risk factor for atherosclerosis (as discussed in Chapter One, Section 1.2.3) 
and does not exert its influence solely through a more prolonged exposure of the 
organism to various pro-atherogenic factors (such as smoking and 
hypercholesterolaemia). Another explanation for the apparent effect of ageing on 
atherogenesis must therefore be sought. The SAM model was employed to look for 
evidence of increased cellular senescence in the context of abnormal organismic 
ageing, and to investigate whether abnormalities in either cellular or organismic 
ageing were associated with a predisposition to atherogenesis.
In these studies, it was found that mice which age at an accelerated rate (SAM-P mice) 
develop more extensive lipid lesions in their aortic roots than do a related strain 
(SAM-R mice) which age at a normal rate; the more extensive lipid lesions in SAM-P 
mice develop despite these mice having a lower serum cholesterol, and an equivalent 
HDL/total cholesterol ratio, compared with SAM-R mice. These data support the 
contention that accelerated organismic ageing predisposes to atherogenesis.
53.2 Lack of evidence for enhanced replicative senescence in SAM spleen, 
skin and aorta
As detailed in Chapter Four (Section 4.7.3.3) previous research has suggested 
differences in the in vitro replicative capacity of cells derived from either SAM-P or 
SAM-R mice, and it was expected that SAM-P cells might be more prone to 
senescence than their SAM-R counterparts. In fact the telomere and SA-p-gal studies 
described in Chapter Four showed no convincing evidence of accelerated cellular 
senescence in SAM-P mice. There were differences in telomere length and SA-p-gal 
staining between SAM-P and SAM-R mice, but these differences were found in young 
mice, and did not become any more accentuated as the mice of the two strains aged. 
Thus while telomeres were shorter in SAM-P than SAM-R mice, on average the 
telomere length of each strain appeared to remain constant, whatever the age of the 
mice. As discussed in Chapter Four, the very great length of murine telomeres 
suggests that senescence of murine cells is likely to occur via mechanisms other than 
telomere shortening; furthermore, the apparent lack of age-related shortening of SAM 
telomeres now suggests that telomere attrition is not aetiologically involved in the 
accelerated ageing of SAM-P mice. On the other hand, because of the limitations of
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TRF analysis, the current study does not exclude the possibility that individual 
telomeres might have shortened beyond a critical length as the SAM strains aged.
The absence of any age-related accumulation of SA-(3-gal-positive cells in the skin or 
aortas of SAM-P mice again argues against a predisposition to cellular senescence in 
SAM-P mice. Thus although dermal fibroblasts from SAM-P mice have a reduced in 
vitro replicative potential compared with equivalent cells from SAM-R mice 
[Hosokawa et al. 1994], the absence of progressive SA-p-gal staining in SAM-P skin 
suggests that in vivo these cells do not undergo sufficient rounds of proliferative 
activity to exhaust their replicative potential. The only SA-p-gal staining seen in 
SAM-P skin was located in sebaceous and eccrine glands, areas where, in human skin, 
such staining has been shown to be a non-specific (i.e. not senescence-related) finding 
[Dimri et al. 1995]; this staining was also found in young SAM-P mice, again 
suggesting that it is not a senescence-related phenomenon.
5.33 Possible interactions between telomere shortening and atherogenesis
It was proposed earlier that accelerated EC senescence may promote atherogenesis, as
it may impair the endothelium’s capacity for self-repair following a breach in its
integrity. In fact the results of a recent study employing a genetically manipulated
murine model suggest that short telomeres are associated with protection from diet-
induced atherosclerosis [Poch et al. 2004]. Mice doubly deficient in apoE and
telomerase RNA (TR) were compared with apoE-deficient mice expressing TR. The
doubly deficient mice experienced greater telomere attrition but reduced
atherosclerosis compared with mice expressing TR. It appeared that the reduced
atherosclerosis was attributable to diminished proliferative capacity of both
lymphocytes and macrophages. In other words, in this situation the development of
replicative senescence in immune cells led to impaired atherogenesis, supporting the
notion that atherogenesis relies on normal proliferative function in immune cells.
Conversely, though, in a small pilot study looking at TRF lengths in leukocytes from
human subjects, the white cells of individuals with severe coronary artery disease
contained TRFs approximately 300 bp shorter than those of age-matched controls, and
equivalent in length to those of individuals with no coronary artery disease who were
nearly nine years older [Samani et al. 2001]. This result appears to be at variance with
the inferences drawn from the findings of Poch et al. mentioned above. The two
studies can be reconciled, though, if it is postulated that atherogenesis requires
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adequate proliferative activity of immune cells, but that the process of lesion 
formation itself exhausts the replicative potential of these cells. In the case of the SAM 
mice, it appears that the substrain with shorter splenic cell telomeres is in fact more 
prone to atherogenesis, though, as discussed, the difference in telomere length between 
the strains does not appear to reflect a predisposition to cellular senescence in the 
SAM-P mice.
5.3.4 Oxidative stress and atherogenesis in SAM mice
The lack of evidence for cellular senescence in SAM-P aortas implies that the 
demonstrated susceptibility of SAM-P mice to atherogenesis is not attributable to such 
a phenomenon. Instead other aetiologies must be sought. Evidence detailed in Chapter 
Four (Section 4.7.3.3) [Nomura et al. 1989, Zhao et al. 1990, Choi et al. 1994, 
Nakamoto et al. 1994, Yoshino et al. 1994b, Park et al. 1996, Butterfield et al. 1997] 
points to abnormalities in the oxidative status of SAM-P mice. Given the proposed 
role of oxidative stress in the development of atheromatous lesions [Steinberg 1995] 
discussed in Chapter One (Section 1.5.5), together with the higher levels of lipid 
peroxides found in SAM-P compared with SAM-R thoracic aortas [Yagi et al. 1995], 
it is tempting to attribute the relative athero-susceptibility of SAM-P mice to the 
known abnormalities in their redox status. Similarly, if the accelerated ageing of 
SAM-P mice is not attributable to enhanced replicative senescence in this strain, and 
given the proposed links between oxidative stress and shortened organismic life-span 
discussed in Chapter One (Section 1.5.3), it seems plausible that the high oxidative 
stress in SAM-P mice may also contribute to their accelerated organismic ageing.
5.3.5 Other possible interactions between organismic ageing and atherogenesis
The nature of the relationship between ageing and atherosclerosis has been discussed 
in some detail in Chapter One. It was suggested that atherosclerosis cannot be 
regarded merely as an intrinsic manifestation of the ageing process (as one might 
regard, for example, the emergence of wrinkled skin) (Chapter One, Section 1.2.2). 
The central argument in this respect is that there are human populations which age 
without developing appreciable levels of atherosclerosis, suggesting that ageing and 
atherosclerosis are not inextricably linked. On the other hand, there is also ample 
clinical evidence that ageing is a risk factor for atherosclerosis, and indeed that it
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exerts its effect independently of other known risk factors such as smoking and 
diabetes mellitus (Chapter One, Sections 1.2.2 and 1.2.3).
Furthermore, evidence is emerging which suggests mechanisms through which 
organismic ageing may exert its influence on atherogenesis. Merat et al. fed a high-fat 
diet to young and old LDL receptor-deficient mice, and found that, despite similar 
plasma cholesterol levels in both groups, the older mice developed more severe aortic 
atherosclerotic lesions than did younger mice [Merat et al. 2000]. This greater degree 
of atherogenesis was associated with a higher level of VCAM-1 expression in the 
older mice. In the same study, VCAM-1 expression was also found to rise with age in 
C57BL/6 mice fed a normal diet, despite there being no age-related increase in plasma 
cholesterol in these mice. Thus, in more than one strain of mouse there appears to be 
an age-dependent increase in VCAM-1 expression which is not related to plasma 
cholesterol levels. This increased expression of VCAM-1 may render the older mice 
more susceptible to atherogenesis by promoting leukocyte adhesion to the 
endothelium.
Other mechanisms through which ageing may lead to increased susceptibility to 
vascular disease have been investigated in non-human primates [Wang et al. 2003]. 
During the development and progression of experimental atherosclerosis in young 
animals, matrix metalloproteinase-2 (MMP-2) is activated, and angiotensin II 
signalling is increased. Wang et al. therefore studied the levels of MMP-2, angiotensin 
II and angiotensin-converting enzyme (ACE) in the aortic walls of young and old 
monkeys. Aortas from the older animals had thickened intimas, as a result of increased 
numbers of VSMCs and more abundant matrix, compared with vessels from younger 
animals. The older vessels contained elevated levels of intimal MMP-2 activity; 
intimal angiotensin II and ACE immunofluoresence also increased, and co-localized 
with MMP-2. Thus mechanisms involved in experimental atherosclerosis also 
appeared to operate in the ageing arterial wall. They may therefore render the ageing 
vessel wall more prone to the development of atherosclerosis.
5.3.6 Organismic ageing: an active or a passive process?
In Chapter One (Section 1.2.3) various teleological ‘explanations’ for the concept of 
ageing were discussed. According to these theories ageing is a passive phenomenon, a 
design redundancy occurring as a by-product of the evolutionary imperative that 
genetic information must be passed from generation to generation with maximal
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stringency. According to a more pragmatic argument, biological ageing can perhaps be 
regarded as the inevitable consequence of processes which proceed relentlessly with 
the passage of time, and which occur as a direct consequence of the nature of 
organismic biology and of the environment in which these organisms live. Thus one 
could argue that replicative senescence and oxidative stress, for example, are 
unavoidable, and indeed carry some benefit for the organism.
Replicative senescence can be regarded as essentially inevitable in the following 
respect: telomeres, in the absence of telomerase activity, are bound to shorten with 
rounds of cellular replication due to the end-replication problem [Olovnikov 1973, 
Levy et al. 1992]; it appears that after a certain degree of telomeric shortening has 
been achieved, a signal is triggered which prevents further cellular replication and 
therefore further loss of DNA. One resultant beneficial aspect of replicative 
senescence is that it provides a mechanism through which cells cease to divide before 
their chromosomal DNA is damaged, reducing the risk of cells with altered DNA 
passing on genetic defects to daughter cells. Indeed, it has been postulated that cell 
senescence may have evolved specifically as a mechanism for the suppression of 
tumour formation [O’Brien et al. 1986]. Alternatively, it has been suggested that 
senescence may have developed as a tool for fine-tuning tissue modelling during 
development [Martin 1993] and that the accompanying tumour-suppressor effect may 
be a felicitous incidental process.
Turning to oxidative stress, it has been mentioned that normal metabolic reactions 
occurring in our aerobic environment lead to the generation of ROS (Chapter One, 
Section 1.3.2.5). As well as their potentially deleterious effects, ROS and other free 
radicals are believed to play various physiological roles (such as redox-mediated 
amplification of immune responses, redox regulation of cell adhesion, and activation 
of various receptor-mediated signalling pathways) as part of normal biological 
function [reviewed in Droge 2002]. In the cardiovascular system, ROS, and in 
particular superoxide ions, are thought to play a role in the vasculature’s ability to 
sense hypoxia, and may also be involved in the regulation of vascular tone [reviewed 
in Li and Shah 2004]. Thus ROS generation may, like replicative senescence, be 
regarded as an unavoidable, and potentially beneficial phenomenon.
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Replicative senescence and the generation of ROS, then, appear to proceed inexorably, 
and to have beneficial consequences in the healthy development and life of the 
organism.
5.3.7 Processes linking cellular and organismic ageing with atherosclerosis
It is possible to construct a network of processes involved with atherogenesis and 
ageing, as illustrated in Figure 5.1 overleaf. As shown, certain processes, including 
replicative senescence and ROS generation, may be involved both in ageing of the 
organism and in atherogenesis. This raises the possibility that certain clearly defined 
cellular and molecular processes contribute to ageing and atherosclerosis as two 
separate manifestations, rather than that the somewhat intangible concept of ageing 
exerts an actual biological influence on the histological and functional changes leading 
to atherogenesis.
5.4 Future experiments
5.4.1 Carotid denudation model
Future experiments may provide interesting insights into the nature of the network 
illustrated, and help to establish whether there is indeed a causal link between ageing 
and atherosclerosis.
The rabbit carotid denudation model provides the opportunity to study the 
consequences of mechanical injury in a species which can develop atheromatous 
lesions when fed a high-cholesterol diet [Orlandi et al. 2000]. It is known that 
prolonged administration of such a diet to rabbits results in focal areas of increased EC 
and VSMC replication in their aortas; leukocyte adhesion to these areas has also been 
demonstrated [Walker et al. 1986]. It seems reasonable to expect that this promotion 
of EC and VSMC replication may bring these cells closer to the limit of their 
replicative potential. It would therefore be interesting to repeat the rabbit denudation 
study after administration of a high-cholesterol diet; if the replicative potential of ECs 
and VSMCs has been partially expended prior to the denudation injury as a result of 
hypercholesterolaemia, one might predict an acceleration of the emergence of 
replicative senescence in the vessel wall.
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Figure 5.1 Network of processes associated with atherosclerosis and 
ageing
Triggers
H ypercholestero laem ia
M echan ical injury
Inflam m ation
ROS generationCell p roliferation
C ell senescence
?
A therogenesisO rganism ic ageing
Figure 5.1 shows a network of processes associated with atherosclerosis, 
organismic ageing and cellular senescence. Hypercholesterolaemia, 
mechanical injury and inflammation have been grouped together as triggers 
which may, individually or in combination, initiate processes such as ROS 
generation and atherogenesis. The potential for positive feedback is 
exemplified by the putative cycle involving inflammation, ROS generation 
and cell senescence, discussed on page 222. It is notable that some 
processes which have been proposed to contribute to organismic ageing are 
also thought to be involved in atherogenesis. The network is not intended to 
be a comprehensive depiction of all the possible associations between the 
processes shown. The symbol ?  represents the uncertainty concerning the 
nature of the association between organismic ageing and atherosclerosis. 
Abbreviation: ROS = reactive oxygen species.
Furthermore, since diet-induced hypercholesterolaemia can lead to oxidative DNA 
damage in the arterial wall [Martinet et al. 2001], hypercholesterolaemia in the rabbit 
denudation model might also lead to an acceleration of SIPS in vascular cells, and to a 
further augmentation of SA-p-gal activity.
Conversely, if the experiments of Chapter Three were to be performed in rabbits 
previously given dietary antioxidants, one might expect an attenuation of the 
development of SA-p-gal-positive cells, since there should be a reduction in SIPS. 
Various studies have suggested a beneficial role of antioxidants in reducing intimal 
hyperplasia following denudation injuries. Thus probucol reduced luminal loss after 
percutaneous transluminal coronary angioplasty (PTCA) in humans [Tardif et al.
1997], while SOD abolished the early tonic vasoconstriction after coronary balloon 
injury in dogs [Laurindo et al. 1991]. Similarly, vitamin E inhibited the intimal 
thickening seen following catheter injury of carotid arteries in cholesterol-fed rabbits 
[Konneh et al. 1995].
One might speculate that the reduction in intimal thickening brought about by 
antioxidants may be mediated by an effect on cellular replicative activity. In theory, 
administration of an antioxidant might lead to a prolongation of EC replicative 
capacity, and this might improve the endothelium’s capacity to repair itself completely 
following injury; this in turn might be expected to reduce the degree of VSMC 
proliferation, given the finding of Stemerman et al. that early re-endothelialization 
inhibits VSMC proliferation [Stemerman et al. 1977].
It would also be informative to repeat the arterial denudation experiment in older 
rabbits, using young rabbits as a control. The rabbits used in the present study were 
sixteen to seventeen weeks old. In rabbits nearer to the end of their natural life-span, 
some cellular turnover may have occurred in the vessel wall during their lifetime, 
albeit at a low rate; the cells in the denuded vessel walls of these older animals might 
therefore be nearer to their replicative limit, and so the emergence of senescent cells 
might be more pronounced.
In these studies it would also be useful to study other potential markers of cellular 
senescence. SA-(3-gal has now gained such acceptance as a marker of senescence that 
it has recently been used as a standard indicator of senescence in the evaluation of 
other putative markers of this cellular state [Kwak et al. 2004]. Nevertheless, as the 
validity of SA-p-gal as a marker of replicative senescence has been open to debate, it
232
would be helpful to look for other evidence that SA-(3-gal-positive cells in the denuded 
arterial wall are indeed senescent. The suspected roles of the Cdk inhibitor pi 6 and of 
an alternative product of the INK4a gene locus, ARF, in the initiation of human and 
murine cell senescence, have been mentioned in Chapter One (Section 1.4.4.4). p i6 
appears to be involved in both replicative and stress-induced senescence, 
predominantly in humans cells; ARF on the other hand appears mainly to mediate 
stress-induced senescence, certainly in murine cells, and possibly in human cells 
[Itahana et al. 2004]. High levels of p i6 have been found to co-exist with short 
telomeres in myocytes from the hearts of elderly patients with systolic heart failure, 
while raised levels of p i6 and ARF have been shown to correlate with SA-p-gal 
activity in various rodent cells [Krishnamurthy et al. 2004]. Immunohistochemical 
detection of these proteins in the rabbit carotid neointima would provide further 
evidence of senescence in the vasculature.
The relationship between VSMC senescence and the production of cathepsins also 
warrants further investigation. While it is known that stimulation of VSMCs with IL- 
ip leads to increased production of activated cathepsin S [Sukhova et al. 1998], and 
while stimulation of VSMCs with Ras protein leads to senescence and the expression 
of IL-lp [Minamino et al. 2003], it is not as yet known whether VSMC senescence 
itself leads to increased production of cathepsin S. This could be investigated by 
growing VSMCs to senescence in culture, and then detecting cathepsins by Western 
blot analysis of cell lysates. One previous study of cathepsin activity in proliferating 
human fibroblasts has in fact shown a decline in lysosomal cathepsin activity as these 
cells senesced [Sitte et al. 2000], while another study has shown that cathepsin activity 
in human retinal pigment epithelial cells rises with increasing donor age [Verdugo and 
Ray 1997]. It is therefore not easy to predict the relationships between VSMC 
cathepsin activity and cellular ageing.
5.4.2 SAM model
The SAM model provides the opportunity to control for the presence of an ageing 
phenotype, by concomitant study of SAM-P and SAM-R strains. A weakness of the 
model is that the genetic differences between the two strains have not been fully 
elucidated. In order to gain more insights from this model into the aetiology of the 
ageing phenotype and into the increased susceptibility of SAM-P mice to
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atherogenesis, it would be helpful to carry out a fuller characterization of the genetic 
differences between SAM-P and SAM-R mice.
As mentioned in Chapter Four, it would also be useful to repeat the atherogenesis 
experiment using a higher-cholesterol diet, in order to look for evidence of more 
advanced lesion formation. On the other hand, any findings from an experiment using 
a diet even less physiological than the Westem-type diet might arguably give less 
reliable results.
The experiments of Poch et al. in which apoE-deficient mice were cross-matched with 
telomerase-deficient mice [Poch et al. 2004] have been described above. An 
equivalent experiment would involve cross-matching SAM-P mice and SAM-R mice 
with apoE-deficient mice. Cross-matching apoE-deficient mice with SAM-P mice 
would allow the study of the effect of imposing a senescent phenotype onto a murine 
strain itself susceptible to atherosclerosis, while the cross-match with SAM-R mice 
would provide a control. SAM-P/apoE-deficient cross-matches might be expected to 
have shorter telomeres than SAM-R/apoE-deficient mice, and it would be interesting 
to observe the effect of this difference on the relative susceptibility of each cross­
matched strain to atherogenesis: while the findings of Poch et al. suggest that those 
mice with a senescent phenotype (and containing cells of decreased replicative 
capacity) should be relatively protected against atherogenesis (owing to the emergence 
of immunosenescence), the results described in Chapter Four suggest that the ageing 
phenotype of SAM-P mice might in fact render the SAM-P/apoE-deficient cross­
matches more prone to atherogenesis than SAM-R/apoE-deficient mice. The findings 
might help to shed light on the relative influences of immunosenescence and other 
aspects of the ageing process (such as altered oxidative status) on an organism’s net 
susceptibility to atherogenesis.
The telomere study described in Chapter Four provided only preliminary data 
concerning telomere length in SAM splenic cells. It would be interesting to extend this 
study to other cell types, and to look in more detail for any evidence of telomeric 
shortening in cells taken from older mice. Alternative methods for telomere length 
measurement, such as FACScan analysis, could be useful in this respect. Similarly, 
measurement of telomerase activity in SAM mice may well provide valuable insights 
into the relevance of telomere dynamics in murine ageing.
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It has been mentioned earlier that administration of the free radical scavenger PBN to 
SAM-P mice can prolong their life-span [Edamatsu et al. 1995], suggesting an 
aetiological role for free radicals in the SAM-P ageing phenotype. It would be 
interesting to explore whether administration of PBN could attenuate the development 
of atheromatous lesions in SAM-P mice, and whether or not it would abolish the 
disparity in telomere length between SAM-P and SAM-R mice.
It would also be interesting to perform endothelial denudation experiments in SAM 
mice. The fact that SAM-P cells appear to be more prone to replicative senescence, 
and that SAM-P tissues show increased levels of oxidative stress, may have interesting 
influences on neointimal development and re-endothelialization in this model. The 
results are difficult to predict, as the effect of ageing on neointima formation is not 
entirely clear-cut. Thus in one study, injury to rat aortas led to significant neointima 
formation in young rats, but not in old rats [Chajara et al. 1998], while in another 
study, aortas from older rats responded to injury with an exaggerated proliferation of 
SMCs compared with aortas from younger animals [McCaffrey et al. 1988].
5.4.3 Human studies
In terms of human studies, the natural successor to the rabbit denudation study would 
be to look for evidence of senescence in human neointima. This might be possible by 
the study of tissue removed during certain PTCA procedures, carotid endarterectomies 
and aortic aneurysm repairs, or perhaps by using post-mortem samples. In terms of 
atherosclerosis, the studies of Minamino et al. [Minamino et al. 2002 and 2003] could 
be systematically repeated in adults of various chronological ages, in order to assess 
the effect of organismic ageing on SA-p-gal positivity in human atheromatous 
plaques.
5.5 Conclusion
In conclusion, the studies described in this thesis suggest that there are intimate links 
between certain biological processes, including replicative senescence and the damage 
caused by oxidative stress, which may be involved both in atherogenesis and in 
organismic ageing. While ageing appears to be an independent risk factor for 
atherosclerosis, it also seems plausible that the ageing phenotype and the development 
of atherosclerosis may emerge as two concomitant pathological end-points of these 
biological processes.
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